4hnp:E (LYS61) to (ILE181) CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH VINYLKETONE CARMAPHYCIN ANALOGUE VNK1 | PROTEASOME, INHIBITOR, CARMAPHYCIN, EPOXYKETONE, VINYLKETONE, HYDROLASE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4hnp:I (LYS41) to (ASP177) CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH VINYLKETONE CARMAPHYCIN ANALOGUE VNK1 | PROTEASOME, INHIBITOR, CARMAPHYCIN, EPOXYKETONE, VINYLKETONE, HYDROLASE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4hnp:J (LYS34) to (LYS170) CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH VINYLKETONE CARMAPHYCIN ANALOGUE VNK1 | PROTEASOME, INHIBITOR, CARMAPHYCIN, EPOXYKETONE, VINYLKETONE, HYDROLASE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4hnp:L (LYS42) to (ARG194) CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH VINYLKETONE CARMAPHYCIN ANALOGUE VNK1 | PROTEASOME, INHIBITOR, CARMAPHYCIN, EPOXYKETONE, VINYLKETONE, HYDROLASE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4hnp:M (ARG41) to (THR168) CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH VINYLKETONE CARMAPHYCIN ANALOGUE VNK1 | PROTEASOME, INHIBITOR, CARMAPHYCIN, EPOXYKETONE, VINYLKETONE, HYDROLASE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4hnp:N (LYS33) to (ASN141) CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH VINYLKETONE CARMAPHYCIN ANALOGUE VNK1 | PROTEASOME, INHIBITOR, CARMAPHYCIN, EPOXYKETONE, VINYLKETONE, HYDROLASE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4hnp:S (LYS61) to (ILE181) CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH VINYLKETONE CARMAPHYCIN ANALOGUE VNK1 | PROTEASOME, INHIBITOR, CARMAPHYCIN, EPOXYKETONE, VINYLKETONE, HYDROLASE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4hnp:T (LYS62) to (GLY182) CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH VINYLKETONE CARMAPHYCIN ANALOGUE VNK1 | PROTEASOME, INHIBITOR, CARMAPHYCIN, EPOXYKETONE, VINYLKETONE, HYDROLASE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4hnp:X (LYS34) to (MET172) CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH VINYLKETONE CARMAPHYCIN ANALOGUE VNK1 | PROTEASOME, INHIBITOR, CARMAPHYCIN, EPOXYKETONE, VINYLKETONE, HYDROLASE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4hnp:Z (LYS42) to (ARG194) CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH VINYLKETONE CARMAPHYCIN ANALOGUE VNK1 | PROTEASOME, INHIBITOR, CARMAPHYCIN, EPOXYKETONE, VINYLKETONE, HYDROLASE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4hnp:b (LYS33) to (ASN141) CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH VINYLKETONE CARMAPHYCIN ANALOGUE VNK1 | PROTEASOME, INHIBITOR, CARMAPHYCIN, EPOXYKETONE, VINYLKETONE, HYDROLASE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4x6z:1 (LYS33) to (ARG185) YEAST 20S PROTEASOME IN COMPLEX WITH PR-VI MODULATOR | 20S PROTEASOME, LOW-MOLECULAR MASS ACTIVATORS, ALLOSTERIC REGULATION, HYDROLASE
4x6z:A (TYR71) to (ALA213) YEAST 20S PROTEASOME IN COMPLEX WITH PR-VI MODULATOR | 20S PROTEASOME, LOW-MOLECULAR MASS ACTIVATORS, ALLOSTERIC REGULATION, HYDROLASE
4x6z:E (LYS66) to (GLU186) YEAST 20S PROTEASOME IN COMPLEX WITH PR-VI MODULATOR | 20S PROTEASOME, LOW-MOLECULAR MASS ACTIVATORS, ALLOSTERIC REGULATION, HYDROLASE
4x6z:F (LYS62) to (ILE182) YEAST 20S PROTEASOME IN COMPLEX WITH PR-VI MODULATOR | 20S PROTEASOME, LOW-MOLECULAR MASS ACTIVATORS, ALLOSTERIC REGULATION, HYDROLASE
4x6z:H (LYS33) to (ASN141) YEAST 20S PROTEASOME IN COMPLEX WITH PR-VI MODULATOR | 20S PROTEASOME, LOW-MOLECULAR MASS ACTIVATORS, ALLOSTERIC REGULATION, HYDROLASE
4x6z:I (LYS33) to (ASP166) YEAST 20S PROTEASOME IN COMPLEX WITH PR-VI MODULATOR | 20S PROTEASOME, LOW-MOLECULAR MASS ACTIVATORS, ALLOSTERIC REGULATION, HYDROLASE
4x6z:J (LYS33) to (ASP169) YEAST 20S PROTEASOME IN COMPLEX WITH PR-VI MODULATOR | 20S PROTEASOME, LOW-MOLECULAR MASS ACTIVATORS, ALLOSTERIC REGULATION, HYDROLASE
4x6z:M (LYS33) to (ARG185) YEAST 20S PROTEASOME IN COMPLEX WITH PR-VI MODULATOR | 20S PROTEASOME, LOW-MOLECULAR MASS ACTIVATORS, ALLOSTERIC REGULATION, HYDROLASE
4x6z:N (ARG33) to (ARG179) YEAST 20S PROTEASOME IN COMPLEX WITH PR-VI MODULATOR | 20S PROTEASOME, LOW-MOLECULAR MASS ACTIVATORS, ALLOSTERIC REGULATION, HYDROLASE
4x6z:O (TYR71) to (ALA213) YEAST 20S PROTEASOME IN COMPLEX WITH PR-VI MODULATOR | 20S PROTEASOME, LOW-MOLECULAR MASS ACTIVATORS, ALLOSTERIC REGULATION, HYDROLASE
4x6z:S (LYS66) to (LEU184) YEAST 20S PROTEASOME IN COMPLEX WITH PR-VI MODULATOR | 20S PROTEASOME, LOW-MOLECULAR MASS ACTIVATORS, ALLOSTERIC REGULATION, HYDROLASE
4x6z:T (LYS62) to (ILE182) YEAST 20S PROTEASOME IN COMPLEX WITH PR-VI MODULATOR | 20S PROTEASOME, LOW-MOLECULAR MASS ACTIVATORS, ALLOSTERIC REGULATION, HYDROLASE
4x6z:V (LYS33) to (ASN141) YEAST 20S PROTEASOME IN COMPLEX WITH PR-VI MODULATOR | 20S PROTEASOME, LOW-MOLECULAR MASS ACTIVATORS, ALLOSTERIC REGULATION, HYDROLASE
4x6z:X (LYS33) to (ASP169) YEAST 20S PROTEASOME IN COMPLEX WITH PR-VI MODULATOR | 20S PROTEASOME, LOW-MOLECULAR MASS ACTIVATORS, ALLOSTERIC REGULATION, HYDROLASE
4x6z:Y (LYS33) to (HIS146) YEAST 20S PROTEASOME IN COMPLEX WITH PR-VI MODULATOR | 20S PROTEASOME, LOW-MOLECULAR MASS ACTIVATORS, ALLOSTERIC REGULATION, HYDROLASE
4hrc:C (LYS61) to (LEU198) CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE CARMAPHYCIN ANALOGUE 3 | PROTEASOME, INHIBITOR, CARMAPHYCIN, EPOXYKETONE, VINYLKETONE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4hrc:E (LYS61) to (ILE181) CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE CARMAPHYCIN ANALOGUE 3 | PROTEASOME, INHIBITOR, CARMAPHYCIN, EPOXYKETONE, VINYLKETONE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4hrc:I (LYS41) to (ASP177) CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE CARMAPHYCIN ANALOGUE 3 | PROTEASOME, INHIBITOR, CARMAPHYCIN, EPOXYKETONE, VINYLKETONE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4hrc:J (LYS34) to (MET172) CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE CARMAPHYCIN ANALOGUE 3 | PROTEASOME, INHIBITOR, CARMAPHYCIN, EPOXYKETONE, VINYLKETONE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4hrc:L (LYS42) to (ARG194) CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE CARMAPHYCIN ANALOGUE 3 | PROTEASOME, INHIBITOR, CARMAPHYCIN, EPOXYKETONE, VINYLKETONE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4hrc:N (LYS33) to (ASN141) CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE CARMAPHYCIN ANALOGUE 3 | PROTEASOME, INHIBITOR, CARMAPHYCIN, EPOXYKETONE, VINYLKETONE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4hrc:S (LYS61) to (ILE181) CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE CARMAPHYCIN ANALOGUE 3 | PROTEASOME, INHIBITOR, CARMAPHYCIN, EPOXYKETONE, VINYLKETONE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4hrc:T (LYS62) to (GLY182) CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE CARMAPHYCIN ANALOGUE 3 | PROTEASOME, INHIBITOR, CARMAPHYCIN, EPOXYKETONE, VINYLKETONE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4hrc:V (LYS33) to (TRP164) CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE CARMAPHYCIN ANALOGUE 3 | PROTEASOME, INHIBITOR, CARMAPHYCIN, EPOXYKETONE, VINYLKETONE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4hrc:X (LYS34) to (LYS170) CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE CARMAPHYCIN ANALOGUE 3 | PROTEASOME, INHIBITOR, CARMAPHYCIN, EPOXYKETONE, VINYLKETONE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4hrc:Z (LYS42) to (ARG194) CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE CARMAPHYCIN ANALOGUE 3 | PROTEASOME, INHIBITOR, CARMAPHYCIN, EPOXYKETONE, VINYLKETONE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4hrc:b (LYS33) to (ASN141) CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE CARMAPHYCIN ANALOGUE 3 | PROTEASOME, INHIBITOR, CARMAPHYCIN, EPOXYKETONE, VINYLKETONE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4hrd:E (LYS61) to (ILE181) CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE NATURAL PRODUCT CARMAPHYCIN A | PROTEASOME, INHIBITOR, CARMAPHYCIN, EPOXYKETONE, VINYLKETONE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4hrd:L (LYS42) to (ARG194) CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE NATURAL PRODUCT CARMAPHYCIN A | PROTEASOME, INHIBITOR, CARMAPHYCIN, EPOXYKETONE, VINYLKETONE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4hrd:M (ARG41) to (THR168) CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE NATURAL PRODUCT CARMAPHYCIN A | PROTEASOME, INHIBITOR, CARMAPHYCIN, EPOXYKETONE, VINYLKETONE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4hrd:N (LYS33) to (ASN141) CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE NATURAL PRODUCT CARMAPHYCIN A | PROTEASOME, INHIBITOR, CARMAPHYCIN, EPOXYKETONE, VINYLKETONE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4hrd:Q (LYS61) to (LEU198) CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE NATURAL PRODUCT CARMAPHYCIN A | PROTEASOME, INHIBITOR, CARMAPHYCIN, EPOXYKETONE, VINYLKETONE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4hrd:S (LYS61) to (ILE181) CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE NATURAL PRODUCT CARMAPHYCIN A | PROTEASOME, INHIBITOR, CARMAPHYCIN, EPOXYKETONE, VINYLKETONE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4hrd:Z (LYS42) to (ARG194) CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE NATURAL PRODUCT CARMAPHYCIN A | PROTEASOME, INHIBITOR, CARMAPHYCIN, EPOXYKETONE, VINYLKETONE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4hrd:b (LYS33) to (ASN141) CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE NATURAL PRODUCT CARMAPHYCIN A | PROTEASOME, INHIBITOR, CARMAPHYCIN, EPOXYKETONE, VINYLKETONE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
3sdi:E (LYS66) to (ILE180) STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 20 | 20S PROTEASOME, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
3sdi:I (LYS33) to (ASP166) STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 20 | 20S PROTEASOME, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
3sdi:L (LYS33) to (ARG165) STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 20 | 20S PROTEASOME, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
3sdi:N (LYS33) to (ASN141) STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 20 | 20S PROTEASOME, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
3sdi:S (LYS66) to (ILE180) STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 20 | 20S PROTEASOME, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
3sdi:T (LYS66) to (LYS206) STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 20 | 20S PROTEASOME, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
3sdi:U (TYR66) to (ALA200) STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 20 | 20S PROTEASOME, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
3sdi:W (LYS33) to (ASP166) STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 20 | 20S PROTEASOME, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
3sdi:Z (LYS33) to (ARG165) STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 20 | 20S PROTEASOME, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
3sdi:1 (LEU33) to (ARG178) STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 20 | 20S PROTEASOME, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
3sdi:2 (LYS33) to (ASN141) STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 20 | 20S PROTEASOME, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
3sdk:E (SER59) to (ILE180) STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 34 | 20S PROTEASOME, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
3sdk:G (TYR66) to (GLY202) STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 34 | 20S PROTEASOME, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
3sdk:I (LYS33) to (ASP166) STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 34 | 20S PROTEASOME, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
3sdk:J (LYS33) to (ARG165) STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 34 | 20S PROTEASOME, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
3sdk:L (LYS33) to (ARG165) STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 34 | 20S PROTEASOME, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
3sdk:M (ARG33) to (THR146) STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 34 | 20S PROTEASOME, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
3sdk:N (LYS33) to (ASN141) STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 34 | 20S PROTEASOME, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
3sdk:Q (LYS66) to (LEU198) STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 34 | 20S PROTEASOME, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
3sdk:R (LYS66) to (ASN178) STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 34 | 20S PROTEASOME, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
3sdk:S (LYS66) to (ILE182) STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 34 | 20S PROTEASOME, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
3sdk:W (LYS33) to (ASP166) STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 34 | 20S PROTEASOME, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
3sdk:X (LYS33) to (ARG165) STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 34 | 20S PROTEASOME, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
3sdk:Z (LYS33) to (ARG165) STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 34 | 20S PROTEASOME, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
3sdk:2 (LYS33) to (ASN141) STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 34 | 20S PROTEASOME, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
1ofi:G (LYS33) to (ASP158) ASYMMETRIC COMPLEX BETWEEN HSLV AND I-DOMAIN DELETED HSLU (H. INFLUENZAE) | CHAPERONE, HYDROLASE, ATP-BINDING
1ofi:H (LYS33) to (ILE159) ASYMMETRIC COMPLEX BETWEEN HSLV AND I-DOMAIN DELETED HSLU (H. INFLUENZAE) | CHAPERONE, HYDROLASE, ATP-BINDING
1ofi:I (LYS33) to (ILE159) ASYMMETRIC COMPLEX BETWEEN HSLV AND I-DOMAIN DELETED HSLU (H. INFLUENZAE) | CHAPERONE, HYDROLASE, ATP-BINDING
3shj:E (LYS66) to (ILE18) PROTEASOME IN COMPLEX WITH HYDROXYUREA DERIVATIVE HU10 | UBIQUITIN, DRUG DEVELOPMENT, CANCER, IMMUNOLOGY, PROTEIN DEGRADATION, UNFOLDED PROTEIN SUBSTRATES, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
3shj:G (TYR66) to (LEU201) PROTEASOME IN COMPLEX WITH HYDROXYUREA DERIVATIVE HU10 | UBIQUITIN, DRUG DEVELOPMENT, CANCER, IMMUNOLOGY, PROTEIN DEGRADATION, UNFOLDED PROTEIN SUBSTRATES, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
3shj:I (LYS33) to (ASP166) PROTEASOME IN COMPLEX WITH HYDROXYUREA DERIVATIVE HU10 | UBIQUITIN, DRUG DEVELOPMENT, CANCER, IMMUNOLOGY, PROTEIN DEGRADATION, UNFOLDED PROTEIN SUBSTRATES, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
3shj:J (LYS33) to (HIS141) PROTEASOME IN COMPLEX WITH HYDROXYUREA DERIVATIVE HU10 | UBIQUITIN, DRUG DEVELOPMENT, CANCER, IMMUNOLOGY, PROTEIN DEGRADATION, UNFOLDED PROTEIN SUBSTRATES, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
3shj:L (LYS33) to (ARG165) PROTEASOME IN COMPLEX WITH HYDROXYUREA DERIVATIVE HU10 | UBIQUITIN, DRUG DEVELOPMENT, CANCER, IMMUNOLOGY, PROTEIN DEGRADATION, UNFOLDED PROTEIN SUBSTRATES, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
3shj:N (LYS33) to (ASN141) PROTEASOME IN COMPLEX WITH HYDROXYUREA DERIVATIVE HU10 | UBIQUITIN, DRUG DEVELOPMENT, CANCER, IMMUNOLOGY, PROTEIN DEGRADATION, UNFOLDED PROTEIN SUBSTRATES, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
3shj:S (LYS66) to (ILE18) PROTEASOME IN COMPLEX WITH HYDROXYUREA DERIVATIVE HU10 | UBIQUITIN, DRUG DEVELOPMENT, CANCER, IMMUNOLOGY, PROTEIN DEGRADATION, UNFOLDED PROTEIN SUBSTRATES, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
3shj:U (TYR66) to (LEU201) PROTEASOME IN COMPLEX WITH HYDROXYUREA DERIVATIVE HU10 | UBIQUITIN, DRUG DEVELOPMENT, CANCER, IMMUNOLOGY, PROTEIN DEGRADATION, UNFOLDED PROTEIN SUBSTRATES, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
3shj:W (LYS33) to (ASP166) PROTEASOME IN COMPLEX WITH HYDROXYUREA DERIVATIVE HU10 | UBIQUITIN, DRUG DEVELOPMENT, CANCER, IMMUNOLOGY, PROTEIN DEGRADATION, UNFOLDED PROTEIN SUBSTRATES, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
3shj:X (LYS33) to (HIS141) PROTEASOME IN COMPLEX WITH HYDROXYUREA DERIVATIVE HU10 | UBIQUITIN, DRUG DEVELOPMENT, CANCER, IMMUNOLOGY, PROTEIN DEGRADATION, UNFOLDED PROTEIN SUBSTRATES, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
3shj:Z (LYS33) to (ARG165) PROTEASOME IN COMPLEX WITH HYDROXYUREA DERIVATIVE HU10 | UBIQUITIN, DRUG DEVELOPMENT, CANCER, IMMUNOLOGY, PROTEIN DEGRADATION, UNFOLDED PROTEIN SUBSTRATES, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
3shj:2 (LYS33) to (ASN141) PROTEASOME IN COMPLEX WITH HYDROXYUREA DERIVATIVE HU10 | UBIQUITIN, DRUG DEVELOPMENT, CANCER, IMMUNOLOGY, PROTEIN DEGRADATION, UNFOLDED PROTEIN SUBSTRATES, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4int:E (SER56) to (ILE181) YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU122 | UPS, DRUG DISCOVERY, IRREVERSIBLE INHIBITION, NTN HYDROLASE, NON- LYSOSOMAL PROTEIN BREAKDOWN, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4int:I (LYS41) to (ASP177) YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU122 | UPS, DRUG DISCOVERY, IRREVERSIBLE INHIBITION, NTN HYDROLASE, NON- LYSOSOMAL PROTEIN BREAKDOWN, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4int:J (LYS34) to (MET172) YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU122 | UPS, DRUG DISCOVERY, IRREVERSIBLE INHIBITION, NTN HYDROLASE, NON- LYSOSOMAL PROTEIN BREAKDOWN, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4int:L (LYS42) to (ARG194) YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU122 | UPS, DRUG DISCOVERY, IRREVERSIBLE INHIBITION, NTN HYDROLASE, NON- LYSOSOMAL PROTEIN BREAKDOWN, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4int:N (LYS33) to (ASN141) YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU122 | UPS, DRUG DISCOVERY, IRREVERSIBLE INHIBITION, NTN HYDROLASE, NON- LYSOSOMAL PROTEIN BREAKDOWN, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4int:S (LYS61) to (ILE181) YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU122 | UPS, DRUG DISCOVERY, IRREVERSIBLE INHIBITION, NTN HYDROLASE, NON- LYSOSOMAL PROTEIN BREAKDOWN, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4int:W (LYS41) to (ASP177) YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU122 | UPS, DRUG DISCOVERY, IRREVERSIBLE INHIBITION, NTN HYDROLASE, NON- LYSOSOMAL PROTEIN BREAKDOWN, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4int:Z (LYS42) to (ARG194) YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU122 | UPS, DRUG DISCOVERY, IRREVERSIBLE INHIBITION, NTN HYDROLASE, NON- LYSOSOMAL PROTEIN BREAKDOWN, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4int:a (ARG41) to (THR168) YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU122 | UPS, DRUG DISCOVERY, IRREVERSIBLE INHIBITION, NTN HYDROLASE, NON- LYSOSOMAL PROTEIN BREAKDOWN, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4int:b (LYS33) to (ASN141) YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU122 | UPS, DRUG DISCOVERY, IRREVERSIBLE INHIBITION, NTN HYDROLASE, NON- LYSOSOMAL PROTEIN BREAKDOWN, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4inr:E (LYS61) to (ILE181) YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU102 | UPS, DRUG DISCOVERY, IRREVERSIBLE INHIBITION, NTN HYDROLASE, NON- LYSOSOMAL PROTEIN BREAKDOWN, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4inr:I (LYS41) to (ASP177) YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU102 | UPS, DRUG DISCOVERY, IRREVERSIBLE INHIBITION, NTN HYDROLASE, NON- LYSOSOMAL PROTEIN BREAKDOWN, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4inr:J (LYS34) to (LYS170) YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU102 | UPS, DRUG DISCOVERY, IRREVERSIBLE INHIBITION, NTN HYDROLASE, NON- LYSOSOMAL PROTEIN BREAKDOWN, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4inr:L (LYS42) to (ARG194) YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU102 | UPS, DRUG DISCOVERY, IRREVERSIBLE INHIBITION, NTN HYDROLASE, NON- LYSOSOMAL PROTEIN BREAKDOWN, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4inr:M (ARG41) to (ARG187) YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU102 | UPS, DRUG DISCOVERY, IRREVERSIBLE INHIBITION, NTN HYDROLASE, NON- LYSOSOMAL PROTEIN BREAKDOWN, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4inr:N (LYS33) to (ASN141) YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU102 | UPS, DRUG DISCOVERY, IRREVERSIBLE INHIBITION, NTN HYDROLASE, NON- LYSOSOMAL PROTEIN BREAKDOWN, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4inr:S (LYS61) to (ILE181) YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU102 | UPS, DRUG DISCOVERY, IRREVERSIBLE INHIBITION, NTN HYDROLASE, NON- LYSOSOMAL PROTEIN BREAKDOWN, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4inr:W (LYS41) to (ASP177) YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU102 | UPS, DRUG DISCOVERY, IRREVERSIBLE INHIBITION, NTN HYDROLASE, NON- LYSOSOMAL PROTEIN BREAKDOWN, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4inr:Z (LYS42) to (ARG194) YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU102 | UPS, DRUG DISCOVERY, IRREVERSIBLE INHIBITION, NTN HYDROLASE, NON- LYSOSOMAL PROTEIN BREAKDOWN, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4inr:a (ARG41) to (ARG187) YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU102 | UPS, DRUG DISCOVERY, IRREVERSIBLE INHIBITION, NTN HYDROLASE, NON- LYSOSOMAL PROTEIN BREAKDOWN, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4inr:b (LYS33) to (ASN141) YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU102 | UPS, DRUG DISCOVERY, IRREVERSIBLE INHIBITION, NTN HYDROLASE, NON- LYSOSOMAL PROTEIN BREAKDOWN, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4inu:E (LYS61) to (ILE181) YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU112 | UPS, DRUG DISCOVERY, IRREVERSIBLE INHIBITION, NTN HYDROLASE, NON- LYSOSOMAL PROTEIN BREAKDOWN, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4inu:I (LYS41) to (ASP177) YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU112 | UPS, DRUG DISCOVERY, IRREVERSIBLE INHIBITION, NTN HYDROLASE, NON- LYSOSOMAL PROTEIN BREAKDOWN, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4inu:J (LYS34) to (LYS170) YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU112 | UPS, DRUG DISCOVERY, IRREVERSIBLE INHIBITION, NTN HYDROLASE, NON- LYSOSOMAL PROTEIN BREAKDOWN, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4inu:L (LYS42) to (ARG194) YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU112 | UPS, DRUG DISCOVERY, IRREVERSIBLE INHIBITION, NTN HYDROLASE, NON- LYSOSOMAL PROTEIN BREAKDOWN, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4inu:M (ARG41) to (THR168) YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU112 | UPS, DRUG DISCOVERY, IRREVERSIBLE INHIBITION, NTN HYDROLASE, NON- LYSOSOMAL PROTEIN BREAKDOWN, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4inu:N (LYS33) to (ASN141) YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU112 | UPS, DRUG DISCOVERY, IRREVERSIBLE INHIBITION, NTN HYDROLASE, NON- LYSOSOMAL PROTEIN BREAKDOWN, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4inu:S (LYS61) to (ILE181) YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU112 | UPS, DRUG DISCOVERY, IRREVERSIBLE INHIBITION, NTN HYDROLASE, NON- LYSOSOMAL PROTEIN BREAKDOWN, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4inu:W (LYS41) to (ASP177) YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU112 | UPS, DRUG DISCOVERY, IRREVERSIBLE INHIBITION, NTN HYDROLASE, NON- LYSOSOMAL PROTEIN BREAKDOWN, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4inu:Z (LYS42) to (ARG194) YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU112 | UPS, DRUG DISCOVERY, IRREVERSIBLE INHIBITION, NTN HYDROLASE, NON- LYSOSOMAL PROTEIN BREAKDOWN, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4inu:a (ARG41) to (THR168) YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU112 | UPS, DRUG DISCOVERY, IRREVERSIBLE INHIBITION, NTN HYDROLASE, NON- LYSOSOMAL PROTEIN BREAKDOWN, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4inu:b (LYS33) to (ASN141) YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU112 | UPS, DRUG DISCOVERY, IRREVERSIBLE INHIBITION, NTN HYDROLASE, NON- LYSOSOMAL PROTEIN BREAKDOWN, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
1pma:A (LYS66) to (SER200) PROTEASOME FROM THERMOPLASMA ACIDOPHILUM | PROTEASE, PROTEASOME, HYDROLASE
1pma:D (LYS66) to (SER200) PROTEASOME FROM THERMOPLASMA ACIDOPHILUM | PROTEASE, PROTEASOME, HYDROLASE
1pma:H (LYS66) to (SER200) PROTEASOME FROM THERMOPLASMA ACIDOPHILUM | PROTEASE, PROTEASOME, HYDROLASE
1pma:I (LYS66) to (SER200) PROTEASOME FROM THERMOPLASMA ACIDOPHILUM | PROTEASE, PROTEASOME, HYDROLASE
1pma:L (LYS66) to (SER200) PROTEASOME FROM THERMOPLASMA ACIDOPHILUM | PROTEASE, PROTEASOME, HYDROLASE
1pma:N (LYS66) to (SER200) PROTEASOME FROM THERMOPLASMA ACIDOPHILUM | PROTEASE, PROTEASOME, HYDROLASE
1pma:Q (LYS33) to (ARG165) PROTEASOME FROM THERMOPLASMA ACIDOPHILUM | PROTEASE, PROTEASOME, HYDROLASE
1pma:R (LYS33) to (ARG165) PROTEASOME FROM THERMOPLASMA ACIDOPHILUM | PROTEASE, PROTEASOME, HYDROLASE
1pma:S (LYS33) to (ARG165) PROTEASOME FROM THERMOPLASMA ACIDOPHILUM | PROTEASE, PROTEASOME, HYDROLASE
1pma:T (LYS33) to (ARG165) PROTEASOME FROM THERMOPLASMA ACIDOPHILUM | PROTEASE, PROTEASOME, HYDROLASE
1pma:V (LYS33) to (ARG165) PROTEASOME FROM THERMOPLASMA ACIDOPHILUM | PROTEASE, PROTEASOME, HYDROLASE
1pma:X (LYS33) to (ARG165) PROTEASOME FROM THERMOPLASMA ACIDOPHILUM | PROTEASE, PROTEASOME, HYDROLASE
1pma:1 (LYS33) to (ARG165) PROTEASOME FROM THERMOPLASMA ACIDOPHILUM | PROTEASE, PROTEASOME, HYDROLASE
1pma:2 (LYS33) to (ARG165) PROTEASOME FROM THERMOPLASMA ACIDOPHILUM | PROTEASE, PROTEASOME, HYDROLASE
3gpj:E (LYS66) to (ILE18) CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SYRINGOLIN B | PROTEASOME, VIRULENCE, UBIQUITIN, CANCER THERAPY, IMMUNOLOGY, CYTOPLASM, HYDROLASE, NUCLEUS, PHOSPHOPROTEIN, PROTEASE, THREONINE PROTEASE, ISOPEPTIDE BOND, UBL CONJUGATION, ZYMOGEN
3gpj:G (TYR66) to (GLY202) CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SYRINGOLIN B | PROTEASOME, VIRULENCE, UBIQUITIN, CANCER THERAPY, IMMUNOLOGY, CYTOPLASM, HYDROLASE, NUCLEUS, PHOSPHOPROTEIN, PROTEASE, THREONINE PROTEASE, ISOPEPTIDE BOND, UBL CONJUGATION, ZYMOGEN
3gpj:I (LYS33) to (ASP166) CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SYRINGOLIN B | PROTEASOME, VIRULENCE, UBIQUITIN, CANCER THERAPY, IMMUNOLOGY, CYTOPLASM, HYDROLASE, NUCLEUS, PHOSPHOPROTEIN, PROTEASE, THREONINE PROTEASE, ISOPEPTIDE BOND, UBL CONJUGATION, ZYMOGEN
3gpj:L (LYS33) to (ARG165) CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SYRINGOLIN B | PROTEASOME, VIRULENCE, UBIQUITIN, CANCER THERAPY, IMMUNOLOGY, CYTOPLASM, HYDROLASE, NUCLEUS, PHOSPHOPROTEIN, PROTEASE, THREONINE PROTEASE, ISOPEPTIDE BOND, UBL CONJUGATION, ZYMOGEN
3gpj:N (LYS33) to (ASN141) CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SYRINGOLIN B | PROTEASOME, VIRULENCE, UBIQUITIN, CANCER THERAPY, IMMUNOLOGY, CYTOPLASM, HYDROLASE, NUCLEUS, PHOSPHOPROTEIN, PROTEASE, THREONINE PROTEASE, ISOPEPTIDE BOND, UBL CONJUGATION, ZYMOGEN
3gpj:S (LYS66) to (ILE18) CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SYRINGOLIN B | PROTEASOME, VIRULENCE, UBIQUITIN, CANCER THERAPY, IMMUNOLOGY, CYTOPLASM, HYDROLASE, NUCLEUS, PHOSPHOPROTEIN, PROTEASE, THREONINE PROTEASE, ISOPEPTIDE BOND, UBL CONJUGATION, ZYMOGEN
3gpj:W (LYS33) to (ASP166) CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SYRINGOLIN B | PROTEASOME, VIRULENCE, UBIQUITIN, CANCER THERAPY, IMMUNOLOGY, CYTOPLASM, HYDROLASE, NUCLEUS, PHOSPHOPROTEIN, PROTEASE, THREONINE PROTEASE, ISOPEPTIDE BOND, UBL CONJUGATION, ZYMOGEN
3gpj:Z (LYS33) to (ARG165) CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SYRINGOLIN B | PROTEASOME, VIRULENCE, UBIQUITIN, CANCER THERAPY, IMMUNOLOGY, CYTOPLASM, HYDROLASE, NUCLEUS, PHOSPHOPROTEIN, PROTEASE, THREONINE PROTEASE, ISOPEPTIDE BOND, UBL CONJUGATION, ZYMOGEN
3gpj:1 (ARG33) to (ARG165) CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SYRINGOLIN B | PROTEASOME, VIRULENCE, UBIQUITIN, CANCER THERAPY, IMMUNOLOGY, CYTOPLASM, HYDROLASE, NUCLEUS, PHOSPHOPROTEIN, PROTEASE, THREONINE PROTEASE, ISOPEPTIDE BOND, UBL CONJUGATION, ZYMOGEN
3gpj:2 (LYS33) to (ASN141) CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SYRINGOLIN B | PROTEASOME, VIRULENCE, UBIQUITIN, CANCER THERAPY, IMMUNOLOGY, CYTOPLASM, HYDROLASE, NUCLEUS, PHOSPHOPROTEIN, PROTEASE, THREONINE PROTEASE, ISOPEPTIDE BOND, UBL CONJUGATION, ZYMOGEN
3gpw:E (LYS66) to (ILE18) CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: IRREVERSIBLE INHIBITOR LIGAND | PROTEASOME, UBIQUITIN, CANCER THERAPY, IMMUNOLOGY, TIME- DEPENDENT ELIMINATION OF A DEFINED LEAVING GROUP, CYTOPLASM, HYDROLASE, NUCLEUS, PHOSPHOPROTEIN, PROTEASE, THREONINE PROTEASE, ISOPEPTIDE BOND, UBL CONJUGATION, ZYMOGEN
3gpw:G (TYR66) to (GLY202) CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: IRREVERSIBLE INHIBITOR LIGAND | PROTEASOME, UBIQUITIN, CANCER THERAPY, IMMUNOLOGY, TIME- DEPENDENT ELIMINATION OF A DEFINED LEAVING GROUP, CYTOPLASM, HYDROLASE, NUCLEUS, PHOSPHOPROTEIN, PROTEASE, THREONINE PROTEASE, ISOPEPTIDE BOND, UBL CONJUGATION, ZYMOGEN
3gpw:I (LYS33) to (ASP166) CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: IRREVERSIBLE INHIBITOR LIGAND | PROTEASOME, UBIQUITIN, CANCER THERAPY, IMMUNOLOGY, TIME- DEPENDENT ELIMINATION OF A DEFINED LEAVING GROUP, CYTOPLASM, HYDROLASE, NUCLEUS, PHOSPHOPROTEIN, PROTEASE, THREONINE PROTEASE, ISOPEPTIDE BOND, UBL CONJUGATION, ZYMOGEN
3gpw:J (LYS33) to (HIS141) CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: IRREVERSIBLE INHIBITOR LIGAND | PROTEASOME, UBIQUITIN, CANCER THERAPY, IMMUNOLOGY, TIME- DEPENDENT ELIMINATION OF A DEFINED LEAVING GROUP, CYTOPLASM, HYDROLASE, NUCLEUS, PHOSPHOPROTEIN, PROTEASE, THREONINE PROTEASE, ISOPEPTIDE BOND, UBL CONJUGATION, ZYMOGEN
3gpw:L (LYS33) to (ARG165) CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: IRREVERSIBLE INHIBITOR LIGAND | PROTEASOME, UBIQUITIN, CANCER THERAPY, IMMUNOLOGY, TIME- DEPENDENT ELIMINATION OF A DEFINED LEAVING GROUP, CYTOPLASM, HYDROLASE, NUCLEUS, PHOSPHOPROTEIN, PROTEASE, THREONINE PROTEASE, ISOPEPTIDE BOND, UBL CONJUGATION, ZYMOGEN
3gpw:M (ARG33) to (ARG165) CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: IRREVERSIBLE INHIBITOR LIGAND | PROTEASOME, UBIQUITIN, CANCER THERAPY, IMMUNOLOGY, TIME- DEPENDENT ELIMINATION OF A DEFINED LEAVING GROUP, CYTOPLASM, HYDROLASE, NUCLEUS, PHOSPHOPROTEIN, PROTEASE, THREONINE PROTEASE, ISOPEPTIDE BOND, UBL CONJUGATION, ZYMOGEN
3gpw:N (LYS33) to (ASN141) CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: IRREVERSIBLE INHIBITOR LIGAND | PROTEASOME, UBIQUITIN, CANCER THERAPY, IMMUNOLOGY, TIME- DEPENDENT ELIMINATION OF A DEFINED LEAVING GROUP, CYTOPLASM, HYDROLASE, NUCLEUS, PHOSPHOPROTEIN, PROTEASE, THREONINE PROTEASE, ISOPEPTIDE BOND, UBL CONJUGATION, ZYMOGEN
3gpw:S (LYS66) to (ILE18) CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: IRREVERSIBLE INHIBITOR LIGAND | PROTEASOME, UBIQUITIN, CANCER THERAPY, IMMUNOLOGY, TIME- DEPENDENT ELIMINATION OF A DEFINED LEAVING GROUP, CYTOPLASM, HYDROLASE, NUCLEUS, PHOSPHOPROTEIN, PROTEASE, THREONINE PROTEASE, ISOPEPTIDE BOND, UBL CONJUGATION, ZYMOGEN
3gpw:U (TYR66) to (GLY202) CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: IRREVERSIBLE INHIBITOR LIGAND | PROTEASOME, UBIQUITIN, CANCER THERAPY, IMMUNOLOGY, TIME- DEPENDENT ELIMINATION OF A DEFINED LEAVING GROUP, CYTOPLASM, HYDROLASE, NUCLEUS, PHOSPHOPROTEIN, PROTEASE, THREONINE PROTEASE, ISOPEPTIDE BOND, UBL CONJUGATION, ZYMOGEN
3gpw:W (LYS33) to (ASP166) CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: IRREVERSIBLE INHIBITOR LIGAND | PROTEASOME, UBIQUITIN, CANCER THERAPY, IMMUNOLOGY, TIME- DEPENDENT ELIMINATION OF A DEFINED LEAVING GROUP, CYTOPLASM, HYDROLASE, NUCLEUS, PHOSPHOPROTEIN, PROTEASE, THREONINE PROTEASE, ISOPEPTIDE BOND, UBL CONJUGATION, ZYMOGEN
3gpw:X (LYS33) to (HIS141) CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: IRREVERSIBLE INHIBITOR LIGAND | PROTEASOME, UBIQUITIN, CANCER THERAPY, IMMUNOLOGY, TIME- DEPENDENT ELIMINATION OF A DEFINED LEAVING GROUP, CYTOPLASM, HYDROLASE, NUCLEUS, PHOSPHOPROTEIN, PROTEASE, THREONINE PROTEASE, ISOPEPTIDE BOND, UBL CONJUGATION, ZYMOGEN
3gpw:Z (LYS33) to (ARG165) CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: IRREVERSIBLE INHIBITOR LIGAND | PROTEASOME, UBIQUITIN, CANCER THERAPY, IMMUNOLOGY, TIME- DEPENDENT ELIMINATION OF A DEFINED LEAVING GROUP, CYTOPLASM, HYDROLASE, NUCLEUS, PHOSPHOPROTEIN, PROTEASE, THREONINE PROTEASE, ISOPEPTIDE BOND, UBL CONJUGATION, ZYMOGEN
3gpw:1 (ARG33) to (ARG165) CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: IRREVERSIBLE INHIBITOR LIGAND | PROTEASOME, UBIQUITIN, CANCER THERAPY, IMMUNOLOGY, TIME- DEPENDENT ELIMINATION OF A DEFINED LEAVING GROUP, CYTOPLASM, HYDROLASE, NUCLEUS, PHOSPHOPROTEIN, PROTEASE, THREONINE PROTEASE, ISOPEPTIDE BOND, UBL CONJUGATION, ZYMOGEN
3gpw:2 (LYS33) to (ASN141) CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: IRREVERSIBLE INHIBITOR LIGAND | PROTEASOME, UBIQUITIN, CANCER THERAPY, IMMUNOLOGY, TIME- DEPENDENT ELIMINATION OF A DEFINED LEAVING GROUP, CYTOPLASM, HYDROLASE, NUCLEUS, PHOSPHOPROTEIN, PROTEASE, THREONINE PROTEASE, ISOPEPTIDE BOND, UBL CONJUGATION, ZYMOGEN
4y69:E (LYS61) to (ILE181) YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAD-EP | HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4y69:I (LYS41) to (ASP177) YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAD-EP | HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4y69:L (LYS42) to (ARG194) YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAD-EP | HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4y69:M (ARG41) to (ARG187) YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAD-EP | HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4y69:N (LYS33) to (ASN141) YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAD-EP | HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4y69:S (LYS61) to (ILE181) YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAD-EP | HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4y69:W (LYS41) to (ASP177) YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAD-EP | HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4y69:Z (LYS42) to (ARG194) YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAD-EP | HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4y69:a (ARG41) to (ARG187) YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAD-EP | HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4y69:b (LYS33) to (ASN141) YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAD-EP | HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4y6a:E (LYS61) to (ILE181) YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAD-EP | HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4y6a:I (LYS41) to (ASP177) YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAD-EP | HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4y6a:L (LYS42) to (ARG194) YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAD-EP | HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4y6a:M (ARG41) to (ARG187) YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAD-EP | HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4y6a:N (LYS33) to (ASN141) YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAD-EP | HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4y6a:S (LYS61) to (ILE181) YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAD-EP | HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4y6a:W (LYS41) to (ASP177) YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAD-EP | HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4y6a:Z (LYS42) to (ARG194) YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAD-EP | HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4y6a:a (ARG41) to (ARG187) YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAD-EP | HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4y6a:b (LYS33) to (ASN141) YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAD-EP | HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4y6v:E (LYS61) to (ILE181) YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAE-EP | HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4y6v:I (LYS41) to (ASP177) YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAE-EP | HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4y6v:L (LYS42) to (ARG194) YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAE-EP | HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4y6v:M (ARG41) to (ARG187) YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAE-EP | HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4y6v:N (LYS33) to (ASN141) YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAE-EP | HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4y6v:S (SER56) to (ILE181) YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAE-EP | HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4y6v:W (LYS41) to (ASP177) YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAE-EP | HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4y6v:Z (LYS42) to (ARG194) YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAE-EP | HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4y6v:a (ARG41) to (ARG187) YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAE-EP | HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4y6v:b (LYS33) to (ASN141) YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAE-EP | HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4y6z:E (SER56) to (ILE181) YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAL-EP | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS
4y6z:I (LYS41) to (ASP177) YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAL-EP | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS
4y6z:L (LYS42) to (ARG194) YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAL-EP | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS
4y6z:M (ARG41) to (ARG187) YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAL-EP | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS
4y6z:N (LYS33) to (ASN141) YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAL-EP | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS
4y6z:S (SER56) to (ILE181) YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAL-EP | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS
4y6z:Z (LYS42) to (ARG194) YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAL-EP | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS
4y6z:a (ARG41) to (ARG187) YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAL-EP | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS
4y6z:b (LYS33) to (ASN141) YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAL-EP | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS
4y70:E (SER56) to (ILE181) YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAV-EP | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS
4y70:I (LYS41) to (ASP177) YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAV-EP | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS
4y70:L (LYS42) to (ARG194) YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAV-EP | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS
4y70:M (ARG41) to (ARG187) YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAV-EP | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS
4y70:N (LYS33) to (ASN141) YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAV-EP | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS
4y70:S (SER56) to (ILE181) YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAV-EP | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS
4y70:W (LYS41) to (ASP177) YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAV-EP | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS
4y70:Z (LYS42) to (ARG194) YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAV-EP | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS
4y70:a (ARG41) to (ARG187) YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAV-EP | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS
4y70:b (LYS33) to (ASN141) YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAV-EP | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS
4y74:E (SER56) to (ILE181) YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAL-EP | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS
4y74:I (LYS41) to (ASP177) YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAL-EP | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS
4y74:L (LYS42) to (ARG194) YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAL-EP | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS
4y74:M (ARG41) to (THR168) YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAL-EP | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS
4y74:N (LYS33) to (ASN141) YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAL-EP | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS
4y74:S (SER56) to (ILE181) YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAL-EP | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS
4y74:W (LYS41) to (ASP177) YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAL-EP | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS
4y74:Z (LYS42) to (ARG194) YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAL-EP | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS
4y74:a (ARG41) to (THR168) YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAL-EP | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS
4y74:b (LYS33) to (ASN141) YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAL-EP | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS
4y77:E (SER56) to (ILE181) YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAF-EP | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS
4y77:I (LYS41) to (ASP177) YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAF-EP | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS
4y77:L (LYS42) to (ARG194) YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAF-EP | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS
4y77:M (ARG41) to (ARG187) YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAF-EP | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS
4y77:N (LYS33) to (ASN141) YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAF-EP | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS
4y77:S (SER56) to (ILE181) YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAF-EP | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS
4y77:W (LYS41) to (ASP177) YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAF-EP | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS
4y77:Z (LYS42) to (ARG194) YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAF-EP | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS
4y77:a (ARG41) to (ARG187) YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAF-EP | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS
4y77:b (LYS33) to (ASN141) YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAF-EP | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS
4y78:E (SER56) to (ILE181) YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAD-EP | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS
4y78:I (LYS41) to (ASP177) YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAD-EP | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS
4y78:L (LYS42) to (ARG194) YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAD-EP | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS
4y78:M (ARG41) to (ARG187) YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAD-EP | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS
4y78:N (LYS33) to (ASN141) YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAD-EP | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS
4y78:S (SER56) to (ILE181) YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAD-EP | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS
4y78:W (LYS41) to (ASP177) YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAD-EP | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS
4y78:Z (LYS42) to (ARG194) YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAD-EP | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS
4y78:a (ARG41) to (ARG187) YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAD-EP | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS
4y78:b (LYS33) to (ASN141) YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAD-EP | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS
4j70:E (LYS61) to (ILE181) YEAST 20S PROTEASOME IN COMPLEX WITH THE BELACTOSIN DERIVATIVE 3E | PROTEASOME, DRUG DISCOVERY, IRREVERSIBLE INHIBITION, BETA-LACTONE, NTN HYDROLASE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4j70:J (LYS34) to (HIS147) YEAST 20S PROTEASOME IN COMPLEX WITH THE BELACTOSIN DERIVATIVE 3E | PROTEASOME, DRUG DISCOVERY, IRREVERSIBLE INHIBITION, BETA-LACTONE, NTN HYDROLASE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4j70:L (LYS42) to (ARG194) YEAST 20S PROTEASOME IN COMPLEX WITH THE BELACTOSIN DERIVATIVE 3E | PROTEASOME, DRUG DISCOVERY, IRREVERSIBLE INHIBITION, BETA-LACTONE, NTN HYDROLASE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4j70:N (LYS33) to (ASN141) YEAST 20S PROTEASOME IN COMPLEX WITH THE BELACTOSIN DERIVATIVE 3E | PROTEASOME, DRUG DISCOVERY, IRREVERSIBLE INHIBITION, BETA-LACTONE, NTN HYDROLASE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4j70:S (LYS61) to (ILE181) YEAST 20S PROTEASOME IN COMPLEX WITH THE BELACTOSIN DERIVATIVE 3E | PROTEASOME, DRUG DISCOVERY, IRREVERSIBLE INHIBITION, BETA-LACTONE, NTN HYDROLASE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4j70:X (LYS34) to (HIS147) YEAST 20S PROTEASOME IN COMPLEX WITH THE BELACTOSIN DERIVATIVE 3E | PROTEASOME, DRUG DISCOVERY, IRREVERSIBLE INHIBITION, BETA-LACTONE, NTN HYDROLASE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4j70:Z (LYS42) to (ARG194) YEAST 20S PROTEASOME IN COMPLEX WITH THE BELACTOSIN DERIVATIVE 3E | PROTEASOME, DRUG DISCOVERY, IRREVERSIBLE INHIBITION, BETA-LACTONE, NTN HYDROLASE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4j70:a (ARG41) to (THR168) YEAST 20S PROTEASOME IN COMPLEX WITH THE BELACTOSIN DERIVATIVE 3E | PROTEASOME, DRUG DISCOVERY, IRREVERSIBLE INHIBITION, BETA-LACTONE, NTN HYDROLASE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4j70:b (LYS33) to (ASN141) YEAST 20S PROTEASOME IN COMPLEX WITH THE BELACTOSIN DERIVATIVE 3E | PROTEASOME, DRUG DISCOVERY, IRREVERSIBLE INHIBITION, BETA-LACTONE, NTN HYDROLASE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4y7w:E (SER56) to (ILE181) YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAE-EP | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS
4y7w:I (LYS41) to (ASP177) YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAE-EP | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS
4y7w:L (LYS42) to (ARG194) YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAE-EP | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS
4y7w:M (ARG41) to (ARG187) YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAE-EP | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS
4y7w:N (LYS33) to (ASN141) YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAE-EP | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS
4y7w:S (SER56) to (ILE181) YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAE-EP | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS
4y7w:W (LYS41) to (ASP177) YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAE-EP | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS
4y7w:Z (LYS42) to (ARG194) YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAE-EP | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS
4y7w:a (ARG41) to (ARG187) YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAE-EP | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS
4y7w:b (LYS33) to (ASN141) YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAE-EP | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS
4y7x:E (SER56) to (ILE181) YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAA-EP | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS
4y7x:I (LYS41) to (ASP177) YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAA-EP | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS
4y7x:L (LYS42) to (ARG194) YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAA-EP | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS
4y7x:M (ARG41) to (ARG187) YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAA-EP | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS
4y7x:N (LYS33) to (ASN141) YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAA-EP | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS
4y7x:S (SER56) to (ILE181) YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAA-EP | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS
4y7x:W (LYS41) to (ASP177) YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAA-EP | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS
4y7x:Z (LYS42) to (ARG194) YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAA-EP | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS
4y7x:a (ARG41) to (ARG187) YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAA-EP | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS
4y7x:b (LYS33) to (ASN141) YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAA-EP | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS
4y7y:E (SER56) to (ILE181) YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAA-EP | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS
4y7y:I (LYS41) to (ASP177) YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAA-EP | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS
4y7y:L (LYS42) to (ARG194) YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAA-EP | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS
4y7y:M (ARG41) to (ARG187) YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAA-EP | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS
4y7y:N (LYS33) to (ASN141) YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAA-EP | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS
4y7y:S (SER56) to (ILE181) YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAA-EP | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS
4y7y:W (LYS41) to (ASP177) YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAA-EP | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS
4y7y:Z (LYS42) to (ARG194) YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAA-EP | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS
4y7y:a (ARG41) to (ARG187) YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAA-EP | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS
4y7y:b (LYS33) to (ASN141) YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAA-EP | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS
4y80:E (SER56) to (ILE181) YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAI-EP | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS
4y80:I (LYS41) to (ASP177) YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAI-EP | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS
4y80:L (LYS42) to (ARG194) YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAI-EP | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS
4y80:M (ARG41) to (ARG187) YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAI-EP | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS
4y80:N (LYS33) to (ASN141) YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAI-EP | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS
4y80:S (SER56) to (ILE181) YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAI-EP | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS
4y80:W (LYS41) to (ASP177) YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAI-EP | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS
4y80:Z (LYS42) to (ARG194) YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAI-EP | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS
4y80:a (ARG41) to (ARG187) YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAI-EP | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS
4y80:b (LYS33) to (ASN141) YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAI-EP | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS
4y81:E (SER56) to (ILE181) YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAY-EP | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS
4y81:I (LYS41) to (ASP177) YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAY-EP | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS
4y81:L (LYS42) to (ARG194) YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAY-EP | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS
4y81:M (ARG41) to (ARG187) YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAY-EP | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS
4y81:N (LYS33) to (ASN141) YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAY-EP | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS
4y81:S (SER56) to (ILE181) YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAY-EP | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS
4y81:W (LYS41) to (ASP177) YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAY-EP | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS
4y81:Z (LYS42) to (ARG194) YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAY-EP | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS
4y81:a (ARG41) to (ARG187) YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAY-EP | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS
4y81:b (LYS33) to (ASN141) YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAY-EP | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS
4y82:E (SER56) to (ILE181) YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAY-EP | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS
4y82:I (LYS41) to (ASP177) YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAY-EP | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS
4y82:L (LYS42) to (ARG194) YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAY-EP | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS
4y82:M (ARG41) to (ARG187) YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAY-EP | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS
4y82:N (LYS33) to (ASN141) YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAY-EP | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS
4y82:S (SER56) to (ILE181) YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAY-EP | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS
4y82:W (LYS41) to (ASP177) YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAY-EP | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS
4y82:Z (LYS42) to (ARG194) YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAY-EP | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS
4y82:a (ARG41) to (ARG187) YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAY-EP | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS
4y82:b (LYS33) to (ASN141) YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAY-EP | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS
4y84:C (LYS61) to (LEU198) YEAST 20S PROTEASOME IN COMPLEX WITH N3-A(4,4-F2P)NLL-EP | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS
4y84:E (LYS61) to (ILE181) YEAST 20S PROTEASOME IN COMPLEX WITH N3-A(4,4-F2P)NLL-EP | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS
4y84:I (LYS41) to (ASP177) YEAST 20S PROTEASOME IN COMPLEX WITH N3-A(4,4-F2P)NLL-EP | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS
4y84:L (LYS42) to (ARG194) YEAST 20S PROTEASOME IN COMPLEX WITH N3-A(4,4-F2P)NLL-EP | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS
4y84:M (ARG41) to (ARG187) YEAST 20S PROTEASOME IN COMPLEX WITH N3-A(4,4-F2P)NLL-EP | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS
4y84:N (LYS33) to (ASN141) YEAST 20S PROTEASOME IN COMPLEX WITH N3-A(4,4-F2P)NLL-EP | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS
4y84:Q (LYS61) to (LEU198) YEAST 20S PROTEASOME IN COMPLEX WITH N3-A(4,4-F2P)NLL-EP | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS
4y84:S (LYS61) to (ILE181) YEAST 20S PROTEASOME IN COMPLEX WITH N3-A(4,4-F2P)NLL-EP | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS
4y84:W (LYS41) to (ASP177) YEAST 20S PROTEASOME IN COMPLEX WITH N3-A(4,4-F2P)NLL-EP | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS
4y84:Z (LYS42) to (ARG194) YEAST 20S PROTEASOME IN COMPLEX WITH N3-A(4,4-F2P)NLL-EP | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS
4y84:b (LYS33) to (ASN141) YEAST 20S PROTEASOME IN COMPLEX WITH N3-A(4,4-F2P)NLL-EP | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS
4y8g:C (LYS61) to (LEU198) YEAST 20S PROTEASOME IN COMPLEX WITH N3-APNLL-EP | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS
4y8g:E (LYS61) to (ILE181) YEAST 20S PROTEASOME IN COMPLEX WITH N3-APNLL-EP | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS
4y8g:I (LYS41) to (ASP177) YEAST 20S PROTEASOME IN COMPLEX WITH N3-APNLL-EP | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS
4y8g:L (LYS42) to (ARG194) YEAST 20S PROTEASOME IN COMPLEX WITH N3-APNLL-EP | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS
4y8g:M (ARG41) to (ARG187) YEAST 20S PROTEASOME IN COMPLEX WITH N3-APNLL-EP | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS
4y8g:N (LYS33) to (ASN141) YEAST 20S PROTEASOME IN COMPLEX WITH N3-APNLL-EP | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS
4y8g:Q (LYS61) to (LEU198) YEAST 20S PROTEASOME IN COMPLEX WITH N3-APNLL-EP | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS
4y8g:S (LYS61) to (ILE181) YEAST 20S PROTEASOME IN COMPLEX WITH N3-APNLL-EP | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS
4y8g:W (LYS41) to (ASP177) YEAST 20S PROTEASOME IN COMPLEX WITH N3-APNLL-EP | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS
4y8g:Z (LYS42) to (ARG194) YEAST 20S PROTEASOME IN COMPLEX WITH N3-APNLL-EP | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS
4y8g:a (ARG41) to (ARG187) YEAST 20S PROTEASOME IN COMPLEX WITH N3-APNLL-EP | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS
4y8g:b (LYS33) to (ASN141) YEAST 20S PROTEASOME IN COMPLEX WITH N3-APNLL-EP | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS
4y8h:C (LYS61) to (LEU198) YEAST 20S PROTEASOME IN COMPLEX WITH N3-APAL-EP | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS
4y8h:E (LYS61) to (ILE181) YEAST 20S PROTEASOME IN COMPLEX WITH N3-APAL-EP | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS
4y8h:I (LYS41) to (ASP177) YEAST 20S PROTEASOME IN COMPLEX WITH N3-APAL-EP | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS
4y8h:L (LYS42) to (ARG194) YEAST 20S PROTEASOME IN COMPLEX WITH N3-APAL-EP | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS
4y8h:M (ARG41) to (ARG187) YEAST 20S PROTEASOME IN COMPLEX WITH N3-APAL-EP | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS
4y8h:N (LYS33) to (ASN141) YEAST 20S PROTEASOME IN COMPLEX WITH N3-APAL-EP | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS
4y8h:Q (LYS61) to (LEU198) YEAST 20S PROTEASOME IN COMPLEX WITH N3-APAL-EP | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS
4y8h:S (LYS61) to (ILE181) YEAST 20S PROTEASOME IN COMPLEX WITH N3-APAL-EP | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS
4y8h:W (LYS41) to (ASP177) YEAST 20S PROTEASOME IN COMPLEX WITH N3-APAL-EP | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS
4y8h:Z (LYS42) to (ARG194) YEAST 20S PROTEASOME IN COMPLEX WITH N3-APAL-EP | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS
4y8h:a (ARG41) to (ARG187) YEAST 20S PROTEASOME IN COMPLEX WITH N3-APAL-EP | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS
4y8h:b (LYS33) to (ASN141) YEAST 20S PROTEASOME IN COMPLEX WITH N3-APAL-EP | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS
4y8j:E (SER56) to (ILE181) YEAST 20S PROTEASOME IN COMPLEX WITH AC-LLL-EP | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS
4y8j:I (LYS41) to (ASP177) YEAST 20S PROTEASOME IN COMPLEX WITH AC-LLL-EP | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS
4y8j:L (LYS42) to (ARG194) YEAST 20S PROTEASOME IN COMPLEX WITH AC-LLL-EP | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS
4y8j:M (ARG41) to (ARG187) YEAST 20S PROTEASOME IN COMPLEX WITH AC-LLL-EP | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS
4y8j:N (LYS33) to (ASN141) YEAST 20S PROTEASOME IN COMPLEX WITH AC-LLL-EP | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS
4y8j:S (SER56) to (ILE181) YEAST 20S PROTEASOME IN COMPLEX WITH AC-LLL-EP | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS
4y8j:W (LYS41) to (ASP177) YEAST 20S PROTEASOME IN COMPLEX WITH AC-LLL-EP | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS
4y8j:Z (LYS42) to (ARG194) YEAST 20S PROTEASOME IN COMPLEX WITH AC-LLL-EP | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS
4y8j:a (ARG41) to (ARG187) YEAST 20S PROTEASOME IN COMPLEX WITH AC-LLL-EP | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS
4y8j:b (LYS33) to (ASN141) YEAST 20S PROTEASOME IN COMPLEX WITH AC-LLL-EP | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS
4y8l:E (SER56) to (ILE181) YEAST 20S PROTEASOME IN COMPLEX WITH AC-APLL-EP | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS
4y8l:I (LYS41) to (ASP177) YEAST 20S PROTEASOME IN COMPLEX WITH AC-APLL-EP | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS
4y8l:L (LYS42) to (ARG194) YEAST 20S PROTEASOME IN COMPLEX WITH AC-APLL-EP | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS
4y8l:M (ARG41) to (ARG187) YEAST 20S PROTEASOME IN COMPLEX WITH AC-APLL-EP | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS
4y8l:N (LYS33) to (ASN141) YEAST 20S PROTEASOME IN COMPLEX WITH AC-APLL-EP | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS
4y8l:S (SER56) to (ILE181) YEAST 20S PROTEASOME IN COMPLEX WITH AC-APLL-EP | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS
4y8l:W (LYS41) to (ASP177) YEAST 20S PROTEASOME IN COMPLEX WITH AC-APLL-EP | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS
4y8l:Z (LYS42) to (ARG194) YEAST 20S PROTEASOME IN COMPLEX WITH AC-APLL-EP | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS
4y8l:a (ARG41) to (ARG187) YEAST 20S PROTEASOME IN COMPLEX WITH AC-APLL-EP | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS
4y8l:b (LYS33) to (ASN141) YEAST 20S PROTEASOME IN COMPLEX WITH AC-APLL-EP | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS
4y8m:E (SER56) to (ILE181) YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS
4y8m:I (LYS41) to (ASP177) YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS
4y8m:L (LYS42) to (ARG194) YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS
4y8m:M (ARG41) to (ARG187) YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS
4y8m:N (LYS33) to (ASN141) YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS
4y8m:S (SER56) to (ILE181) YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS
4y8m:W (LYS41) to (ASP177) YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS
4y8m:Z (LYS42) to (ARG194) YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS
4y8m:a (ARG41) to (ARG187) YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS
4y8m:b (LYS33) to (ASN141) YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS
4y8n:E (LYS61) to (ILE181) YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAE- EP | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
4y8n:I (LYS41) to (ASP177) YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAE- EP | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
4y8n:L (LYS42) to (ARG194) YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAE- EP | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
4y8n:M (ARG41) to (ARG187) YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAE- EP | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
4y8n:N (LYS33) to (ASN141) YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAE- EP | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
4y8n:S (SER56) to (ILE181) YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAE- EP | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
4y8n:W (LYS41) to (ASP177) YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAE- EP | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
4y8n:Z (LYS42) to (ARG194) YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAE- EP | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
4y8n:a (ARG41) to (ARG187) YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAE- EP | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
4y8n:b (LYS33) to (ASN141) YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAE- EP | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
4y8o:E (SER56) to (ILE181) YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAF- EP | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
4y8o:I (LYS41) to (ASP177) YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAF- EP | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
4y8o:L (LYS42) to (ARG194) YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAF- EP | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
4y8o:M (ARG41) to (ARG187) YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAF- EP | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
4y8o:N (LYS33) to (ASN141) YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAF- EP | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
4y8o:S (SER56) to (ILE181) YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAF- EP | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
4y8o:W (LYS41) to (ASP177) YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAF- EP | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
4y8o:Z (LYS42) to (ARG194) YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAF- EP | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
4y8o:a (ARG41) to (ARG187) YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAF- EP | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
4y8o:b (LYS33) to (ASN141) YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAF- EP | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
1q5q:A (LYS52) to (GLN190) THE RHODOCOCCUS 20S PROTEASOME | PROTEASOME ASSEMBLY, PRO-PEPTIDE, INTER-SUBUNIT CONTACTS, RHODOCOCCUS ERYTHROPOLIS, HYDROLASE
1q5q:B (LYS52) to (GLN190) THE RHODOCOCCUS 20S PROTEASOME | PROTEASOME ASSEMBLY, PRO-PEPTIDE, INTER-SUBUNIT CONTACTS, RHODOCOCCUS ERYTHROPOLIS, HYDROLASE
1q5q:C (LYS52) to (GLN190) THE RHODOCOCCUS 20S PROTEASOME | PROTEASOME ASSEMBLY, PRO-PEPTIDE, INTER-SUBUNIT CONTACTS, RHODOCOCCUS ERYTHROPOLIS, HYDROLASE
1q5q:D (LYS52) to (GLN190) THE RHODOCOCCUS 20S PROTEASOME | PROTEASOME ASSEMBLY, PRO-PEPTIDE, INTER-SUBUNIT CONTACTS, RHODOCOCCUS ERYTHROPOLIS, HYDROLASE
1q5q:E (LYS52) to (GLN190) THE RHODOCOCCUS 20S PROTEASOME | PROTEASOME ASSEMBLY, PRO-PEPTIDE, INTER-SUBUNIT CONTACTS, RHODOCOCCUS ERYTHROPOLIS, HYDROLASE
1q5q:F (LYS52) to (GLN190) THE RHODOCOCCUS 20S PROTEASOME | PROTEASOME ASSEMBLY, PRO-PEPTIDE, INTER-SUBUNIT CONTACTS, RHODOCOCCUS ERYTHROPOLIS, HYDROLASE
1q5q:G (LYS52) to (GLN190) THE RHODOCOCCUS 20S PROTEASOME | PROTEASOME ASSEMBLY, PRO-PEPTIDE, INTER-SUBUNIT CONTACTS, RHODOCOCCUS ERYTHROPOLIS, HYDROLASE
4y8q:E (SER56) to (ILE181) YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAY- EP | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
4y8q:I (LYS41) to (ASP177) YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAY- EP | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
4y8q:L (LYS42) to (ARG194) YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAY- EP | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
4y8q:M (ARG41) to (ARG187) YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAY- EP | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
4y8q:N (LYS33) to (ASN141) YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAY- EP | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
4y8q:S (SER56) to (ILE181) YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAY- EP | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
4y8q:W (LYS41) to (ASP177) YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAY- EP | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
4y8q:Z (LYS42) to (ARG194) YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAY- EP | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
4y8q:a (ARG41) to (ARG187) YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAY- EP | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
4y8q:b (LYS33) to (ASN141) YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAY- EP | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
4y8s:E (LYS61) to (ILE181) YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-LAE-EP | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
4y8s:L (LYS42) to (ARG194) YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-LAE-EP | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
4y8s:M (ARG41) to (ARG187) YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-LAE-EP | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
4y8s:N (LYS33) to (ASN141) YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-LAE-EP | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
4y8s:S (LYS61) to (ILE181) YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-LAE-EP | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
4y8s:Z (LYS42) to (ARG194) YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-LAE-EP | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
4y8s:a (ARG41) to (ARG187) YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-LAE-EP | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
4y8s:b (LYS33) to (ASN141) YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-LAE-EP | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
4y8t:E (LYS61) to (ILE181) YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAE-EP | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
4y8t:I (LYS41) to (ASP177) YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAE-EP | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
4y8t:L (LYS42) to (ARG194) YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAE-EP | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
4y8t:M (ARG41) to (ARG187) YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAE-EP | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
4y8t:N (LYS33) to (ASN141) YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAE-EP | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
4y8t:S (LYS61) to (ILE181) YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAE-EP | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
4y8t:W (LYS41) to (ASP177) YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAE-EP | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
4y8t:Z (LYS42) to (ARG194) YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAE-EP | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
4y8t:a (ARG41) to (ARG187) YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAE-EP | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
4y8t:b (LYS33) to (ASN141) YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAE-EP | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
4y8u:E (LYS61) to (ILE181) YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAD-EP | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
4y8u:I (LYS41) to (ASP177) YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAD-EP | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
4y8u:L (LYS42) to (ARG194) YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAD-EP | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
4y8u:M (ARG41) to (ARG187) YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAD-EP | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
4y8u:N (LYS33) to (ASN141) YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAD-EP | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
4y8u:S (LYS61) to (ILE181) YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAD-EP | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
4y8u:W (LYS41) to (ASP177) YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAD-EP | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
4y8u:Z (LYS42) to (ARG194) YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAD-EP | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
4y8u:a (ARG41) to (ARG187) YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAD-EP | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
4y8u:b (LYS33) to (ASN141) YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAD-EP | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
4y9y:E (SER56) to (ILE181) YEAST 20S PROTEASOME BETA2-H116E MUTANT | HYDROLASE, PROTEASOME, MUTANT, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4y9y:I (LYS41) to (ASP177) YEAST 20S PROTEASOME BETA2-H116E MUTANT | HYDROLASE, PROTEASOME, MUTANT, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4y9y:L (LYS42) to (ARG194) YEAST 20S PROTEASOME BETA2-H116E MUTANT | HYDROLASE, PROTEASOME, MUTANT, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4y9y:M (ARG41) to (ARG187) YEAST 20S PROTEASOME BETA2-H116E MUTANT | HYDROLASE, PROTEASOME, MUTANT, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4y9y:N (LYS33) to (ASN141) YEAST 20S PROTEASOME BETA2-H116E MUTANT | HYDROLASE, PROTEASOME, MUTANT, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4y9y:S (SER56) to (ILE181) YEAST 20S PROTEASOME BETA2-H116E MUTANT | HYDROLASE, PROTEASOME, MUTANT, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4y9y:W (LYS41) to (ASP177) YEAST 20S PROTEASOME BETA2-H116E MUTANT | HYDROLASE, PROTEASOME, MUTANT, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4y9y:Z (LYS42) to (ARG194) YEAST 20S PROTEASOME BETA2-H116E MUTANT | HYDROLASE, PROTEASOME, MUTANT, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4y9y:a (ARG41) to (ARG187) YEAST 20S PROTEASOME BETA2-H116E MUTANT | HYDROLASE, PROTEASOME, MUTANT, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4y9y:b (LYS33) to (ASN141) YEAST 20S PROTEASOME BETA2-H116E MUTANT | HYDROLASE, PROTEASOME, MUTANT, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4y9z:E (SER56) to (ILE181) YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-LAE-EP | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
4y9z:I (LYS41) to (ASP177) YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-LAE-EP | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
4y9z:L (LYS42) to (ARG194) YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-LAE-EP | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
4y9z:M (ARG41) to (ARG187) YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-LAE-EP | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
4y9z:N (LYS33) to (ASN141) YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-LAE-EP | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
4y9z:S (SER56) to (ILE181) YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-LAE-EP | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
4y9z:W (LYS41) to (ASP177) YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-LAE-EP | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
4y9z:Z (LYS42) to (ARG194) YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-LAE-EP | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
4y9z:a (ARG41) to (ARG187) YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-LAE-EP | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
4y9z:b (LYS33) to (ASN141) YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-LAE-EP | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
4ya0:E (LYS61) to (ILE181) YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-PAE-EP | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
4ya0:I (LYS41) to (ASP177) YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-PAE-EP | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
4ya0:L (LYS42) to (ARG194) YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-PAE-EP | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
4ya0:M (ARG41) to (ARG187) YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-PAE-EP | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
4ya0:N (LYS33) to (ASN141) YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-PAE-EP | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
4ya0:S (LYS61) to (ILE181) YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-PAE-EP | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
4ya0:W (LYS41) to (ASP177) YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-PAE-EP | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
4ya0:Z (LYS42) to (ARG194) YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-PAE-EP | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
4ya0:a (ARG41) to (ARG187) YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-PAE-EP | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
4ya0:b (LYS33) to (ASN141) YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-PAE-EP | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
4ya1:E (LYS61) to (ILE181) YEAST 20S PROTEASOME BETA2-H116N MUTANT | HYDROLASE, PROTEASOME, MUTANT, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4ya1:I (LYS41) to (ASP177) YEAST 20S PROTEASOME BETA2-H116N MUTANT | HYDROLASE, PROTEASOME, MUTANT, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4ya1:L (LYS42) to (ARG194) YEAST 20S PROTEASOME BETA2-H116N MUTANT | HYDROLASE, PROTEASOME, MUTANT, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4ya1:M (ARG41) to (ARG187) YEAST 20S PROTEASOME BETA2-H116N MUTANT | HYDROLASE, PROTEASOME, MUTANT, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4ya1:N (LYS33) to (ASN141) YEAST 20S PROTEASOME BETA2-H116N MUTANT | HYDROLASE, PROTEASOME, MUTANT, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4ya1:S (LYS61) to (ILE181) YEAST 20S PROTEASOME BETA2-H116N MUTANT | HYDROLASE, PROTEASOME, MUTANT, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4ya1:W (LYS41) to (ASP177) YEAST 20S PROTEASOME BETA2-H116N MUTANT | HYDROLASE, PROTEASOME, MUTANT, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4ya1:Z (LYS42) to (ARG194) YEAST 20S PROTEASOME BETA2-H116N MUTANT | HYDROLASE, PROTEASOME, MUTANT, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4ya1:a (ARG41) to (ARG187) YEAST 20S PROTEASOME BETA2-H116N MUTANT | HYDROLASE, PROTEASOME, MUTANT, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4ya1:b (LYS33) to (ASN141) YEAST 20S PROTEASOME BETA2-H116N MUTANT | HYDROLASE, PROTEASOME, MUTANT, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4ya2:E (LYS61) to (ILE181) YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-LAE-EP | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
4ya2:I (LYS41) to (ASP177) YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-LAE-EP | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
4ya2:L (LYS42) to (ARG194) YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-LAE-EP | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
4ya2:M (ARG41) to (ARG187) YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-LAE-EP | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
4ya2:N (LYS33) to (ASN141) YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-LAE-EP | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
4ya2:S (LYS61) to (ILE181) YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-LAE-EP | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
4ya2:W (LYS41) to (ASP177) YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-LAE-EP | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
4ya2:Z (LYS42) to (ARG194) YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-LAE-EP | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
4ya2:a (ARG41) to (ARG187) YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-LAE-EP | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
4ya2:b (LYS33) to (ASN141) YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-LAE-EP | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
4ya3:E (SER56) to (ILE181) YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-PAE-EP | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
4ya3:I (LYS41) to (ASP177) YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-PAE-EP | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
4ya3:L (LYS42) to (ARG194) YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-PAE-EP | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
4ya3:M (ARG41) to (ARG187) YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-PAE-EP | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
4ya3:N (LYS33) to (ASN141) YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-PAE-EP | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
4ya3:S (SER56) to (ILE181) YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-PAE-EP | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
4ya3:W (LYS41) to (ASP177) YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-PAE-EP | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
4ya3:Z (LYS42) to (ARG194) YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-PAE-EP | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
4ya3:a (ARG41) to (ARG187) YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-PAE-EP | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
4ya3:b (LYS33) to (ASN141) YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-PAE-EP | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
4ya4:E (LYS61) to (ILE181) YEAST 20S PROTEASOME BETA2-H114D MUTANT | HYDROLASE, PROTEASOME, MUTANT, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4ya4:I (LYS41) to (ASP177) YEAST 20S PROTEASOME BETA2-H114D MUTANT | HYDROLASE, PROTEASOME, MUTANT, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4ya4:L (LYS42) to (ARG194) YEAST 20S PROTEASOME BETA2-H114D MUTANT | HYDROLASE, PROTEASOME, MUTANT, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4ya4:M (ARG41) to (ARG187) YEAST 20S PROTEASOME BETA2-H114D MUTANT | HYDROLASE, PROTEASOME, MUTANT, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4ya4:N (LYS33) to (ASN141) YEAST 20S PROTEASOME BETA2-H114D MUTANT | HYDROLASE, PROTEASOME, MUTANT, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4ya4:S (LYS61) to (ILE181) YEAST 20S PROTEASOME BETA2-H114D MUTANT | HYDROLASE, PROTEASOME, MUTANT, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4ya4:W (LYS41) to (ASP177) YEAST 20S PROTEASOME BETA2-H114D MUTANT | HYDROLASE, PROTEASOME, MUTANT, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4ya4:Z (LYS42) to (ARG194) YEAST 20S PROTEASOME BETA2-H114D MUTANT | HYDROLASE, PROTEASOME, MUTANT, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4ya4:a (ARG41) to (ARG187) YEAST 20S PROTEASOME BETA2-H114D MUTANT | HYDROLASE, PROTEASOME, MUTANT, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4ya4:b (LYS33) to (ASN141) YEAST 20S PROTEASOME BETA2-H114D MUTANT | HYDROLASE, PROTEASOME, MUTANT, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4ya7:E (SER56) to (ILE181) YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAE-EP | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
4ya7:I (LYS41) to (ASP177) YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAE-EP | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
4ya7:L (LYS42) to (ARG194) YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAE-EP | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
4ya7:M (ARG41) to (ARG187) YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAE-EP | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
4ya7:N (LYS33) to (ASN141) YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAE-EP | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
4ya7:S (SER56) to (ILE181) YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAE-EP | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
4ya7:W (LYS41) to (ASP177) YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAE-EP | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
4ya7:Z (LYS42) to (ARG194) YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAE-EP | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
4ya7:a (ARG41) to (ARG187) YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAE-EP | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
4ya7:b (LYS33) to (ASN141) YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAE-EP | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
4ya9:E (SER56) to (ILE181) YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAD-EP | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
4ya9:I (LYS41) to (ASP177) YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAD-EP | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
4ya9:L (LYS42) to (ARG194) YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAD-EP | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
4ya9:M (ARG41) to (ARG187) YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAD-EP | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
4ya9:N (LYS33) to (ASN141) YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAD-EP | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
4ya9:S (SER56) to (ILE181) YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAD-EP | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
4ya9:W (LYS41) to (ASP177) YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAD-EP | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
4ya9:Z (LYS42) to (ARG194) YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAD-EP | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
4ya9:a (ARG41) to (ARG187) YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAD-EP | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
4ya9:b (LYS33) to (ASN141) YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAD-EP | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
3h4p:E (LYS67) to (ASN202) PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII | 20S, PROTEASOME, CORE PARTICLE, HYDROLASE, PROTEASE, THREONINE PROTEASE
3h4p:a (LYS39) to (ARG174) PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII | 20S, PROTEASOME, CORE PARTICLE, HYDROLASE, PROTEASE, THREONINE PROTEASE
3h4p:b (LYS39) to (ASP175) PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII | 20S, PROTEASOME, CORE PARTICLE, HYDROLASE, PROTEASE, THREONINE PROTEASE
3h4p:c (LYS39) to (ARG174) PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII | 20S, PROTEASOME, CORE PARTICLE, HYDROLASE, PROTEASE, THREONINE PROTEASE
3h4p:d (LYS39) to (ARG174) PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII | 20S, PROTEASOME, CORE PARTICLE, HYDROLASE, PROTEASE, THREONINE PROTEASE
3h4p:e (LYS39) to (ARG174) PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII | 20S, PROTEASOME, CORE PARTICLE, HYDROLASE, PROTEASE, THREONINE PROTEASE
3h4p:f (LYS39) to (ARG174) PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII | 20S, PROTEASOME, CORE PARTICLE, HYDROLASE, PROTEASE, THREONINE PROTEASE
3h4p:g (LYS39) to (ARG174) PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII | 20S, PROTEASOME, CORE PARTICLE, HYDROLASE, PROTEASE, THREONINE PROTEASE
3h4p:H (LYS67) to (ASN202) PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII | 20S, PROTEASOME, CORE PARTICLE, HYDROLASE, PROTEASE, THREONINE PROTEASE
3h4p:h (LYS39) to (ARG174) PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII | 20S, PROTEASOME, CORE PARTICLE, HYDROLASE, PROTEASE, THREONINE PROTEASE
3h4p:i (LYS39) to (ARG174) PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII | 20S, PROTEASOME, CORE PARTICLE, HYDROLASE, PROTEASE, THREONINE PROTEASE
3h4p:j (LYS39) to (ASP175) PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII | 20S, PROTEASOME, CORE PARTICLE, HYDROLASE, PROTEASE, THREONINE PROTEASE
3h4p:k (LYS39) to (ARG174) PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII | 20S, PROTEASOME, CORE PARTICLE, HYDROLASE, PROTEASE, THREONINE PROTEASE
3h4p:l (LYS39) to (ASP175) PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII | 20S, PROTEASOME, CORE PARTICLE, HYDROLASE, PROTEASE, THREONINE PROTEASE
3h4p:m (LYS39) to (ARG174) PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII | 20S, PROTEASOME, CORE PARTICLE, HYDROLASE, PROTEASE, THREONINE PROTEASE
3h4p:n (LYS39) to (ARG174) PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII | 20S, PROTEASOME, CORE PARTICLE, HYDROLASE, PROTEASE, THREONINE PROTEASE
3h6f:C (LYS333) to (SER479) CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR HT1171 | BINDING SITES, OXAZOLIDIN-2-ONE, CRYSTALLOGRAPHY, X-RAY, MYCOBACTERIUM TUBERCULOSIS, PROTEASE INHIBITORS, PROTEASOME ENDOPEPTIDASE COMPLEX, PROTEIN SUBUNITS, SUBSTRATE SPECIFICITY, HYDROLASE, PROTEASOME
3h6f:E (LYS333) to (SER479) CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR HT1171 | BINDING SITES, OXAZOLIDIN-2-ONE, CRYSTALLOGRAPHY, X-RAY, MYCOBACTERIUM TUBERCULOSIS, PROTEASE INHIBITORS, PROTEASOME ENDOPEPTIDASE COMPLEX, PROTEIN SUBUNITS, SUBSTRATE SPECIFICITY, HYDROLASE, PROTEASOME
3h6f:G (LYS333) to (SER479) CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR HT1171 | BINDING SITES, OXAZOLIDIN-2-ONE, CRYSTALLOGRAPHY, X-RAY, MYCOBACTERIUM TUBERCULOSIS, PROTEASE INHIBITORS, PROTEASOME ENDOPEPTIDASE COMPLEX, PROTEIN SUBUNITS, SUBSTRATE SPECIFICITY, HYDROLASE, PROTEASOME
3h6f:H (LYS333) to (SER479) CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR HT1171 | BINDING SITES, OXAZOLIDIN-2-ONE, CRYSTALLOGRAPHY, X-RAY, MYCOBACTERIUM TUBERCULOSIS, PROTEASE INHIBITORS, PROTEASOME ENDOPEPTIDASE COMPLEX, PROTEIN SUBUNITS, SUBSTRATE SPECIFICITY, HYDROLASE, PROTEASOME
3h6f:J (LYS333) to (SER479) CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR HT1171 | BINDING SITES, OXAZOLIDIN-2-ONE, CRYSTALLOGRAPHY, X-RAY, MYCOBACTERIUM TUBERCULOSIS, PROTEASE INHIBITORS, PROTEASOME ENDOPEPTIDASE COMPLEX, PROTEIN SUBUNITS, SUBSTRATE SPECIFICITY, HYDROLASE, PROTEASOME
3h6f:L (LYS333) to (ASP476) CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR HT1171 | BINDING SITES, OXAZOLIDIN-2-ONE, CRYSTALLOGRAPHY, X-RAY, MYCOBACTERIUM TUBERCULOSIS, PROTEASE INHIBITORS, PROTEASOME ENDOPEPTIDASE COMPLEX, PROTEIN SUBUNITS, SUBSTRATE SPECIFICITY, HYDROLASE, PROTEASOME
3h6f:N (LYS333) to (SER479) CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR HT1171 | BINDING SITES, OXAZOLIDIN-2-ONE, CRYSTALLOGRAPHY, X-RAY, MYCOBACTERIUM TUBERCULOSIS, PROTEASE INHIBITORS, PROTEASOME ENDOPEPTIDASE COMPLEX, PROTEIN SUBUNITS, SUBSTRATE SPECIFICITY, HYDROLASE, PROTEASOME
3h6f:P (LYS333) to (ASP477) CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR HT1171 | BINDING SITES, OXAZOLIDIN-2-ONE, CRYSTALLOGRAPHY, X-RAY, MYCOBACTERIUM TUBERCULOSIS, PROTEASE INHIBITORS, PROTEASOME ENDOPEPTIDASE COMPLEX, PROTEIN SUBUNITS, SUBSTRATE SPECIFICITY, HYDROLASE, PROTEASOME
3h6f:R (LYS333) to (SER479) CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR HT1171 | BINDING SITES, OXAZOLIDIN-2-ONE, CRYSTALLOGRAPHY, X-RAY, MYCOBACTERIUM TUBERCULOSIS, PROTEASE INHIBITORS, PROTEASOME ENDOPEPTIDASE COMPLEX, PROTEIN SUBUNITS, SUBSTRATE SPECIFICITY, HYDROLASE, PROTEASOME
3h6f:T (LYS333) to (ASP477) CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR HT1171 | BINDING SITES, OXAZOLIDIN-2-ONE, CRYSTALLOGRAPHY, X-RAY, MYCOBACTERIUM TUBERCULOSIS, PROTEASE INHIBITORS, PROTEASOME ENDOPEPTIDASE COMPLEX, PROTEIN SUBUNITS, SUBSTRATE SPECIFICITY, HYDROLASE, PROTEASOME
3h6f:V (LYS333) to (SER479) CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR HT1171 | BINDING SITES, OXAZOLIDIN-2-ONE, CRYSTALLOGRAPHY, X-RAY, MYCOBACTERIUM TUBERCULOSIS, PROTEASE INHIBITORS, PROTEASOME ENDOPEPTIDASE COMPLEX, PROTEIN SUBUNITS, SUBSTRATE SPECIFICITY, HYDROLASE, PROTEASOME
3h6f:X (LYS333) to (SER479) CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR HT1171 | BINDING SITES, OXAZOLIDIN-2-ONE, CRYSTALLOGRAPHY, X-RAY, MYCOBACTERIUM TUBERCULOSIS, PROTEASE INHIBITORS, PROTEASOME ENDOPEPTIDASE COMPLEX, PROTEIN SUBUNITS, SUBSTRATE SPECIFICITY, HYDROLASE, PROTEASOME
3h6f:Z (LYS333) to (ASP476) CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR HT1171 | BINDING SITES, OXAZOLIDIN-2-ONE, CRYSTALLOGRAPHY, X-RAY, MYCOBACTERIUM TUBERCULOSIS, PROTEASE INHIBITORS, PROTEASOME ENDOPEPTIDASE COMPLEX, PROTEIN SUBUNITS, SUBSTRATE SPECIFICITY, HYDROLASE, PROTEASOME
3h6f:2 (LYS333) to (ASP477) CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR HT1171 | BINDING SITES, OXAZOLIDIN-2-ONE, CRYSTALLOGRAPHY, X-RAY, MYCOBACTERIUM TUBERCULOSIS, PROTEASE INHIBITORS, PROTEASOME ENDOPEPTIDASE COMPLEX, PROTEIN SUBUNITS, SUBSTRATE SPECIFICITY, HYDROLASE, PROTEASOME
3h6i:C (LYS333) to (SER479) CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR GL1 | BINDING SITES, OXAZOLIDIN-2-ONE, CRYSTALLOGRAPHY, X-RAY, MYCOBACTERIUM TUBERCULOSIS, PROTEASE INHIBITORS, PROTEASOME ENDOPEPTIDASE COMPLEX, PROTEIN SUBUNITS, SUBSTRATE SPECIFICITY, HYDROLASE, PROTEASOME
3h6i:E (LYS333) to (SER479) CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR GL1 | BINDING SITES, OXAZOLIDIN-2-ONE, CRYSTALLOGRAPHY, X-RAY, MYCOBACTERIUM TUBERCULOSIS, PROTEASE INHIBITORS, PROTEASOME ENDOPEPTIDASE COMPLEX, PROTEIN SUBUNITS, SUBSTRATE SPECIFICITY, HYDROLASE, PROTEASOME
3h6i:G (LYS333) to (SER479) CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR GL1 | BINDING SITES, OXAZOLIDIN-2-ONE, CRYSTALLOGRAPHY, X-RAY, MYCOBACTERIUM TUBERCULOSIS, PROTEASE INHIBITORS, PROTEASOME ENDOPEPTIDASE COMPLEX, PROTEIN SUBUNITS, SUBSTRATE SPECIFICITY, HYDROLASE, PROTEASOME
3h6i:H (LYS333) to (SER479) CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR GL1 | BINDING SITES, OXAZOLIDIN-2-ONE, CRYSTALLOGRAPHY, X-RAY, MYCOBACTERIUM TUBERCULOSIS, PROTEASE INHIBITORS, PROTEASOME ENDOPEPTIDASE COMPLEX, PROTEIN SUBUNITS, SUBSTRATE SPECIFICITY, HYDROLASE, PROTEASOME
3h6i:J (LYS333) to (SER479) CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR GL1 | BINDING SITES, OXAZOLIDIN-2-ONE, CRYSTALLOGRAPHY, X-RAY, MYCOBACTERIUM TUBERCULOSIS, PROTEASE INHIBITORS, PROTEASOME ENDOPEPTIDASE COMPLEX, PROTEIN SUBUNITS, SUBSTRATE SPECIFICITY, HYDROLASE, PROTEASOME
3h6i:L (LYS333) to (ASP477) CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR GL1 | BINDING SITES, OXAZOLIDIN-2-ONE, CRYSTALLOGRAPHY, X-RAY, MYCOBACTERIUM TUBERCULOSIS, PROTEASE INHIBITORS, PROTEASOME ENDOPEPTIDASE COMPLEX, PROTEIN SUBUNITS, SUBSTRATE SPECIFICITY, HYDROLASE, PROTEASOME
3h6i:N (LYS333) to (ASP477) CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR GL1 | BINDING SITES, OXAZOLIDIN-2-ONE, CRYSTALLOGRAPHY, X-RAY, MYCOBACTERIUM TUBERCULOSIS, PROTEASE INHIBITORS, PROTEASOME ENDOPEPTIDASE COMPLEX, PROTEIN SUBUNITS, SUBSTRATE SPECIFICITY, HYDROLASE, PROTEASOME
3h6i:P (LYS333) to (SER479) CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR GL1 | BINDING SITES, OXAZOLIDIN-2-ONE, CRYSTALLOGRAPHY, X-RAY, MYCOBACTERIUM TUBERCULOSIS, PROTEASE INHIBITORS, PROTEASOME ENDOPEPTIDASE COMPLEX, PROTEIN SUBUNITS, SUBSTRATE SPECIFICITY, HYDROLASE, PROTEASOME
3h6i:R (LYS333) to (SER479) CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR GL1 | BINDING SITES, OXAZOLIDIN-2-ONE, CRYSTALLOGRAPHY, X-RAY, MYCOBACTERIUM TUBERCULOSIS, PROTEASE INHIBITORS, PROTEASOME ENDOPEPTIDASE COMPLEX, PROTEIN SUBUNITS, SUBSTRATE SPECIFICITY, HYDROLASE, PROTEASOME
3h6i:T (LYS333) to (ASP477) CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR GL1 | BINDING SITES, OXAZOLIDIN-2-ONE, CRYSTALLOGRAPHY, X-RAY, MYCOBACTERIUM TUBERCULOSIS, PROTEASE INHIBITORS, PROTEASOME ENDOPEPTIDASE COMPLEX, PROTEIN SUBUNITS, SUBSTRATE SPECIFICITY, HYDROLASE, PROTEASOME
3h6i:V (LYS333) to (SER479) CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR GL1 | BINDING SITES, OXAZOLIDIN-2-ONE, CRYSTALLOGRAPHY, X-RAY, MYCOBACTERIUM TUBERCULOSIS, PROTEASE INHIBITORS, PROTEASOME ENDOPEPTIDASE COMPLEX, PROTEIN SUBUNITS, SUBSTRATE SPECIFICITY, HYDROLASE, PROTEASOME
3h6i:X (LYS333) to (SER479) CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR GL1 | BINDING SITES, OXAZOLIDIN-2-ONE, CRYSTALLOGRAPHY, X-RAY, MYCOBACTERIUM TUBERCULOSIS, PROTEASE INHIBITORS, PROTEASOME ENDOPEPTIDASE COMPLEX, PROTEIN SUBUNITS, SUBSTRATE SPECIFICITY, HYDROLASE, PROTEASOME
3h6i:Z (LYS333) to (SER479) CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR GL1 | BINDING SITES, OXAZOLIDIN-2-ONE, CRYSTALLOGRAPHY, X-RAY, MYCOBACTERIUM TUBERCULOSIS, PROTEASE INHIBITORS, PROTEASOME ENDOPEPTIDASE COMPLEX, PROTEIN SUBUNITS, SUBSTRATE SPECIFICITY, HYDROLASE, PROTEASOME
3h6i:2 (LYS333) to (SER479) CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR GL1 | BINDING SITES, OXAZOLIDIN-2-ONE, CRYSTALLOGRAPHY, X-RAY, MYCOBACTERIUM TUBERCULOSIS, PROTEASE INHIBITORS, PROTEASOME ENDOPEPTIDASE COMPLEX, PROTEIN SUBUNITS, SUBSTRATE SPECIFICITY, HYDROLASE, PROTEASOME
4jsq:E (LYS61) to (ILE181) YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4E | UPS, PROTEASOME, DRUG DISCOVERY, NON-COVALENT REVERSIBLE INHIBITION, BIVALENCE, TMC-95A DERIVATIVES, NTN HYDROLASE, NON-LYSOSOMAL PROTEIN BREAKDOWN, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4jsq:I (LYS41) to (ASP177) YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4E | UPS, PROTEASOME, DRUG DISCOVERY, NON-COVALENT REVERSIBLE INHIBITION, BIVALENCE, TMC-95A DERIVATIVES, NTN HYDROLASE, NON-LYSOSOMAL PROTEIN BREAKDOWN, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4jsq:L (LYS42) to (ARG194) YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4E | UPS, PROTEASOME, DRUG DISCOVERY, NON-COVALENT REVERSIBLE INHIBITION, BIVALENCE, TMC-95A DERIVATIVES, NTN HYDROLASE, NON-LYSOSOMAL PROTEIN BREAKDOWN, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4jsq:M (ARG41) to (ARG187) YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4E | UPS, PROTEASOME, DRUG DISCOVERY, NON-COVALENT REVERSIBLE INHIBITION, BIVALENCE, TMC-95A DERIVATIVES, NTN HYDROLASE, NON-LYSOSOMAL PROTEIN BREAKDOWN, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4jsq:N (LYS33) to (ASN141) YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4E | UPS, PROTEASOME, DRUG DISCOVERY, NON-COVALENT REVERSIBLE INHIBITION, BIVALENCE, TMC-95A DERIVATIVES, NTN HYDROLASE, NON-LYSOSOMAL PROTEIN BREAKDOWN, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4jsq:S (LYS61) to (ILE181) YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4E | UPS, PROTEASOME, DRUG DISCOVERY, NON-COVALENT REVERSIBLE INHIBITION, BIVALENCE, TMC-95A DERIVATIVES, NTN HYDROLASE, NON-LYSOSOMAL PROTEIN BREAKDOWN, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4jsq:W (LYS41) to (ASP177) YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4E | UPS, PROTEASOME, DRUG DISCOVERY, NON-COVALENT REVERSIBLE INHIBITION, BIVALENCE, TMC-95A DERIVATIVES, NTN HYDROLASE, NON-LYSOSOMAL PROTEIN BREAKDOWN, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4jsq:Z (LYS42) to (ARG194) YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4E | UPS, PROTEASOME, DRUG DISCOVERY, NON-COVALENT REVERSIBLE INHIBITION, BIVALENCE, TMC-95A DERIVATIVES, NTN HYDROLASE, NON-LYSOSOMAL PROTEIN BREAKDOWN, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4jsq:a (ARG41) to (ARG187) YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4E | UPS, PROTEASOME, DRUG DISCOVERY, NON-COVALENT REVERSIBLE INHIBITION, BIVALENCE, TMC-95A DERIVATIVES, NTN HYDROLASE, NON-LYSOSOMAL PROTEIN BREAKDOWN, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4jsq:b (LYS33) to (ASN141) YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4E | UPS, PROTEASOME, DRUG DISCOVERY, NON-COVALENT REVERSIBLE INHIBITION, BIVALENCE, TMC-95A DERIVATIVES, NTN HYDROLASE, NON-LYSOSOMAL PROTEIN BREAKDOWN, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4jsu:E (LYS61) to (ILE181) YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:3A | UPS, PROTEASOME, DRUG DISCOVERY, NON-COVALENT REVERSIBLE INHIBITION, BIVALENCE, TMC-95A DERIVATIVES, NTN HYDROLASE, NON-LYSOSOMAL PROTEIN BREAKDOWN, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4jsu:I (LYS41) to (ASP177) YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:3A | UPS, PROTEASOME, DRUG DISCOVERY, NON-COVALENT REVERSIBLE INHIBITION, BIVALENCE, TMC-95A DERIVATIVES, NTN HYDROLASE, NON-LYSOSOMAL PROTEIN BREAKDOWN, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4jsu:J (LYS34) to (LYS170) YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:3A | UPS, PROTEASOME, DRUG DISCOVERY, NON-COVALENT REVERSIBLE INHIBITION, BIVALENCE, TMC-95A DERIVATIVES, NTN HYDROLASE, NON-LYSOSOMAL PROTEIN BREAKDOWN, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4jsu:L (LYS42) to (ARG194) YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:3A | UPS, PROTEASOME, DRUG DISCOVERY, NON-COVALENT REVERSIBLE INHIBITION, BIVALENCE, TMC-95A DERIVATIVES, NTN HYDROLASE, NON-LYSOSOMAL PROTEIN BREAKDOWN, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4jsu:M (ARG41) to (ARG187) YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:3A | UPS, PROTEASOME, DRUG DISCOVERY, NON-COVALENT REVERSIBLE INHIBITION, BIVALENCE, TMC-95A DERIVATIVES, NTN HYDROLASE, NON-LYSOSOMAL PROTEIN BREAKDOWN, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4jsu:N (LYS33) to (ASN141) YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:3A | UPS, PROTEASOME, DRUG DISCOVERY, NON-COVALENT REVERSIBLE INHIBITION, BIVALENCE, TMC-95A DERIVATIVES, NTN HYDROLASE, NON-LYSOSOMAL PROTEIN BREAKDOWN, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4jsu:S (LYS61) to (ILE181) YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:3A | UPS, PROTEASOME, DRUG DISCOVERY, NON-COVALENT REVERSIBLE INHIBITION, BIVALENCE, TMC-95A DERIVATIVES, NTN HYDROLASE, NON-LYSOSOMAL PROTEIN BREAKDOWN, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4jsu:W (LYS41) to (ASP177) YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:3A | UPS, PROTEASOME, DRUG DISCOVERY, NON-COVALENT REVERSIBLE INHIBITION, BIVALENCE, TMC-95A DERIVATIVES, NTN HYDROLASE, NON-LYSOSOMAL PROTEIN BREAKDOWN, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4jsu:X (LYS34) to (LYS170) YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:3A | UPS, PROTEASOME, DRUG DISCOVERY, NON-COVALENT REVERSIBLE INHIBITION, BIVALENCE, TMC-95A DERIVATIVES, NTN HYDROLASE, NON-LYSOSOMAL PROTEIN BREAKDOWN, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4jsu:Z (LYS42) to (ARG194) YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:3A | UPS, PROTEASOME, DRUG DISCOVERY, NON-COVALENT REVERSIBLE INHIBITION, BIVALENCE, TMC-95A DERIVATIVES, NTN HYDROLASE, NON-LYSOSOMAL PROTEIN BREAKDOWN, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4jsu:a (ARG41) to (ARG187) YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:3A | UPS, PROTEASOME, DRUG DISCOVERY, NON-COVALENT REVERSIBLE INHIBITION, BIVALENCE, TMC-95A DERIVATIVES, NTN HYDROLASE, NON-LYSOSOMAL PROTEIN BREAKDOWN, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4jsu:b (LYS33) to (ASN141) YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:3A | UPS, PROTEASOME, DRUG DISCOVERY, NON-COVALENT REVERSIBLE INHIBITION, BIVALENCE, TMC-95A DERIVATIVES, NTN HYDROLASE, NON-LYSOSOMAL PROTEIN BREAKDOWN, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4jt0:E (LYS61) to (ILE181) YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4A | UPS, PROTEASOME, DRUG DISCOVERY, NON-COVALENT REVERSIBLE INHIBITION, BIVALENCE, TMC-95A DERIVATIVES, NTN HYDROLASE, NON-LYSOSOMAL PROTEIN BREAKDOWN, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4jt0:I (LYS41) to (ASP177) YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4A | UPS, PROTEASOME, DRUG DISCOVERY, NON-COVALENT REVERSIBLE INHIBITION, BIVALENCE, TMC-95A DERIVATIVES, NTN HYDROLASE, NON-LYSOSOMAL PROTEIN BREAKDOWN, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4jt0:J (LYS34) to (LYS170) YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4A | UPS, PROTEASOME, DRUG DISCOVERY, NON-COVALENT REVERSIBLE INHIBITION, BIVALENCE, TMC-95A DERIVATIVES, NTN HYDROLASE, NON-LYSOSOMAL PROTEIN BREAKDOWN, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4jt0:L (LYS42) to (ARG194) YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4A | UPS, PROTEASOME, DRUG DISCOVERY, NON-COVALENT REVERSIBLE INHIBITION, BIVALENCE, TMC-95A DERIVATIVES, NTN HYDROLASE, NON-LYSOSOMAL PROTEIN BREAKDOWN, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4jt0:N (LYS33) to (ASN141) YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4A | UPS, PROTEASOME, DRUG DISCOVERY, NON-COVALENT REVERSIBLE INHIBITION, BIVALENCE, TMC-95A DERIVATIVES, NTN HYDROLASE, NON-LYSOSOMAL PROTEIN BREAKDOWN, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4jt0:S (LYS61) to (ILE181) YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4A | UPS, PROTEASOME, DRUG DISCOVERY, NON-COVALENT REVERSIBLE INHIBITION, BIVALENCE, TMC-95A DERIVATIVES, NTN HYDROLASE, NON-LYSOSOMAL PROTEIN BREAKDOWN, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4jt0:W (LYS41) to (ASP177) YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4A | UPS, PROTEASOME, DRUG DISCOVERY, NON-COVALENT REVERSIBLE INHIBITION, BIVALENCE, TMC-95A DERIVATIVES, NTN HYDROLASE, NON-LYSOSOMAL PROTEIN BREAKDOWN, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4jt0:X (LYS34) to (LYS170) YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4A | UPS, PROTEASOME, DRUG DISCOVERY, NON-COVALENT REVERSIBLE INHIBITION, BIVALENCE, TMC-95A DERIVATIVES, NTN HYDROLASE, NON-LYSOSOMAL PROTEIN BREAKDOWN, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4jt0:Z (LYS42) to (ARG194) YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4A | UPS, PROTEASOME, DRUG DISCOVERY, NON-COVALENT REVERSIBLE INHIBITION, BIVALENCE, TMC-95A DERIVATIVES, NTN HYDROLASE, NON-LYSOSOMAL PROTEIN BREAKDOWN, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4jt0:b (LYS33) to (ASN141) YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4A | UPS, PROTEASOME, DRUG DISCOVERY, NON-COVALENT REVERSIBLE INHIBITION, BIVALENCE, TMC-95A DERIVATIVES, NTN HYDROLASE, NON-LYSOSOMAL PROTEIN BREAKDOWN, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
3hf9:H (LYS33) to (ASP176) CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1 | BINDING SITES, OXAZOLIDIN-2-ONE, CRYSTALLOGRAPHY, X-RAY, MYCOBACTERIUM TUBERCULOSIS, PROTEASE INHIBITORS, PROTEASOME ENDOPEPTIDASE COMPLEX, PROTEIN SUBUNITS, SUBSTRATE SPECIFICITY, OPEN GATE, MUTANT, HYDROLASE, PROTEASOME
3hf9:E (LYS33) to (ASP176) CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1 | BINDING SITES, OXAZOLIDIN-2-ONE, CRYSTALLOGRAPHY, X-RAY, MYCOBACTERIUM TUBERCULOSIS, PROTEASE INHIBITORS, PROTEASOME ENDOPEPTIDASE COMPLEX, PROTEIN SUBUNITS, SUBSTRATE SPECIFICITY, OPEN GATE, MUTANT, HYDROLASE, PROTEASOME
3hf9:G (LYS33) to (ASP176) CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1 | BINDING SITES, OXAZOLIDIN-2-ONE, CRYSTALLOGRAPHY, X-RAY, MYCOBACTERIUM TUBERCULOSIS, PROTEASE INHIBITORS, PROTEASOME ENDOPEPTIDASE COMPLEX, PROTEIN SUBUNITS, SUBSTRATE SPECIFICITY, OPEN GATE, MUTANT, HYDROLASE, PROTEASOME
3hf9:J (LYS33) to (ASP176) CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1 | BINDING SITES, OXAZOLIDIN-2-ONE, CRYSTALLOGRAPHY, X-RAY, MYCOBACTERIUM TUBERCULOSIS, PROTEASE INHIBITORS, PROTEASOME ENDOPEPTIDASE COMPLEX, PROTEIN SUBUNITS, SUBSTRATE SPECIFICITY, OPEN GATE, MUTANT, HYDROLASE, PROTEASOME
3hf9:N (LYS33) to (ASP176) CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1 | BINDING SITES, OXAZOLIDIN-2-ONE, CRYSTALLOGRAPHY, X-RAY, MYCOBACTERIUM TUBERCULOSIS, PROTEASE INHIBITORS, PROTEASOME ENDOPEPTIDASE COMPLEX, PROTEIN SUBUNITS, SUBSTRATE SPECIFICITY, OPEN GATE, MUTANT, HYDROLASE, PROTEASOME
3hf9:P (LYS33) to (ASP176) CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1 | BINDING SITES, OXAZOLIDIN-2-ONE, CRYSTALLOGRAPHY, X-RAY, MYCOBACTERIUM TUBERCULOSIS, PROTEASE INHIBITORS, PROTEASOME ENDOPEPTIDASE COMPLEX, PROTEIN SUBUNITS, SUBSTRATE SPECIFICITY, OPEN GATE, MUTANT, HYDROLASE, PROTEASOME
3hf9:R (LYS33) to (ASP176) CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1 | BINDING SITES, OXAZOLIDIN-2-ONE, CRYSTALLOGRAPHY, X-RAY, MYCOBACTERIUM TUBERCULOSIS, PROTEASE INHIBITORS, PROTEASOME ENDOPEPTIDASE COMPLEX, PROTEIN SUBUNITS, SUBSTRATE SPECIFICITY, OPEN GATE, MUTANT, HYDROLASE, PROTEASOME
3hf9:T (LYS33) to (ASP176) CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1 | BINDING SITES, OXAZOLIDIN-2-ONE, CRYSTALLOGRAPHY, X-RAY, MYCOBACTERIUM TUBERCULOSIS, PROTEASE INHIBITORS, PROTEASOME ENDOPEPTIDASE COMPLEX, PROTEIN SUBUNITS, SUBSTRATE SPECIFICITY, OPEN GATE, MUTANT, HYDROLASE, PROTEASOME
3hf9:V (LYS33) to (ASP176) CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1 | BINDING SITES, OXAZOLIDIN-2-ONE, CRYSTALLOGRAPHY, X-RAY, MYCOBACTERIUM TUBERCULOSIS, PROTEASE INHIBITORS, PROTEASOME ENDOPEPTIDASE COMPLEX, PROTEIN SUBUNITS, SUBSTRATE SPECIFICITY, OPEN GATE, MUTANT, HYDROLASE, PROTEASOME
3hf9:X (LYS33) to (ASP176) CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1 | BINDING SITES, OXAZOLIDIN-2-ONE, CRYSTALLOGRAPHY, X-RAY, MYCOBACTERIUM TUBERCULOSIS, PROTEASE INHIBITORS, PROTEASOME ENDOPEPTIDASE COMPLEX, PROTEIN SUBUNITS, SUBSTRATE SPECIFICITY, OPEN GATE, MUTANT, HYDROLASE, PROTEASOME
3hf9:Z (LYS33) to (ASP176) CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1 | BINDING SITES, OXAZOLIDIN-2-ONE, CRYSTALLOGRAPHY, X-RAY, MYCOBACTERIUM TUBERCULOSIS, PROTEASE INHIBITORS, PROTEASOME ENDOPEPTIDASE COMPLEX, PROTEIN SUBUNITS, SUBSTRATE SPECIFICITY, OPEN GATE, MUTANT, HYDROLASE, PROTEASOME
3hf9:2 (LYS33) to (ASP176) CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1 | BINDING SITES, OXAZOLIDIN-2-ONE, CRYSTALLOGRAPHY, X-RAY, MYCOBACTERIUM TUBERCULOSIS, PROTEASE INHIBITORS, PROTEASOME ENDOPEPTIDASE COMPLEX, PROTEIN SUBUNITS, SUBSTRATE SPECIFICITY, OPEN GATE, MUTANT, HYDROLASE, PROTEASOME
3hf9:h (LYS333) to (ASP476) CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1 | BINDING SITES, OXAZOLIDIN-2-ONE, CRYSTALLOGRAPHY, X-RAY, MYCOBACTERIUM TUBERCULOSIS, PROTEASE INHIBITORS, PROTEASOME ENDOPEPTIDASE COMPLEX, PROTEIN SUBUNITS, SUBSTRATE SPECIFICITY, OPEN GATE, MUTANT, HYDROLASE, PROTEASOME
3hf9:c (LYS333) to (ASP476) CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1 | BINDING SITES, OXAZOLIDIN-2-ONE, CRYSTALLOGRAPHY, X-RAY, MYCOBACTERIUM TUBERCULOSIS, PROTEASE INHIBITORS, PROTEASOME ENDOPEPTIDASE COMPLEX, PROTEIN SUBUNITS, SUBSTRATE SPECIFICITY, OPEN GATE, MUTANT, HYDROLASE, PROTEASOME
3hf9:e (LYS333) to (ASP476) CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1 | BINDING SITES, OXAZOLIDIN-2-ONE, CRYSTALLOGRAPHY, X-RAY, MYCOBACTERIUM TUBERCULOSIS, PROTEASE INHIBITORS, PROTEASOME ENDOPEPTIDASE COMPLEX, PROTEIN SUBUNITS, SUBSTRATE SPECIFICITY, OPEN GATE, MUTANT, HYDROLASE, PROTEASOME
3hf9:g (LYS333) to (ASP476) CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1 | BINDING SITES, OXAZOLIDIN-2-ONE, CRYSTALLOGRAPHY, X-RAY, MYCOBACTERIUM TUBERCULOSIS, PROTEASE INHIBITORS, PROTEASOME ENDOPEPTIDASE COMPLEX, PROTEIN SUBUNITS, SUBSTRATE SPECIFICITY, OPEN GATE, MUTANT, HYDROLASE, PROTEASOME
3hf9:j (LYS333) to (ASP476) CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1 | BINDING SITES, OXAZOLIDIN-2-ONE, CRYSTALLOGRAPHY, X-RAY, MYCOBACTERIUM TUBERCULOSIS, PROTEASE INHIBITORS, PROTEASOME ENDOPEPTIDASE COMPLEX, PROTEIN SUBUNITS, SUBSTRATE SPECIFICITY, OPEN GATE, MUTANT, HYDROLASE, PROTEASOME
3hf9:l (LYS333) to (ASP476) CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1 | BINDING SITES, OXAZOLIDIN-2-ONE, CRYSTALLOGRAPHY, X-RAY, MYCOBACTERIUM TUBERCULOSIS, PROTEASE INHIBITORS, PROTEASOME ENDOPEPTIDASE COMPLEX, PROTEIN SUBUNITS, SUBSTRATE SPECIFICITY, OPEN GATE, MUTANT, HYDROLASE, PROTEASOME
3hf9:n (LYS333) to (ASP476) CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1 | BINDING SITES, OXAZOLIDIN-2-ONE, CRYSTALLOGRAPHY, X-RAY, MYCOBACTERIUM TUBERCULOSIS, PROTEASE INHIBITORS, PROTEASOME ENDOPEPTIDASE COMPLEX, PROTEIN SUBUNITS, SUBSTRATE SPECIFICITY, OPEN GATE, MUTANT, HYDROLASE, PROTEASOME
3hf9:p (LYS333) to (ASP476) CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1 | BINDING SITES, OXAZOLIDIN-2-ONE, CRYSTALLOGRAPHY, X-RAY, MYCOBACTERIUM TUBERCULOSIS, PROTEASE INHIBITORS, PROTEASOME ENDOPEPTIDASE COMPLEX, PROTEIN SUBUNITS, SUBSTRATE SPECIFICITY, OPEN GATE, MUTANT, HYDROLASE, PROTEASOME
3hf9:r (LYS333) to (ASP476) CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1 | BINDING SITES, OXAZOLIDIN-2-ONE, CRYSTALLOGRAPHY, X-RAY, MYCOBACTERIUM TUBERCULOSIS, PROTEASE INHIBITORS, PROTEASOME ENDOPEPTIDASE COMPLEX, PROTEIN SUBUNITS, SUBSTRATE SPECIFICITY, OPEN GATE, MUTANT, HYDROLASE, PROTEASOME
3hf9:t (LYS333) to (ASP476) CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1 | BINDING SITES, OXAZOLIDIN-2-ONE, CRYSTALLOGRAPHY, X-RAY, MYCOBACTERIUM TUBERCULOSIS, PROTEASE INHIBITORS, PROTEASOME ENDOPEPTIDASE COMPLEX, PROTEIN SUBUNITS, SUBSTRATE SPECIFICITY, OPEN GATE, MUTANT, HYDROLASE, PROTEASOME
3hf9:v (LYS333) to (ASP476) CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1 | BINDING SITES, OXAZOLIDIN-2-ONE, CRYSTALLOGRAPHY, X-RAY, MYCOBACTERIUM TUBERCULOSIS, PROTEASE INHIBITORS, PROTEASOME ENDOPEPTIDASE COMPLEX, PROTEIN SUBUNITS, SUBSTRATE SPECIFICITY, OPEN GATE, MUTANT, HYDROLASE, PROTEASOME
3hf9:x (LYS333) to (ASP476) CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1 | BINDING SITES, OXAZOLIDIN-2-ONE, CRYSTALLOGRAPHY, X-RAY, MYCOBACTERIUM TUBERCULOSIS, PROTEASE INHIBITORS, PROTEASOME ENDOPEPTIDASE COMPLEX, PROTEIN SUBUNITS, SUBSTRATE SPECIFICITY, OPEN GATE, MUTANT, HYDROLASE, PROTEASOME
3hf9:z (LYS333) to (ASP476) CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1 | BINDING SITES, OXAZOLIDIN-2-ONE, CRYSTALLOGRAPHY, X-RAY, MYCOBACTERIUM TUBERCULOSIS, PROTEASE INHIBITORS, PROTEASOME ENDOPEPTIDASE COMPLEX, PROTEIN SUBUNITS, SUBSTRATE SPECIFICITY, OPEN GATE, MUTANT, HYDROLASE, PROTEASOME
1fnt:E (LYS66) to (GLN206) CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION | MULTICATALYTIC PROTEINASE, 20S PROTEASOME, PROTEIN DEGRADATION, ANTIGEN PROCESSING, PROTEASE, PROTEASOME ACTIVATOR, CELL ADHESION, INTERFERON INDUCTION, HYDROLASE/HYDROLASE ACTIVATOR COMPLEX
1fnt:F (SER57) to (ILE182) CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION | MULTICATALYTIC PROTEINASE, 20S PROTEASOME, PROTEIN DEGRADATION, ANTIGEN PROCESSING, PROTEASE, PROTEASOME ACTIVATOR, CELL ADHESION, INTERFERON INDUCTION, HYDROLASE/HYDROLASE ACTIVATOR COMPLEX
1fnt:H (LYS33) to (TRP165) CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION | MULTICATALYTIC PROTEINASE, 20S PROTEASOME, PROTEIN DEGRADATION, ANTIGEN PROCESSING, PROTEASE, PROTEASOME ACTIVATOR, CELL ADHESION, INTERFERON INDUCTION, HYDROLASE/HYDROLASE ACTIVATOR COMPLEX
1fnt:M (LYS33) to (ARG185) CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION | MULTICATALYTIC PROTEINASE, 20S PROTEASOME, PROTEIN DEGRADATION, ANTIGEN PROCESSING, PROTEASE, PROTEASOME ACTIVATOR, CELL ADHESION, INTERFERON INDUCTION, HYDROLASE/HYDROLASE ACTIVATOR COMPLEX
1fnt:O (TYR71) to (ALA213) CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION | MULTICATALYTIC PROTEINASE, 20S PROTEASOME, PROTEIN DEGRADATION, ANTIGEN PROCESSING, PROTEASE, PROTEASOME ACTIVATOR, CELL ADHESION, INTERFERON INDUCTION, HYDROLASE/HYDROLASE ACTIVATOR COMPLEX
1fnt:S (LYS66) to (GLN206) CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION | MULTICATALYTIC PROTEINASE, 20S PROTEASOME, PROTEIN DEGRADATION, ANTIGEN PROCESSING, PROTEASE, PROTEASOME ACTIVATOR, CELL ADHESION, INTERFERON INDUCTION, HYDROLASE/HYDROLASE ACTIVATOR COMPLEX
1fnt:T (SER57) to (ILE182) CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION | MULTICATALYTIC PROTEINASE, 20S PROTEASOME, PROTEIN DEGRADATION, ANTIGEN PROCESSING, PROTEASE, PROTEASOME ACTIVATOR, CELL ADHESION, INTERFERON INDUCTION, HYDROLASE/HYDROLASE ACTIVATOR COMPLEX
1fnt:a (LYS33) to (ARG185) CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION | MULTICATALYTIC PROTEINASE, 20S PROTEASOME, PROTEIN DEGRADATION, ANTIGEN PROCESSING, PROTEASE, PROTEASOME ACTIVATOR, CELL ADHESION, INTERFERON INDUCTION, HYDROLASE/HYDROLASE ACTIVATOR COMPLEX
2f16:E (LYS66) to (ILE18) CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH BORTEZOMIB | BETA-SANDWICH FLANKED BY HELICES, COMPLEX STRUCTURE COVALENTLY BOUND TO THE SYNTHETIC INIHIBTOR BORTEZOMIB, HYDROLASE
2f16:I (LYS33) to (ASP166) CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH BORTEZOMIB | BETA-SANDWICH FLANKED BY HELICES, COMPLEX STRUCTURE COVALENTLY BOUND TO THE SYNTHETIC INIHIBTOR BORTEZOMIB, HYDROLASE
2f16:J (LYS33) to (LYS164) CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH BORTEZOMIB | BETA-SANDWICH FLANKED BY HELICES, COMPLEX STRUCTURE COVALENTLY BOUND TO THE SYNTHETIC INIHIBTOR BORTEZOMIB, HYDROLASE
2f16:L (LYS33) to (ARG165) CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH BORTEZOMIB | BETA-SANDWICH FLANKED BY HELICES, COMPLEX STRUCTURE COVALENTLY BOUND TO THE SYNTHETIC INIHIBTOR BORTEZOMIB, HYDROLASE
2f16:M (ARG33) to (ARG165) CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH BORTEZOMIB | BETA-SANDWICH FLANKED BY HELICES, COMPLEX STRUCTURE COVALENTLY BOUND TO THE SYNTHETIC INIHIBTOR BORTEZOMIB, HYDROLASE
2f16:N (LYS33) to (ASN141) CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH BORTEZOMIB | BETA-SANDWICH FLANKED BY HELICES, COMPLEX STRUCTURE COVALENTLY BOUND TO THE SYNTHETIC INIHIBTOR BORTEZOMIB, HYDROLASE
2f16:S (LYS66) to (ILE18) CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH BORTEZOMIB | BETA-SANDWICH FLANKED BY HELICES, COMPLEX STRUCTURE COVALENTLY BOUND TO THE SYNTHETIC INIHIBTOR BORTEZOMIB, HYDROLASE
2f16:W (LYS33) to (ASP166) CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH BORTEZOMIB | BETA-SANDWICH FLANKED BY HELICES, COMPLEX STRUCTURE COVALENTLY BOUND TO THE SYNTHETIC INIHIBTOR BORTEZOMIB, HYDROLASE
2f16:X (LYS33) to (LYS164) CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH BORTEZOMIB | BETA-SANDWICH FLANKED BY HELICES, COMPLEX STRUCTURE COVALENTLY BOUND TO THE SYNTHETIC INIHIBTOR BORTEZOMIB, HYDROLASE
2f16:Z (LYS33) to (ARG165) CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH BORTEZOMIB | BETA-SANDWICH FLANKED BY HELICES, COMPLEX STRUCTURE COVALENTLY BOUND TO THE SYNTHETIC INIHIBTOR BORTEZOMIB, HYDROLASE
2f16:1 (ARG33) to (ARG165) CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH BORTEZOMIB | BETA-SANDWICH FLANKED BY HELICES, COMPLEX STRUCTURE COVALENTLY BOUND TO THE SYNTHETIC INIHIBTOR BORTEZOMIB, HYDROLASE
2f16:2 (LYS33) to (ASN141) CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH BORTEZOMIB | BETA-SANDWICH FLANKED BY HELICES, COMPLEX STRUCTURE COVALENTLY BOUND TO THE SYNTHETIC INIHIBTOR BORTEZOMIB, HYDROLASE
3un4:E (LYS61) to (ILE181) YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (MORPHOLINE) | PROTEASOME, ANTIGEN PRESENTATION, DRUG DEVELOPMENT, PROTEIN DEGRADATION, HYDROLASE -HYDROLASE-INHIBITOR COMPLEX, HYDROLASE- HYDROLASE INHIBITOR COMPLEX
3un4:I (LYS41) to (ASP177) YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (MORPHOLINE) | PROTEASOME, ANTIGEN PRESENTATION, DRUG DEVELOPMENT, PROTEIN DEGRADATION, HYDROLASE -HYDROLASE-INHIBITOR COMPLEX, HYDROLASE- HYDROLASE INHIBITOR COMPLEX
3un4:L (LYS42) to (ARG194) YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (MORPHOLINE) | PROTEASOME, ANTIGEN PRESENTATION, DRUG DEVELOPMENT, PROTEIN DEGRADATION, HYDROLASE -HYDROLASE-INHIBITOR COMPLEX, HYDROLASE- HYDROLASE INHIBITOR COMPLEX
3un4:M (ARG41) to (THR168) YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (MORPHOLINE) | PROTEASOME, ANTIGEN PRESENTATION, DRUG DEVELOPMENT, PROTEIN DEGRADATION, HYDROLASE -HYDROLASE-INHIBITOR COMPLEX, HYDROLASE- HYDROLASE INHIBITOR COMPLEX
3un4:N (LYS33) to (ASN141) YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (MORPHOLINE) | PROTEASOME, ANTIGEN PRESENTATION, DRUG DEVELOPMENT, PROTEIN DEGRADATION, HYDROLASE -HYDROLASE-INHIBITOR COMPLEX, HYDROLASE- HYDROLASE INHIBITOR COMPLEX
3un4:S (LYS61) to (ILE181) YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (MORPHOLINE) | PROTEASOME, ANTIGEN PRESENTATION, DRUG DEVELOPMENT, PROTEIN DEGRADATION, HYDROLASE -HYDROLASE-INHIBITOR COMPLEX, HYDROLASE- HYDROLASE INHIBITOR COMPLEX
3un4:W (LYS41) to (ASP177) YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (MORPHOLINE) | PROTEASOME, ANTIGEN PRESENTATION, DRUG DEVELOPMENT, PROTEIN DEGRADATION, HYDROLASE -HYDROLASE-INHIBITOR COMPLEX, HYDROLASE- HYDROLASE INHIBITOR COMPLEX
3un4:Z (LYS42) to (ARG194) YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (MORPHOLINE) | PROTEASOME, ANTIGEN PRESENTATION, DRUG DEVELOPMENT, PROTEIN DEGRADATION, HYDROLASE -HYDROLASE-INHIBITOR COMPLEX, HYDROLASE- HYDROLASE INHIBITOR COMPLEX
3un4:a (ARG41) to (THR168) YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (MORPHOLINE) | PROTEASOME, ANTIGEN PRESENTATION, DRUG DEVELOPMENT, PROTEIN DEGRADATION, HYDROLASE -HYDROLASE-INHIBITOR COMPLEX, HYDROLASE- HYDROLASE INHIBITOR COMPLEX
3un4:b (LYS33) to (ASN141) YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (MORPHOLINE) | PROTEASOME, ANTIGEN PRESENTATION, DRUG DEVELOPMENT, PROTEIN DEGRADATION, HYDROLASE -HYDROLASE-INHIBITOR COMPLEX, HYDROLASE- HYDROLASE INHIBITOR COMPLEX
3un8:E (LYS61) to (ILE181) YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (EPOXIDE) | PROTEASOME, ANTIGEN PRESENTATION, DRUG DEVELOPMENT, PROTEIN DEGRADATION, HYDROLASE-HYDROLASE INHIBTIOR COMPLEX
3un8:I (LYS41) to (ASP177) YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (EPOXIDE) | PROTEASOME, ANTIGEN PRESENTATION, DRUG DEVELOPMENT, PROTEIN DEGRADATION, HYDROLASE-HYDROLASE INHIBTIOR COMPLEX
3un8:K (LYS33) to (ASP168) YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (EPOXIDE) | PROTEASOME, ANTIGEN PRESENTATION, DRUG DEVELOPMENT, PROTEIN DEGRADATION, HYDROLASE-HYDROLASE INHIBTIOR COMPLEX
3un8:L (LYS42) to (ARG194) YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (EPOXIDE) | PROTEASOME, ANTIGEN PRESENTATION, DRUG DEVELOPMENT, PROTEIN DEGRADATION, HYDROLASE-HYDROLASE INHIBTIOR COMPLEX
3un8:N (LYS33) to (ASN141) YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (EPOXIDE) | PROTEASOME, ANTIGEN PRESENTATION, DRUG DEVELOPMENT, PROTEIN DEGRADATION, HYDROLASE-HYDROLASE INHIBTIOR COMPLEX
3un8:S (SER56) to (ILE181) YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (EPOXIDE) | PROTEASOME, ANTIGEN PRESENTATION, DRUG DEVELOPMENT, PROTEIN DEGRADATION, HYDROLASE-HYDROLASE INHIBTIOR COMPLEX
3un8:W (LYS41) to (ASP177) YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (EPOXIDE) | PROTEASOME, ANTIGEN PRESENTATION, DRUG DEVELOPMENT, PROTEIN DEGRADATION, HYDROLASE-HYDROLASE INHIBTIOR COMPLEX
3un8:X (LYS34) to (HIS147) YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (EPOXIDE) | PROTEASOME, ANTIGEN PRESENTATION, DRUG DEVELOPMENT, PROTEIN DEGRADATION, HYDROLASE-HYDROLASE INHIBTIOR COMPLEX
3un8:Y (LYS33) to (ARG167) YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (EPOXIDE) | PROTEASOME, ANTIGEN PRESENTATION, DRUG DEVELOPMENT, PROTEIN DEGRADATION, HYDROLASE-HYDROLASE INHIBTIOR COMPLEX
3un8:Z (LYS42) to (ARG194) YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (EPOXIDE) | PROTEASOME, ANTIGEN PRESENTATION, DRUG DEVELOPMENT, PROTEIN DEGRADATION, HYDROLASE-HYDROLASE INHIBTIOR COMPLEX
3un8:b (LYS33) to (ASN141) YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (EPOXIDE) | PROTEASOME, ANTIGEN PRESENTATION, DRUG DEVELOPMENT, PROTEIN DEGRADATION, HYDROLASE-HYDROLASE INHIBTIOR COMPLEX
1g0u:E (SER59) to (ILE180) A GATED CHANNEL INTO THE PROTEASOME CORE PARTICLE | PROTEASOME, UBIQUITIN, DEGRADATION, PROTEASE, NTN-HYDROLASE
1g0u:G (TYR66) to (ALA200) A GATED CHANNEL INTO THE PROTEASOME CORE PARTICLE | PROTEASOME, UBIQUITIN, DEGRADATION, PROTEASE, NTN-HYDROLASE
1g0u:I (LYS33) to (ASP166) A GATED CHANNEL INTO THE PROTEASOME CORE PARTICLE | PROTEASOME, UBIQUITIN, DEGRADATION, PROTEASE, NTN-HYDROLASE
1g0u:J (LYS33) to (HIS141) A GATED CHANNEL INTO THE PROTEASOME CORE PARTICLE | PROTEASOME, UBIQUITIN, DEGRADATION, PROTEASE, NTN-HYDROLASE
1g0u:L (LYS33) to (ARG165) A GATED CHANNEL INTO THE PROTEASOME CORE PARTICLE | PROTEASOME, UBIQUITIN, DEGRADATION, PROTEASE, NTN-HYDROLASE
1g0u:N (LYS33) to (ASN141) A GATED CHANNEL INTO THE PROTEASOME CORE PARTICLE | PROTEASOME, UBIQUITIN, DEGRADATION, PROTEASE, NTN-HYDROLASE
1g0u:R (LYS66) to (GLU179) A GATED CHANNEL INTO THE PROTEASOME CORE PARTICLE | PROTEASOME, UBIQUITIN, DEGRADATION, PROTEASE, NTN-HYDROLASE
1g0u:S (SER59) to (ILE180) A GATED CHANNEL INTO THE PROTEASOME CORE PARTICLE | PROTEASOME, UBIQUITIN, DEGRADATION, PROTEASE, NTN-HYDROLASE
1g0u:W (LYS33) to (ASP166) A GATED CHANNEL INTO THE PROTEASOME CORE PARTICLE | PROTEASOME, UBIQUITIN, DEGRADATION, PROTEASE, NTN-HYDROLASE
1g0u:X (LYS33) to (HIS141) A GATED CHANNEL INTO THE PROTEASOME CORE PARTICLE | PROTEASOME, UBIQUITIN, DEGRADATION, PROTEASE, NTN-HYDROLASE
1g0u:Z (LYS33) to (ARG165) A GATED CHANNEL INTO THE PROTEASOME CORE PARTICLE | PROTEASOME, UBIQUITIN, DEGRADATION, PROTEASE, NTN-HYDROLASE
1g0u:1 (ARG33) to (ASP166) A GATED CHANNEL INTO THE PROTEASOME CORE PARTICLE | PROTEASOME, UBIQUITIN, DEGRADATION, PROTEASE, NTN-HYDROLASE
1g0u:2 (LYS33) to (ASN141) A GATED CHANNEL INTO THE PROTEASOME CORE PARTICLE | PROTEASOME, UBIQUITIN, DEGRADATION, PROTEASE, NTN-HYDROLASE
2fak:E (SER59) to (ILE18) CRYSTAL STRUCTURE OF SALINOSPORAMIDE A IN COMPLEX WITH THE YEAST 20S PROTEASOME | PROTEASOME, UBIQUITIN, DRUG DESIGN, INHIBITOR, PROTEASE, HYDROLASE
2fak:I (LYS33) to (ASP166) CRYSTAL STRUCTURE OF SALINOSPORAMIDE A IN COMPLEX WITH THE YEAST 20S PROTEASOME | PROTEASOME, UBIQUITIN, DRUG DESIGN, INHIBITOR, PROTEASE, HYDROLASE
2fak:J (LYS33) to (HIS141) CRYSTAL STRUCTURE OF SALINOSPORAMIDE A IN COMPLEX WITH THE YEAST 20S PROTEASOME | PROTEASOME, UBIQUITIN, DRUG DESIGN, INHIBITOR, PROTEASE, HYDROLASE
2fak:L (LYS33) to (ARG165) CRYSTAL STRUCTURE OF SALINOSPORAMIDE A IN COMPLEX WITH THE YEAST 20S PROTEASOME | PROTEASOME, UBIQUITIN, DRUG DESIGN, INHIBITOR, PROTEASE, HYDROLASE
2fak:M (ARG33) to (ARG165) CRYSTAL STRUCTURE OF SALINOSPORAMIDE A IN COMPLEX WITH THE YEAST 20S PROTEASOME | PROTEASOME, UBIQUITIN, DRUG DESIGN, INHIBITOR, PROTEASE, HYDROLASE
2fak:N (LYS33) to (ASN141) CRYSTAL STRUCTURE OF SALINOSPORAMIDE A IN COMPLEX WITH THE YEAST 20S PROTEASOME | PROTEASOME, UBIQUITIN, DRUG DESIGN, INHIBITOR, PROTEASE, HYDROLASE
2fak:S (SER59) to (ILE18) CRYSTAL STRUCTURE OF SALINOSPORAMIDE A IN COMPLEX WITH THE YEAST 20S PROTEASOME | PROTEASOME, UBIQUITIN, DRUG DESIGN, INHIBITOR, PROTEASE, HYDROLASE
2fak:W (LYS33) to (ASP166) CRYSTAL STRUCTURE OF SALINOSPORAMIDE A IN COMPLEX WITH THE YEAST 20S PROTEASOME | PROTEASOME, UBIQUITIN, DRUG DESIGN, INHIBITOR, PROTEASE, HYDROLASE
2fak:X (LYS33) to (HIS141) CRYSTAL STRUCTURE OF SALINOSPORAMIDE A IN COMPLEX WITH THE YEAST 20S PROTEASOME | PROTEASOME, UBIQUITIN, DRUG DESIGN, INHIBITOR, PROTEASE, HYDROLASE
2fak:Z (LYS33) to (ARG165) CRYSTAL STRUCTURE OF SALINOSPORAMIDE A IN COMPLEX WITH THE YEAST 20S PROTEASOME | PROTEASOME, UBIQUITIN, DRUG DESIGN, INHIBITOR, PROTEASE, HYDROLASE
2fak:1 (ARG33) to (ARG165) CRYSTAL STRUCTURE OF SALINOSPORAMIDE A IN COMPLEX WITH THE YEAST 20S PROTEASOME | PROTEASOME, UBIQUITIN, DRUG DESIGN, INHIBITOR, PROTEASE, HYDROLASE
2fak:2 (LYS33) to (ASN141) CRYSTAL STRUCTURE OF SALINOSPORAMIDE A IN COMPLEX WITH THE YEAST 20S PROTEASOME | PROTEASOME, UBIQUITIN, DRUG DESIGN, INHIBITOR, PROTEASE, HYDROLASE
3une:F (ARG65) to (HIS201) MOUSE CONSTITUTIVE 20S PROTEASOME | 20S PROTEASOME COMPRISES 28 SUBUNITS, PROTEASE, CYTOSOL, HYDROLASE
3une:I (LYS40) to (ASP177) MOUSE CONSTITUTIVE 20S PROTEASOME | 20S PROTEASOME COMPRISES 28 SUBUNITS, PROTEASE, CYTOSOL, HYDROLASE
3une:J (LYS34) to (LYS169) MOUSE CONSTITUTIVE 20S PROTEASOME | 20S PROTEASOME COMPRISES 28 SUBUNITS, PROTEASE, CYTOSOL, HYDROLASE
3une:L (LYS42) to (ARG185) MOUSE CONSTITUTIVE 20S PROTEASOME | 20S PROTEASOME COMPRISES 28 SUBUNITS, PROTEASE, CYTOSOL, HYDROLASE
3une:N (LYS33) to (THR142) MOUSE CONSTITUTIVE 20S PROTEASOME | 20S PROTEASOME COMPRISES 28 SUBUNITS, PROTEASE, CYTOSOL, HYDROLASE
3une:O (LYS63) to (GLU196) MOUSE CONSTITUTIVE 20S PROTEASOME | 20S PROTEASOME COMPRISES 28 SUBUNITS, PROTEASE, CYTOSOL, HYDROLASE
3une:T (ARG65) to (HIS201) MOUSE CONSTITUTIVE 20S PROTEASOME | 20S PROTEASOME COMPRISES 28 SUBUNITS, PROTEASE, CYTOSOL, HYDROLASE
3une:W (LYS40) to (ASP177) MOUSE CONSTITUTIVE 20S PROTEASOME | 20S PROTEASOME COMPRISES 28 SUBUNITS, PROTEASE, CYTOSOL, HYDROLASE
3une:X (LYS34) to (LYS169) MOUSE CONSTITUTIVE 20S PROTEASOME | 20S PROTEASOME COMPRISES 28 SUBUNITS, PROTEASE, CYTOSOL, HYDROLASE
3une:Z (LYS42) to (ARG185) MOUSE CONSTITUTIVE 20S PROTEASOME | 20S PROTEASOME COMPRISES 28 SUBUNITS, PROTEASE, CYTOSOL, HYDROLASE
3une:b (LYS33) to (THR142) MOUSE CONSTITUTIVE 20S PROTEASOME | 20S PROTEASOME COMPRISES 28 SUBUNITS, PROTEASE, CYTOSOL, HYDROLASE
3une:h (ARG65) to (HIS201) MOUSE CONSTITUTIVE 20S PROTEASOME | 20S PROTEASOME COMPRISES 28 SUBUNITS, PROTEASE, CYTOSOL, HYDROLASE
3une:k (LYS40) to (ASP177) MOUSE CONSTITUTIVE 20S PROTEASOME | 20S PROTEASOME COMPRISES 28 SUBUNITS, PROTEASE, CYTOSOL, HYDROLASE
3une:n (LYS42) to (ARG185) MOUSE CONSTITUTIVE 20S PROTEASOME | 20S PROTEASOME COMPRISES 28 SUBUNITS, PROTEASE, CYTOSOL, HYDROLASE
3une:o (ARG41) to (ARG179) MOUSE CONSTITUTIVE 20S PROTEASOME | 20S PROTEASOME COMPRISES 28 SUBUNITS, PROTEASE, CYTOSOL, HYDROLASE
3une:p (LYS33) to (THR142) MOUSE CONSTITUTIVE 20S PROTEASOME | 20S PROTEASOME COMPRISES 28 SUBUNITS, PROTEASE, CYTOSOL, HYDROLASE
3une:v (ARG65) to (HIS201) MOUSE CONSTITUTIVE 20S PROTEASOME | 20S PROTEASOME COMPRISES 28 SUBUNITS, PROTEASE, CYTOSOL, HYDROLASE
3une:y (LYS40) to (ASP177) MOUSE CONSTITUTIVE 20S PROTEASOME | 20S PROTEASOME COMPRISES 28 SUBUNITS, PROTEASE, CYTOSOL, HYDROLASE
3une:z (LYS34) to (LYS169) MOUSE CONSTITUTIVE 20S PROTEASOME | 20S PROTEASOME COMPRISES 28 SUBUNITS, PROTEASE, CYTOSOL, HYDROLASE
3une:2 (LYS42) to (ARG185) MOUSE CONSTITUTIVE 20S PROTEASOME | 20S PROTEASOME COMPRISES 28 SUBUNITS, PROTEASE, CYTOSOL, HYDROLASE
3une:3 (ARG41) to (ARG179) MOUSE CONSTITUTIVE 20S PROTEASOME | 20S PROTEASOME COMPRISES 28 SUBUNITS, PROTEASE, CYTOSOL, HYDROLASE
3une:4 (LYS33) to (THR142) MOUSE CONSTITUTIVE 20S PROTEASOME | 20S PROTEASOME COMPRISES 28 SUBUNITS, PROTEASE, CYTOSOL, HYDROLASE
3unf:F (ARG65) to (HIS201) MOUSE 20S IMMUNOPROTEASOME IN COMPLEX WITH PR-957 | PROTEASOME, ANTIGEN PRESENTATION, DRUG DEVELOPMENT, PROTEIN DEGRADATION, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
3unf:J (LYS34) to (LYS169) MOUSE 20S IMMUNOPROTEASOME IN COMPLEX WITH PR-957 | PROTEASOME, ANTIGEN PRESENTATION, DRUG DEVELOPMENT, PROTEIN DEGRADATION, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
3unf:L (LYS42) to (ARG185) MOUSE 20S IMMUNOPROTEASOME IN COMPLEX WITH PR-957 | PROTEASOME, ANTIGEN PRESENTATION, DRUG DEVELOPMENT, PROTEIN DEGRADATION, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
3unf:M (ARG41) to (ARG179) MOUSE 20S IMMUNOPROTEASOME IN COMPLEX WITH PR-957 | PROTEASOME, ANTIGEN PRESENTATION, DRUG DEVELOPMENT, PROTEIN DEGRADATION, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
3unf:N (LYS33) to (ALA140) MOUSE 20S IMMUNOPROTEASOME IN COMPLEX WITH PR-957 | PROTEASOME, ANTIGEN PRESENTATION, DRUG DEVELOPMENT, PROTEIN DEGRADATION, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
3unf:T (ARG65) to (HIS201) MOUSE 20S IMMUNOPROTEASOME IN COMPLEX WITH PR-957 | PROTEASOME, ANTIGEN PRESENTATION, DRUG DEVELOPMENT, PROTEIN DEGRADATION, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
3unf:X (LYS34) to (LYS169) MOUSE 20S IMMUNOPROTEASOME IN COMPLEX WITH PR-957 | PROTEASOME, ANTIGEN PRESENTATION, DRUG DEVELOPMENT, PROTEIN DEGRADATION, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
3unf:Z (LYS42) to (ARG185) MOUSE 20S IMMUNOPROTEASOME IN COMPLEX WITH PR-957 | PROTEASOME, ANTIGEN PRESENTATION, DRUG DEVELOPMENT, PROTEIN DEGRADATION, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
3unf:a (ARG41) to (ARG179) MOUSE 20S IMMUNOPROTEASOME IN COMPLEX WITH PR-957 | PROTEASOME, ANTIGEN PRESENTATION, DRUG DEVELOPMENT, PROTEIN DEGRADATION, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
3unf:b (LYS33) to (ALA140) MOUSE 20S IMMUNOPROTEASOME IN COMPLEX WITH PR-957 | PROTEASOME, ANTIGEN PRESENTATION, DRUG DEVELOPMENT, PROTEIN DEGRADATION, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4z1l:E (SER56) to (ILE181) YEAST 20S PROTEASOME IN COMPLEX WITH BELACTOSIN C DERIVATIVE 3 | HYDROLASE, PROTEASOME, INHIBITOR, BINDING ANALYSIS, LEAD STRUCTURE MOTIF, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4z1l:I (LYS41) to (ASP177) YEAST 20S PROTEASOME IN COMPLEX WITH BELACTOSIN C DERIVATIVE 3 | HYDROLASE, PROTEASOME, INHIBITOR, BINDING ANALYSIS, LEAD STRUCTURE MOTIF, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4z1l:M (ARG41) to (ARG187) YEAST 20S PROTEASOME IN COMPLEX WITH BELACTOSIN C DERIVATIVE 3 | HYDROLASE, PROTEASOME, INHIBITOR, BINDING ANALYSIS, LEAD STRUCTURE MOTIF, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4z1l:N (LYS33) to (ASN141) YEAST 20S PROTEASOME IN COMPLEX WITH BELACTOSIN C DERIVATIVE 3 | HYDROLASE, PROTEASOME, INHIBITOR, BINDING ANALYSIS, LEAD STRUCTURE MOTIF, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4z1l:S (SER56) to (ILE181) YEAST 20S PROTEASOME IN COMPLEX WITH BELACTOSIN C DERIVATIVE 3 | HYDROLASE, PROTEASOME, INHIBITOR, BINDING ANALYSIS, LEAD STRUCTURE MOTIF, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4z1l:W (LYS41) to (ASP177) YEAST 20S PROTEASOME IN COMPLEX WITH BELACTOSIN C DERIVATIVE 3 | HYDROLASE, PROTEASOME, INHIBITOR, BINDING ANALYSIS, LEAD STRUCTURE MOTIF, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4z1l:a (ARG41) to (ARG187) YEAST 20S PROTEASOME IN COMPLEX WITH BELACTOSIN C DERIVATIVE 3 | HYDROLASE, PROTEASOME, INHIBITOR, BINDING ANALYSIS, LEAD STRUCTURE MOTIF, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4z1l:b (LYS33) to (ASN141) YEAST 20S PROTEASOME IN COMPLEX WITH BELACTOSIN C DERIVATIVE 3 | HYDROLASE, PROTEASOME, INHIBITOR, BINDING ANALYSIS, LEAD STRUCTURE MOTIF, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
3unh:F (ARG65) to (HIS201) MOUSE 20S IMMUNOPROTEASOME | 20S PROTEASOME COMPRISES 28 SUBUNITS, PROTEASE, CYTOSOL, HYDROLASE
3unh:I (LYS40) to (ASP177) MOUSE 20S IMMUNOPROTEASOME | 20S PROTEASOME COMPRISES 28 SUBUNITS, PROTEASE, CYTOSOL, HYDROLASE
3unh:J (LYS34) to (LYS169) MOUSE 20S IMMUNOPROTEASOME | 20S PROTEASOME COMPRISES 28 SUBUNITS, PROTEASE, CYTOSOL, HYDROLASE
3unh:L (LYS42) to (ARG185) MOUSE 20S IMMUNOPROTEASOME | 20S PROTEASOME COMPRISES 28 SUBUNITS, PROTEASE, CYTOSOL, HYDROLASE
3unh:M (ARG41) to (ARG179) MOUSE 20S IMMUNOPROTEASOME | 20S PROTEASOME COMPRISES 28 SUBUNITS, PROTEASE, CYTOSOL, HYDROLASE
3unh:N (LYS33) to (ALA140) MOUSE 20S IMMUNOPROTEASOME | 20S PROTEASOME COMPRISES 28 SUBUNITS, PROTEASE, CYTOSOL, HYDROLASE
3unh:T (ARG65) to (HIS201) MOUSE 20S IMMUNOPROTEASOME | 20S PROTEASOME COMPRISES 28 SUBUNITS, PROTEASE, CYTOSOL, HYDROLASE
3unh:V (LYS33) to (LEU164) MOUSE 20S IMMUNOPROTEASOME | 20S PROTEASOME COMPRISES 28 SUBUNITS, PROTEASE, CYTOSOL, HYDROLASE
3unh:W (LYS40) to (ASP177) MOUSE 20S IMMUNOPROTEASOME | 20S PROTEASOME COMPRISES 28 SUBUNITS, PROTEASE, CYTOSOL, HYDROLASE
3unh:X (LYS34) to (LYS169) MOUSE 20S IMMUNOPROTEASOME | 20S PROTEASOME COMPRISES 28 SUBUNITS, PROTEASE, CYTOSOL, HYDROLASE
3unh:Z (LYS42) to (ARG185) MOUSE 20S IMMUNOPROTEASOME | 20S PROTEASOME COMPRISES 28 SUBUNITS, PROTEASE, CYTOSOL, HYDROLASE
3unh:a (ARG41) to (ARG179) MOUSE 20S IMMUNOPROTEASOME | 20S PROTEASOME COMPRISES 28 SUBUNITS, PROTEASE, CYTOSOL, HYDROLASE
3unh:b (LYS33) to (ALA140) MOUSE 20S IMMUNOPROTEASOME | 20S PROTEASOME COMPRISES 28 SUBUNITS, PROTEASE, CYTOSOL, HYDROLASE
1g3i:G (LYS33) to (ILE159) CRYSTAL STRUCTURE OF THE HSLUV PROTEASE-CHAPERONE COMPLEX | CHAPERONE/HYDROLASE
1g3i:H (LYS33) to (ILE159) CRYSTAL STRUCTURE OF THE HSLUV PROTEASE-CHAPERONE COMPLEX | CHAPERONE/HYDROLASE
1g3i:I (LYS33) to (ILE159) CRYSTAL STRUCTURE OF THE HSLUV PROTEASE-CHAPERONE COMPLEX | CHAPERONE/HYDROLASE
1g3i:J (LYS33) to (ILE159) CRYSTAL STRUCTURE OF THE HSLUV PROTEASE-CHAPERONE COMPLEX | CHAPERONE/HYDROLASE
1g3i:K (LYS33) to (ILE159) CRYSTAL STRUCTURE OF THE HSLUV PROTEASE-CHAPERONE COMPLEX | CHAPERONE/HYDROLASE
1g3i:L (LYS33) to (ILE159) CRYSTAL STRUCTURE OF THE HSLUV PROTEASE-CHAPERONE COMPLEX | CHAPERONE/HYDROLASE
1g3i:O (LYS33) to (ILE159) CRYSTAL STRUCTURE OF THE HSLUV PROTEASE-CHAPERONE COMPLEX | CHAPERONE/HYDROLASE
1g3i:P (LYS33) to (ILE159) CRYSTAL STRUCTURE OF THE HSLUV PROTEASE-CHAPERONE COMPLEX | CHAPERONE/HYDROLASE
1g3i:Q (LYS33) to (ILE159) CRYSTAL STRUCTURE OF THE HSLUV PROTEASE-CHAPERONE COMPLEX | CHAPERONE/HYDROLASE
1g3i:R (LYS33) to (ILE159) CRYSTAL STRUCTURE OF THE HSLUV PROTEASE-CHAPERONE COMPLEX | CHAPERONE/HYDROLASE
1g65:E (SER59) to (ILE180) CRYSTAL STRUCTURE OF EPOXOMICIN:20S PROTEASOME REVEALS A MOLECULAR BASIS FOR SELECTIVITY OF ALPHA,BETA-EPOXYKETONE PROTEASOME INHIBITORS | PROTEASOME, EPOXOMICIN, UBIQUITIN, NTN-HYDOLASE, PROTEASE, HYDROLASE- HYDROLASE INHIBITOR COMPLEX
1g65:I (LYS33) to (ASP166) CRYSTAL STRUCTURE OF EPOXOMICIN:20S PROTEASOME REVEALS A MOLECULAR BASIS FOR SELECTIVITY OF ALPHA,BETA-EPOXYKETONE PROTEASOME INHIBITORS | PROTEASOME, EPOXOMICIN, UBIQUITIN, NTN-HYDOLASE, PROTEASE, HYDROLASE- HYDROLASE INHIBITOR COMPLEX
1g65:J (LYS33) to (LYS164) CRYSTAL STRUCTURE OF EPOXOMICIN:20S PROTEASOME REVEALS A MOLECULAR BASIS FOR SELECTIVITY OF ALPHA,BETA-EPOXYKETONE PROTEASOME INHIBITORS | PROTEASOME, EPOXOMICIN, UBIQUITIN, NTN-HYDOLASE, PROTEASE, HYDROLASE- HYDROLASE INHIBITOR COMPLEX
1g65:L (LYS33) to (ARG165) CRYSTAL STRUCTURE OF EPOXOMICIN:20S PROTEASOME REVEALS A MOLECULAR BASIS FOR SELECTIVITY OF ALPHA,BETA-EPOXYKETONE PROTEASOME INHIBITORS | PROTEASOME, EPOXOMICIN, UBIQUITIN, NTN-HYDOLASE, PROTEASE, HYDROLASE- HYDROLASE INHIBITOR COMPLEX
1g65:N (LYS33) to (ASN141) CRYSTAL STRUCTURE OF EPOXOMICIN:20S PROTEASOME REVEALS A MOLECULAR BASIS FOR SELECTIVITY OF ALPHA,BETA-EPOXYKETONE PROTEASOME INHIBITORS | PROTEASOME, EPOXOMICIN, UBIQUITIN, NTN-HYDOLASE, PROTEASE, HYDROLASE- HYDROLASE INHIBITOR COMPLEX
1g65:S (LYS66) to (ILE182) CRYSTAL STRUCTURE OF EPOXOMICIN:20S PROTEASOME REVEALS A MOLECULAR BASIS FOR SELECTIVITY OF ALPHA,BETA-EPOXYKETONE PROTEASOME INHIBITORS | PROTEASOME, EPOXOMICIN, UBIQUITIN, NTN-HYDOLASE, PROTEASE, HYDROLASE- HYDROLASE INHIBITOR COMPLEX
1g65:U (TYR66) to (GLY202) CRYSTAL STRUCTURE OF EPOXOMICIN:20S PROTEASOME REVEALS A MOLECULAR BASIS FOR SELECTIVITY OF ALPHA,BETA-EPOXYKETONE PROTEASOME INHIBITORS | PROTEASOME, EPOXOMICIN, UBIQUITIN, NTN-HYDOLASE, PROTEASE, HYDROLASE- HYDROLASE INHIBITOR COMPLEX
1g65:W (LYS33) to (ASP166) CRYSTAL STRUCTURE OF EPOXOMICIN:20S PROTEASOME REVEALS A MOLECULAR BASIS FOR SELECTIVITY OF ALPHA,BETA-EPOXYKETONE PROTEASOME INHIBITORS | PROTEASOME, EPOXOMICIN, UBIQUITIN, NTN-HYDOLASE, PROTEASE, HYDROLASE- HYDROLASE INHIBITOR COMPLEX
1g65:X (LYS33) to (MET166) CRYSTAL STRUCTURE OF EPOXOMICIN:20S PROTEASOME REVEALS A MOLECULAR BASIS FOR SELECTIVITY OF ALPHA,BETA-EPOXYKETONE PROTEASOME INHIBITORS | PROTEASOME, EPOXOMICIN, UBIQUITIN, NTN-HYDOLASE, PROTEASE, HYDROLASE- HYDROLASE INHIBITOR COMPLEX
1g65:Z (LYS33) to (ARG165) CRYSTAL STRUCTURE OF EPOXOMICIN:20S PROTEASOME REVEALS A MOLECULAR BASIS FOR SELECTIVITY OF ALPHA,BETA-EPOXYKETONE PROTEASOME INHIBITORS | PROTEASOME, EPOXOMICIN, UBIQUITIN, NTN-HYDOLASE, PROTEASE, HYDROLASE- HYDROLASE INHIBITOR COMPLEX
1g65:1 (LEU34) to (ASP166) CRYSTAL STRUCTURE OF EPOXOMICIN:20S PROTEASOME REVEALS A MOLECULAR BASIS FOR SELECTIVITY OF ALPHA,BETA-EPOXYKETONE PROTEASOME INHIBITORS | PROTEASOME, EPOXOMICIN, UBIQUITIN, NTN-HYDOLASE, PROTEASE, HYDROLASE- HYDROLASE INHIBITOR COMPLEX
1g65:2 (LYS33) to (ASN141) CRYSTAL STRUCTURE OF EPOXOMICIN:20S PROTEASOME REVEALS A MOLECULAR BASIS FOR SELECTIVITY OF ALPHA,BETA-EPOXYKETONE PROTEASOME INHIBITORS | PROTEASOME, EPOXOMICIN, UBIQUITIN, NTN-HYDOLASE, PROTEASE, HYDROLASE- HYDROLASE INHIBITOR COMPLEX
1ryp:F (LYS62) to (ILE182) CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST AT 2.4 ANGSTROMS RESOLUTION | MULTICATALYTIC PROTEINASE, 20S PROTEASOME, PROTEIN DEGRADATION, ANTIGEN PROCESSING, HYDROLASE, PROTEASE
1ryp:H (LYS33) to (LYS164) CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST AT 2.4 ANGSTROMS RESOLUTION | MULTICATALYTIC PROTEINASE, 20S PROTEASOME, PROTEIN DEGRADATION, ANTIGEN PROCESSING, HYDROLASE, PROTEASE
1ryp:J (LYS33) to (ASP169) CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST AT 2.4 ANGSTROMS RESOLUTION | MULTICATALYTIC PROTEINASE, 20S PROTEASOME, PROTEIN DEGRADATION, ANTIGEN PROCESSING, HYDROLASE, PROTEASE
1ryp:K (LYS33) to (HIS146) CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST AT 2.4 ANGSTROMS RESOLUTION | MULTICATALYTIC PROTEINASE, 20S PROTEASOME, PROTEIN DEGRADATION, ANTIGEN PROCESSING, HYDROLASE, PROTEASE
1ryp:M (LYS33) to (ARG185) CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST AT 2.4 ANGSTROMS RESOLUTION | MULTICATALYTIC PROTEINASE, 20S PROTEASOME, PROTEIN DEGRADATION, ANTIGEN PROCESSING, HYDROLASE, PROTEASE
1ryp:T (LYS62) to (ILE182) CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST AT 2.4 ANGSTROMS RESOLUTION | MULTICATALYTIC PROTEINASE, 20S PROTEASOME, PROTEIN DEGRADATION, ANTIGEN PROCESSING, HYDROLASE, PROTEASE
1ryp:V (LYS33) to (ASN141) CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST AT 2.4 ANGSTROMS RESOLUTION | MULTICATALYTIC PROTEINASE, 20S PROTEASOME, PROTEIN DEGRADATION, ANTIGEN PROCESSING, HYDROLASE, PROTEASE
1ryp:X (LYS33) to (ASP169) CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST AT 2.4 ANGSTROMS RESOLUTION | MULTICATALYTIC PROTEINASE, 20S PROTEASOME, PROTEIN DEGRADATION, ANTIGEN PROCESSING, HYDROLASE, PROTEASE
1ryp:Y (LYS33) to (HIS146) CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST AT 2.4 ANGSTROMS RESOLUTION | MULTICATALYTIC PROTEINASE, 20S PROTEASOME, PROTEIN DEGRADATION, ANTIGEN PROCESSING, HYDROLASE, PROTEASE
1ryp:1 (LYS33) to (ARG185) CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST AT 2.4 ANGSTROMS RESOLUTION | MULTICATALYTIC PROTEINASE, 20S PROTEASOME, PROTEIN DEGRADATION, ANTIGEN PROCESSING, HYDROLASE, PROTEASE
1ryp:2 (ARG33) to (ARG179) CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST AT 2.4 ANGSTROMS RESOLUTION | MULTICATALYTIC PROTEINASE, 20S PROTEASOME, PROTEIN DEGRADATION, ANTIGEN PROCESSING, HYDROLASE, PROTEASE
3hye:E (LYS66) to (ILE18) CRYSTAL STRUCTURE OF 20S PROTEASOME IN COMPLEX WITH HYDROXYLATED SALINOSPORAMIDE | CYTOPLASM, HYDROLASE, NUCLEUS, PHOSPHOPROTEIN, PROTEASE, PROTEASOME, THREONINE PROTEASE, ISOPEPTIDE BOND, UBL CONJUGATION, ZYMOGEN
3hye:I (LYS33) to (ASP166) CRYSTAL STRUCTURE OF 20S PROTEASOME IN COMPLEX WITH HYDROXYLATED SALINOSPORAMIDE | CYTOPLASM, HYDROLASE, NUCLEUS, PHOSPHOPROTEIN, PROTEASE, PROTEASOME, THREONINE PROTEASE, ISOPEPTIDE BOND, UBL CONJUGATION, ZYMOGEN
3hye:J (LYS33) to (HIS141) CRYSTAL STRUCTURE OF 20S PROTEASOME IN COMPLEX WITH HYDROXYLATED SALINOSPORAMIDE | CYTOPLASM, HYDROLASE, NUCLEUS, PHOSPHOPROTEIN, PROTEASE, PROTEASOME, THREONINE PROTEASE, ISOPEPTIDE BOND, UBL CONJUGATION, ZYMOGEN
3hye:L (LYS33) to (ARG165) CRYSTAL STRUCTURE OF 20S PROTEASOME IN COMPLEX WITH HYDROXYLATED SALINOSPORAMIDE | CYTOPLASM, HYDROLASE, NUCLEUS, PHOSPHOPROTEIN, PROTEASE, PROTEASOME, THREONINE PROTEASE, ISOPEPTIDE BOND, UBL CONJUGATION, ZYMOGEN
3hye:M (ARG33) to (ARG165) CRYSTAL STRUCTURE OF 20S PROTEASOME IN COMPLEX WITH HYDROXYLATED SALINOSPORAMIDE | CYTOPLASM, HYDROLASE, NUCLEUS, PHOSPHOPROTEIN, PROTEASE, PROTEASOME, THREONINE PROTEASE, ISOPEPTIDE BOND, UBL CONJUGATION, ZYMOGEN
3hye:N (LYS33) to (ASN141) CRYSTAL STRUCTURE OF 20S PROTEASOME IN COMPLEX WITH HYDROXYLATED SALINOSPORAMIDE | CYTOPLASM, HYDROLASE, NUCLEUS, PHOSPHOPROTEIN, PROTEASE, PROTEASOME, THREONINE PROTEASE, ISOPEPTIDE BOND, UBL CONJUGATION, ZYMOGEN
3hye:S (LYS66) to (ILE18) CRYSTAL STRUCTURE OF 20S PROTEASOME IN COMPLEX WITH HYDROXYLATED SALINOSPORAMIDE | CYTOPLASM, HYDROLASE, NUCLEUS, PHOSPHOPROTEIN, PROTEASE, PROTEASOME, THREONINE PROTEASE, ISOPEPTIDE BOND, UBL CONJUGATION, ZYMOGEN
3hye:W (LYS33) to (ASP166) CRYSTAL STRUCTURE OF 20S PROTEASOME IN COMPLEX WITH HYDROXYLATED SALINOSPORAMIDE | CYTOPLASM, HYDROLASE, NUCLEUS, PHOSPHOPROTEIN, PROTEASE, PROTEASOME, THREONINE PROTEASE, ISOPEPTIDE BOND, UBL CONJUGATION, ZYMOGEN
3hye:X (LYS33) to (HIS141) CRYSTAL STRUCTURE OF 20S PROTEASOME IN COMPLEX WITH HYDROXYLATED SALINOSPORAMIDE | CYTOPLASM, HYDROLASE, NUCLEUS, PHOSPHOPROTEIN, PROTEASE, PROTEASOME, THREONINE PROTEASE, ISOPEPTIDE BOND, UBL CONJUGATION, ZYMOGEN
3hye:Z (LYS33) to (ARG165) CRYSTAL STRUCTURE OF 20S PROTEASOME IN COMPLEX WITH HYDROXYLATED SALINOSPORAMIDE | CYTOPLASM, HYDROLASE, NUCLEUS, PHOSPHOPROTEIN, PROTEASE, PROTEASOME, THREONINE PROTEASE, ISOPEPTIDE BOND, UBL CONJUGATION, ZYMOGEN
3hye:1 (ARG33) to (ARG165) CRYSTAL STRUCTURE OF 20S PROTEASOME IN COMPLEX WITH HYDROXYLATED SALINOSPORAMIDE | CYTOPLASM, HYDROLASE, NUCLEUS, PHOSPHOPROTEIN, PROTEASE, PROTEASOME, THREONINE PROTEASE, ISOPEPTIDE BOND, UBL CONJUGATION, ZYMOGEN
3hye:2 (LYS33) to (ASN141) CRYSTAL STRUCTURE OF 20S PROTEASOME IN COMPLEX WITH HYDROXYLATED SALINOSPORAMIDE | CYTOPLASM, HYDROLASE, NUCLEUS, PHOSPHOPROTEIN, PROTEASE, PROTEASOME, THREONINE PROTEASE, ISOPEPTIDE BOND, UBL CONJUGATION, ZYMOGEN
2gpl:E (LYS66) to (ILE18) TMC-95 BASED BIPHENYL-ETHER MACROCYCLES: SPECIFIC PROTEASOME INHIBITORS | PROTEASOMAL SUBUNIT FOLD REPRESENTS AN ANTIPARALLEL BETA- SHEET FLANKED BY HELICES; NTN-HYDROLASE
2gpl:I (LYS33) to (ASP166) TMC-95 BASED BIPHENYL-ETHER MACROCYCLES: SPECIFIC PROTEASOME INHIBITORS | PROTEASOMAL SUBUNIT FOLD REPRESENTS AN ANTIPARALLEL BETA- SHEET FLANKED BY HELICES; NTN-HYDROLASE
2gpl:J (LYS33) to (HIS141) TMC-95 BASED BIPHENYL-ETHER MACROCYCLES: SPECIFIC PROTEASOME INHIBITORS | PROTEASOMAL SUBUNIT FOLD REPRESENTS AN ANTIPARALLEL BETA- SHEET FLANKED BY HELICES; NTN-HYDROLASE
2gpl:L (LYS33) to (ARG165) TMC-95 BASED BIPHENYL-ETHER MACROCYCLES: SPECIFIC PROTEASOME INHIBITORS | PROTEASOMAL SUBUNIT FOLD REPRESENTS AN ANTIPARALLEL BETA- SHEET FLANKED BY HELICES; NTN-HYDROLASE
2gpl:M (ARG33) to (ARG165) TMC-95 BASED BIPHENYL-ETHER MACROCYCLES: SPECIFIC PROTEASOME INHIBITORS | PROTEASOMAL SUBUNIT FOLD REPRESENTS AN ANTIPARALLEL BETA- SHEET FLANKED BY HELICES; NTN-HYDROLASE
2gpl:N (LYS33) to (ASN141) TMC-95 BASED BIPHENYL-ETHER MACROCYCLES: SPECIFIC PROTEASOME INHIBITORS | PROTEASOMAL SUBUNIT FOLD REPRESENTS AN ANTIPARALLEL BETA- SHEET FLANKED BY HELICES; NTN-HYDROLASE
2gpl:S (LYS66) to (ILE18) TMC-95 BASED BIPHENYL-ETHER MACROCYCLES: SPECIFIC PROTEASOME INHIBITORS | PROTEASOMAL SUBUNIT FOLD REPRESENTS AN ANTIPARALLEL BETA- SHEET FLANKED BY HELICES; NTN-HYDROLASE
2gpl:W (LYS33) to (ASP166) TMC-95 BASED BIPHENYL-ETHER MACROCYCLES: SPECIFIC PROTEASOME INHIBITORS | PROTEASOMAL SUBUNIT FOLD REPRESENTS AN ANTIPARALLEL BETA- SHEET FLANKED BY HELICES; NTN-HYDROLASE
2gpl:X (LYS33) to (HIS141) TMC-95 BASED BIPHENYL-ETHER MACROCYCLES: SPECIFIC PROTEASOME INHIBITORS | PROTEASOMAL SUBUNIT FOLD REPRESENTS AN ANTIPARALLEL BETA- SHEET FLANKED BY HELICES; NTN-HYDROLASE
2gpl:Z (LYS33) to (ARG165) TMC-95 BASED BIPHENYL-ETHER MACROCYCLES: SPECIFIC PROTEASOME INHIBITORS | PROTEASOMAL SUBUNIT FOLD REPRESENTS AN ANTIPARALLEL BETA- SHEET FLANKED BY HELICES; NTN-HYDROLASE
2gpl:1 (ARG33) to (ARG165) TMC-95 BASED BIPHENYL-ETHER MACROCYCLES: SPECIFIC PROTEASOME INHIBITORS | PROTEASOMAL SUBUNIT FOLD REPRESENTS AN ANTIPARALLEL BETA- SHEET FLANKED BY HELICES; NTN-HYDROLASE
2gpl:2 (LYS33) to (ASN141) TMC-95 BASED BIPHENYL-ETHER MACROCYCLES: SPECIFIC PROTEASOME INHIBITORS | PROTEASOMAL SUBUNIT FOLD REPRESENTS AN ANTIPARALLEL BETA- SHEET FLANKED BY HELICES; NTN-HYDROLASE
3ipm:G (LYS66) to (LEU201) CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH THE C- TERMINUS OF PAN | PROTEASOME, PROTEASOMAL ATPASE, PROTEIN DEGRADATION, AAA ATPASE, ELECTRON CRYOMICROSCOPY, HYDROLASE, PROTEASE, THREONINE PROTEASE, HYDROLASE-HYDROLASE ACTIVATOR COMPLEX
2h6j:A (LYS52) to (GLN190) CRYSTAL STRUCTURE OF THE BETA F145A RHODOCOCCUS PROTEASOME (CASP TARGET) | 20S PROTEASOME, HALF PROTEASOME, ASSEMBLY-DEPENDENT ACTIVATION, HYDROLASE
2h6j:B (LYS52) to (GLN190) CRYSTAL STRUCTURE OF THE BETA F145A RHODOCOCCUS PROTEASOME (CASP TARGET) | 20S PROTEASOME, HALF PROTEASOME, ASSEMBLY-DEPENDENT ACTIVATION, HYDROLASE
2h6j:C (LYS52) to (GLN190) CRYSTAL STRUCTURE OF THE BETA F145A RHODOCOCCUS PROTEASOME (CASP TARGET) | 20S PROTEASOME, HALF PROTEASOME, ASSEMBLY-DEPENDENT ACTIVATION, HYDROLASE
2h6j:D (LYS52) to (GLN190) CRYSTAL STRUCTURE OF THE BETA F145A RHODOCOCCUS PROTEASOME (CASP TARGET) | 20S PROTEASOME, HALF PROTEASOME, ASSEMBLY-DEPENDENT ACTIVATION, HYDROLASE
2h6j:E (LYS52) to (GLN190) CRYSTAL STRUCTURE OF THE BETA F145A RHODOCOCCUS PROTEASOME (CASP TARGET) | 20S PROTEASOME, HALF PROTEASOME, ASSEMBLY-DEPENDENT ACTIVATION, HYDROLASE
2h6j:F (LYS52) to (GLN190) CRYSTAL STRUCTURE OF THE BETA F145A RHODOCOCCUS PROTEASOME (CASP TARGET) | 20S PROTEASOME, HALF PROTEASOME, ASSEMBLY-DEPENDENT ACTIVATION, HYDROLASE
4zzg:C (LYS65) to (THR200) YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR | 20S PROTEASOME, LOW-MOLECULAR MASS ACTIVATORS, ALLOSTERIC REGULATION, HYDROLASE
4zzg:E (LYS66) to (TRP187) YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR | 20S PROTEASOME, LOW-MOLECULAR MASS ACTIVATORS, ALLOSTERIC REGULATION, HYDROLASE
4zzg:F (LYS62) to (ILE182) YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR | 20S PROTEASOME, LOW-MOLECULAR MASS ACTIVATORS, ALLOSTERIC REGULATION, HYDROLASE
4zzg:H (LYS33) to (ASN141) YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR | 20S PROTEASOME, LOW-MOLECULAR MASS ACTIVATORS, ALLOSTERIC REGULATION, HYDROLASE
4zzg:I (LYS33) to (ASP166) YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR | 20S PROTEASOME, LOW-MOLECULAR MASS ACTIVATORS, ALLOSTERIC REGULATION, HYDROLASE
4zzg:K (LYS33) to (HIS146) YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR | 20S PROTEASOME, LOW-MOLECULAR MASS ACTIVATORS, ALLOSTERIC REGULATION, HYDROLASE
4zzg:M (LYS33) to (ARG185) YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR | 20S PROTEASOME, LOW-MOLECULAR MASS ACTIVATORS, ALLOSTERIC REGULATION, HYDROLASE
4zzg:N (ARG33) to (ARG179) YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR | 20S PROTEASOME, LOW-MOLECULAR MASS ACTIVATORS, ALLOSTERIC REGULATION, HYDROLASE
4zzg:O (TYR71) to (GLY215) YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR | 20S PROTEASOME, LOW-MOLECULAR MASS ACTIVATORS, ALLOSTERIC REGULATION, HYDROLASE
4zzg:V (LYS33) to (ASN141) YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR | 20S PROTEASOME, LOW-MOLECULAR MASS ACTIVATORS, ALLOSTERIC REGULATION, HYDROLASE
4zzg:W (LYS33) to (ASP166) YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR | 20S PROTEASOME, LOW-MOLECULAR MASS ACTIVATORS, ALLOSTERIC REGULATION, HYDROLASE
4zzg:X (LYS33) to (ASP169) YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR | 20S PROTEASOME, LOW-MOLECULAR MASS ACTIVATORS, ALLOSTERIC REGULATION, HYDROLASE
4zzg:Y (LYS33) to (LYS169) YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR | 20S PROTEASOME, LOW-MOLECULAR MASS ACTIVATORS, ALLOSTERIC REGULATION, HYDROLASE
4zzg:1 (LYS33) to (ARG185) YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR | 20S PROTEASOME, LOW-MOLECULAR MASS ACTIVATORS, ALLOSTERIC REGULATION, HYDROLASE
4zzg:2 (ARG33) to (THR160) YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR | 20S PROTEASOME, LOW-MOLECULAR MASS ACTIVATORS, ALLOSTERIC REGULATION, HYDROLASE
4lqi:E (LYS66) to (ILE180) YEAST 20S PROTEASOME IN COMPLEX WITH VIBRALACTONE | BETA-LACTONE, INHIBITOR, NATURAL PRODUCT, TARGET IDENTIFICATION, NTN- PROTEASE, CELLULAR PROTEIN DEGRADATION, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4lqi:G (TYR66) to (GLY202) YEAST 20S PROTEASOME IN COMPLEX WITH VIBRALACTONE | BETA-LACTONE, INHIBITOR, NATURAL PRODUCT, TARGET IDENTIFICATION, NTN- PROTEASE, CELLULAR PROTEIN DEGRADATION, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4lqi:I (LYS33) to (ASP166) YEAST 20S PROTEASOME IN COMPLEX WITH VIBRALACTONE | BETA-LACTONE, INHIBITOR, NATURAL PRODUCT, TARGET IDENTIFICATION, NTN- PROTEASE, CELLULAR PROTEIN DEGRADATION, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4lqi:J (LYS33) to (HIS141) YEAST 20S PROTEASOME IN COMPLEX WITH VIBRALACTONE | BETA-LACTONE, INHIBITOR, NATURAL PRODUCT, TARGET IDENTIFICATION, NTN- PROTEASE, CELLULAR PROTEIN DEGRADATION, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4lqi:L (LYS32) to (ARG184) YEAST 20S PROTEASOME IN COMPLEX WITH VIBRALACTONE | BETA-LACTONE, INHIBITOR, NATURAL PRODUCT, TARGET IDENTIFICATION, NTN- PROTEASE, CELLULAR PROTEIN DEGRADATION, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4lqi:M (ARG33) to (THR146) YEAST 20S PROTEASOME IN COMPLEX WITH VIBRALACTONE | BETA-LACTONE, INHIBITOR, NATURAL PRODUCT, TARGET IDENTIFICATION, NTN- PROTEASE, CELLULAR PROTEIN DEGRADATION, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4lqi:N (LYS33) to (ASN141) YEAST 20S PROTEASOME IN COMPLEX WITH VIBRALACTONE | BETA-LACTONE, INHIBITOR, NATURAL PRODUCT, TARGET IDENTIFICATION, NTN- PROTEASE, CELLULAR PROTEIN DEGRADATION, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4lqi:S (LYS66) to (ILE180) YEAST 20S PROTEASOME IN COMPLEX WITH VIBRALACTONE | BETA-LACTONE, INHIBITOR, NATURAL PRODUCT, TARGET IDENTIFICATION, NTN- PROTEASE, CELLULAR PROTEIN DEGRADATION, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4lqi:U (TYR66) to (GLY202) YEAST 20S PROTEASOME IN COMPLEX WITH VIBRALACTONE | BETA-LACTONE, INHIBITOR, NATURAL PRODUCT, TARGET IDENTIFICATION, NTN- PROTEASE, CELLULAR PROTEIN DEGRADATION, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4lqi:W (LYS33) to (ASP166) YEAST 20S PROTEASOME IN COMPLEX WITH VIBRALACTONE | BETA-LACTONE, INHIBITOR, NATURAL PRODUCT, TARGET IDENTIFICATION, NTN- PROTEASE, CELLULAR PROTEIN DEGRADATION, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4lqi:X (LYS33) to (HIS141) YEAST 20S PROTEASOME IN COMPLEX WITH VIBRALACTONE | BETA-LACTONE, INHIBITOR, NATURAL PRODUCT, TARGET IDENTIFICATION, NTN- PROTEASE, CELLULAR PROTEIN DEGRADATION, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4lqi:Z (LYS32) to (ARG184) YEAST 20S PROTEASOME IN COMPLEX WITH VIBRALACTONE | BETA-LACTONE, INHIBITOR, NATURAL PRODUCT, TARGET IDENTIFICATION, NTN- PROTEASE, CELLULAR PROTEIN DEGRADATION, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4lqi:a (ARG33) to (THR146) YEAST 20S PROTEASOME IN COMPLEX WITH VIBRALACTONE | BETA-LACTONE, INHIBITOR, NATURAL PRODUCT, TARGET IDENTIFICATION, NTN- PROTEASE, CELLULAR PROTEIN DEGRADATION, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4lqi:b (LYS33) to (ASN141) YEAST 20S PROTEASOME IN COMPLEX WITH VIBRALACTONE | BETA-LACTONE, INHIBITOR, NATURAL PRODUCT, TARGET IDENTIFICATION, NTN- PROTEASE, CELLULAR PROTEIN DEGRADATION, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4ltc:E (LYS61) to (ILE181) CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH ENONE CARMAPHYCIN ANALOGUE 6 | PROTEASOME, INHIBITOR, CARMAPHYCIN, EPOXYKETONE, VINYLKETONE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4ltc:S (LYS61) to (ILE181) CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH ENONE CARMAPHYCIN ANALOGUE 6 | PROTEASOME, INHIBITOR, CARMAPHYCIN, EPOXYKETONE, VINYLKETONE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4ltc:J (LYS34) to (MET172) CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH ENONE CARMAPHYCIN ANALOGUE 6 | PROTEASOME, INHIBITOR, CARMAPHYCIN, EPOXYKETONE, VINYLKETONE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4ltc:L (LYS42) to (ARG194) CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH ENONE CARMAPHYCIN ANALOGUE 6 | PROTEASOME, INHIBITOR, CARMAPHYCIN, EPOXYKETONE, VINYLKETONE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4ltc:M (ARG41) to (THR168) CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH ENONE CARMAPHYCIN ANALOGUE 6 | PROTEASOME, INHIBITOR, CARMAPHYCIN, EPOXYKETONE, VINYLKETONE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4ltc:N (LYS33) to (ASN141) CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH ENONE CARMAPHYCIN ANALOGUE 6 | PROTEASOME, INHIBITOR, CARMAPHYCIN, EPOXYKETONE, VINYLKETONE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4ltc:Z (LYS42) to (ARG194) CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH ENONE CARMAPHYCIN ANALOGUE 6 | PROTEASOME, INHIBITOR, CARMAPHYCIN, EPOXYKETONE, VINYLKETONE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4ltc:a (ARG41) to (ARG187) CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH ENONE CARMAPHYCIN ANALOGUE 6 | PROTEASOME, INHIBITOR, CARMAPHYCIN, EPOXYKETONE, VINYLKETONE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4ltc:b (LYS33) to (ASN141) CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH ENONE CARMAPHYCIN ANALOGUE 6 | PROTEASOME, INHIBITOR, CARMAPHYCIN, EPOXYKETONE, VINYLKETONE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
1iru:D (LYS61) to (GLU197) CRYSTAL STRUCTURE OF THE MAMMALIAN 20S PROTEASOME AT 2.75 A RESOLUTION | 20S PROTEASOME, CELL CYCLE, IMMUNE RESPONSE, PROTEOLYSIS, UBIQUITIN, HYDROLASE
1iru:F (LYS62) to (CYS182) CRYSTAL STRUCTURE OF THE MAMMALIAN 20S PROTEASOME AT 2.75 A RESOLUTION | 20S PROTEASOME, CELL CYCLE, IMMUNE RESPONSE, PROTEOLYSIS, UBIQUITIN, HYDROLASE
1iru:G (ARG65) to (ILE199) CRYSTAL STRUCTURE OF THE MAMMALIAN 20S PROTEASOME AT 2.75 A RESOLUTION | 20S PROTEASOME, CELL CYCLE, IMMUNE RESPONSE, PROTEOLYSIS, UBIQUITIN, HYDROLASE
1iru:H (LYS33) to (THR142) CRYSTAL STRUCTURE OF THE MAMMALIAN 20S PROTEASOME AT 2.75 A RESOLUTION | 20S PROTEASOME, CELL CYCLE, IMMUNE RESPONSE, PROTEOLYSIS, UBIQUITIN, HYDROLASE
1iru:J (LYS41) to (ASP178) CRYSTAL STRUCTURE OF THE MAMMALIAN 20S PROTEASOME AT 2.75 A RESOLUTION | 20S PROTEASOME, CELL CYCLE, IMMUNE RESPONSE, PROTEOLYSIS, UBIQUITIN, HYDROLASE
1iru:R (LYS61) to (GLU197) CRYSTAL STRUCTURE OF THE MAMMALIAN 20S PROTEASOME AT 2.75 A RESOLUTION | 20S PROTEASOME, CELL CYCLE, IMMUNE RESPONSE, PROTEOLYSIS, UBIQUITIN, HYDROLASE
1iru:U (ARG65) to (ILE199) CRYSTAL STRUCTURE OF THE MAMMALIAN 20S PROTEASOME AT 2.75 A RESOLUTION | 20S PROTEASOME, CELL CYCLE, IMMUNE RESPONSE, PROTEOLYSIS, UBIQUITIN, HYDROLASE
1iru:V (LYS33) to (THR142) CRYSTAL STRUCTURE OF THE MAMMALIAN 20S PROTEASOME AT 2.75 A RESOLUTION | 20S PROTEASOME, CELL CYCLE, IMMUNE RESPONSE, PROTEOLYSIS, UBIQUITIN, HYDROLASE
1iru:X (LYS41) to (ASP178) CRYSTAL STRUCTURE OF THE MAMMALIAN 20S PROTEASOME AT 2.75 A RESOLUTION | 20S PROTEASOME, CELL CYCLE, IMMUNE RESPONSE, PROTEOLYSIS, UBIQUITIN, HYDROLASE
1iru:1 (LYS42) to (ARG185) CRYSTAL STRUCTURE OF THE MAMMALIAN 20S PROTEASOME AT 2.75 A RESOLUTION | 20S PROTEASOME, CELL CYCLE, IMMUNE RESPONSE, PROTEOLYSIS, UBIQUITIN, HYDROLASE
2x1d:A (THR142) to (LEU289) THE CRYSTAL STRUCTURE OF MATURE ACYL COENZYME A:ISOPENICILLIN N ACYLTRANSFERASE FROM PENICILLIUM CHRYSOGENUM | ZYMOGEN, TRANSFERASE, NTN-HYDROLASE, PENICILLIN BIOSYNTHESIS, ANTIBIOTIC BIOSYNTHESIS
2x1d:B (VAL155) to (LEU289) THE CRYSTAL STRUCTURE OF MATURE ACYL COENZYME A:ISOPENICILLIN N ACYLTRANSFERASE FROM PENICILLIUM CHRYSOGENUM | ZYMOGEN, TRANSFERASE, NTN-HYDROLASE, PENICILLIN BIOSYNTHESIS, ANTIBIOTIC BIOSYNTHESIS
5ahj:E (SER56) to (ILE181) YEAST 20S PROTEASOME IN COMPLEX WITH MACYRANONE A | HYDROLASE, PROTEASOME, NATURAL PRODUCT, TARGET IDENTIFICATION, INHIBITION, BINDING ANALYSIS
5ahj:I (LYS41) to (ASP177) YEAST 20S PROTEASOME IN COMPLEX WITH MACYRANONE A | HYDROLASE, PROTEASOME, NATURAL PRODUCT, TARGET IDENTIFICATION, INHIBITION, BINDING ANALYSIS
5ahj:L (LYS42) to (ARG194) YEAST 20S PROTEASOME IN COMPLEX WITH MACYRANONE A | HYDROLASE, PROTEASOME, NATURAL PRODUCT, TARGET IDENTIFICATION, INHIBITION, BINDING ANALYSIS
5ahj:M (ARG41) to (ARG187) YEAST 20S PROTEASOME IN COMPLEX WITH MACYRANONE A | HYDROLASE, PROTEASOME, NATURAL PRODUCT, TARGET IDENTIFICATION, INHIBITION, BINDING ANALYSIS
5ahj:N (LYS33) to (ASN141) YEAST 20S PROTEASOME IN COMPLEX WITH MACYRANONE A | HYDROLASE, PROTEASOME, NATURAL PRODUCT, TARGET IDENTIFICATION, INHIBITION, BINDING ANALYSIS
5ahj:S (SER56) to (ILE181) YEAST 20S PROTEASOME IN COMPLEX WITH MACYRANONE A | HYDROLASE, PROTEASOME, NATURAL PRODUCT, TARGET IDENTIFICATION, INHIBITION, BINDING ANALYSIS
5ahj:W (LYS41) to (ASP177) YEAST 20S PROTEASOME IN COMPLEX WITH MACYRANONE A | HYDROLASE, PROTEASOME, NATURAL PRODUCT, TARGET IDENTIFICATION, INHIBITION, BINDING ANALYSIS
5ahj:Z (LYS42) to (ARG194) YEAST 20S PROTEASOME IN COMPLEX WITH MACYRANONE A | HYDROLASE, PROTEASOME, NATURAL PRODUCT, TARGET IDENTIFICATION, INHIBITION, BINDING ANALYSIS
5ahj:a (ARG41) to (ARG187) YEAST 20S PROTEASOME IN COMPLEX WITH MACYRANONE A | HYDROLASE, PROTEASOME, NATURAL PRODUCT, TARGET IDENTIFICATION, INHIBITION, BINDING ANALYSIS
5ahj:b (LYS33) to (ASN141) YEAST 20S PROTEASOME IN COMPLEX WITH MACYRANONE A | HYDROLASE, PROTEASOME, NATURAL PRODUCT, TARGET IDENTIFICATION, INHIBITION, BINDING ANALYSIS
1jd2:E (LYS66) to (ILE180) CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME:TMC-95A COMPLEX: A NON- COVALENT PROTEASOME INHIBITOR | BETA-SANDWICH, PROTEASOME:INHIBITOR COMPLEX, HYDROLASE, HYDROLASE- HYDROLASE INHIBITOR COMPLEX
1jd2:I (LYS33) to (ASP166) CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME:TMC-95A COMPLEX: A NON- COVALENT PROTEASOME INHIBITOR | BETA-SANDWICH, PROTEASOME:INHIBITOR COMPLEX, HYDROLASE, HYDROLASE- HYDROLASE INHIBITOR COMPLEX
1jd2:J (LYS33) to (ARG165) CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME:TMC-95A COMPLEX: A NON- COVALENT PROTEASOME INHIBITOR | BETA-SANDWICH, PROTEASOME:INHIBITOR COMPLEX, HYDROLASE, HYDROLASE- HYDROLASE INHIBITOR COMPLEX
1jd2:L (LYS33) to (ARG165) CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME:TMC-95A COMPLEX: A NON- COVALENT PROTEASOME INHIBITOR | BETA-SANDWICH, PROTEASOME:INHIBITOR COMPLEX, HYDROLASE, HYDROLASE- HYDROLASE INHIBITOR COMPLEX
1jd2:N (LYS33) to (ASN141) CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME:TMC-95A COMPLEX: A NON- COVALENT PROTEASOME INHIBITOR | BETA-SANDWICH, PROTEASOME:INHIBITOR COMPLEX, HYDROLASE, HYDROLASE- HYDROLASE INHIBITOR COMPLEX
1jd2:P (LYS33) to (ASP166) CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME:TMC-95A COMPLEX: A NON- COVALENT PROTEASOME INHIBITOR | BETA-SANDWICH, PROTEASOME:INHIBITOR COMPLEX, HYDROLASE, HYDROLASE- HYDROLASE INHIBITOR COMPLEX
1jd2:Q (LYS33) to (ARG165) CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME:TMC-95A COMPLEX: A NON- COVALENT PROTEASOME INHIBITOR | BETA-SANDWICH, PROTEASOME:INHIBITOR COMPLEX, HYDROLASE, HYDROLASE- HYDROLASE INHIBITOR COMPLEX
1jd2:S (LYS33) to (ARG165) CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME:TMC-95A COMPLEX: A NON- COVALENT PROTEASOME INHIBITOR | BETA-SANDWICH, PROTEASOME:INHIBITOR COMPLEX, HYDROLASE, HYDROLASE- HYDROLASE INHIBITOR COMPLEX
1jd2:U (LYS33) to (ASN141) CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME:TMC-95A COMPLEX: A NON- COVALENT PROTEASOME INHIBITOR | BETA-SANDWICH, PROTEASOME:INHIBITOR COMPLEX, HYDROLASE, HYDROLASE- HYDROLASE INHIBITOR COMPLEX
1jd2:Z (LYS66) to (ILE180) CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME:TMC-95A COMPLEX: A NON- COVALENT PROTEASOME INHIBITOR | BETA-SANDWICH, PROTEASOME:INHIBITOR COMPLEX, HYDROLASE, HYDROLASE- HYDROLASE INHIBITOR COMPLEX
3wxr:D (LYS63) to (LEU200) YEAST 20S PROTEASOME WITH A MUTATION OF ALPHA7 SUBUNIT | UPS, 20S PROTEASOME, HYDROLASE, PROTEASE, 19S REGULATORY PARTICLE, MULTICATALYTIC PROTEASE
3wxr:F (SER57) to (ILE182) YEAST 20S PROTEASOME WITH A MUTATION OF ALPHA7 SUBUNIT | UPS, 20S PROTEASOME, HYDROLASE, PROTEASE, 19S REGULATORY PARTICLE, MULTICATALYTIC PROTEASE
3wxr:H (LYS33) to (ASN141) YEAST 20S PROTEASOME WITH A MUTATION OF ALPHA7 SUBUNIT | UPS, 20S PROTEASOME, HYDROLASE, PROTEASE, 19S REGULATORY PARTICLE, MULTICATALYTIC PROTEASE
3wxr:J (LYS33) to (ASP169) YEAST 20S PROTEASOME WITH A MUTATION OF ALPHA7 SUBUNIT | UPS, 20S PROTEASOME, HYDROLASE, PROTEASE, 19S REGULATORY PARTICLE, MULTICATALYTIC PROTEASE
3wxr:K (LYS33) to (HIS146) YEAST 20S PROTEASOME WITH A MUTATION OF ALPHA7 SUBUNIT | UPS, 20S PROTEASOME, HYDROLASE, PROTEASE, 19S REGULATORY PARTICLE, MULTICATALYTIC PROTEASE
3wxr:M (LYS33) to (ARG185) YEAST 20S PROTEASOME WITH A MUTATION OF ALPHA7 SUBUNIT | UPS, 20S PROTEASOME, HYDROLASE, PROTEASE, 19S REGULATORY PARTICLE, MULTICATALYTIC PROTEASE
3wxr:T (LYS62) to (ILE182) YEAST 20S PROTEASOME WITH A MUTATION OF ALPHA7 SUBUNIT | UPS, 20S PROTEASOME, HYDROLASE, PROTEASE, 19S REGULATORY PARTICLE, MULTICATALYTIC PROTEASE
3wxr:V (LYS33) to (ASN141) YEAST 20S PROTEASOME WITH A MUTATION OF ALPHA7 SUBUNIT | UPS, 20S PROTEASOME, HYDROLASE, PROTEASE, 19S REGULATORY PARTICLE, MULTICATALYTIC PROTEASE
3wxr:X (LYS33) to (ASP169) YEAST 20S PROTEASOME WITH A MUTATION OF ALPHA7 SUBUNIT | UPS, 20S PROTEASOME, HYDROLASE, PROTEASE, 19S REGULATORY PARTICLE, MULTICATALYTIC PROTEASE
3wxr:Y (LYS33) to (HIS146) YEAST 20S PROTEASOME WITH A MUTATION OF ALPHA7 SUBUNIT | UPS, 20S PROTEASOME, HYDROLASE, PROTEASE, 19S REGULATORY PARTICLE, MULTICATALYTIC PROTEASE
3wxr:1 (LYS33) to (ARG185) YEAST 20S PROTEASOME WITH A MUTATION OF ALPHA7 SUBUNIT | UPS, 20S PROTEASOME, HYDROLASE, PROTEASE, 19S REGULATORY PARTICLE, MULTICATALYTIC PROTEASE
2ku1:A (LYS66) to (SER200) DYNAMIC REGULATION OF ARCHAEAL PROTEASOME GATE OPENING AS STUDIED BY TROSY-NMR | PROTEASOME, PROTEOLYSIS, GATING RESIDUES, CYTOPLASM, HYDROLASE, PROTEASE, THREONINE PROTEASE
2ku1:B (LYS66) to (SER200) DYNAMIC REGULATION OF ARCHAEAL PROTEASOME GATE OPENING AS STUDIED BY TROSY-NMR | PROTEASOME, PROTEOLYSIS, GATING RESIDUES, CYTOPLASM, HYDROLASE, PROTEASE, THREONINE PROTEASE
2ku1:C (LYS66) to (SER200) DYNAMIC REGULATION OF ARCHAEAL PROTEASOME GATE OPENING AS STUDIED BY TROSY-NMR | PROTEASOME, PROTEOLYSIS, GATING RESIDUES, CYTOPLASM, HYDROLASE, PROTEASE, THREONINE PROTEASE
2ku1:D (LYS66) to (SER200) DYNAMIC REGULATION OF ARCHAEAL PROTEASOME GATE OPENING AS STUDIED BY TROSY-NMR | PROTEASOME, PROTEOLYSIS, GATING RESIDUES, CYTOPLASM, HYDROLASE, PROTEASE, THREONINE PROTEASE
2ku1:E (LYS66) to (SER200) DYNAMIC REGULATION OF ARCHAEAL PROTEASOME GATE OPENING AS STUDIED BY TROSY-NMR | PROTEASOME, PROTEOLYSIS, GATING RESIDUES, CYTOPLASM, HYDROLASE, PROTEASE, THREONINE PROTEASE
2ku1:F (LYS66) to (SER200) DYNAMIC REGULATION OF ARCHAEAL PROTEASOME GATE OPENING AS STUDIED BY TROSY-NMR | PROTEASOME, PROTEOLYSIS, GATING RESIDUES, CYTOPLASM, HYDROLASE, PROTEASE, THREONINE PROTEASE
2ku1:G (LYS66) to (SER200) DYNAMIC REGULATION OF ARCHAEAL PROTEASOME GATE OPENING AS STUDIED BY TROSY-NMR | PROTEASOME, PROTEOLYSIS, GATING RESIDUES, CYTOPLASM, HYDROLASE, PROTEASE, THREONINE PROTEASE
2ku2:A (LYS66) to (SER200) DYNAMIC REGULATION OF ARCHAEAL PROTEASOME GATE OPENING AS STUDIED BY TROSY-NMR | PROTEASOME, PROTEOLYSIS, GATING RESIDUES, CYTOPLASM, HYDROLASE, PROTEASE, THREONINE PROTEASE
2ku2:B (LYS66) to (SER200) DYNAMIC REGULATION OF ARCHAEAL PROTEASOME GATE OPENING AS STUDIED BY TROSY-NMR | PROTEASOME, PROTEOLYSIS, GATING RESIDUES, CYTOPLASM, HYDROLASE, PROTEASE, THREONINE PROTEASE
2ku2:C (LYS66) to (SER200) DYNAMIC REGULATION OF ARCHAEAL PROTEASOME GATE OPENING AS STUDIED BY TROSY-NMR | PROTEASOME, PROTEOLYSIS, GATING RESIDUES, CYTOPLASM, HYDROLASE, PROTEASE, THREONINE PROTEASE
2ku2:D (LYS66) to (SER200) DYNAMIC REGULATION OF ARCHAEAL PROTEASOME GATE OPENING AS STUDIED BY TROSY-NMR | PROTEASOME, PROTEOLYSIS, GATING RESIDUES, CYTOPLASM, HYDROLASE, PROTEASE, THREONINE PROTEASE
2ku2:E (LYS66) to (SER200) DYNAMIC REGULATION OF ARCHAEAL PROTEASOME GATE OPENING AS STUDIED BY TROSY-NMR | PROTEASOME, PROTEOLYSIS, GATING RESIDUES, CYTOPLASM, HYDROLASE, PROTEASE, THREONINE PROTEASE
2ku2:F (LYS66) to (SER200) DYNAMIC REGULATION OF ARCHAEAL PROTEASOME GATE OPENING AS STUDIED BY TROSY-NMR | PROTEASOME, PROTEOLYSIS, GATING RESIDUES, CYTOPLASM, HYDROLASE, PROTEASE, THREONINE PROTEASE
2ku2:G (LYS66) to (SER200) DYNAMIC REGULATION OF ARCHAEAL PROTEASOME GATE OPENING AS STUDIED BY TROSY-NMR | PROTEASOME, PROTEOLYSIS, GATING RESIDUES, CYTOPLASM, HYDROLASE, PROTEASE, THREONINE PROTEASE
4nnn:E (SER56) to (ILE181) YCP IN COMPLEX WITH MG132 | PROTEASOME, PEPTIDE ELECTROPHILE, BINDING ANALYSIS, REVERSIBLE INHIBITOR, ALDEHYDE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4nnn:I (LYS41) to (ASP177) YCP IN COMPLEX WITH MG132 | PROTEASOME, PEPTIDE ELECTROPHILE, BINDING ANALYSIS, REVERSIBLE INHIBITOR, ALDEHYDE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4nnn:L (LYS42) to (ARG194) YCP IN COMPLEX WITH MG132 | PROTEASOME, PEPTIDE ELECTROPHILE, BINDING ANALYSIS, REVERSIBLE INHIBITOR, ALDEHYDE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4nnn:M (ARG41) to (THR168) YCP IN COMPLEX WITH MG132 | PROTEASOME, PEPTIDE ELECTROPHILE, BINDING ANALYSIS, REVERSIBLE INHIBITOR, ALDEHYDE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4nnn:N (LYS33) to (ASN141) YCP IN COMPLEX WITH MG132 | PROTEASOME, PEPTIDE ELECTROPHILE, BINDING ANALYSIS, REVERSIBLE INHIBITOR, ALDEHYDE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4nnn:S (SER56) to (ILE181) YCP IN COMPLEX WITH MG132 | PROTEASOME, PEPTIDE ELECTROPHILE, BINDING ANALYSIS, REVERSIBLE INHIBITOR, ALDEHYDE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4nnn:W (LYS41) to (ASP177) YCP IN COMPLEX WITH MG132 | PROTEASOME, PEPTIDE ELECTROPHILE, BINDING ANALYSIS, REVERSIBLE INHIBITOR, ALDEHYDE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4nnn:Z (LYS42) to (ARG194) YCP IN COMPLEX WITH MG132 | PROTEASOME, PEPTIDE ELECTROPHILE, BINDING ANALYSIS, REVERSIBLE INHIBITOR, ALDEHYDE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4nnn:a (ARG41) to (THR168) YCP IN COMPLEX WITH MG132 | PROTEASOME, PEPTIDE ELECTROPHILE, BINDING ANALYSIS, REVERSIBLE INHIBITOR, ALDEHYDE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4nnn:b (LYS33) to (ASN141) YCP IN COMPLEX WITH MG132 | PROTEASOME, PEPTIDE ELECTROPHILE, BINDING ANALYSIS, REVERSIBLE INHIBITOR, ALDEHYDE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4nnw:E (SER56) to (ILE181) YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOALDEHYDE | PROTEASOME, PEPTIDE ELECTROPHILE, BINDING ANALYSIS, REVERSIBLE INHIBITOR, KETOALDEHYDE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4nnw:I (LYS41) to (ASP177) YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOALDEHYDE | PROTEASOME, PEPTIDE ELECTROPHILE, BINDING ANALYSIS, REVERSIBLE INHIBITOR, KETOALDEHYDE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4nnw:L (LYS42) to (ARG194) YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOALDEHYDE | PROTEASOME, PEPTIDE ELECTROPHILE, BINDING ANALYSIS, REVERSIBLE INHIBITOR, KETOALDEHYDE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4nnw:N (LYS33) to (ASN141) YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOALDEHYDE | PROTEASOME, PEPTIDE ELECTROPHILE, BINDING ANALYSIS, REVERSIBLE INHIBITOR, KETOALDEHYDE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4nnw:S (SER56) to (ILE181) YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOALDEHYDE | PROTEASOME, PEPTIDE ELECTROPHILE, BINDING ANALYSIS, REVERSIBLE INHIBITOR, KETOALDEHYDE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4nnw:W (LYS41) to (ASP177) YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOALDEHYDE | PROTEASOME, PEPTIDE ELECTROPHILE, BINDING ANALYSIS, REVERSIBLE INHIBITOR, KETOALDEHYDE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4nnw:Z (LYS42) to (ARG194) YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOALDEHYDE | PROTEASOME, PEPTIDE ELECTROPHILE, BINDING ANALYSIS, REVERSIBLE INHIBITOR, KETOALDEHYDE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4nnw:b (LYS33) to (ASN141) YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOALDEHYDE | PROTEASOME, PEPTIDE ELECTROPHILE, BINDING ANALYSIS, REVERSIBLE INHIBITOR, KETOALDEHYDE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4no1:E (SER56) to (ILE181) YCP IN COMPLEX WITH Z-LEU-LEU-LEU-B(OH)2 | PROTEASOME, PEPTIDE ELECTROPHILE, BINDING ANALYSIS, IRREVERSIBLE INHIBITOR, BORONIC ACID, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4no1:L (LYS42) to (ARG194) YCP IN COMPLEX WITH Z-LEU-LEU-LEU-B(OH)2 | PROTEASOME, PEPTIDE ELECTROPHILE, BINDING ANALYSIS, IRREVERSIBLE INHIBITOR, BORONIC ACID, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4no1:M (ARG41) to (ARG187) YCP IN COMPLEX WITH Z-LEU-LEU-LEU-B(OH)2 | PROTEASOME, PEPTIDE ELECTROPHILE, BINDING ANALYSIS, IRREVERSIBLE INHIBITOR, BORONIC ACID, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4no1:N (LYS33) to (ASN141) YCP IN COMPLEX WITH Z-LEU-LEU-LEU-B(OH)2 | PROTEASOME, PEPTIDE ELECTROPHILE, BINDING ANALYSIS, IRREVERSIBLE INHIBITOR, BORONIC ACID, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4no1:S (SER56) to (ILE181) YCP IN COMPLEX WITH Z-LEU-LEU-LEU-B(OH)2 | PROTEASOME, PEPTIDE ELECTROPHILE, BINDING ANALYSIS, IRREVERSIBLE INHIBITOR, BORONIC ACID, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4no1:Z (LYS42) to (ARG194) YCP IN COMPLEX WITH Z-LEU-LEU-LEU-B(OH)2 | PROTEASOME, PEPTIDE ELECTROPHILE, BINDING ANALYSIS, IRREVERSIBLE INHIBITOR, BORONIC ACID, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4no1:a (ARG41) to (ARG187) YCP IN COMPLEX WITH Z-LEU-LEU-LEU-B(OH)2 | PROTEASOME, PEPTIDE ELECTROPHILE, BINDING ANALYSIS, IRREVERSIBLE INHIBITOR, BORONIC ACID, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4no1:b (LYS33) to (ASN141) YCP IN COMPLEX WITH Z-LEU-LEU-LEU-B(OH)2 | PROTEASOME, PEPTIDE ELECTROPHILE, BINDING ANALYSIS, IRREVERSIBLE INHIBITOR, BORONIC ACID, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4no6:E (SER56) to (ILE181) YCP IN COMPLEX WITH Z-LEU-LEU-LEU-VINYLSULFONE | PROTEASOME, PEPTIDE ELECTROPHILE, BINDING ANALYSIS, IRREVERSIBLE INHIBITOR, VINYLSULFONE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4no6:I (LYS41) to (ASP177) YCP IN COMPLEX WITH Z-LEU-LEU-LEU-VINYLSULFONE | PROTEASOME, PEPTIDE ELECTROPHILE, BINDING ANALYSIS, IRREVERSIBLE INHIBITOR, VINYLSULFONE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4no6:L (LYS42) to (ARG194) YCP IN COMPLEX WITH Z-LEU-LEU-LEU-VINYLSULFONE | PROTEASOME, PEPTIDE ELECTROPHILE, BINDING ANALYSIS, IRREVERSIBLE INHIBITOR, VINYLSULFONE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4no6:S (SER56) to (ILE181) YCP IN COMPLEX WITH Z-LEU-LEU-LEU-VINYLSULFONE | PROTEASOME, PEPTIDE ELECTROPHILE, BINDING ANALYSIS, IRREVERSIBLE INHIBITOR, VINYLSULFONE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4no6:W (LYS41) to (ASP177) YCP IN COMPLEX WITH Z-LEU-LEU-LEU-VINYLSULFONE | PROTEASOME, PEPTIDE ELECTROPHILE, BINDING ANALYSIS, IRREVERSIBLE INHIBITOR, VINYLSULFONE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4no6:Z (LYS42) to (ARG194) YCP IN COMPLEX WITH Z-LEU-LEU-LEU-VINYLSULFONE | PROTEASOME, PEPTIDE ELECTROPHILE, BINDING ANALYSIS, IRREVERSIBLE INHIBITOR, VINYLSULFONE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4no8:E (SER56) to (ILE181) YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOAMIDE | PROTEASOME, PEPTIDE ELECTROPHILE, BINDING ANALYSIS, REVERSIBLE INHIBITOR, KETOAMIDE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4no8:I (LYS41) to (ASP177) YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOAMIDE | PROTEASOME, PEPTIDE ELECTROPHILE, BINDING ANALYSIS, REVERSIBLE INHIBITOR, KETOAMIDE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4no8:L (LYS42) to (ARG194) YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOAMIDE | PROTEASOME, PEPTIDE ELECTROPHILE, BINDING ANALYSIS, REVERSIBLE INHIBITOR, KETOAMIDE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4no8:M (ARG41) to (ARG187) YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOAMIDE | PROTEASOME, PEPTIDE ELECTROPHILE, BINDING ANALYSIS, REVERSIBLE INHIBITOR, KETOAMIDE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4no8:N (LYS33) to (ASN141) YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOAMIDE | PROTEASOME, PEPTIDE ELECTROPHILE, BINDING ANALYSIS, REVERSIBLE INHIBITOR, KETOAMIDE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4no8:S (SER56) to (ILE181) YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOAMIDE | PROTEASOME, PEPTIDE ELECTROPHILE, BINDING ANALYSIS, REVERSIBLE INHIBITOR, KETOAMIDE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4no8:W (LYS41) to (ASP177) YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOAMIDE | PROTEASOME, PEPTIDE ELECTROPHILE, BINDING ANALYSIS, REVERSIBLE INHIBITOR, KETOAMIDE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4no8:Z (LYS42) to (ARG194) YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOAMIDE | PROTEASOME, PEPTIDE ELECTROPHILE, BINDING ANALYSIS, REVERSIBLE INHIBITOR, KETOAMIDE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4no8:a (ARG41) to (ARG187) YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOAMIDE | PROTEASOME, PEPTIDE ELECTROPHILE, BINDING ANALYSIS, REVERSIBLE INHIBITOR, KETOAMIDE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4no8:b (LYS33) to (ASN141) YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOAMIDE | PROTEASOME, PEPTIDE ELECTROPHILE, BINDING ANALYSIS, REVERSIBLE INHIBITOR, KETOAMIDE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
1kuu:A (CYS61) to (THR180) CRYSTAL STRUCTURE OF METHANOBACTERIUM THERMOAUTOTROPHICUM CONSERVED PROTEIN MTH1020 REVEALS AN NTN-HYDROLASE FOLD | STRUCTURAL GENOMICS, CONSERVED PROTEIN, NTN-HYDROLASE FOLD, UNKNOWN FUNCTION
1kyi:G (LYS33) to (ILE159) HSLUV (H. INFLUENZAE)-NLVS VINYL SULFONE INHIBITOR COMPLEX | PROKARYOTIC PROTEASOME, PROTEASE, AAA-PROTEIN, ATP-DEPENDENT CHAPERONE; CLP/HSP100, VINYL SULFONE INHIBITOR, CHAPERONE-HYDROLASE COMPLEX
1kyi:H (LYS33) to (ILE159) HSLUV (H. INFLUENZAE)-NLVS VINYL SULFONE INHIBITOR COMPLEX | PROKARYOTIC PROTEASOME, PROTEASE, AAA-PROTEIN, ATP-DEPENDENT CHAPERONE; CLP/HSP100, VINYL SULFONE INHIBITOR, CHAPERONE-HYDROLASE COMPLEX
1kyi:I (LYS33) to (ILE159) HSLUV (H. INFLUENZAE)-NLVS VINYL SULFONE INHIBITOR COMPLEX | PROKARYOTIC PROTEASOME, PROTEASE, AAA-PROTEIN, ATP-DEPENDENT CHAPERONE; CLP/HSP100, VINYL SULFONE INHIBITOR, CHAPERONE-HYDROLASE COMPLEX
1kyi:J (LYS33) to (ILE159) HSLUV (H. INFLUENZAE)-NLVS VINYL SULFONE INHIBITOR COMPLEX | PROKARYOTIC PROTEASOME, PROTEASE, AAA-PROTEIN, ATP-DEPENDENT CHAPERONE; CLP/HSP100, VINYL SULFONE INHIBITOR, CHAPERONE-HYDROLASE COMPLEX
1kyi:K (LYS33) to (ILE159) HSLUV (H. INFLUENZAE)-NLVS VINYL SULFONE INHIBITOR COMPLEX | PROKARYOTIC PROTEASOME, PROTEASE, AAA-PROTEIN, ATP-DEPENDENT CHAPERONE; CLP/HSP100, VINYL SULFONE INHIBITOR, CHAPERONE-HYDROLASE COMPLEX
1kyi:L (LYS33) to (ILE159) HSLUV (H. INFLUENZAE)-NLVS VINYL SULFONE INHIBITOR COMPLEX | PROKARYOTIC PROTEASOME, PROTEASE, AAA-PROTEIN, ATP-DEPENDENT CHAPERONE; CLP/HSP100, VINYL SULFONE INHIBITOR, CHAPERONE-HYDROLASE COMPLEX
1kyi:M (LYS33) to (CYS160) HSLUV (H. INFLUENZAE)-NLVS VINYL SULFONE INHIBITOR COMPLEX | PROKARYOTIC PROTEASOME, PROTEASE, AAA-PROTEIN, ATP-DEPENDENT CHAPERONE; CLP/HSP100, VINYL SULFONE INHIBITOR, CHAPERONE-HYDROLASE COMPLEX
1kyi:N (LYS33) to (CYS160) HSLUV (H. INFLUENZAE)-NLVS VINYL SULFONE INHIBITOR COMPLEX | PROKARYOTIC PROTEASOME, PROTEASE, AAA-PROTEIN, ATP-DEPENDENT CHAPERONE; CLP/HSP100, VINYL SULFONE INHIBITOR, CHAPERONE-HYDROLASE COMPLEX
1kyi:O (LYS33) to (ILE159) HSLUV (H. INFLUENZAE)-NLVS VINYL SULFONE INHIBITOR COMPLEX | PROKARYOTIC PROTEASOME, PROTEASE, AAA-PROTEIN, ATP-DEPENDENT CHAPERONE; CLP/HSP100, VINYL SULFONE INHIBITOR, CHAPERONE-HYDROLASE COMPLEX
1kyi:P (LYS33) to (CYS160) HSLUV (H. INFLUENZAE)-NLVS VINYL SULFONE INHIBITOR COMPLEX | PROKARYOTIC PROTEASOME, PROTEASE, AAA-PROTEIN, ATP-DEPENDENT CHAPERONE; CLP/HSP100, VINYL SULFONE INHIBITOR, CHAPERONE-HYDROLASE COMPLEX
1kyi:Q (LYS33) to (ILE159) HSLUV (H. INFLUENZAE)-NLVS VINYL SULFONE INHIBITOR COMPLEX | PROKARYOTIC PROTEASOME, PROTEASE, AAA-PROTEIN, ATP-DEPENDENT CHAPERONE; CLP/HSP100, VINYL SULFONE INHIBITOR, CHAPERONE-HYDROLASE COMPLEX
1kyi:R (LYS33) to (CYS160) HSLUV (H. INFLUENZAE)-NLVS VINYL SULFONE INHIBITOR COMPLEX | PROKARYOTIC PROTEASOME, PROTEASE, AAA-PROTEIN, ATP-DEPENDENT CHAPERONE; CLP/HSP100, VINYL SULFONE INHIBITOR, CHAPERONE-HYDROLASE COMPLEX
3jse:B (LYS66) to (LEU201) CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR | 20S PROTEASOME, PA26, PROTEASOME ACTIVATION, CYTOPLASM, HYDROLASE, PROTEASE, PROTEASOME, THREONINE PROTEASE, HYDROLASE/HYDROLASE ACTIVATOR COMPLEX
3jse:E (LYS66) to (LEU201) CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR | 20S PROTEASOME, PA26, PROTEASOME ACTIVATION, CYTOPLASM, HYDROLASE, PROTEASE, PROTEASOME, THREONINE PROTEASE, HYDROLASE/HYDROLASE ACTIVATOR COMPLEX
3jse:F (LYS66) to (LEU201) CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR | 20S PROTEASOME, PA26, PROTEASOME ACTIVATION, CYTOPLASM, HYDROLASE, PROTEASE, PROTEASOME, THREONINE PROTEASE, HYDROLASE/HYDROLASE ACTIVATOR COMPLEX
3jse:H (LYS33) to (GLN164) CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR | 20S PROTEASOME, PA26, PROTEASOME ACTIVATION, CYTOPLASM, HYDROLASE, PROTEASE, PROTEASOME, THREONINE PROTEASE, HYDROLASE/HYDROLASE ACTIVATOR COMPLEX
3jse:I (LYS33) to (GLN164) CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR | 20S PROTEASOME, PA26, PROTEASOME ACTIVATION, CYTOPLASM, HYDROLASE, PROTEASE, PROTEASOME, THREONINE PROTEASE, HYDROLASE/HYDROLASE ACTIVATOR COMPLEX
3jse:J (LYS33) to (GLN164) CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR | 20S PROTEASOME, PA26, PROTEASOME ACTIVATION, CYTOPLASM, HYDROLASE, PROTEASE, PROTEASOME, THREONINE PROTEASE, HYDROLASE/HYDROLASE ACTIVATOR COMPLEX
3jse:K (LYS33) to (GLN164) CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR | 20S PROTEASOME, PA26, PROTEASOME ACTIVATION, CYTOPLASM, HYDROLASE, PROTEASE, PROTEASOME, THREONINE PROTEASE, HYDROLASE/HYDROLASE ACTIVATOR COMPLEX
3jse:L (LYS33) to (GLN164) CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR | 20S PROTEASOME, PA26, PROTEASOME ACTIVATION, CYTOPLASM, HYDROLASE, PROTEASE, PROTEASOME, THREONINE PROTEASE, HYDROLASE/HYDROLASE ACTIVATOR COMPLEX
3jse:M (LYS33) to (GLN164) CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR | 20S PROTEASOME, PA26, PROTEASOME ACTIVATION, CYTOPLASM, HYDROLASE, PROTEASE, PROTEASOME, THREONINE PROTEASE, HYDROLASE/HYDROLASE ACTIVATOR COMPLEX
3jse:N (LYS33) to (GLN164) CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR | 20S PROTEASOME, PA26, PROTEASOME ACTIVATION, CYTOPLASM, HYDROLASE, PROTEASE, PROTEASOME, THREONINE PROTEASE, HYDROLASE/HYDROLASE ACTIVATOR COMPLEX
2ntk:A (CYS61) to (THR180) CRYSTAL STRUCTURE OF PURO/IMP FROM METHANOTHERMOBACTER THERMOAUTOTROPHICUS | ALPHA-BETA-BETA-ALPHA NTN HYDROLASE FOLD
2ntk:B (CYS61) to (THR180) CRYSTAL STRUCTURE OF PURO/IMP FROM METHANOTHERMOBACTER THERMOAUTOTROPHICUS | ALPHA-BETA-BETA-ALPHA NTN HYDROLASE FOLD
2ntk:C (CYS61) to (THR180) CRYSTAL STRUCTURE OF PURO/IMP FROM METHANOTHERMOBACTER THERMOAUTOTROPHICUS | ALPHA-BETA-BETA-ALPHA NTN HYDROLASE FOLD
2ntk:D (CYS61) to (THR180) CRYSTAL STRUCTURE OF PURO/IMP FROM METHANOTHERMOBACTER THERMOAUTOTROPHICUS | ALPHA-BETA-BETA-ALPHA NTN HYDROLASE FOLD
2ntl:A (CYS61) to (THR180) CRYSTAL STRUCTURE OF PURO/AICAR FROM METHANOTHERMOBACTER THERMOAUTOTROPHICUS | ALPHA-BETA-BETA-ALPHA NTN HYDROLASE FOLD
2ntl:B (CYS61) to (THR180) CRYSTAL STRUCTURE OF PURO/AICAR FROM METHANOTHERMOBACTER THERMOAUTOTROPHICUS | ALPHA-BETA-BETA-ALPHA NTN HYDROLASE FOLD
2ntl:C (CYS61) to (THR180) CRYSTAL STRUCTURE OF PURO/AICAR FROM METHANOTHERMOBACTER THERMOAUTOTROPHICUS | ALPHA-BETA-BETA-ALPHA NTN HYDROLASE FOLD
2ntl:D (CYS61) to (THR180) CRYSTAL STRUCTURE OF PURO/AICAR FROM METHANOTHERMOBACTER THERMOAUTOTROPHICUS | ALPHA-BETA-BETA-ALPHA NTN HYDROLASE FOLD
2ntm:A (CYS61) to (THR180) CRYSTAL STRUCTURE OF PURO FROM METHANOTHERMOBACTER THERMOAUTOTROPHICUS | ALPHA-BETA-BETA-ALPHA NTN HYDROLASE FOLD
2ntm:B (CYS61) to (THR180) CRYSTAL STRUCTURE OF PURO FROM METHANOTHERMOBACTER THERMOAUTOTROPHICUS | ALPHA-BETA-BETA-ALPHA NTN HYDROLASE FOLD
2ntm:C (CYS61) to (THR180) CRYSTAL STRUCTURE OF PURO FROM METHANOTHERMOBACTER THERMOAUTOTROPHICUS | ALPHA-BETA-BETA-ALPHA NTN HYDROLASE FOLD
2ntm:D (CYS61) to (THR180) CRYSTAL STRUCTURE OF PURO FROM METHANOTHERMOBACTER THERMOAUTOTROPHICUS | ALPHA-BETA-BETA-ALPHA NTN HYDROLASE FOLD
3jtl:H (LYS33) to (ASP166) CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR | 20S PROTEASOME, PA26, CYTOPLASM, HYDROLASE, PROTEASE, PROTEASOME, THREONINE PROTEASE
3jtl:I (LYS33) to (ASP166) CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR | 20S PROTEASOME, PA26, CYTOPLASM, HYDROLASE, PROTEASE, PROTEASOME, THREONINE PROTEASE
3jtl:M (LYS33) to (ASP166) CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR | 20S PROTEASOME, PA26, CYTOPLASM, HYDROLASE, PROTEASE, PROTEASOME, THREONINE PROTEASE
3jtl:N (LYS33) to (ASP166) CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR | 20S PROTEASOME, PA26, CYTOPLASM, HYDROLASE, PROTEASE, PROTEASOME, THREONINE PROTEASE
5cgg:E (SER56) to (ILE181) YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 1 | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5cgg:I (LYS41) to (ASP177) YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 1 | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5cgg:L (LYS42) to (ARG194) YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 1 | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5cgg:M (ARG41) to (ARG187) YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 1 | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5cgg:N (LYS33) to (ASN141) YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 1 | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5cgg:S (SER56) to (ILE181) YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 1 | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5cgg:W (LYS41) to (ASP177) YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 1 | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5cgg:Z (LYS42) to (ARG194) YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 1 | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5cgg:a (ARG41) to (ARG187) YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 1 | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5cgg:b (LYS33) to (ASN141) YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 1 | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5cgh:E (SER56) to (ILE181) YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 5 | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5cgh:I (LYS41) to (ASP177) YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 5 | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5cgh:L (LYS42) to (ARG194) YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 5 | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5cgh:M (ARG41) to (ARG187) YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 5 | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5cgh:N (LYS33) to (ASN141) YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 5 | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5cgh:S (SER56) to (ILE181) YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 5 | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5cgh:W (LYS41) to (ASP177) YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 5 | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5cgh:Z (LYS42) to (ARG194) YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 5 | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5cgh:a (ARG41) to (ARG187) YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 5 | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5cgh:b (LYS33) to (ASN141) YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 5 | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5cgi:E (SER56) to (ILE181) YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ONX 0914 | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5cgi:L (LYS42) to (ARG194) YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ONX 0914 | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5cgi:M (ARG41) to (ARG187) YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ONX 0914 | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5cgi:N (LYS33) to (ASN141) YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ONX 0914 | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5cgi:S (SER56) to (ILE181) YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ONX 0914 | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5cgi:Z (LYS42) to (ARG194) YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ONX 0914 | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5cgi:a (ARG41) to (ARG187) YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ONX 0914 | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5cgi:b (LYS33) to (ASN141) YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ONX 0914 | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
2z3b:F (LYS39) to (ILE166) CRYSTAL STRUCTURE OF BACILLUS SUBTILIS CODW, A NON- CANONICAL HSLV-LIKE PEPTIDASE WITH AN IMPAIRED CATALYTIC APPARATUS | N-TERMINAL NUCLEOPHILE HYDROLASE
2zcy:E (LYS66) to (ILE18) YEAST 20S PROTEASOME:SYRINGOLIN A-COMPLEX | ALPHA/BETA SANDWICH, CYTOPLASM, HYDROLASE, NUCLEUS, PROTEASE, PROTEASOME, THREONINE PROTEASE, UBL CONJUGATION, PHOSPHOPROTEIN, ZYMOGEN
2zcy:F (ILE67) to (LYS206) YEAST 20S PROTEASOME:SYRINGOLIN A-COMPLEX | ALPHA/BETA SANDWICH, CYTOPLASM, HYDROLASE, NUCLEUS, PROTEASE, PROTEASOME, THREONINE PROTEASE, UBL CONJUGATION, PHOSPHOPROTEIN, ZYMOGEN
2zcy:I (LYS33) to (ASP166) YEAST 20S PROTEASOME:SYRINGOLIN A-COMPLEX | ALPHA/BETA SANDWICH, CYTOPLASM, HYDROLASE, NUCLEUS, PROTEASE, PROTEASOME, THREONINE PROTEASE, UBL CONJUGATION, PHOSPHOPROTEIN, ZYMOGEN
2zcy:L (LYS33) to (ARG165) YEAST 20S PROTEASOME:SYRINGOLIN A-COMPLEX | ALPHA/BETA SANDWICH, CYTOPLASM, HYDROLASE, NUCLEUS, PROTEASE, PROTEASOME, THREONINE PROTEASE, UBL CONJUGATION, PHOSPHOPROTEIN, ZYMOGEN
2zcy:M (ARG33) to (ARG165) YEAST 20S PROTEASOME:SYRINGOLIN A-COMPLEX | ALPHA/BETA SANDWICH, CYTOPLASM, HYDROLASE, NUCLEUS, PROTEASE, PROTEASOME, THREONINE PROTEASE, UBL CONJUGATION, PHOSPHOPROTEIN, ZYMOGEN
2zcy:N (LYS33) to (ASN141) YEAST 20S PROTEASOME:SYRINGOLIN A-COMPLEX | ALPHA/BETA SANDWICH, CYTOPLASM, HYDROLASE, NUCLEUS, PROTEASE, PROTEASOME, THREONINE PROTEASE, UBL CONJUGATION, PHOSPHOPROTEIN, ZYMOGEN
2zcy:S (LYS66) to (ILE18) YEAST 20S PROTEASOME:SYRINGOLIN A-COMPLEX | ALPHA/BETA SANDWICH, CYTOPLASM, HYDROLASE, NUCLEUS, PROTEASE, PROTEASOME, THREONINE PROTEASE, UBL CONJUGATION, PHOSPHOPROTEIN, ZYMOGEN
2zcy:T (ILE67) to (LYS206) YEAST 20S PROTEASOME:SYRINGOLIN A-COMPLEX | ALPHA/BETA SANDWICH, CYTOPLASM, HYDROLASE, NUCLEUS, PROTEASE, PROTEASOME, THREONINE PROTEASE, UBL CONJUGATION, PHOSPHOPROTEIN, ZYMOGEN
2zcy:W (LYS33) to (ASP166) YEAST 20S PROTEASOME:SYRINGOLIN A-COMPLEX | ALPHA/BETA SANDWICH, CYTOPLASM, HYDROLASE, NUCLEUS, PROTEASE, PROTEASOME, THREONINE PROTEASE, UBL CONJUGATION, PHOSPHOPROTEIN, ZYMOGEN
2zcy:Z (LYS33) to (ARG165) YEAST 20S PROTEASOME:SYRINGOLIN A-COMPLEX | ALPHA/BETA SANDWICH, CYTOPLASM, HYDROLASE, NUCLEUS, PROTEASE, PROTEASOME, THREONINE PROTEASE, UBL CONJUGATION, PHOSPHOPROTEIN, ZYMOGEN
2zcy:0 (ARG33) to (ARG165) YEAST 20S PROTEASOME:SYRINGOLIN A-COMPLEX | ALPHA/BETA SANDWICH, CYTOPLASM, HYDROLASE, NUCLEUS, PROTEASE, PROTEASOME, THREONINE PROTEASE, UBL CONJUGATION, PHOSPHOPROTEIN, ZYMOGEN
2zcy:1 (LYS33) to (ASN141) YEAST 20S PROTEASOME:SYRINGOLIN A-COMPLEX | ALPHA/BETA SANDWICH, CYTOPLASM, HYDROLASE, NUCLEUS, PROTEASE, PROTEASOME, THREONINE PROTEASE, UBL CONJUGATION, PHOSPHOPROTEIN, ZYMOGEN
5cz6:E (SER56) to (ILE181) YEAST 20S PROTEASOME BETA5-T1A MUTANT IN COMPLEX WITH SYRINGOLIN A, PROPEPTIDE EXPRESSED IN TRANS | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5cz6:I (LYS41) to (ASP177) YEAST 20S PROTEASOME BETA5-T1A MUTANT IN COMPLEX WITH SYRINGOLIN A, PROPEPTIDE EXPRESSED IN TRANS | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5cz6:L (LYS42) to (ARG194) YEAST 20S PROTEASOME BETA5-T1A MUTANT IN COMPLEX WITH SYRINGOLIN A, PROPEPTIDE EXPRESSED IN TRANS | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5cz6:M (ARG41) to (ARG187) YEAST 20S PROTEASOME BETA5-T1A MUTANT IN COMPLEX WITH SYRINGOLIN A, PROPEPTIDE EXPRESSED IN TRANS | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5cz6:N (LYS33) to (ASN141) YEAST 20S PROTEASOME BETA5-T1A MUTANT IN COMPLEX WITH SYRINGOLIN A, PROPEPTIDE EXPRESSED IN TRANS | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5cz6:S (SER56) to (ILE181) YEAST 20S PROTEASOME BETA5-T1A MUTANT IN COMPLEX WITH SYRINGOLIN A, PROPEPTIDE EXPRESSED IN TRANS | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5cz6:W (LYS41) to (ASP177) YEAST 20S PROTEASOME BETA5-T1A MUTANT IN COMPLEX WITH SYRINGOLIN A, PROPEPTIDE EXPRESSED IN TRANS | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5cz6:Z (LYS42) to (ARG194) YEAST 20S PROTEASOME BETA5-T1A MUTANT IN COMPLEX WITH SYRINGOLIN A, PROPEPTIDE EXPRESSED IN TRANS | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5cz6:a (ARG41) to (ARG187) YEAST 20S PROTEASOME BETA5-T1A MUTANT IN COMPLEX WITH SYRINGOLIN A, PROPEPTIDE EXPRESSED IN TRANS | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5cz6:b (LYS33) to (ASN141) YEAST 20S PROTEASOME BETA5-T1A MUTANT IN COMPLEX WITH SYRINGOLIN A, PROPEPTIDE EXPRESSED IN TRANS | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5cz5:E (SER56) to (ILE181) YEAST 20S PROTEASOME BETA1-T1A MUTANT IN COMPLEX WITH CARFILZOMIB | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5cz5:I (LYS41) to (ASP177) YEAST 20S PROTEASOME BETA1-T1A MUTANT IN COMPLEX WITH CARFILZOMIB | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5cz5:L (LYS42) to (ARG194) YEAST 20S PROTEASOME BETA1-T1A MUTANT IN COMPLEX WITH CARFILZOMIB | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5cz5:M (ARG41) to (ARG187) YEAST 20S PROTEASOME BETA1-T1A MUTANT IN COMPLEX WITH CARFILZOMIB | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5cz5:N (LYS33) to (ASN141) YEAST 20S PROTEASOME BETA1-T1A MUTANT IN COMPLEX WITH CARFILZOMIB | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5cz5:S (SER56) to (ILE181) YEAST 20S PROTEASOME BETA1-T1A MUTANT IN COMPLEX WITH CARFILZOMIB | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5cz5:W (LYS41) to (ASP177) YEAST 20S PROTEASOME BETA1-T1A MUTANT IN COMPLEX WITH CARFILZOMIB | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5cz5:Z (LYS42) to (ARG194) YEAST 20S PROTEASOME BETA1-T1A MUTANT IN COMPLEX WITH CARFILZOMIB | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5cz5:a (ARG41) to (ARG187) YEAST 20S PROTEASOME BETA1-T1A MUTANT IN COMPLEX WITH CARFILZOMIB | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5cz5:b (LYS33) to (ASN141) YEAST 20S PROTEASOME BETA1-T1A MUTANT IN COMPLEX WITH CARFILZOMIB | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5cza:E (SER56) to (ILE181) YEAST 20S PROTEASOME BETA5-D166N MUTANT | HYDROLASE COMPLEX, PROTEASOME, MUTANT, BINDING ANALYSIS, HYDROLASE- HYDROLASE INHIBITOR COMPLEX
5cza:I (LYS41) to (ASP177) YEAST 20S PROTEASOME BETA5-D166N MUTANT | HYDROLASE COMPLEX, PROTEASOME, MUTANT, BINDING ANALYSIS, HYDROLASE- HYDROLASE INHIBITOR COMPLEX
5cza:L (LYS42) to (ARG194) YEAST 20S PROTEASOME BETA5-D166N MUTANT | HYDROLASE COMPLEX, PROTEASOME, MUTANT, BINDING ANALYSIS, HYDROLASE- HYDROLASE INHIBITOR COMPLEX
5cza:M (ARG41) to (ARG187) YEAST 20S PROTEASOME BETA5-D166N MUTANT | HYDROLASE COMPLEX, PROTEASOME, MUTANT, BINDING ANALYSIS, HYDROLASE- HYDROLASE INHIBITOR COMPLEX
5cza:N (LYS33) to (ASN141) YEAST 20S PROTEASOME BETA5-D166N MUTANT | HYDROLASE COMPLEX, PROTEASOME, MUTANT, BINDING ANALYSIS, HYDROLASE- HYDROLASE INHIBITOR COMPLEX
5cza:S (SER56) to (ILE181) YEAST 20S PROTEASOME BETA5-D166N MUTANT | HYDROLASE COMPLEX, PROTEASOME, MUTANT, BINDING ANALYSIS, HYDROLASE- HYDROLASE INHIBITOR COMPLEX
5cza:W (LYS41) to (ASP177) YEAST 20S PROTEASOME BETA5-D166N MUTANT | HYDROLASE COMPLEX, PROTEASOME, MUTANT, BINDING ANALYSIS, HYDROLASE- HYDROLASE INHIBITOR COMPLEX
5cza:Z (LYS42) to (ARG194) YEAST 20S PROTEASOME BETA5-D166N MUTANT | HYDROLASE COMPLEX, PROTEASOME, MUTANT, BINDING ANALYSIS, HYDROLASE- HYDROLASE INHIBITOR COMPLEX
5cza:a (ARG41) to (ARG187) YEAST 20S PROTEASOME BETA5-D166N MUTANT | HYDROLASE COMPLEX, PROTEASOME, MUTANT, BINDING ANALYSIS, HYDROLASE- HYDROLASE INHIBITOR COMPLEX
5cza:b (LYS33) to (ASN141) YEAST 20S PROTEASOME BETA5-D166N MUTANT | HYDROLASE COMPLEX, PROTEASOME, MUTANT, BINDING ANALYSIS, HYDROLASE- HYDROLASE INHIBITOR COMPLEX
5d0s:E (SER56) to (ILE181) YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH CARFILZOMIB | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5d0s:I (LYS41) to (ASP177) YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH CARFILZOMIB | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5d0s:L (LYS42) to (ARG194) YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH CARFILZOMIB | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5d0s:M (ARG41) to (ARG187) YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH CARFILZOMIB | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5d0s:N (LYS33) to (ASN141) YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH CARFILZOMIB | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5d0s:S (SER56) to (ILE181) YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH CARFILZOMIB | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5d0s:W (LYS41) to (ASP177) YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH CARFILZOMIB | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5d0s:Z (LYS42) to (ARG194) YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH CARFILZOMIB | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5d0s:a (ARG41) to (ARG187) YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH CARFILZOMIB | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5d0s:b (LYS33) to (ASN141) YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH CARFILZOMIB | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5d0t:E (LYS61) to (ILE181) YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH MG132 | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5d0t:I (LYS41) to (ASP177) YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH MG132 | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5d0t:L (LYS42) to (ARG194) YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH MG132 | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5d0t:M (ARG41) to (ARG187) YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH MG132 | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5d0t:N (LYS33) to (ASN141) YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH MG132 | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5d0t:S (LYS61) to (ILE181) YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH MG132 | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5d0t:W (LYS41) to (ASP177) YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH MG132 | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5d0t:Z (LYS42) to (ARG194) YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH MG132 | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5d0t:a (ARG41) to (ARG187) YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH MG132 | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5d0t:b (LYS33) to (ASN141) YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH MG132 | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5d0v:E (SER56) to (ILE181) YEAST 20S PROTEASOME BETA5-T1C MUTANT IN COMPLEX WITH CARFILZOMIB | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5d0v:I (LYS41) to (ASP177) YEAST 20S PROTEASOME BETA5-T1C MUTANT IN COMPLEX WITH CARFILZOMIB | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5d0v:L (LYS42) to (ARG194) YEAST 20S PROTEASOME BETA5-T1C MUTANT IN COMPLEX WITH CARFILZOMIB | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5d0v:M (ARG41) to (ARG187) YEAST 20S PROTEASOME BETA5-T1C MUTANT IN COMPLEX WITH CARFILZOMIB | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5d0v:N (LYS33) to (ASN141) YEAST 20S PROTEASOME BETA5-T1C MUTANT IN COMPLEX WITH CARFILZOMIB | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5d0v:S (SER56) to (ILE181) YEAST 20S PROTEASOME BETA5-T1C MUTANT IN COMPLEX WITH CARFILZOMIB | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5d0v:W (LYS41) to (ASP177) YEAST 20S PROTEASOME BETA5-T1C MUTANT IN COMPLEX WITH CARFILZOMIB | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5d0v:Z (LYS42) to (ARG194) YEAST 20S PROTEASOME BETA5-T1C MUTANT IN COMPLEX WITH CARFILZOMIB | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5d0v:a (ARG41) to (ARG187) YEAST 20S PROTEASOME BETA5-T1C MUTANT IN COMPLEX WITH CARFILZOMIB | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5d0v:b (LYS33) to (ASN141) YEAST 20S PROTEASOME BETA5-T1C MUTANT IN COMPLEX WITH CARFILZOMIB | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5d0w:E (LYS61) to (ILE181) YEAST 20S PROTEASOME BETA5-T1S MUTANT | HYDROLASE COMPLEX, PROTEASOME, MUTANT, BINDING ANALYSIS, HYDROLASE- HYDROLASE INHIBITOR COMPLEX
5d0w:I (LYS41) to (ASP177) YEAST 20S PROTEASOME BETA5-T1S MUTANT | HYDROLASE COMPLEX, PROTEASOME, MUTANT, BINDING ANALYSIS, HYDROLASE- HYDROLASE INHIBITOR COMPLEX
5d0w:L (LYS42) to (ARG194) YEAST 20S PROTEASOME BETA5-T1S MUTANT | HYDROLASE COMPLEX, PROTEASOME, MUTANT, BINDING ANALYSIS, HYDROLASE- HYDROLASE INHIBITOR COMPLEX
5d0w:M (ARG41) to (ARG187) YEAST 20S PROTEASOME BETA5-T1S MUTANT | HYDROLASE COMPLEX, PROTEASOME, MUTANT, BINDING ANALYSIS, HYDROLASE- HYDROLASE INHIBITOR COMPLEX
5d0w:N (LYS33) to (ASN141) YEAST 20S PROTEASOME BETA5-T1S MUTANT | HYDROLASE COMPLEX, PROTEASOME, MUTANT, BINDING ANALYSIS, HYDROLASE- HYDROLASE INHIBITOR COMPLEX
5d0w:S (LYS61) to (ILE181) YEAST 20S PROTEASOME BETA5-T1S MUTANT | HYDROLASE COMPLEX, PROTEASOME, MUTANT, BINDING ANALYSIS, HYDROLASE- HYDROLASE INHIBITOR COMPLEX
5d0w:W (LYS41) to (ASP177) YEAST 20S PROTEASOME BETA5-T1S MUTANT | HYDROLASE COMPLEX, PROTEASOME, MUTANT, BINDING ANALYSIS, HYDROLASE- HYDROLASE INHIBITOR COMPLEX
5d0w:Z (LYS42) to (ARG194) YEAST 20S PROTEASOME BETA5-T1S MUTANT | HYDROLASE COMPLEX, PROTEASOME, MUTANT, BINDING ANALYSIS, HYDROLASE- HYDROLASE INHIBITOR COMPLEX
5d0w:a (ARG41) to (ARG187) YEAST 20S PROTEASOME BETA5-T1S MUTANT | HYDROLASE COMPLEX, PROTEASOME, MUTANT, BINDING ANALYSIS, HYDROLASE- HYDROLASE INHIBITOR COMPLEX
5d0w:b (LYS33) to (ASN141) YEAST 20S PROTEASOME BETA5-T1S MUTANT | HYDROLASE COMPLEX, PROTEASOME, MUTANT, BINDING ANALYSIS, HYDROLASE- HYDROLASE INHIBITOR COMPLEX
5d0x:E (LYS61) to (ILE181) YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH BORTEZOMIB | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5d0x:I (LYS41) to (ASP177) YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH BORTEZOMIB | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5d0x:L (LYS42) to (ARG194) YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH BORTEZOMIB | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5d0x:M (ARG41) to (ARG187) YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH BORTEZOMIB | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5d0x:N (LYS33) to (ASN141) YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH BORTEZOMIB | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5d0x:S (LYS61) to (ILE181) YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH BORTEZOMIB | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5d0x:W (LYS41) to (ASP177) YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH BORTEZOMIB | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5d0x:Z (LYS42) to (ARG194) YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH BORTEZOMIB | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5d0x:a (ARG41) to (ARG187) YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH BORTEZOMIB | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5d0x:b (LYS33) to (ASN141) YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH BORTEZOMIB | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5d0z:E (SER56) to (ILE181) YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH CARFILZOMIB | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5d0z:L (LYS42) to (ARG194) YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH CARFILZOMIB | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5d0z:M (ARG41) to (ARG187) YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH CARFILZOMIB | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5d0z:N (LYS33) to (ASN141) YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH CARFILZOMIB | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5d0z:S (SER56) to (ILE181) YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH CARFILZOMIB | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5d0z:Z (LYS42) to (ARG194) YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH CARFILZOMIB | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5d0z:a (ARG41) to (ARG187) YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH CARFILZOMIB | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5d0z:b (LYS33) to (ASN141) YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH CARFILZOMIB | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
1ya7:A (LYS66) to (LEU201) IMPLICATIONS FOR INTERACTIONS OF PROTEASOME WITH PAN AND PA700 FROM THE 1.9 A STRUCTURE OF A PROTEASOME-11S ACTIVATOR COMPLEX | ARCHAEAL PROTEASOME, PA26, COPMLEX, OPEN GATE, HYDROLASE-HYDROLASE ACTIVATOR COMPLEX
1ya7:H (LYS33) to (ARG165) IMPLICATIONS FOR INTERACTIONS OF PROTEASOME WITH PAN AND PA700 FROM THE 1.9 A STRUCTURE OF A PROTEASOME-11S ACTIVATOR COMPLEX | ARCHAEAL PROTEASOME, PA26, COPMLEX, OPEN GATE, HYDROLASE-HYDROLASE ACTIVATOR COMPLEX
1ya7:I (LYS33) to (ARG165) IMPLICATIONS FOR INTERACTIONS OF PROTEASOME WITH PAN AND PA700 FROM THE 1.9 A STRUCTURE OF A PROTEASOME-11S ACTIVATOR COMPLEX | ARCHAEAL PROTEASOME, PA26, COPMLEX, OPEN GATE, HYDROLASE-HYDROLASE ACTIVATOR COMPLEX
1ya7:J (LYS33) to (ARG165) IMPLICATIONS FOR INTERACTIONS OF PROTEASOME WITH PAN AND PA700 FROM THE 1.9 A STRUCTURE OF A PROTEASOME-11S ACTIVATOR COMPLEX | ARCHAEAL PROTEASOME, PA26, COPMLEX, OPEN GATE, HYDROLASE-HYDROLASE ACTIVATOR COMPLEX
1ya7:K (LYS33) to (ARG165) IMPLICATIONS FOR INTERACTIONS OF PROTEASOME WITH PAN AND PA700 FROM THE 1.9 A STRUCTURE OF A PROTEASOME-11S ACTIVATOR COMPLEX | ARCHAEAL PROTEASOME, PA26, COPMLEX, OPEN GATE, HYDROLASE-HYDROLASE ACTIVATOR COMPLEX
1ya7:L (LYS33) to (ARG165) IMPLICATIONS FOR INTERACTIONS OF PROTEASOME WITH PAN AND PA700 FROM THE 1.9 A STRUCTURE OF A PROTEASOME-11S ACTIVATOR COMPLEX | ARCHAEAL PROTEASOME, PA26, COPMLEX, OPEN GATE, HYDROLASE-HYDROLASE ACTIVATOR COMPLEX
1ya7:M (LYS33) to (ARG165) IMPLICATIONS FOR INTERACTIONS OF PROTEASOME WITH PAN AND PA700 FROM THE 1.9 A STRUCTURE OF A PROTEASOME-11S ACTIVATOR COMPLEX | ARCHAEAL PROTEASOME, PA26, COPMLEX, OPEN GATE, HYDROLASE-HYDROLASE ACTIVATOR COMPLEX
1ya7:N (LYS33) to (ARG165) IMPLICATIONS FOR INTERACTIONS OF PROTEASOME WITH PAN AND PA700 FROM THE 1.9 A STRUCTURE OF A PROTEASOME-11S ACTIVATOR COMPLEX | ARCHAEAL PROTEASOME, PA26, COPMLEX, OPEN GATE, HYDROLASE-HYDROLASE ACTIVATOR COMPLEX
1yau:A (LYS66) to (LEU201) STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME- PA26 COMPLEX | PROTEASOME 20S, PA26 PROTEASOME ACTIVATOR 11S, HYDROLASE-HYDROLASE ACTIVATOR COMPLEX
1yau:B (LYS66) to (LEU201) STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME- PA26 COMPLEX | PROTEASOME 20S, PA26 PROTEASOME ACTIVATOR 11S, HYDROLASE-HYDROLASE ACTIVATOR COMPLEX
1yau:H (LYS33) to (ARG165) STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME- PA26 COMPLEX | PROTEASOME 20S, PA26 PROTEASOME ACTIVATOR 11S, HYDROLASE-HYDROLASE ACTIVATOR COMPLEX
1yau:I (LYS33) to (ARG165) STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME- PA26 COMPLEX | PROTEASOME 20S, PA26 PROTEASOME ACTIVATOR 11S, HYDROLASE-HYDROLASE ACTIVATOR COMPLEX
1yau:J (LYS33) to (ARG165) STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME- PA26 COMPLEX | PROTEASOME 20S, PA26 PROTEASOME ACTIVATOR 11S, HYDROLASE-HYDROLASE ACTIVATOR COMPLEX
1yau:K (LYS33) to (ARG165) STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME- PA26 COMPLEX | PROTEASOME 20S, PA26 PROTEASOME ACTIVATOR 11S, HYDROLASE-HYDROLASE ACTIVATOR COMPLEX
1yau:L (LYS33) to (ARG165) STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME- PA26 COMPLEX | PROTEASOME 20S, PA26 PROTEASOME ACTIVATOR 11S, HYDROLASE-HYDROLASE ACTIVATOR COMPLEX
1yau:M (LYS33) to (ARG165) STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME- PA26 COMPLEX | PROTEASOME 20S, PA26 PROTEASOME ACTIVATOR 11S, HYDROLASE-HYDROLASE ACTIVATOR COMPLEX
1yau:N (LYS33) to (ARG165) STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME- PA26 COMPLEX | PROTEASOME 20S, PA26 PROTEASOME ACTIVATOR 11S, HYDROLASE-HYDROLASE ACTIVATOR COMPLEX
3krd:M (LYS52) to (ALA190) CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH FELLUTAMIDE B | BINDING SITES, MYCOBACTERIUM TUBERCULOSIS, PROTEIN SUBUNITS, SUBSTRATE SPECIFICITY, HYDROLASE, PROTEASOME, FELLUTAMIDE B, INHIBITION, PROTEASE, THREONINE PROTEASE, VIRULENCE, AUTOCATALYTIC CLEAVAGE, ZYMOGEN
3krd:Q (LYS52) to (GLY191) CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH FELLUTAMIDE B | BINDING SITES, MYCOBACTERIUM TUBERCULOSIS, PROTEIN SUBUNITS, SUBSTRATE SPECIFICITY, HYDROLASE, PROTEASOME, FELLUTAMIDE B, INHIBITION, PROTEASE, THREONINE PROTEASE, VIRULENCE, AUTOCATALYTIC CLEAVAGE, ZYMOGEN
5dki:E (LYS61) to (ILE181) YEAST 20S PROTEASOME IN COMPLEX WITH ALKYNE-PI | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, TARGET DELIVERY, PROTEASOME, INHIBITOR, BINDING ANALYSIS
5dki:L (LYS42) to (ARG194) YEAST 20S PROTEASOME IN COMPLEX WITH ALKYNE-PI | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, TARGET DELIVERY, PROTEASOME, INHIBITOR, BINDING ANALYSIS
5dki:M (ARG41) to (ARG187) YEAST 20S PROTEASOME IN COMPLEX WITH ALKYNE-PI | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, TARGET DELIVERY, PROTEASOME, INHIBITOR, BINDING ANALYSIS
5dki:N (LYS33) to (ASN141) YEAST 20S PROTEASOME IN COMPLEX WITH ALKYNE-PI | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, TARGET DELIVERY, PROTEASOME, INHIBITOR, BINDING ANALYSIS
5dki:S (LYS61) to (ILE181) YEAST 20S PROTEASOME IN COMPLEX WITH ALKYNE-PI | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, TARGET DELIVERY, PROTEASOME, INHIBITOR, BINDING ANALYSIS
5dki:Z (LYS42) to (ARG194) YEAST 20S PROTEASOME IN COMPLEX WITH ALKYNE-PI | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, TARGET DELIVERY, PROTEASOME, INHIBITOR, BINDING ANALYSIS
5dki:a (ARG41) to (ARG187) YEAST 20S PROTEASOME IN COMPLEX WITH ALKYNE-PI | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, TARGET DELIVERY, PROTEASOME, INHIBITOR, BINDING ANALYSIS
5dki:b (LYS33) to (ASN141) YEAST 20S PROTEASOME IN COMPLEX WITH ALKYNE-PI | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, TARGET DELIVERY, PROTEASOME, INHIBITOR, BINDING ANALYSIS
5dkj:E (LYS61) to (ILE181) YEAST 20S PROTEASOME IN COMPLEX WITH OCTREOTIDE-PI | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, TARGET DELIVERY, PROTEASOME, INHIBITOR, BINDING ANALYSIS
5dkj:L (LYS42) to (ARG194) YEAST 20S PROTEASOME IN COMPLEX WITH OCTREOTIDE-PI | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, TARGET DELIVERY, PROTEASOME, INHIBITOR, BINDING ANALYSIS
5dkj:N (LYS33) to (ASN141) YEAST 20S PROTEASOME IN COMPLEX WITH OCTREOTIDE-PI | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, TARGET DELIVERY, PROTEASOME, INHIBITOR, BINDING ANALYSIS
5dkj:S (LYS61) to (ILE181) YEAST 20S PROTEASOME IN COMPLEX WITH OCTREOTIDE-PI | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, TARGET DELIVERY, PROTEASOME, INHIBITOR, BINDING ANALYSIS
5dkj:Z (LYS42) to (ARG194) YEAST 20S PROTEASOME IN COMPLEX WITH OCTREOTIDE-PI | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, TARGET DELIVERY, PROTEASOME, INHIBITOR, BINDING ANALYSIS
5dkj:b (LYS33) to (ASN141) YEAST 20S PROTEASOME IN COMPLEX WITH OCTREOTIDE-PI | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, TARGET DELIVERY, PROTEASOME, INHIBITOR, BINDING ANALYSIS
1z7q:B (LYS63) to (ARG178) CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION | 20S, PROTEASOME, PA26, ACTIVATOR, MULTI-CATALYTIC PROTEASE, HYDROLASE-HYDROLASE ACTIVATOR COMPLEX
1z7q:E (LYS66) to (GLN206) CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION | 20S, PROTEASOME, PA26, ACTIVATOR, MULTI-CATALYTIC PROTEASE, HYDROLASE-HYDROLASE ACTIVATOR COMPLEX
1z7q:F (SER57) to (ILE182) CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION | 20S, PROTEASOME, PA26, ACTIVATOR, MULTI-CATALYTIC PROTEASE, HYDROLASE-HYDROLASE ACTIVATOR COMPLEX
1z7q:H (LYS33) to (ASN141) CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION | 20S, PROTEASOME, PA26, ACTIVATOR, MULTI-CATALYTIC PROTEASE, HYDROLASE-HYDROLASE ACTIVATOR COMPLEX
1z7q:M (LYS42) to (ARG194) CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION | 20S, PROTEASOME, PA26, ACTIVATOR, MULTI-CATALYTIC PROTEASE, HYDROLASE-HYDROLASE ACTIVATOR COMPLEX
1z7q:P (LYS63) to (ARG178) CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION | 20S, PROTEASOME, PA26, ACTIVATOR, MULTI-CATALYTIC PROTEASE, HYDROLASE-HYDROLASE ACTIVATOR COMPLEX
1z7q:S (LYS66) to (GLN206) CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION | 20S, PROTEASOME, PA26, ACTIVATOR, MULTI-CATALYTIC PROTEASE, HYDROLASE-HYDROLASE ACTIVATOR COMPLEX
1z7q:T (SER57) to (ILE182) CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION | 20S, PROTEASOME, PA26, ACTIVATOR, MULTI-CATALYTIC PROTEASE, HYDROLASE-HYDROLASE ACTIVATOR COMPLEX
1z7q:V (LYS33) to (ASN141) CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION | 20S, PROTEASOME, PA26, ACTIVATOR, MULTI-CATALYTIC PROTEASE, HYDROLASE-HYDROLASE ACTIVATOR COMPLEX
1z7q:X (LYS41) to (ASP177) CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION | 20S, PROTEASOME, PA26, ACTIVATOR, MULTI-CATALYTIC PROTEASE, HYDROLASE-HYDROLASE ACTIVATOR COMPLEX
1z7q:a (LYS42) to (ARG194) CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION | 20S, PROTEASOME, PA26, ACTIVATOR, MULTI-CATALYTIC PROTEASE, HYDROLASE-HYDROLASE ACTIVATOR COMPLEX
5dsv:A (ARG65) to (VAL200) CRYSTAL STRUCTURE OF HUMAN PROTEASOME ALPHA7 TETRADECAMER | PROTEASOME, HYDROLASE
5dsv:B (ARG65) to (VAL200) CRYSTAL STRUCTURE OF HUMAN PROTEASOME ALPHA7 TETRADECAMER | PROTEASOME, HYDROLASE
5dsv:C (ARG65) to (HIS201) CRYSTAL STRUCTURE OF HUMAN PROTEASOME ALPHA7 TETRADECAMER | PROTEASOME, HYDROLASE
5dsv:D (ARG65) to (VAL200) CRYSTAL STRUCTURE OF HUMAN PROTEASOME ALPHA7 TETRADECAMER | PROTEASOME, HYDROLASE
5dsv:E (ARG65) to (HIS201) CRYSTAL STRUCTURE OF HUMAN PROTEASOME ALPHA7 TETRADECAMER | PROTEASOME, HYDROLASE
5dsv:F (ARG65) to (HIS201) CRYSTAL STRUCTURE OF HUMAN PROTEASOME ALPHA7 TETRADECAMER | PROTEASOME, HYDROLASE
5dsv:G (ARG65) to (HIS201) CRYSTAL STRUCTURE OF HUMAN PROTEASOME ALPHA7 TETRADECAMER | PROTEASOME, HYDROLASE
5dsv:H (ARG65) to (HIS201) CRYSTAL STRUCTURE OF HUMAN PROTEASOME ALPHA7 TETRADECAMER | PROTEASOME, HYDROLASE
5dsv:I (ARG65) to (HIS201) CRYSTAL STRUCTURE OF HUMAN PROTEASOME ALPHA7 TETRADECAMER | PROTEASOME, HYDROLASE
5dsv:J (ARG65) to (HIS201) CRYSTAL STRUCTURE OF HUMAN PROTEASOME ALPHA7 TETRADECAMER | PROTEASOME, HYDROLASE
5dsv:K (ARG65) to (HIS201) CRYSTAL STRUCTURE OF HUMAN PROTEASOME ALPHA7 TETRADECAMER | PROTEASOME, HYDROLASE
5dsv:L (ARG65) to (VAL200) CRYSTAL STRUCTURE OF HUMAN PROTEASOME ALPHA7 TETRADECAMER | PROTEASOME, HYDROLASE
5dsv:M (ARG65) to (HIS201) CRYSTAL STRUCTURE OF HUMAN PROTEASOME ALPHA7 TETRADECAMER | PROTEASOME, HYDROLASE
5dsv:N (ARG65) to (HIS201) CRYSTAL STRUCTURE OF HUMAN PROTEASOME ALPHA7 TETRADECAMER | PROTEASOME, HYDROLASE
4q1s:E (LYS61) to (ILE181) YEAST 20S PROTEASOME IN COMPLEX WITH KENDOMYCIN | PROTEASOME, NATURAL PRODUCT, QUINONE METHIDE, COVALENT BINDING, EXOSITE, HYDROLASE-TOXIN COMPLEX
4q1s:G (TYR62) to (GLY206) YEAST 20S PROTEASOME IN COMPLEX WITH KENDOMYCIN | PROTEASOME, NATURAL PRODUCT, QUINONE METHIDE, COVALENT BINDING, EXOSITE, HYDROLASE-TOXIN COMPLEX
4q1s:L (LYS42) to (ARG194) YEAST 20S PROTEASOME IN COMPLEX WITH KENDOMYCIN | PROTEASOME, NATURAL PRODUCT, QUINONE METHIDE, COVALENT BINDING, EXOSITE, HYDROLASE-TOXIN COMPLEX
4q1s:N (LYS33) to (LYS164) YEAST 20S PROTEASOME IN COMPLEX WITH KENDOMYCIN | PROTEASOME, NATURAL PRODUCT, QUINONE METHIDE, COVALENT BINDING, EXOSITE, HYDROLASE-TOXIN COMPLEX
4q1s:S (LYS61) to (ILE181) YEAST 20S PROTEASOME IN COMPLEX WITH KENDOMYCIN | PROTEASOME, NATURAL PRODUCT, QUINONE METHIDE, COVALENT BINDING, EXOSITE, HYDROLASE-TOXIN COMPLEX
4q1s:W (LYS41) to (ASP177) YEAST 20S PROTEASOME IN COMPLEX WITH KENDOMYCIN | PROTEASOME, NATURAL PRODUCT, QUINONE METHIDE, COVALENT BINDING, EXOSITE, HYDROLASE-TOXIN COMPLEX
4q1s:Z (LYS42) to (ARG194) YEAST 20S PROTEASOME IN COMPLEX WITH KENDOMYCIN | PROTEASOME, NATURAL PRODUCT, QUINONE METHIDE, COVALENT BINDING, EXOSITE, HYDROLASE-TOXIN COMPLEX
4q1s:a (ARG41) to (ARG187) YEAST 20S PROTEASOME IN COMPLEX WITH KENDOMYCIN | PROTEASOME, NATURAL PRODUCT, QUINONE METHIDE, COVALENT BINDING, EXOSITE, HYDROLASE-TOXIN COMPLEX
4q1s:b (LYS33) to (LYS164) YEAST 20S PROTEASOME IN COMPLEX WITH KENDOMYCIN | PROTEASOME, NATURAL PRODUCT, QUINONE METHIDE, COVALENT BINDING, EXOSITE, HYDROLASE-TOXIN COMPLEX
4qls:E (LYS61) to (ILE181) YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 11 | PROTEASOME, EPOXYKETONE, IMMUNOPROTEASOME INHIBITOR, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4qls:I (LYS41) to (ASP177) YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 11 | PROTEASOME, EPOXYKETONE, IMMUNOPROTEASOME INHIBITOR, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4qls:L (LYS42) to (ARG194) YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 11 | PROTEASOME, EPOXYKETONE, IMMUNOPROTEASOME INHIBITOR, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4qls:M (ARG41) to (ARG187) YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 11 | PROTEASOME, EPOXYKETONE, IMMUNOPROTEASOME INHIBITOR, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4qls:N (LYS33) to (LYS164) YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 11 | PROTEASOME, EPOXYKETONE, IMMUNOPROTEASOME INHIBITOR, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4qls:S (LYS61) to (ILE181) YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 11 | PROTEASOME, EPOXYKETONE, IMMUNOPROTEASOME INHIBITOR, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4qls:W (LYS41) to (ASP177) YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 11 | PROTEASOME, EPOXYKETONE, IMMUNOPROTEASOME INHIBITOR, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4qls:Z (LYS42) to (ARG194) YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 11 | PROTEASOME, EPOXYKETONE, IMMUNOPROTEASOME INHIBITOR, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4qls:a (ARG41) to (ARG187) YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 11 | PROTEASOME, EPOXYKETONE, IMMUNOPROTEASOME INHIBITOR, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4qls:b (LYS33) to (LYS164) YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 11 | PROTEASOME, EPOXYKETONE, IMMUNOPROTEASOME INHIBITOR, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4qlq:C (LYS61) to (GLU199) YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 8 | PROTEASOME, EPOXYKETONE, IMMUNOPROTEASOME INHIBITOR, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4qlq:E (SER56) to (ILE181) YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 8 | PROTEASOME, EPOXYKETONE, IMMUNOPROTEASOME INHIBITOR, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4qlq:L (LYS42) to (ARG194) YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 8 | PROTEASOME, EPOXYKETONE, IMMUNOPROTEASOME INHIBITOR, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4qlq:M (ARG41) to (ARG187) YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 8 | PROTEASOME, EPOXYKETONE, IMMUNOPROTEASOME INHIBITOR, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4qlq:N (LYS33) to (ASN141) YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 8 | PROTEASOME, EPOXYKETONE, IMMUNOPROTEASOME INHIBITOR, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4qlq:Q (LYS61) to (GLU199) YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 8 | PROTEASOME, EPOXYKETONE, IMMUNOPROTEASOME INHIBITOR, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4qlq:S (SER56) to (ILE181) YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 8 | PROTEASOME, EPOXYKETONE, IMMUNOPROTEASOME INHIBITOR, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4qlq:Z (LYS42) to (ARG194) YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 8 | PROTEASOME, EPOXYKETONE, IMMUNOPROTEASOME INHIBITOR, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4qlq:a (ARG41) to (ARG187) YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 8 | PROTEASOME, EPOXYKETONE, IMMUNOPROTEASOME INHIBITOR, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4qlq:b (LYS33) to (ASN141) YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 8 | PROTEASOME, EPOXYKETONE, IMMUNOPROTEASOME INHIBITOR, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4qlt:E (SER56) to (ILE181) YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 2 (PR924) | PROTEASOME, EPOXYKETONE, IMMUNOPROTEASOME INHIBITOR, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4qlt:I (LYS41) to (ASP177) YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 2 (PR924) | PROTEASOME, EPOXYKETONE, IMMUNOPROTEASOME INHIBITOR, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4qlt:L (LYS42) to (ARG194) YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 2 (PR924) | PROTEASOME, EPOXYKETONE, IMMUNOPROTEASOME INHIBITOR, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4qlt:M (ARG41) to (ARG187) YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 2 (PR924) | PROTEASOME, EPOXYKETONE, IMMUNOPROTEASOME INHIBITOR, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4qlt:N (LYS33) to (LYS164) YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 2 (PR924) | PROTEASOME, EPOXYKETONE, IMMUNOPROTEASOME INHIBITOR, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4qlt:S (SER56) to (ILE181) YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 2 (PR924) | PROTEASOME, EPOXYKETONE, IMMUNOPROTEASOME INHIBITOR, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4qlt:W (LYS41) to (ASP177) YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 2 (PR924) | PROTEASOME, EPOXYKETONE, IMMUNOPROTEASOME INHIBITOR, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4qlt:Z (LYS42) to (ARG194) YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 2 (PR924) | PROTEASOME, EPOXYKETONE, IMMUNOPROTEASOME INHIBITOR, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4qlt:a (ARG41) to (ARG187) YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 2 (PR924) | PROTEASOME, EPOXYKETONE, IMMUNOPROTEASOME INHIBITOR, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4qlt:b (LYS33) to (ASN141) YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 2 (PR924) | PROTEASOME, EPOXYKETONE, IMMUNOPROTEASOME INHIBITOR, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4qlu:F (ILE63) to (LYS204) YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 9 | PROTEASOME, EPOXYKETONE, IMMUNOPROTEASOME INHIBITOR, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4qlu:I (LYS41) to (ASP177) YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 9 | PROTEASOME, EPOXYKETONE, IMMUNOPROTEASOME INHIBITOR, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4qlu:L (LYS42) to (ARG194) YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 9 | PROTEASOME, EPOXYKETONE, IMMUNOPROTEASOME INHIBITOR, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4qlu:N (LYS33) to (ASN141) YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 9 | PROTEASOME, EPOXYKETONE, IMMUNOPROTEASOME INHIBITOR, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4qlu:T (ILE63) to (LYS204) YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 9 | PROTEASOME, EPOXYKETONE, IMMUNOPROTEASOME INHIBITOR, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4qlu:W (LYS41) to (ASP177) YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 9 | PROTEASOME, EPOXYKETONE, IMMUNOPROTEASOME INHIBITOR, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4qlu:Z (LYS42) to (ARG194) YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 9 | PROTEASOME, EPOXYKETONE, IMMUNOPROTEASOME INHIBITOR, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4qlu:b (LYS33) to (ASN141) YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 9 | PROTEASOME, EPOXYKETONE, IMMUNOPROTEASOME INHIBITOR, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
3mfe:H (LYS333) to (SER479) CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT WITH H0 MOVEMENT | CATALYTIC DOMAIN, HYDROGEN BONDING, MYCOBACTERIUM TUBERCULOSIS, OXAZOLIDINONES, PROTEASE INHIBITORS, PROTEASOME ENDOPEPTIDASE COMPLEX, PROTEIN CARBONYLATION, PROTEIN CONFORMATION, PROTEIN SUBUNITS, SUBSTRATE SPECIFICITY, THIAZOLES, HELIX MOVEMENT, HYDROLASE
3mfe:A (LYS52) to (GLY191) CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT WITH H0 MOVEMENT | CATALYTIC DOMAIN, HYDROGEN BONDING, MYCOBACTERIUM TUBERCULOSIS, OXAZOLIDINONES, PROTEASE INHIBITORS, PROTEASOME ENDOPEPTIDASE COMPLEX, PROTEIN CARBONYLATION, PROTEIN CONFORMATION, PROTEIN SUBUNITS, SUBSTRATE SPECIFICITY, THIAZOLES, HELIX MOVEMENT, HYDROLASE
3mfe:W (LYS52) to (SER192) CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT WITH H0 MOVEMENT | CATALYTIC DOMAIN, HYDROGEN BONDING, MYCOBACTERIUM TUBERCULOSIS, OXAZOLIDINONES, PROTEASE INHIBITORS, PROTEASOME ENDOPEPTIDASE COMPLEX, PROTEIN CARBONYLATION, PROTEIN CONFORMATION, PROTEIN SUBUNITS, SUBSTRATE SPECIFICITY, THIAZOLES, HELIX MOVEMENT, HYDROLASE
3mg0:E (LYS66) to (ILE18) STRUCTURE OF YEAST 20S PROTEASOME WITH BORTEZOMIB | 20S PROTEASOME, HYDROLASE
3mg0:F (ILE67) to (GLY18) STRUCTURE OF YEAST 20S PROTEASOME WITH BORTEZOMIB | 20S PROTEASOME, HYDROLASE
3mg0:I (LYS33) to (ASP166) STRUCTURE OF YEAST 20S PROTEASOME WITH BORTEZOMIB | 20S PROTEASOME, HYDROLASE
3mg0:L (LYS33) to (ARG165) STRUCTURE OF YEAST 20S PROTEASOME WITH BORTEZOMIB | 20S PROTEASOME, HYDROLASE
3mg0:N (LYS33) to (ASN141) STRUCTURE OF YEAST 20S PROTEASOME WITH BORTEZOMIB | 20S PROTEASOME, HYDROLASE
3mg0:S (LYS66) to (ILE18) STRUCTURE OF YEAST 20S PROTEASOME WITH BORTEZOMIB | 20S PROTEASOME, HYDROLASE
3mg0:Z (LYS33) to (ARG165) STRUCTURE OF YEAST 20S PROTEASOME WITH BORTEZOMIB | 20S PROTEASOME, HYDROLASE
3mg0:2 (LYS33) to (ASN141) STRUCTURE OF YEAST 20S PROTEASOME WITH BORTEZOMIB | 20S PROTEASOME, HYDROLASE
3mg4:I (LYS33) to (ASP166) STRUCTURE OF YEAST 20S PROTEASOME WITH COMPOUND 1 | 20S PROTEASOME, HYDROLASE
3mg4:J (LYS33) to (LYS164) STRUCTURE OF YEAST 20S PROTEASOME WITH COMPOUND 1 | 20S PROTEASOME, HYDROLASE
3mg4:L (LYS33) to (ARG165) STRUCTURE OF YEAST 20S PROTEASOME WITH COMPOUND 1 | 20S PROTEASOME, HYDROLASE
3mg4:N (LYS33) to (LYS164) STRUCTURE OF YEAST 20S PROTEASOME WITH COMPOUND 1 | 20S PROTEASOME, HYDROLASE
3mg4:S (LYS66) to (ILE182) STRUCTURE OF YEAST 20S PROTEASOME WITH COMPOUND 1 | 20S PROTEASOME, HYDROLASE
3mg4:W (LYS33) to (ASP166) STRUCTURE OF YEAST 20S PROTEASOME WITH COMPOUND 1 | 20S PROTEASOME, HYDROLASE
3mg4:X (LYS33) to (LYS164) STRUCTURE OF YEAST 20S PROTEASOME WITH COMPOUND 1 | 20S PROTEASOME, HYDROLASE
3mg4:Z (LYS33) to (ARG165) STRUCTURE OF YEAST 20S PROTEASOME WITH COMPOUND 1 | 20S PROTEASOME, HYDROLASE
3mg4:1 (ARG33) to (ARG165) STRUCTURE OF YEAST 20S PROTEASOME WITH COMPOUND 1 | 20S PROTEASOME, HYDROLASE
3mg4:2 (LYS33) to (ASN141) STRUCTURE OF YEAST 20S PROTEASOME WITH COMPOUND 1 | 20S PROTEASOME, HYDROLASE
3mg6:E (SER59) to (ILE180) STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 6 | 20S PROTEASOME, HYDROLASE
3mg6:F (LYS66) to (HIS180) STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 6 | 20S PROTEASOME, HYDROLASE
3mg6:G (TYR66) to (ALA200) STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 6 | 20S PROTEASOME, HYDROLASE
3mg6:I (LYS33) to (ASP166) STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 6 | 20S PROTEASOME, HYDROLASE
3mg6:L (LYS33) to (ARG165) STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 6 | 20S PROTEASOME, HYDROLASE
3mg6:M (ARG33) to (ARG165) STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 6 | 20S PROTEASOME, HYDROLASE
3mg6:N (LYS33) to (ASN141) STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 6 | 20S PROTEASOME, HYDROLASE
3mg6:S (LYS66) to (ILE182) STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 6 | 20S PROTEASOME, HYDROLASE
3mg6:U (TYR66) to (ALA200) STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 6 | 20S PROTEASOME, HYDROLASE
3mg6:W (LYS33) to (ASP166) STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 6 | 20S PROTEASOME, HYDROLASE
3mg6:X (LYS33) to (ARG165) STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 6 | 20S PROTEASOME, HYDROLASE
3mg6:Z (LYS33) to (ARG165) STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 6 | 20S PROTEASOME, HYDROLASE
3mg6:1 (ARG33) to (ARG165) STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 6 | 20S PROTEASOME, HYDROLASE
3mg6:2 (LYS33) to (ASN141) STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 6 | 20S PROTEASOME, HYDROLASE
3mg7:E (SER59) to (ILE180) STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 8 | 20S PROTEASOME, HYDROLASE
3mg7:I (LYS33) to (ASP166) STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 8 | 20S PROTEASOME, HYDROLASE
3mg7:L (LYS33) to (ARG165) STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 8 | 20S PROTEASOME, HYDROLASE
3mg7:M (ARG33) to (ARG165) STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 8 | 20S PROTEASOME, HYDROLASE
3mg7:N (LYS33) to (ASN141) STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 8 | 20S PROTEASOME, HYDROLASE
3mg7:S (SER59) to (ILE182) STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 8 | 20S PROTEASOME, HYDROLASE
3mg7:W (LYS33) to (ASP166) STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 8 | 20S PROTEASOME, HYDROLASE
3mg7:Z (LYS33) to (ARG165) STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 8 | 20S PROTEASOME, HYDROLASE
3mg7:1 (ARG33) to (ARG165) STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 8 | 20S PROTEASOME, HYDROLASE
3mg7:2 (LYS33) to (ASN141) STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 8 | 20S PROTEASOME, HYDROLASE
3mg8:E (SER59) to (ILE180) STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 16 | 20S PROTEASOME, HYDROLASE
3mg8:L (LYS33) to (ARG165) STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 16 | 20S PROTEASOME, HYDROLASE
3mg8:M (ARG33) to (ARG165) STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 16 | 20S PROTEASOME, HYDROLASE
3mg8:N (LYS33) to (ASN141) STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 16 | 20S PROTEASOME, HYDROLASE
3mg8:Q (LYS66) to (LEU198) STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 16 | 20S PROTEASOME, HYDROLASE
3mg8:S (LYS66) to (ILE182) STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 16 | 20S PROTEASOME, HYDROLASE
3mg8:U (TYR66) to (LEU201) STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 16 | 20S PROTEASOME, HYDROLASE
3mg8:Z (LYS33) to (ARG165) STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 16 | 20S PROTEASOME, HYDROLASE
3mg8:2 (LYS33) to (ASN141) STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 16 | 20S PROTEASOME, HYDROLASE
3mka:A (LYS52) to (ALA190) CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME WITH PROPETIDE AND AN T1A MUTATION AT BETA-SUBUNIT | MYCOBACTERIUM TUBERCULOSIS, PROTEASOME ENDOPEPTIDASE COMPLEX, PROTEIN SUBUNITS, PROPEPTIDE, PROTEIN MATURATION, PROTEASOME ASSEMBLY, HYDROLASE
3mka:D (LYS52) to (ALA190) CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME WITH PROPETIDE AND AN T1A MUTATION AT BETA-SUBUNIT | MYCOBACTERIUM TUBERCULOSIS, PROTEASOME ENDOPEPTIDASE COMPLEX, PROTEIN SUBUNITS, PROPEPTIDE, PROTEIN MATURATION, PROTEASOME ASSEMBLY, HYDROLASE
3mka:I (LYS52) to (SER192) CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME WITH PROPETIDE AND AN T1A MUTATION AT BETA-SUBUNIT | MYCOBACTERIUM TUBERCULOSIS, PROTEASOME ENDOPEPTIDASE COMPLEX, PROTEIN SUBUNITS, PROPEPTIDE, PROTEIN MATURATION, PROTEASOME ASSEMBLY, HYDROLASE
3mka:K (LYS52) to (SER192) CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME WITH PROPETIDE AND AN T1A MUTATION AT BETA-SUBUNIT | MYCOBACTERIUM TUBERCULOSIS, PROTEASOME ENDOPEPTIDASE COMPLEX, PROTEIN SUBUNITS, PROPEPTIDE, PROTEIN MATURATION, PROTEASOME ASSEMBLY, HYDROLASE
3mka:Q (LYS52) to (SER192) CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME WITH PROPETIDE AND AN T1A MUTATION AT BETA-SUBUNIT | MYCOBACTERIUM TUBERCULOSIS, PROTEASOME ENDOPEPTIDASE COMPLEX, PROTEIN SUBUNITS, PROPEPTIDE, PROTEIN MATURATION, PROTEASOME ASSEMBLY, HYDROLASE
3mka:1 (LYS52) to (ARG189) CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME WITH PROPETIDE AND AN T1A MUTATION AT BETA-SUBUNIT | MYCOBACTERIUM TUBERCULOSIS, PROTEASOME ENDOPEPTIDASE COMPLEX, PROTEIN SUBUNITS, PROPEPTIDE, PROTEIN MATURATION, PROTEASOME ASSEMBLY, HYDROLASE
4qux:E (LYS61) to (ILE181) YCP BETA5-A49T-MUTANT | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE
4qux:I (LYS41) to (ASP177) YCP BETA5-A49T-MUTANT | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE
4qux:L (LYS42) to (ARG194) YCP BETA5-A49T-MUTANT | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE
4qux:M (ARG41) to (ARG187) YCP BETA5-A49T-MUTANT | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE
4qux:N (LYS33) to (ASN141) YCP BETA5-A49T-MUTANT | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE
4qux:S (LYS61) to (ILE181) YCP BETA5-A49T-MUTANT | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE
4qux:W (LYS41) to (ASP177) YCP BETA5-A49T-MUTANT | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE
4qux:Z (LYS42) to (ARG194) YCP BETA5-A49T-MUTANT | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE
4qux:a (ARG41) to (ARG187) YCP BETA5-A49T-MUTANT | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE
4qux:b (LYS33) to (ASN141) YCP BETA5-A49T-MUTANT | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE
4qv1:E (LYS61) to (ILE181) YCP BETA5-M45A MUTANT | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4qv1:I (LYS41) to (ASP177) YCP BETA5-M45A MUTANT | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4qv1:L (LYS42) to (ARG194) YCP BETA5-M45A MUTANT | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4qv1:M (ARG41) to (ARG187) YCP BETA5-M45A MUTANT | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4qv1:N (LYS33) to (ASN141) YCP BETA5-M45A MUTANT | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4qv1:S (LYS61) to (ILE181) YCP BETA5-M45A MUTANT | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4qv1:W (LYS41) to (ASP177) YCP BETA5-M45A MUTANT | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4qv1:Z (LYS42) to (ARG194) YCP BETA5-M45A MUTANT | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4qv1:a (ARG41) to (ARG187) YCP BETA5-M45A MUTANT | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4qv1:b (LYS33) to (ASN141) YCP BETA5-M45A MUTANT | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4quy:E (LYS61) to (ILE181) YCP BETA5-A49S-MUTANT | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE
4quy:I (LYS41) to (ASP177) YCP BETA5-A49S-MUTANT | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE
4quy:L (LYS42) to (ARG194) YCP BETA5-A49S-MUTANT | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE
4quy:M (ARG41) to (ARG187) YCP BETA5-A49S-MUTANT | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE
4quy:N (LYS33) to (ASN141) YCP BETA5-A49S-MUTANT | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE
4quy:S (LYS61) to (ILE181) YCP BETA5-A49S-MUTANT | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE
4quy:W (LYS41) to (ASP177) YCP BETA5-A49S-MUTANT | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE
4quy:Z (LYS42) to (ARG194) YCP BETA5-A49S-MUTANT | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE
4quy:a (ARG41) to (ARG187) YCP BETA5-A49S-MUTANT | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE
4quy:b (LYS33) to (ASN141) YCP BETA5-A49S-MUTANT | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE
4qv0:E (LYS61) to (ILE181) YCP BETA5-A49T-A50V-DOUBLE MUTANT | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE
4qv0:I (LYS41) to (ASP177) YCP BETA5-A49T-A50V-DOUBLE MUTANT | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE
4qv0:L (LYS42) to (ARG194) YCP BETA5-A49T-A50V-DOUBLE MUTANT | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE
4qv0:M (ARG41) to (ARG187) YCP BETA5-A49T-A50V-DOUBLE MUTANT | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE
4qv0:N (LYS33) to (ASN141) YCP BETA5-A49T-A50V-DOUBLE MUTANT | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE
4qv0:S (LYS61) to (ILE181) YCP BETA5-A49T-A50V-DOUBLE MUTANT | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE
4qv0:W (LYS41) to (ASP177) YCP BETA5-A49T-A50V-DOUBLE MUTANT | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE
4qv0:Z (LYS42) to (ARG194) YCP BETA5-A49T-A50V-DOUBLE MUTANT | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE
4qv0:a (ARG41) to (ARG187) YCP BETA5-A49T-A50V-DOUBLE MUTANT | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE
4qv0:b (LYS33) to (ASN141) YCP BETA5-A49T-A50V-DOUBLE MUTANT | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE
4qv3:E (LYS61) to (ILE181) YCP BETA5-M45V MUTANT | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE
4qv3:I (LYS41) to (ASP177) YCP BETA5-M45V MUTANT | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE
4qv3:L (LYS42) to (ARG194) YCP BETA5-M45V MUTANT | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE
4qv3:M (ARG41) to (ARG187) YCP BETA5-M45V MUTANT | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE
4qv3:N (LYS33) to (ASN141) YCP BETA5-M45V MUTANT | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE
4qv3:S (LYS61) to (ILE181) YCP BETA5-M45V MUTANT | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE
4qv3:W (LYS41) to (ASP177) YCP BETA5-M45V MUTANT | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE
4qv3:Z (LYS42) to (ARG194) YCP BETA5-M45V MUTANT | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE
4qv3:a (ARG41) to (ARG187) YCP BETA5-M45V MUTANT | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE
4qv3:b (LYS33) to (ASN141) YCP BETA5-M45V MUTANT | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE
4qv4:E (LYS61) to (ILE181) YCP BETA5-M45T MUTANT | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE
4qv4:I (LYS41) to (ASP177) YCP BETA5-M45T MUTANT | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE
4qv4:L (LYS42) to (ARG194) YCP BETA5-M45T MUTANT | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE
4qv4:M (ARG41) to (ARG187) YCP BETA5-M45T MUTANT | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE
4qv4:N (LYS33) to (ASN141) YCP BETA5-M45T MUTANT | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE
4qv4:S (LYS61) to (ILE181) YCP BETA5-M45T MUTANT | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE
4qv4:W (LYS41) to (ASP177) YCP BETA5-M45T MUTANT | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE
4qv4:Z (LYS42) to (ARG194) YCP BETA5-M45T MUTANT | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE
4qv4:a (ARG41) to (ARG187) YCP BETA5-M45T MUTANT | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE
4qv4:b (LYS33) to (ASN141) YCP BETA5-M45T MUTANT | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE
4qv5:E (LYS61) to (ILE181) YCP BETA5-M45I MUTANT | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE
4qv5:I (LYS41) to (ASP177) YCP BETA5-M45I MUTANT | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE
4qv5:L (LYS42) to (ARG194) YCP BETA5-M45I MUTANT | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE
4qv5:M (ARG41) to (ARG187) YCP BETA5-M45I MUTANT | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE
4qv5:N (LYS33) to (ASN141) YCP BETA5-M45I MUTANT | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE
4qv5:S (LYS61) to (ILE181) YCP BETA5-M45I MUTANT | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE
4qv5:W (LYS41) to (ASP177) YCP BETA5-M45I MUTANT | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE
4qv5:Z (LYS42) to (ARG194) YCP BETA5-M45I MUTANT | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE
4qv5:a (ARG41) to (ARG187) YCP BETA5-M45I MUTANT | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE
4qv5:b (LYS33) to (ASN141) YCP BETA5-M45I MUTANT | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE
4qv6:E (LYS61) to (ILE181) YCP BETA5-A49V MUTANT | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE
4qv6:I (LYS41) to (ASP177) YCP BETA5-A49V MUTANT | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE
4qv6:L (LYS42) to (ARG194) YCP BETA5-A49V MUTANT | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE
4qv6:M (ARG41) to (ARG187) YCP BETA5-A49V MUTANT | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE
4qv6:N (LYS33) to (ASN141) YCP BETA5-A49V MUTANT | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE
4qv6:S (LYS61) to (ILE181) YCP BETA5-A49V MUTANT | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE
4qv6:W (LYS41) to (ASP177) YCP BETA5-A49V MUTANT | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE
4qv6:Z (LYS42) to (ARG194) YCP BETA5-A49V MUTANT | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE
4qv6:a (ARG41) to (ARG187) YCP BETA5-A49V MUTANT | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE
4qv6:b (LYS33) to (ASN141) YCP BETA5-A49V MUTANT | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE
4qv7:E (LYS61) to (ILE181) YCP BETA5-A50V MUTANT | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE
4qv7:I (LYS41) to (ASP177) YCP BETA5-A50V MUTANT | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE
4qv7:L (LYS42) to (ARG194) YCP BETA5-A50V MUTANT | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE
4qv7:M (ARG41) to (ARG187) YCP BETA5-A50V MUTANT | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE
4qv7:N (LYS33) to (ASN141) YCP BETA5-A50V MUTANT | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE
4qv7:S (LYS61) to (ILE181) YCP BETA5-A50V MUTANT | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE
4qv7:W (LYS41) to (ASP177) YCP BETA5-A50V MUTANT | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE
4qv7:Z (LYS42) to (ARG194) YCP BETA5-A50V MUTANT | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE
4qv7:a (ARG41) to (ARG187) YCP BETA5-A50V MUTANT | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE
4qv7:b (LYS33) to (ASN141) YCP BETA5-A50V MUTANT | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE
4qv8:E (LYS61) to (ILE181) YCP BETA5-C52F MUTANT | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE
4qv8:I (LYS41) to (ASP177) YCP BETA5-C52F MUTANT | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE
4qv8:L (LYS42) to (ARG194) YCP BETA5-C52F MUTANT | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE
4qv8:M (ARG41) to (ARG187) YCP BETA5-C52F MUTANT | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE
4qv8:N (LYS33) to (ASN141) YCP BETA5-C52F MUTANT | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE
4qv8:S (LYS61) to (ILE181) YCP BETA5-C52F MUTANT | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE
4qv8:W (LYS41) to (ASP177) YCP BETA5-C52F MUTANT | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE
4qv8:Z (LYS42) to (ARG194) YCP BETA5-C52F MUTANT | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE
4qv8:a (ARG41) to (ARG187) YCP BETA5-C52F MUTANT | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE
4qv8:b (LYS33) to (ASN141) YCP BETA5-C52F MUTANT | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE
4qv9:E (LYS61) to (ILE181) YCP BETA5-C63F MUTANT | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE
4qv9:I (LYS41) to (ASP177) YCP BETA5-C63F MUTANT | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE
4qv9:L (LYS42) to (ARG194) YCP BETA5-C63F MUTANT | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE
4qv9:M (ARG41) to (ARG187) YCP BETA5-C63F MUTANT | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE
4qv9:N (LYS33) to (ASN141) YCP BETA5-C63F MUTANT | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE
4qv9:S (LYS61) to (ILE181) YCP BETA5-C63F MUTANT | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE
4qv9:W (LYS41) to (ASP177) YCP BETA5-C63F MUTANT | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE
4qv9:Z (LYS42) to (ARG194) YCP BETA5-C63F MUTANT | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE
4qv9:a (ARG41) to (ARG187) YCP BETA5-C63F MUTANT | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE
4qv9:b (LYS33) to (ASN141) YCP BETA5-C63F MUTANT | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE
4qvl:E (LYS61) to (ILE181) YCP IN COMPLEX WITH BORTEZOMIB | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4qvl:I (LYS41) to (ASP177) YCP IN COMPLEX WITH BORTEZOMIB | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4qvl:L (LYS42) to (ARG194) YCP IN COMPLEX WITH BORTEZOMIB | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4qvl:M (ARG41) to (ARG187) YCP IN COMPLEX WITH BORTEZOMIB | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4qvl:N (LYS33) to (ASN141) YCP IN COMPLEX WITH BORTEZOMIB | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4qvl:S (LYS61) to (ILE181) YCP IN COMPLEX WITH BORTEZOMIB | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4qvl:W (LYS41) to (ASP177) YCP IN COMPLEX WITH BORTEZOMIB | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4qvl:Z (LYS42) to (ARG194) YCP IN COMPLEX WITH BORTEZOMIB | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4qvl:a (ARG41) to (ARG187) YCP IN COMPLEX WITH BORTEZOMIB | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4qvl:b (LYS33) to (ASN141) YCP IN COMPLEX WITH BORTEZOMIB | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4qvm:E (LYS61) to (ILE181) YCP BETA5-M45A MUTANT IN COMPLEX WITH BORTEZOMIB | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4qvm:I (LYS41) to (ASP177) YCP BETA5-M45A MUTANT IN COMPLEX WITH BORTEZOMIB | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4qvm:L (LYS42) to (ARG194) YCP BETA5-M45A MUTANT IN COMPLEX WITH BORTEZOMIB | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4qvm:M (ARG41) to (THR168) YCP BETA5-M45A MUTANT IN COMPLEX WITH BORTEZOMIB | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4qvm:N (LYS33) to (ASN141) YCP BETA5-M45A MUTANT IN COMPLEX WITH BORTEZOMIB | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4qvm:S (LYS61) to (ILE181) YCP BETA5-M45A MUTANT IN COMPLEX WITH BORTEZOMIB | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4qvm:W (LYS41) to (ASP177) YCP BETA5-M45A MUTANT IN COMPLEX WITH BORTEZOMIB | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4qvm:Z (LYS42) to (ARG194) YCP BETA5-M45A MUTANT IN COMPLEX WITH BORTEZOMIB | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4qvm:a (ARG41) to (ARG187) YCP BETA5-M45A MUTANT IN COMPLEX WITH BORTEZOMIB | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4qvm:b (LYS33) to (ASN141) YCP BETA5-M45A MUTANT IN COMPLEX WITH BORTEZOMIB | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4qvn:E (LYS61) to (ILE181) YCP BETA5-M45V MUTANT IN COMPLEX WITH BORTEZOMIB | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4qvn:I (LYS41) to (ASP177) YCP BETA5-M45V MUTANT IN COMPLEX WITH BORTEZOMIB | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4qvn:L (LYS42) to (ARG194) YCP BETA5-M45V MUTANT IN COMPLEX WITH BORTEZOMIB | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4qvn:M (ARG41) to (ARG187) YCP BETA5-M45V MUTANT IN COMPLEX WITH BORTEZOMIB | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4qvn:N (LYS33) to (ASN141) YCP BETA5-M45V MUTANT IN COMPLEX WITH BORTEZOMIB | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4qvn:S (LYS61) to (ILE181) YCP BETA5-M45V MUTANT IN COMPLEX WITH BORTEZOMIB | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4qvn:W (LYS41) to (ASP177) YCP BETA5-M45V MUTANT IN COMPLEX WITH BORTEZOMIB | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4qvn:Z (LYS42) to (ARG194) YCP BETA5-M45V MUTANT IN COMPLEX WITH BORTEZOMIB | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4qvn:a (ARG41) to (ARG187) YCP BETA5-M45V MUTANT IN COMPLEX WITH BORTEZOMIB | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4qvn:b (LYS33) to (ASN141) YCP BETA5-M45V MUTANT IN COMPLEX WITH BORTEZOMIB | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4qvp:E (LYS61) to (ILE181) YCP BETA5-M45T MUTANT IN COMPLEX WITH BORTEZOMIB | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4qvp:I (LYS41) to (ASP177) YCP BETA5-M45T MUTANT IN COMPLEX WITH BORTEZOMIB | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4qvp:L (LYS42) to (ARG194) YCP BETA5-M45T MUTANT IN COMPLEX WITH BORTEZOMIB | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4qvp:M (ARG41) to (ARG187) YCP BETA5-M45T MUTANT IN COMPLEX WITH BORTEZOMIB | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4qvp:N (LYS33) to (ASN141) YCP BETA5-M45T MUTANT IN COMPLEX WITH BORTEZOMIB | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4qvp:S (LYS61) to (ILE181) YCP BETA5-M45T MUTANT IN COMPLEX WITH BORTEZOMIB | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4qvp:W (LYS41) to (ASP177) YCP BETA5-M45T MUTANT IN COMPLEX WITH BORTEZOMIB | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4qvp:Z (LYS42) to (ARG194) YCP BETA5-M45T MUTANT IN COMPLEX WITH BORTEZOMIB | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4qvp:a (ARG41) to (ARG187) YCP BETA5-M45T MUTANT IN COMPLEX WITH BORTEZOMIB | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4qvp:b (LYS33) to (ASN141) YCP BETA5-M45T MUTANT IN COMPLEX WITH BORTEZOMIB | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4qvq:E (LYS61) to (ILE181) YCP BETA5-M45I MUTANT IN COMPLEX WITH BORTEZOMIB | CANCER, PROTEASOME, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE- HYDROLASE INHIBITOR COMPLEX
4qvq:I (LYS41) to (ASP177) YCP BETA5-M45I MUTANT IN COMPLEX WITH BORTEZOMIB | CANCER, PROTEASOME, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE- HYDROLASE INHIBITOR COMPLEX
4qvq:L (LYS42) to (ARG194) YCP BETA5-M45I MUTANT IN COMPLEX WITH BORTEZOMIB | CANCER, PROTEASOME, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE- HYDROLASE INHIBITOR COMPLEX
4qvq:M (ARG41) to (ARG187) YCP BETA5-M45I MUTANT IN COMPLEX WITH BORTEZOMIB | CANCER, PROTEASOME, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE- HYDROLASE INHIBITOR COMPLEX
4qvq:N (LYS33) to (ASN141) YCP BETA5-M45I MUTANT IN COMPLEX WITH BORTEZOMIB | CANCER, PROTEASOME, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE- HYDROLASE INHIBITOR COMPLEX
4qvq:S (LYS61) to (ILE181) YCP BETA5-M45I MUTANT IN COMPLEX WITH BORTEZOMIB | CANCER, PROTEASOME, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE- HYDROLASE INHIBITOR COMPLEX
4qvq:W (LYS41) to (ASP177) YCP BETA5-M45I MUTANT IN COMPLEX WITH BORTEZOMIB | CANCER, PROTEASOME, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE- HYDROLASE INHIBITOR COMPLEX
4qvq:Z (LYS42) to (ARG194) YCP BETA5-M45I MUTANT IN COMPLEX WITH BORTEZOMIB | CANCER, PROTEASOME, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE- HYDROLASE INHIBITOR COMPLEX
4qvq:a (ARG41) to (ARG187) YCP BETA5-M45I MUTANT IN COMPLEX WITH BORTEZOMIB | CANCER, PROTEASOME, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE- HYDROLASE INHIBITOR COMPLEX
4qvq:b (LYS33) to (ASN141) YCP BETA5-M45I MUTANT IN COMPLEX WITH BORTEZOMIB | CANCER, PROTEASOME, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE- HYDROLASE INHIBITOR COMPLEX
4qvv:E (SER56) to (ILE181) YCP BETA5-A49V MUTANT IN COMPLEX WITH BORTEZOMIB | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4qvv:I (LYS41) to (ASP177) YCP BETA5-A49V MUTANT IN COMPLEX WITH BORTEZOMIB | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4qvv:M (ARG41) to (ARG187) YCP BETA5-A49V MUTANT IN COMPLEX WITH BORTEZOMIB | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4qvv:N (LYS33) to (ASN141) YCP BETA5-A49V MUTANT IN COMPLEX WITH BORTEZOMIB | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4qvv:S (SER56) to (ILE181) YCP BETA5-A49V MUTANT IN COMPLEX WITH BORTEZOMIB | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4qvv:W (LYS41) to (ASP177) YCP BETA5-A49V MUTANT IN COMPLEX WITH BORTEZOMIB | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4qvv:a (ARG41) to (ARG187) YCP BETA5-A49V MUTANT IN COMPLEX WITH BORTEZOMIB | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4qvv:b (LYS33) to (ASN141) YCP BETA5-A49V MUTANT IN COMPLEX WITH BORTEZOMIB | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4qvw:E (LYS61) to (ILE181) YCP BETA5-A49S-MUTANT IN COMPLEX WITH BORTEZOMIB | CANCER, PROTEASOME, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE- HYDROLASE INHIBITOR COMPLEX
4qvw:I (LYS41) to (ASP177) YCP BETA5-A49S-MUTANT IN COMPLEX WITH BORTEZOMIB | CANCER, PROTEASOME, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE- HYDROLASE INHIBITOR COMPLEX
4qvw:L (LYS42) to (ARG194) YCP BETA5-A49S-MUTANT IN COMPLEX WITH BORTEZOMIB | CANCER, PROTEASOME, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE- HYDROLASE INHIBITOR COMPLEX
4qvw:M (ARG41) to (ARG187) YCP BETA5-A49S-MUTANT IN COMPLEX WITH BORTEZOMIB | CANCER, PROTEASOME, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE- HYDROLASE INHIBITOR COMPLEX
4qvw:N (LYS33) to (ASN141) YCP BETA5-A49S-MUTANT IN COMPLEX WITH BORTEZOMIB | CANCER, PROTEASOME, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE- HYDROLASE INHIBITOR COMPLEX
4qvw:S (LYS61) to (ILE181) YCP BETA5-A49S-MUTANT IN COMPLEX WITH BORTEZOMIB | CANCER, PROTEASOME, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE- HYDROLASE INHIBITOR COMPLEX
4qvw:W (LYS41) to (ASP177) YCP BETA5-A49S-MUTANT IN COMPLEX WITH BORTEZOMIB | CANCER, PROTEASOME, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE- HYDROLASE INHIBITOR COMPLEX
4qvw:Z (LYS42) to (ARG194) YCP BETA5-A49S-MUTANT IN COMPLEX WITH BORTEZOMIB | CANCER, PROTEASOME, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE- HYDROLASE INHIBITOR COMPLEX
4qvw:a (ARG41) to (ARG187) YCP BETA5-A49S-MUTANT IN COMPLEX WITH BORTEZOMIB | CANCER, PROTEASOME, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE- HYDROLASE INHIBITOR COMPLEX
4qvw:b (LYS33) to (ASN141) YCP BETA5-A49S-MUTANT IN COMPLEX WITH BORTEZOMIB | CANCER, PROTEASOME, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE- HYDROLASE INHIBITOR COMPLEX
4qvy:E (SER56) to (ILE181) YCP BETA5-A49T-MUTANT IN COMPLEX WITH BORTEZOMIB | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4qvy:I (LYS41) to (ASP177) YCP BETA5-A49T-MUTANT IN COMPLEX WITH BORTEZOMIB | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4qvy:L (LYS42) to (ARG194) YCP BETA5-A49T-MUTANT IN COMPLEX WITH BORTEZOMIB | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4qvy:M (ARG41) to (ARG187) YCP BETA5-A49T-MUTANT IN COMPLEX WITH BORTEZOMIB | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4qvy:N (LYS33) to (ASN141) YCP BETA5-A49T-MUTANT IN COMPLEX WITH BORTEZOMIB | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4qvy:S (SER56) to (ILE181) YCP BETA5-A49T-MUTANT IN COMPLEX WITH BORTEZOMIB | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4qvy:W (LYS41) to (ASP177) YCP BETA5-A49T-MUTANT IN COMPLEX WITH BORTEZOMIB | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4qvy:Z (LYS42) to (ARG194) YCP BETA5-A49T-MUTANT IN COMPLEX WITH BORTEZOMIB | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4qvy:a (ARG41) to (ARG187) YCP BETA5-A49T-MUTANT IN COMPLEX WITH BORTEZOMIB | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4qvy:b (LYS33) to (ASN141) YCP BETA5-A49T-MUTANT IN COMPLEX WITH BORTEZOMIB | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4qw0:E (LYS61) to (ILE181) YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4qw0:I (LYS41) to (ASP177) YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4qw0:L (LYS42) to (ARG194) YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4qw0:M (ARG41) to (ARG187) YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4qw0:N (LYS33) to (ASN141) YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4qw0:S (LYS61) to (ILE181) YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4qw0:W (LYS41) to (ASP177) YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4qw0:Z (LYS42) to (ARG194) YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4qw0:a (ARG41) to (ARG187) YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4qw0:b (LYS33) to (ASN141) YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4qw1:E (LYS61) to (ILE181) YCP BETA5-A50V MUTANT IN COMPLEX WITH BORTEZOMIB | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4qw1:I (LYS41) to (ASP177) YCP BETA5-A50V MUTANT IN COMPLEX WITH BORTEZOMIB | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4qw1:L (LYS42) to (ARG194) YCP BETA5-A50V MUTANT IN COMPLEX WITH BORTEZOMIB | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4qw1:M (ARG41) to (ARG187) YCP BETA5-A50V MUTANT IN COMPLEX WITH BORTEZOMIB | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4qw1:N (LYS33) to (ASN141) YCP BETA5-A50V MUTANT IN COMPLEX WITH BORTEZOMIB | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4qw1:S (LYS61) to (ILE181) YCP BETA5-A50V MUTANT IN COMPLEX WITH BORTEZOMIB | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4qw1:W (LYS41) to (ASP177) YCP BETA5-A50V MUTANT IN COMPLEX WITH BORTEZOMIB | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4qw1:Z (LYS42) to (ARG194) YCP BETA5-A50V MUTANT IN COMPLEX WITH BORTEZOMIB | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4qw1:a (ARG41) to (ARG187) YCP BETA5-A50V MUTANT IN COMPLEX WITH BORTEZOMIB | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4qw1:b (LYS33) to (ASN141) YCP BETA5-A50V MUTANT IN COMPLEX WITH BORTEZOMIB | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4qw5:E (SER56) to (ILE181) YCP BETA5-M45A MUTANT IN COMPLEX WITH CARFILZOMIB | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4qw5:I (LYS41) to (ASP177) YCP BETA5-M45A MUTANT IN COMPLEX WITH CARFILZOMIB | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4qw5:L (LYS42) to (ARG194) YCP BETA5-M45A MUTANT IN COMPLEX WITH CARFILZOMIB | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4qw5:M (ARG41) to (ARG187) YCP BETA5-M45A MUTANT IN COMPLEX WITH CARFILZOMIB | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4qw5:N (LYS33) to (ASN141) YCP BETA5-M45A MUTANT IN COMPLEX WITH CARFILZOMIB | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4qw5:S (SER56) to (ILE181) YCP BETA5-M45A MUTANT IN COMPLEX WITH CARFILZOMIB | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4qw5:W (LYS41) to (ASP177) YCP BETA5-M45A MUTANT IN COMPLEX WITH CARFILZOMIB | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4qw5:Z (LYS42) to (ARG194) YCP BETA5-M45A MUTANT IN COMPLEX WITH CARFILZOMIB | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4qw5:a (ARG41) to (ARG187) YCP BETA5-M45A MUTANT IN COMPLEX WITH CARFILZOMIB | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4qw5:b (LYS33) to (ASN141) YCP BETA5-M45A MUTANT IN COMPLEX WITH CARFILZOMIB | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4qw4:E (SER56) to (ILE181) YCP IN COMPLEX WITH CARFILZOMIB | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4qw4:I (LYS41) to (ASP177) YCP IN COMPLEX WITH CARFILZOMIB | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4qw4:L (LYS42) to (ARG194) YCP IN COMPLEX WITH CARFILZOMIB | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4qw4:M (ARG41) to (ARG187) YCP IN COMPLEX WITH CARFILZOMIB | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4qw4:N (LYS33) to (ASN141) YCP IN COMPLEX WITH CARFILZOMIB | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4qw4:S (SER56) to (ILE181) YCP IN COMPLEX WITH CARFILZOMIB | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4qw4:W (LYS41) to (ASP177) YCP IN COMPLEX WITH CARFILZOMIB | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4qw4:Z (LYS42) to (ARG194) YCP IN COMPLEX WITH CARFILZOMIB | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4qw4:a (ARG41) to (ARG187) YCP IN COMPLEX WITH CARFILZOMIB | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4qw4:b (LYS33) to (ASN141) YCP IN COMPLEX WITH CARFILZOMIB | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4qw6:E (SER56) to (ILE181) YCP BETA5-M45V MUTANT IN COMPLEX WITH CARFILZOMIB | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4qw6:I (LYS41) to (ASP177) YCP BETA5-M45V MUTANT IN COMPLEX WITH CARFILZOMIB | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4qw6:L (LYS42) to (ARG194) YCP BETA5-M45V MUTANT IN COMPLEX WITH CARFILZOMIB | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4qw6:M (ARG41) to (ARG187) YCP BETA5-M45V MUTANT IN COMPLEX WITH CARFILZOMIB | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4qw6:N (LYS33) to (ASN141) YCP BETA5-M45V MUTANT IN COMPLEX WITH CARFILZOMIB | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4qw6:S (SER56) to (ILE181) YCP BETA5-M45V MUTANT IN COMPLEX WITH CARFILZOMIB | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4qw6:W (LYS41) to (ASP177) YCP BETA5-M45V MUTANT IN COMPLEX WITH CARFILZOMIB | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4qw6:Z (LYS42) to (ARG194) YCP BETA5-M45V MUTANT IN COMPLEX WITH CARFILZOMIB | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4qw6:a (ARG41) to (ARG187) YCP BETA5-M45V MUTANT IN COMPLEX WITH CARFILZOMIB | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4qw6:b (LYS33) to (ASN141) YCP BETA5-M45V MUTANT IN COMPLEX WITH CARFILZOMIB | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4qwj:E (SER56) to (ILE181) YCP BETA5-A49T-MUTANT IN COMPLEX WITH CARFILZOMIB | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4qwj:I (LYS41) to (ASP177) YCP BETA5-A49T-MUTANT IN COMPLEX WITH CARFILZOMIB | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4qwj:L (LYS42) to (ARG194) YCP BETA5-A49T-MUTANT IN COMPLEX WITH CARFILZOMIB | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4qwj:M (ARG41) to (ARG187) YCP BETA5-A49T-MUTANT IN COMPLEX WITH CARFILZOMIB | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4qwj:N (LYS33) to (ASN141) YCP BETA5-A49T-MUTANT IN COMPLEX WITH CARFILZOMIB | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4qwj:S (SER56) to (ILE181) YCP BETA5-A49T-MUTANT IN COMPLEX WITH CARFILZOMIB | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4qwj:W (LYS41) to (ASP177) YCP BETA5-A49T-MUTANT IN COMPLEX WITH CARFILZOMIB | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4qwj:Z (LYS42) to (ARG194) YCP BETA5-A49T-MUTANT IN COMPLEX WITH CARFILZOMIB | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4qwj:a (ARG41) to (ARG187) YCP BETA5-A49T-MUTANT IN COMPLEX WITH CARFILZOMIB | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4qwj:b (LYS33) to (ASN141) YCP BETA5-A49T-MUTANT IN COMPLEX WITH CARFILZOMIB | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4qwf:E (SER56) to (ILE181) YCP BETA5-M45I MUTANT IN COMPLEX WITH CARFILZOMIB | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4qwf:I (LYS41) to (ASP177) YCP BETA5-M45I MUTANT IN COMPLEX WITH CARFILZOMIB | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4qwf:L (LYS42) to (ARG194) YCP BETA5-M45I MUTANT IN COMPLEX WITH CARFILZOMIB | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4qwf:M (ARG41) to (ARG187) YCP BETA5-M45I MUTANT IN COMPLEX WITH CARFILZOMIB | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4qwf:N (LYS33) to (ASN141) YCP BETA5-M45I MUTANT IN COMPLEX WITH CARFILZOMIB | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4qwf:S (SER56) to (ILE181) YCP BETA5-M45I MUTANT IN COMPLEX WITH CARFILZOMIB | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4qwf:W (LYS41) to (ASP177) YCP BETA5-M45I MUTANT IN COMPLEX WITH CARFILZOMIB | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4qwf:Z (LYS42) to (ARG194) YCP BETA5-M45I MUTANT IN COMPLEX WITH CARFILZOMIB | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4qwf:a (ARG41) to (ARG187) YCP BETA5-M45I MUTANT IN COMPLEX WITH CARFILZOMIB | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4qwf:b (LYS33) to (ASN141) YCP BETA5-M45I MUTANT IN COMPLEX WITH CARFILZOMIB | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4qwg:E (SER56) to (ILE181) YCP BETA5-A49V MUTANT IN COMPLEX WITH CARFILZOMIB | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4qwg:M (ARG41) to (ARG187) YCP BETA5-A49V MUTANT IN COMPLEX WITH CARFILZOMIB | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4qwg:N (LYS33) to (ASN141) YCP BETA5-A49V MUTANT IN COMPLEX WITH CARFILZOMIB | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4qwg:S (SER56) to (ILE181) YCP BETA5-A49V MUTANT IN COMPLEX WITH CARFILZOMIB | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4qwg:a (ARG41) to (ARG187) YCP BETA5-A49V MUTANT IN COMPLEX WITH CARFILZOMIB | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4qwg:b (LYS33) to (ASN141) YCP BETA5-A49V MUTANT IN COMPLEX WITH CARFILZOMIB | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4qwk:E (SER56) to (ILE181) YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4qwk:I (LYS41) to (ASP177) YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4qwk:L (LYS42) to (ARG194) YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4qwk:M (ARG41) to (ARG187) YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4qwk:N (LYS33) to (ASN141) YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4qwk:S (SER56) to (ILE181) YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4qwk:W (LYS41) to (ASP177) YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4qwk:Z (LYS42) to (ARG194) YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4qwk:a (ARG41) to (ARG187) YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4qwk:b (LYS33) to (ASN141) YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4qwl:E (SER56) to (ILE181) YCP BETA5-A50V MUTANT IN COMPLEX WITH CARFILZOMIB | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4qwl:I (LYS41) to (ASP177) YCP BETA5-A50V MUTANT IN COMPLEX WITH CARFILZOMIB | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4qwl:L (LYS42) to (ARG194) YCP BETA5-A50V MUTANT IN COMPLEX WITH CARFILZOMIB | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4qwl:M (ARG41) to (ARG187) YCP BETA5-A50V MUTANT IN COMPLEX WITH CARFILZOMIB | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4qwl:N (LYS33) to (ASN141) YCP BETA5-A50V MUTANT IN COMPLEX WITH CARFILZOMIB | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4qwl:S (SER56) to (ILE181) YCP BETA5-A50V MUTANT IN COMPLEX WITH CARFILZOMIB | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4qwl:W (LYS41) to (ASP177) YCP BETA5-A50V MUTANT IN COMPLEX WITH CARFILZOMIB | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4qwl:Z (LYS42) to (ARG194) YCP BETA5-A50V MUTANT IN COMPLEX WITH CARFILZOMIB | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4qwl:a (ARG41) to (ARG187) YCP BETA5-A50V MUTANT IN COMPLEX WITH CARFILZOMIB | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4qwl:b (LYS33) to (ASN141) YCP BETA5-A50V MUTANT IN COMPLEX WITH CARFILZOMIB | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4qwr:E (SER56) to (ILE181) YCP BETA5-C52F MUTANT IN COMPLEX WITH CARFILZOMIB | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4qwr:I (LYS41) to (ASP177) YCP BETA5-C52F MUTANT IN COMPLEX WITH CARFILZOMIB | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4qwr:L (LYS42) to (ARG194) YCP BETA5-C52F MUTANT IN COMPLEX WITH CARFILZOMIB | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4qwr:M (ARG41) to (ARG187) YCP BETA5-C52F MUTANT IN COMPLEX WITH CARFILZOMIB | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4qwr:N (LYS33) to (ASN141) YCP BETA5-C52F MUTANT IN COMPLEX WITH CARFILZOMIB | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4qwr:S (SER56) to (ILE181) YCP BETA5-C52F MUTANT IN COMPLEX WITH CARFILZOMIB | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4qwr:W (LYS41) to (ASP177) YCP BETA5-C52F MUTANT IN COMPLEX WITH CARFILZOMIB | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4qwr:Z (LYS42) to (ARG194) YCP BETA5-C52F MUTANT IN COMPLEX WITH CARFILZOMIB | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4qwr:a (ARG41) to (ARG187) YCP BETA5-C52F MUTANT IN COMPLEX WITH CARFILZOMIB | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4qws:E (SER56) to (ILE181) YCP BETA5-C63F MUTANT IN COMPLEX WITH CARFILZOMIB | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4qws:J (LYS34) to (ARG171) YCP BETA5-C63F MUTANT IN COMPLEX WITH CARFILZOMIB | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4qws:L (LYS42) to (ARG194) YCP BETA5-C63F MUTANT IN COMPLEX WITH CARFILZOMIB | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4qws:M (ARG41) to (ARG187) YCP BETA5-C63F MUTANT IN COMPLEX WITH CARFILZOMIB | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4qws:N (LYS33) to (ASN141) YCP BETA5-C63F MUTANT IN COMPLEX WITH CARFILZOMIB | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4qws:S (SER56) to (ILE181) YCP BETA5-C63F MUTANT IN COMPLEX WITH CARFILZOMIB | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4qws:X (LYS34) to (ARG171) YCP BETA5-C63F MUTANT IN COMPLEX WITH CARFILZOMIB | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4qws:Z (LYS42) to (ARG194) YCP BETA5-C63F MUTANT IN COMPLEX WITH CARFILZOMIB | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4qws:a (ARG41) to (ARG187) YCP BETA5-C63F MUTANT IN COMPLEX WITH CARFILZOMIB | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4qws:b (LYS33) to (ASN141) YCP BETA5-C63F MUTANT IN COMPLEX WITH CARFILZOMIB | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4qwu:E (LYS61) to (ILE181) YCP BETA5-C52F MUTANT IN COMPLEX WITH BORTEZOMIB | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4qwu:I (LYS41) to (ASP177) YCP BETA5-C52F MUTANT IN COMPLEX WITH BORTEZOMIB | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4qwu:L (LYS42) to (ARG194) YCP BETA5-C52F MUTANT IN COMPLEX WITH BORTEZOMIB | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4qwu:M (ARG41) to (ARG187) YCP BETA5-C52F MUTANT IN COMPLEX WITH BORTEZOMIB | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4qwu:N (LYS33) to (ASN141) YCP BETA5-C52F MUTANT IN COMPLEX WITH BORTEZOMIB | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4qwu:S (LYS61) to (ILE181) YCP BETA5-C52F MUTANT IN COMPLEX WITH BORTEZOMIB | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4qwu:W (LYS41) to (ASP177) YCP BETA5-C52F MUTANT IN COMPLEX WITH BORTEZOMIB | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4qwu:a (ARG41) to (ARG187) YCP BETA5-C52F MUTANT IN COMPLEX WITH BORTEZOMIB | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4qwu:b (LYS33) to (ASN141) YCP BETA5-C52F MUTANT IN COMPLEX WITH BORTEZOMIB | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4qwx:E (SER56) to (ILE181) YCP IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914 | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4qwx:I (LYS41) to (ASP177) YCP IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914 | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4qwx:L (LYS42) to (ARG194) YCP IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914 | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4qwx:M (ARG41) to (ARG187) YCP IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914 | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4qwx:N (LYS33) to (LYS164) YCP IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914 | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4qwx:S (SER56) to (ILE181) YCP IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914 | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4qwx:W (LYS41) to (ASP177) YCP IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914 | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4qwx:Z (LYS42) to (ARG194) YCP IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914 | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4qwx:a (ARG41) to (ARG187) YCP IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914 | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4qwx:b (LYS33) to (LYS164) YCP IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914 | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4qxj:E (SER56) to (ILE181) YCP BETA5-M45A MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914 | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4qxj:I (LYS41) to (ASP177) YCP BETA5-M45A MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914 | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4qxj:L (LYS42) to (ARG194) YCP BETA5-M45A MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914 | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4qxj:M (ARG41) to (ARG187) YCP BETA5-M45A MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914 | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4qxj:N (LYS33) to (ASN141) YCP BETA5-M45A MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914 | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4qxj:S (SER56) to (ILE181) YCP BETA5-M45A MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914 | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4qxj:W (LYS41) to (ASP177) YCP BETA5-M45A MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914 | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4qxj:Z (LYS42) to (ARG194) YCP BETA5-M45A MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914 | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4qxj:a (ARG41) to (ARG187) YCP BETA5-M45A MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914 | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4qxj:b (LYS33) to (ASN141) YCP BETA5-M45A MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914 | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4qz0:E (SER56) to (ILE181) YCP BETA5-M45V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914 | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4qz0:I (LYS41) to (ASP177) YCP BETA5-M45V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914 | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4qz0:L (LYS42) to (ARG194) YCP BETA5-M45V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914 | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4qz0:M (ARG41) to (ARG187) YCP BETA5-M45V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914 | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4qz0:N (LYS33) to (TRP165) YCP BETA5-M45V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914 | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4qz0:S (SER56) to (ILE181) YCP BETA5-M45V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914 | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4qz0:W (LYS41) to (ASP177) YCP BETA5-M45V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914 | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4qz0:Z (LYS42) to (ARG194) YCP BETA5-M45V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914 | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4qz0:a (ARG41) to (ARG187) YCP BETA5-M45V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914 | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4qz0:b (LYS33) to (TRP165) YCP BETA5-M45V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914 | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4qz2:E (SER56) to (ILE181) YCP BETA5-M45I MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914 | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4qz2:I (LYS41) to (ASP177) YCP BETA5-M45I MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914 | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4qz2:L (LYS42) to (ARG194) YCP BETA5-M45I MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914 | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4qz2:M (ARG41) to (ARG187) YCP BETA5-M45I MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914 | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4qz2:N (LYS33) to (TRP165) YCP BETA5-M45I MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914 | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4qz2:S (SER56) to (ILE181) YCP BETA5-M45I MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914 | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4qz2:W (LYS41) to (ASP177) YCP BETA5-M45I MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914 | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4qz2:Z (LYS42) to (ARG194) YCP BETA5-M45I MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914 | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4qz2:a (ARG41) to (ARG187) YCP BETA5-M45I MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914 | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4qz2:b (LYS33) to (TRP165) YCP BETA5-M45I MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914 | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4qz3:E (SER56) to (ILE181) YCP BETA5-A49V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914 | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4qz3:I (LYS41) to (ASP177) YCP BETA5-A49V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914 | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4qz3:L (LYS42) to (ARG194) YCP BETA5-A49V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914 | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4qz3:M (ARG41) to (ARG187) YCP BETA5-A49V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914 | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4qz3:N (LYS33) to (ASN141) YCP BETA5-A49V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914 | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4qz3:S (SER56) to (ILE181) YCP BETA5-A49V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914 | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4qz3:W (LYS41) to (ASP177) YCP BETA5-A49V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914 | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4qz3:Z (LYS42) to (ARG194) YCP BETA5-A49V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914 | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4qz3:a (ARG41) to (ARG187) YCP BETA5-A49V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914 | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4qz3:b (LYS33) to (ASN141) YCP BETA5-A49V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914 | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4qz4:E (SER56) to (ILE181) YCP BETA5-A49S MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914 | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4qz4:I (LYS41) to (ASP177) YCP BETA5-A49S MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914 | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4qz4:L (LYS42) to (ARG194) YCP BETA5-A49S MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914 | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4qz4:M (ARG41) to (ARG187) YCP BETA5-A49S MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914 | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4qz4:S (SER56) to (ILE181) YCP BETA5-A49S MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914 | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4qz4:W (LYS41) to (ASP177) YCP BETA5-A49S MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914 | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4qz4:Z (LYS42) to (ARG194) YCP BETA5-A49S MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914 | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4qz4:a (ARG41) to (ARG187) YCP BETA5-A49S MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914 | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4qz5:E (SER56) to (ILE181) YCP BETA5-A49T-MUTANT IN COMPLEX WITH ONX 0914 | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4qz5:I (LYS41) to (ASP177) YCP BETA5-A49T-MUTANT IN COMPLEX WITH ONX 0914 | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4qz5:L (LYS42) to (ARG194) YCP BETA5-A49T-MUTANT IN COMPLEX WITH ONX 0914 | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4qz5:M (ARG41) to (ARG187) YCP BETA5-A49T-MUTANT IN COMPLEX WITH ONX 0914 | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4qz5:N (LYS33) to (ASN141) YCP BETA5-A49T-MUTANT IN COMPLEX WITH ONX 0914 | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4qz5:S (SER56) to (ILE181) YCP BETA5-A49T-MUTANT IN COMPLEX WITH ONX 0914 | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4qz5:W (LYS41) to (ASP177) YCP BETA5-A49T-MUTANT IN COMPLEX WITH ONX 0914 | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4qz5:Z (LYS42) to (ARG194) YCP BETA5-A49T-MUTANT IN COMPLEX WITH ONX 0914 | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4qz5:a (ARG41) to (ARG187) YCP BETA5-A49T-MUTANT IN COMPLEX WITH ONX 0914 | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4qz5:b (LYS33) to (ASN141) YCP BETA5-A49T-MUTANT IN COMPLEX WITH ONX 0914 | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4qz6:E (SER56) to (ILE181) YCP BETA5-A49T-A50V DOUBLE MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914 | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4qz6:I (LYS41) to (ASP177) YCP BETA5-A49T-A50V DOUBLE MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914 | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4qz6:L (LYS42) to (ARG194) YCP BETA5-A49T-A50V DOUBLE MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914 | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4qz6:M (ARG41) to (THR168) YCP BETA5-A49T-A50V DOUBLE MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914 | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4qz6:N (LYS33) to (ASN141) YCP BETA5-A49T-A50V DOUBLE MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914 | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4qz6:S (SER56) to (ILE181) YCP BETA5-A49T-A50V DOUBLE MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914 | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4qz6:W (LYS41) to (ASP177) YCP BETA5-A49T-A50V DOUBLE MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914 | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4qz6:Z (LYS42) to (ARG194) YCP BETA5-A49T-A50V DOUBLE MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914 | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4qz6:a (ARG41) to (THR168) YCP BETA5-A49T-A50V DOUBLE MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914 | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4qz6:b (LYS33) to (ASN141) YCP BETA5-A49T-A50V DOUBLE MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914 | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4qzw:E (SER56) to (ILE181) YCP BETA5-C52F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914 | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4qzw:I (LYS41) to (ASP177) YCP BETA5-C52F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914 | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4qzw:J (LYS34) to (LYS170) YCP BETA5-C52F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914 | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4qzw:L (LYS42) to (ARG194) YCP BETA5-C52F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914 | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4qzw:M (ARG41) to (ARG187) YCP BETA5-C52F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914 | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4qzw:S (SER56) to (ILE181) YCP BETA5-C52F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914 | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4qzw:W (LYS41) to (ASP177) YCP BETA5-C52F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914 | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4qzw:X (LYS34) to (LYS170) YCP BETA5-C52F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914 | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4qzw:Z (LYS42) to (ARG194) YCP BETA5-C52F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914 | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4qzw:a (ARG41) to (ARG187) YCP BETA5-C52F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914 | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4qzx:E (SER56) to (ILE181) YCP BETA5-C63F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914 | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4qzx:I (LYS41) to (ASP177) YCP BETA5-C63F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914 | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4qzx:L (LYS42) to (ARG194) YCP BETA5-C63F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914 | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4qzx:M (ARG41) to (ARG187) YCP BETA5-C63F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914 | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4qzx:S (SER56) to (ILE181) YCP BETA5-C63F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914 | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4qzx:W (LYS41) to (ASP177) YCP BETA5-C63F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914 | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4qzx:Z (LYS42) to (ARG194) YCP BETA5-C63F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914 | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4qzx:a (ARG41) to (ARG187) YCP BETA5-C63F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914 | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4r00:E (LYS61) to (ILE181) YCP BETA5-C52F MUTANT IN COMPLEX WITH OMURALIDE | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4r00:I (LYS41) to (ASP177) YCP BETA5-C52F MUTANT IN COMPLEX WITH OMURALIDE | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4r00:L (LYS42) to (ARG194) YCP BETA5-C52F MUTANT IN COMPLEX WITH OMURALIDE | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4r00:M (ARG41) to (ARG187) YCP BETA5-C52F MUTANT IN COMPLEX WITH OMURALIDE | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4r00:N (LYS33) to (ASN141) YCP BETA5-C52F MUTANT IN COMPLEX WITH OMURALIDE | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4r00:S (LYS61) to (ILE181) YCP BETA5-C52F MUTANT IN COMPLEX WITH OMURALIDE | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4r00:W (LYS41) to (ASP177) YCP BETA5-C52F MUTANT IN COMPLEX WITH OMURALIDE | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4r00:Z (LYS42) to (ARG194) YCP BETA5-C52F MUTANT IN COMPLEX WITH OMURALIDE | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4r00:a (ARG41) to (ARG187) YCP BETA5-C52F MUTANT IN COMPLEX WITH OMURALIDE | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4r00:b (LYS33) to (ASN141) YCP BETA5-C52F MUTANT IN COMPLEX WITH OMURALIDE | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4qzz:E (LYS61) to (ILE181) YCP IN COMPLEX WITH OMURALIDE | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4qzz:I (LYS41) to (ASP177) YCP IN COMPLEX WITH OMURALIDE | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4qzz:L (LYS42) to (ARG194) YCP IN COMPLEX WITH OMURALIDE | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4qzz:M (ARG41) to (ARG187) YCP IN COMPLEX WITH OMURALIDE | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4qzz:N (LYS33) to (ASN141) YCP IN COMPLEX WITH OMURALIDE | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4qzz:S (LYS61) to (ILE181) YCP IN COMPLEX WITH OMURALIDE | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4qzz:W (LYS41) to (ASP177) YCP IN COMPLEX WITH OMURALIDE | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4qzz:Z (LYS42) to (ARG194) YCP IN COMPLEX WITH OMURALIDE | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4qzz:a (ARG41) to (ARG187) YCP IN COMPLEX WITH OMURALIDE | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4qzz:b (LYS33) to (ASN141) YCP IN COMPLEX WITH OMURALIDE | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4r02:C (LYS61) to (LEU198) YCP IN COMPLEX WITH BSC4999 (ALPHA-KETO PHENYLAMIDE) | CANCER, PROTEASOME, DRUG DEVELOPMENT, BINDING ANALYSIS, REVERSIBLE COVALENT LIGAND, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4r02:E (LYS61) to (ILE181) YCP IN COMPLEX WITH BSC4999 (ALPHA-KETO PHENYLAMIDE) | CANCER, PROTEASOME, DRUG DEVELOPMENT, BINDING ANALYSIS, REVERSIBLE COVALENT LIGAND, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4r02:I (LYS41) to (ASP177) YCP IN COMPLEX WITH BSC4999 (ALPHA-KETO PHENYLAMIDE) | CANCER, PROTEASOME, DRUG DEVELOPMENT, BINDING ANALYSIS, REVERSIBLE COVALENT LIGAND, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4r02:J (LYS34) to (MET172) YCP IN COMPLEX WITH BSC4999 (ALPHA-KETO PHENYLAMIDE) | CANCER, PROTEASOME, DRUG DEVELOPMENT, BINDING ANALYSIS, REVERSIBLE COVALENT LIGAND, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4r02:L (LYS42) to (ARG194) YCP IN COMPLEX WITH BSC4999 (ALPHA-KETO PHENYLAMIDE) | CANCER, PROTEASOME, DRUG DEVELOPMENT, BINDING ANALYSIS, REVERSIBLE COVALENT LIGAND, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4r02:M (ARG41) to (ARG187) YCP IN COMPLEX WITH BSC4999 (ALPHA-KETO PHENYLAMIDE) | CANCER, PROTEASOME, DRUG DEVELOPMENT, BINDING ANALYSIS, REVERSIBLE COVALENT LIGAND, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4r02:N (LYS33) to (ASN141) YCP IN COMPLEX WITH BSC4999 (ALPHA-KETO PHENYLAMIDE) | CANCER, PROTEASOME, DRUG DEVELOPMENT, BINDING ANALYSIS, REVERSIBLE COVALENT LIGAND, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4r02:S (SER56) to (ILE181) YCP IN COMPLEX WITH BSC4999 (ALPHA-KETO PHENYLAMIDE) | CANCER, PROTEASOME, DRUG DEVELOPMENT, BINDING ANALYSIS, REVERSIBLE COVALENT LIGAND, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4r02:Z (LYS42) to (ARG194) YCP IN COMPLEX WITH BSC4999 (ALPHA-KETO PHENYLAMIDE) | CANCER, PROTEASOME, DRUG DEVELOPMENT, BINDING ANALYSIS, REVERSIBLE COVALENT LIGAND, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4r02:a (ARG41) to (ARG187) YCP IN COMPLEX WITH BSC4999 (ALPHA-KETO PHENYLAMIDE) | CANCER, PROTEASOME, DRUG DEVELOPMENT, BINDING ANALYSIS, REVERSIBLE COVALENT LIGAND, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4r02:b (LYS33) to (ASN141) YCP IN COMPLEX WITH BSC4999 (ALPHA-KETO PHENYLAMIDE) | CANCER, PROTEASOME, DRUG DEVELOPMENT, BINDING ANALYSIS, REVERSIBLE COVALENT LIGAND, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4r17:E (LYS61) to (ILE181) LIGAND-INDUCED AZIRIDINE-FORMATION AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME | PROTEASOME, DRUG DEVELOPMENT, BINDING ANALYSIS, UMPOLUNG, CROSSLINK, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4r17:L (LYS42) to (ARG194) LIGAND-INDUCED AZIRIDINE-FORMATION AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME | PROTEASOME, DRUG DEVELOPMENT, BINDING ANALYSIS, UMPOLUNG, CROSSLINK, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4r17:M (ARG41) to (ARG187) LIGAND-INDUCED AZIRIDINE-FORMATION AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME | PROTEASOME, DRUG DEVELOPMENT, BINDING ANALYSIS, UMPOLUNG, CROSSLINK, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4r17:N (LYS33) to (ASN141) LIGAND-INDUCED AZIRIDINE-FORMATION AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME | PROTEASOME, DRUG DEVELOPMENT, BINDING ANALYSIS, UMPOLUNG, CROSSLINK, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4r17:S (LYS61) to (ILE181) LIGAND-INDUCED AZIRIDINE-FORMATION AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME | PROTEASOME, DRUG DEVELOPMENT, BINDING ANALYSIS, UMPOLUNG, CROSSLINK, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4r17:Z (LYS42) to (ARG194) LIGAND-INDUCED AZIRIDINE-FORMATION AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME | PROTEASOME, DRUG DEVELOPMENT, BINDING ANALYSIS, UMPOLUNG, CROSSLINK, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4r17:a (ARG41) to (ARG187) LIGAND-INDUCED AZIRIDINE-FORMATION AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME | PROTEASOME, DRUG DEVELOPMENT, BINDING ANALYSIS, UMPOLUNG, CROSSLINK, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4r17:b (LYS33) to (ASN141) LIGAND-INDUCED AZIRIDINE-FORMATION AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME | PROTEASOME, DRUG DEVELOPMENT, BINDING ANALYSIS, UMPOLUNG, CROSSLINK, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4r18:E (LYS61) to (ILE181) LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME | PROTEASOME, DRUG DEVELOPMENT, BINDING ANALYSIS, UMPOLUNG, CROSSLINK, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4r18:I (LYS41) to (ASP177) LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME | PROTEASOME, DRUG DEVELOPMENT, BINDING ANALYSIS, UMPOLUNG, CROSSLINK, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4r18:L (LYS42) to (ARG194) LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME | PROTEASOME, DRUG DEVELOPMENT, BINDING ANALYSIS, UMPOLUNG, CROSSLINK, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4r18:M (ARG41) to (ARG187) LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME | PROTEASOME, DRUG DEVELOPMENT, BINDING ANALYSIS, UMPOLUNG, CROSSLINK, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4r18:N (LYS33) to (ASN141) LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME | PROTEASOME, DRUG DEVELOPMENT, BINDING ANALYSIS, UMPOLUNG, CROSSLINK, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4r18:S (LYS61) to (ILE181) LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME | PROTEASOME, DRUG DEVELOPMENT, BINDING ANALYSIS, UMPOLUNG, CROSSLINK, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4r18:W (LYS41) to (ASP177) LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME | PROTEASOME, DRUG DEVELOPMENT, BINDING ANALYSIS, UMPOLUNG, CROSSLINK, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4r18:Z (LYS42) to (ARG194) LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME | PROTEASOME, DRUG DEVELOPMENT, BINDING ANALYSIS, UMPOLUNG, CROSSLINK, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4r18:a (ARG41) to (ARG187) LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME | PROTEASOME, DRUG DEVELOPMENT, BINDING ANALYSIS, UMPOLUNG, CROSSLINK, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4r18:b (LYS33) to (ASN141) LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME | PROTEASOME, DRUG DEVELOPMENT, BINDING ANALYSIS, UMPOLUNG, CROSSLINK, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4r3o:A (HIS68) to (LEU206) HUMAN CONSTITUTIVE 20S PROTEASOME | HYDROLASE
4r3o:B (LYS63) to (GLU196) HUMAN CONSTITUTIVE 20S PROTEASOME | HYDROLASE
4r3o:F (LYS62) to (CYS182) HUMAN CONSTITUTIVE 20S PROTEASOME | HYDROLASE
4r3o:G (ARG65) to (ILE199) HUMAN CONSTITUTIVE 20S PROTEASOME | HYDROLASE
4r3o:J (LYS41) to (ASP178) HUMAN CONSTITUTIVE 20S PROTEASOME | HYDROLASE
4r3o:K (LYS34) to (LYS169) HUMAN CONSTITUTIVE 20S PROTEASOME | HYDROLASE
4r3o:M (LYS42) to (ARG185) HUMAN CONSTITUTIVE 20S PROTEASOME | HYDROLASE
4r3o:O (HIS68) to (SER207) HUMAN CONSTITUTIVE 20S PROTEASOME | HYDROLASE
4r3o:P (LYS63) to (GLU196) HUMAN CONSTITUTIVE 20S PROTEASOME | HYDROLASE
4r3o:R (LYS61) to (GLU197) HUMAN CONSTITUTIVE 20S PROTEASOME | HYDROLASE
4r3o:T (LYS62) to (CYS182) HUMAN CONSTITUTIVE 20S PROTEASOME | HYDROLASE
4r3o:U (ARG65) to (ILE199) HUMAN CONSTITUTIVE 20S PROTEASOME | HYDROLASE
4r3o:X (LYS41) to (ASP178) HUMAN CONSTITUTIVE 20S PROTEASOME | HYDROLASE
4r3o:Y (LYS34) to (LYS169) HUMAN CONSTITUTIVE 20S PROTEASOME | HYDROLASE
4r3o:1 (LYS42) to (ARG185) HUMAN CONSTITUTIVE 20S PROTEASOME | HYDROLASE
5fgd:E (SER56) to (ILE181) YEAST 20S PROTEASOME BETA5-H(-2)L-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5fgd:J (LYS34) to (LYS170) YEAST 20S PROTEASOME BETA5-H(-2)L-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5fgd:L (LYS42) to (ARG194) YEAST 20S PROTEASOME BETA5-H(-2)L-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5fgd:M (ARG41) to (ARG187) YEAST 20S PROTEASOME BETA5-H(-2)L-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5fgd:N (LYS33) to (ASN141) YEAST 20S PROTEASOME BETA5-H(-2)L-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5fgd:S (SER56) to (ILE181) YEAST 20S PROTEASOME BETA5-H(-2)L-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5fgd:X (LYS34) to (LYS170) YEAST 20S PROTEASOME BETA5-H(-2)L-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5fgd:Z (LYS42) to (ARG194) YEAST 20S PROTEASOME BETA5-H(-2)L-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5fgd:a (ARG41) to (ARG187) YEAST 20S PROTEASOME BETA5-H(-2)L-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5fgd:b (LYS33) to (ASN141) YEAST 20S PROTEASOME BETA5-H(-2)L-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5fg7:E (SER56) to (ILE181) YEAST 20S PROTEASOME BETA2-T1A MUTANT | HYDROLASE COMPLEX, PROTEASOME, MUTANT, BINDING ANALYSIS, HYDROLASE- HYDROLASE INHIBITOR COMPLEX
5fg7:I (LYS41) to (ASP177) YEAST 20S PROTEASOME BETA2-T1A MUTANT | HYDROLASE COMPLEX, PROTEASOME, MUTANT, BINDING ANALYSIS, HYDROLASE- HYDROLASE INHIBITOR COMPLEX
5fg7:L (LYS42) to (ARG194) YEAST 20S PROTEASOME BETA2-T1A MUTANT | HYDROLASE COMPLEX, PROTEASOME, MUTANT, BINDING ANALYSIS, HYDROLASE- HYDROLASE INHIBITOR COMPLEX
5fg7:M (ARG41) to (ARG187) YEAST 20S PROTEASOME BETA2-T1A MUTANT | HYDROLASE COMPLEX, PROTEASOME, MUTANT, BINDING ANALYSIS, HYDROLASE- HYDROLASE INHIBITOR COMPLEX
5fg7:N (LYS33) to (ASN141) YEAST 20S PROTEASOME BETA2-T1A MUTANT | HYDROLASE COMPLEX, PROTEASOME, MUTANT, BINDING ANALYSIS, HYDROLASE- HYDROLASE INHIBITOR COMPLEX
5fg7:S (SER56) to (ILE181) YEAST 20S PROTEASOME BETA2-T1A MUTANT | HYDROLASE COMPLEX, PROTEASOME, MUTANT, BINDING ANALYSIS, HYDROLASE- HYDROLASE INHIBITOR COMPLEX
5fg7:W (LYS41) to (ASP177) YEAST 20S PROTEASOME BETA2-T1A MUTANT | HYDROLASE COMPLEX, PROTEASOME, MUTANT, BINDING ANALYSIS, HYDROLASE- HYDROLASE INHIBITOR COMPLEX
5fg7:Z (LYS42) to (ARG194) YEAST 20S PROTEASOME BETA2-T1A MUTANT | HYDROLASE COMPLEX, PROTEASOME, MUTANT, BINDING ANALYSIS, HYDROLASE- HYDROLASE INHIBITOR COMPLEX
5fg7:a (ARG41) to (ARG187) YEAST 20S PROTEASOME BETA2-T1A MUTANT | HYDROLASE COMPLEX, PROTEASOME, MUTANT, BINDING ANALYSIS, HYDROLASE- HYDROLASE INHIBITOR COMPLEX
5fg7:b (LYS33) to (ASN141) YEAST 20S PROTEASOME BETA2-T1A MUTANT | HYDROLASE COMPLEX, PROTEASOME, MUTANT, BINDING ANALYSIS, HYDROLASE- HYDROLASE INHIBITOR COMPLEX
5fg9:E (SER56) to (ILE181) YEAST 20S PROTEASOME BETA2-T(-2)V MUTANT | HYDROLASE COMPLEX, PROTEASOME, MUTANT, BINDING ANALYSIS, HYDROLASE- HYDROLASE INHIBITOR COMPLEX
5fg9:I (LYS41) to (ASP177) YEAST 20S PROTEASOME BETA2-T(-2)V MUTANT | HYDROLASE COMPLEX, PROTEASOME, MUTANT, BINDING ANALYSIS, HYDROLASE- HYDROLASE INHIBITOR COMPLEX
5fg9:L (LYS42) to (ARG194) YEAST 20S PROTEASOME BETA2-T(-2)V MUTANT | HYDROLASE COMPLEX, PROTEASOME, MUTANT, BINDING ANALYSIS, HYDROLASE- HYDROLASE INHIBITOR COMPLEX
5fg9:M (ARG41) to (ARG187) YEAST 20S PROTEASOME BETA2-T(-2)V MUTANT | HYDROLASE COMPLEX, PROTEASOME, MUTANT, BINDING ANALYSIS, HYDROLASE- HYDROLASE INHIBITOR COMPLEX
5fg9:N (LYS33) to (ASN141) YEAST 20S PROTEASOME BETA2-T(-2)V MUTANT | HYDROLASE COMPLEX, PROTEASOME, MUTANT, BINDING ANALYSIS, HYDROLASE- HYDROLASE INHIBITOR COMPLEX
5fg9:S (SER56) to (ILE181) YEAST 20S PROTEASOME BETA2-T(-2)V MUTANT | HYDROLASE COMPLEX, PROTEASOME, MUTANT, BINDING ANALYSIS, HYDROLASE- HYDROLASE INHIBITOR COMPLEX
5fg9:W (LYS41) to (ASP177) YEAST 20S PROTEASOME BETA2-T(-2)V MUTANT | HYDROLASE COMPLEX, PROTEASOME, MUTANT, BINDING ANALYSIS, HYDROLASE- HYDROLASE INHIBITOR COMPLEX
5fg9:Z (LYS42) to (ARG194) YEAST 20S PROTEASOME BETA2-T(-2)V MUTANT | HYDROLASE COMPLEX, PROTEASOME, MUTANT, BINDING ANALYSIS, HYDROLASE- HYDROLASE INHIBITOR COMPLEX
5fg9:a (ARG41) to (ARG187) YEAST 20S PROTEASOME BETA2-T(-2)V MUTANT | HYDROLASE COMPLEX, PROTEASOME, MUTANT, BINDING ANALYSIS, HYDROLASE- HYDROLASE INHIBITOR COMPLEX
5fg9:b (LYS33) to (ASN141) YEAST 20S PROTEASOME BETA2-T(-2)V MUTANT | HYDROLASE COMPLEX, PROTEASOME, MUTANT, BINDING ANALYSIS, HYDROLASE- HYDROLASE INHIBITOR COMPLEX
5fge:E (SER56) to (ILE181) YEAST 20S PROTEASOME BETA5-H(-2)T-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5fge:I (LYS41) to (ASP177) YEAST 20S PROTEASOME BETA5-H(-2)T-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5fge:J (LYS34) to (MET172) YEAST 20S PROTEASOME BETA5-H(-2)T-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5fge:L (LYS42) to (ARG194) YEAST 20S PROTEASOME BETA5-H(-2)T-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5fge:M (ARG41) to (ARG187) YEAST 20S PROTEASOME BETA5-H(-2)T-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5fge:N (LYS33) to (ASN141) YEAST 20S PROTEASOME BETA5-H(-2)T-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5fge:S (SER56) to (ILE181) YEAST 20S PROTEASOME BETA5-H(-2)T-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5fge:W (LYS41) to (ASP177) YEAST 20S PROTEASOME BETA5-H(-2)T-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5fge:X (LYS34) to (MET172) YEAST 20S PROTEASOME BETA5-H(-2)T-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5fge:Z (LYS42) to (ARG194) YEAST 20S PROTEASOME BETA5-H(-2)T-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5fge:a (ARG41) to (ARG187) YEAST 20S PROTEASOME BETA5-H(-2)T-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5fge:b (LYS33) to (ASN141) YEAST 20S PROTEASOME BETA5-H(-2)T-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5fgf:E (SER56) to (ILE181) YEAST 20S PROTEASOME BETA5-H(-2)A-T1A-K81R TRIPLE MUTANT IN COMPLEX WITH CARFILZOMIB | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5fgf:I (LYS41) to (ASP177) YEAST 20S PROTEASOME BETA5-H(-2)A-T1A-K81R TRIPLE MUTANT IN COMPLEX WITH CARFILZOMIB | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5fgf:L (LYS42) to (ARG194) YEAST 20S PROTEASOME BETA5-H(-2)A-T1A-K81R TRIPLE MUTANT IN COMPLEX WITH CARFILZOMIB | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5fgf:M (ARG41) to (ARG187) YEAST 20S PROTEASOME BETA5-H(-2)A-T1A-K81R TRIPLE MUTANT IN COMPLEX WITH CARFILZOMIB | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5fgf:N (LYS33) to (ASN141) YEAST 20S PROTEASOME BETA5-H(-2)A-T1A-K81R TRIPLE MUTANT IN COMPLEX WITH CARFILZOMIB | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5fgf:S (SER56) to (ILE181) YEAST 20S PROTEASOME BETA5-H(-2)A-T1A-K81R TRIPLE MUTANT IN COMPLEX WITH CARFILZOMIB | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5fgf:W (LYS41) to (ASP177) YEAST 20S PROTEASOME BETA5-H(-2)A-T1A-K81R TRIPLE MUTANT IN COMPLEX WITH CARFILZOMIB | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5fgf:Z (LYS42) to (ARG194) YEAST 20S PROTEASOME BETA5-H(-2)A-T1A-K81R TRIPLE MUTANT IN COMPLEX WITH CARFILZOMIB | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5fgf:a (ARG41) to (ARG187) YEAST 20S PROTEASOME BETA5-H(-2)A-T1A-K81R TRIPLE MUTANT IN COMPLEX WITH CARFILZOMIB | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5fgf:b (LYS33) to (ASN141) YEAST 20S PROTEASOME BETA5-H(-2)A-T1A-K81R TRIPLE MUTANT IN COMPLEX WITH CARFILZOMIB | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5fhs:E (SER56) to (ILE181) YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH CARFILZOMIB | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5fhs:L (LYS42) to (ARG194) YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH CARFILZOMIB | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5fhs:M (ARG41) to (ARG187) YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH CARFILZOMIB | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5fhs:N (LYS33) to (ASN141) YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH CARFILZOMIB | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5fhs:S (SER56) to (ILE181) YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH CARFILZOMIB | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5fhs:Z (LYS42) to (ARG194) YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH CARFILZOMIB | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5fhs:a (ARG41) to (ARG187) YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH CARFILZOMIB | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5fhs:b (LYS33) to (ASN141) YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH CARFILZOMIB | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
3nzj:E (LYS66) to (ILE18) CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2A | UBIQUITIN, PROTEIN DEGRADATION, N-TERMINAL NUCLEOPHILIC HYDROLASE, 19S REGULATORY PARTICLE, UBIQUITIN-TAGGED SUBSTRATES, CYTOSOL, NUCLEUS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
3nzj:G (TYR66) to (ALA200) CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2A | UBIQUITIN, PROTEIN DEGRADATION, N-TERMINAL NUCLEOPHILIC HYDROLASE, 19S REGULATORY PARTICLE, UBIQUITIN-TAGGED SUBSTRATES, CYTOSOL, NUCLEUS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
3nzj:I (LYS33) to (ASP166) CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2A | UBIQUITIN, PROTEIN DEGRADATION, N-TERMINAL NUCLEOPHILIC HYDROLASE, 19S REGULATORY PARTICLE, UBIQUITIN-TAGGED SUBSTRATES, CYTOSOL, NUCLEUS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
3nzj:J (LYS33) to (LYS164) CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2A | UBIQUITIN, PROTEIN DEGRADATION, N-TERMINAL NUCLEOPHILIC HYDROLASE, 19S REGULATORY PARTICLE, UBIQUITIN-TAGGED SUBSTRATES, CYTOSOL, NUCLEUS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
3nzj:L (LYS33) to (ARG165) CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2A | UBIQUITIN, PROTEIN DEGRADATION, N-TERMINAL NUCLEOPHILIC HYDROLASE, 19S REGULATORY PARTICLE, UBIQUITIN-TAGGED SUBSTRATES, CYTOSOL, NUCLEUS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
3nzj:M (ARG33) to (ARG165) CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2A | UBIQUITIN, PROTEIN DEGRADATION, N-TERMINAL NUCLEOPHILIC HYDROLASE, 19S REGULATORY PARTICLE, UBIQUITIN-TAGGED SUBSTRATES, CYTOSOL, NUCLEUS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
3nzj:N (LYS33) to (ASN141) CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2A | UBIQUITIN, PROTEIN DEGRADATION, N-TERMINAL NUCLEOPHILIC HYDROLASE, 19S REGULATORY PARTICLE, UBIQUITIN-TAGGED SUBSTRATES, CYTOSOL, NUCLEUS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
3nzj:S (LYS66) to (ILE18) CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2A | UBIQUITIN, PROTEIN DEGRADATION, N-TERMINAL NUCLEOPHILIC HYDROLASE, 19S REGULATORY PARTICLE, UBIQUITIN-TAGGED SUBSTRATES, CYTOSOL, NUCLEUS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
3nzj:U (TYR66) to (ALA200) CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2A | UBIQUITIN, PROTEIN DEGRADATION, N-TERMINAL NUCLEOPHILIC HYDROLASE, 19S REGULATORY PARTICLE, UBIQUITIN-TAGGED SUBSTRATES, CYTOSOL, NUCLEUS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
3nzj:W (LYS33) to (ASP166) CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2A | UBIQUITIN, PROTEIN DEGRADATION, N-TERMINAL NUCLEOPHILIC HYDROLASE, 19S REGULATORY PARTICLE, UBIQUITIN-TAGGED SUBSTRATES, CYTOSOL, NUCLEUS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
3nzj:X (LYS33) to (LYS164) CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2A | UBIQUITIN, PROTEIN DEGRADATION, N-TERMINAL NUCLEOPHILIC HYDROLASE, 19S REGULATORY PARTICLE, UBIQUITIN-TAGGED SUBSTRATES, CYTOSOL, NUCLEUS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
3nzj:Z (LYS33) to (ARG165) CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2A | UBIQUITIN, PROTEIN DEGRADATION, N-TERMINAL NUCLEOPHILIC HYDROLASE, 19S REGULATORY PARTICLE, UBIQUITIN-TAGGED SUBSTRATES, CYTOSOL, NUCLEUS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
3nzj:1 (ARG33) to (ARG165) CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2A | UBIQUITIN, PROTEIN DEGRADATION, N-TERMINAL NUCLEOPHILIC HYDROLASE, 19S REGULATORY PARTICLE, UBIQUITIN-TAGGED SUBSTRATES, CYTOSOL, NUCLEUS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
3nzj:2 (LYS33) to (ASN141) CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2A | UBIQUITIN, PROTEIN DEGRADATION, N-TERMINAL NUCLEOPHILIC HYDROLASE, 19S REGULATORY PARTICLE, UBIQUITIN-TAGGED SUBSTRATES, CYTOSOL, NUCLEUS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
3nzw:E (LYS66) to (ILE18) CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH 2B | UBIQUITIN, PROTEIN DEGRADATION, N-TERMINAL NUCLEOPHILIC HYDROLASE, 19S REGULATORY PARTICLE, UBIQUITIN-TAGGED SUBSTRATES, CYTOSOL, NUCLEUS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
3nzw:I (LYS33) to (ASP166) CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH 2B | UBIQUITIN, PROTEIN DEGRADATION, N-TERMINAL NUCLEOPHILIC HYDROLASE, 19S REGULATORY PARTICLE, UBIQUITIN-TAGGED SUBSTRATES, CYTOSOL, NUCLEUS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
3nzw:L (LYS33) to (ARG165) CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH 2B | UBIQUITIN, PROTEIN DEGRADATION, N-TERMINAL NUCLEOPHILIC HYDROLASE, 19S REGULATORY PARTICLE, UBIQUITIN-TAGGED SUBSTRATES, CYTOSOL, NUCLEUS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
3nzw:M (ARG33) to (ARG165) CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH 2B | UBIQUITIN, PROTEIN DEGRADATION, N-TERMINAL NUCLEOPHILIC HYDROLASE, 19S REGULATORY PARTICLE, UBIQUITIN-TAGGED SUBSTRATES, CYTOSOL, NUCLEUS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
3nzw:N (LYS33) to (ASN141) CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH 2B | UBIQUITIN, PROTEIN DEGRADATION, N-TERMINAL NUCLEOPHILIC HYDROLASE, 19S REGULATORY PARTICLE, UBIQUITIN-TAGGED SUBSTRATES, CYTOSOL, NUCLEUS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
3nzw:S (LYS66) to (ILE18) CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH 2B | UBIQUITIN, PROTEIN DEGRADATION, N-TERMINAL NUCLEOPHILIC HYDROLASE, 19S REGULATORY PARTICLE, UBIQUITIN-TAGGED SUBSTRATES, CYTOSOL, NUCLEUS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
3nzw:W (LYS33) to (ASP166) CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH 2B | UBIQUITIN, PROTEIN DEGRADATION, N-TERMINAL NUCLEOPHILIC HYDROLASE, 19S REGULATORY PARTICLE, UBIQUITIN-TAGGED SUBSTRATES, CYTOSOL, NUCLEUS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
3nzw:Z (LYS33) to (ARG165) CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH 2B | UBIQUITIN, PROTEIN DEGRADATION, N-TERMINAL NUCLEOPHILIC HYDROLASE, 19S REGULATORY PARTICLE, UBIQUITIN-TAGGED SUBSTRATES, CYTOSOL, NUCLEUS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
3nzw:1 (ARG33) to (ARG165) CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH 2B | UBIQUITIN, PROTEIN DEGRADATION, N-TERMINAL NUCLEOPHILIC HYDROLASE, 19S REGULATORY PARTICLE, UBIQUITIN-TAGGED SUBSTRATES, CYTOSOL, NUCLEUS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
3nzw:2 (LYS33) to (ASN141) CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH 2B | UBIQUITIN, PROTEIN DEGRADATION, N-TERMINAL NUCLEOPHILIC HYDROLASE, 19S REGULATORY PARTICLE, UBIQUITIN-TAGGED SUBSTRATES, CYTOSOL, NUCLEUS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
3d29:E (LYS66) to (ILE18) PROTEASOME INHIBITION BY FELLUTAMIDE B | ANTI-PARALLEL BETA-SHEET STRUCTURE FLANKED BY ALPHA-HELICES, CYTOPLASM, HYDROLASE, NUCLEUS, PROTEASE, PROTEASOME, THREONINE PROTEASE, UBL CONJUGATION, PHOSPHOPROTEIN, ZYMOGEN
3d29:F (ILE67) to (ASN205) PROTEASOME INHIBITION BY FELLUTAMIDE B | ANTI-PARALLEL BETA-SHEET STRUCTURE FLANKED BY ALPHA-HELICES, CYTOPLASM, HYDROLASE, NUCLEUS, PROTEASE, PROTEASOME, THREONINE PROTEASE, UBL CONJUGATION, PHOSPHOPROTEIN, ZYMOGEN
3d29:I (LYS33) to (ASP166) PROTEASOME INHIBITION BY FELLUTAMIDE B | ANTI-PARALLEL BETA-SHEET STRUCTURE FLANKED BY ALPHA-HELICES, CYTOPLASM, HYDROLASE, NUCLEUS, PROTEASE, PROTEASOME, THREONINE PROTEASE, UBL CONJUGATION, PHOSPHOPROTEIN, ZYMOGEN
3d29:L (LYS33) to (ARG165) PROTEASOME INHIBITION BY FELLUTAMIDE B | ANTI-PARALLEL BETA-SHEET STRUCTURE FLANKED BY ALPHA-HELICES, CYTOPLASM, HYDROLASE, NUCLEUS, PROTEASE, PROTEASOME, THREONINE PROTEASE, UBL CONJUGATION, PHOSPHOPROTEIN, ZYMOGEN
3d29:M (ARG33) to (ARG165) PROTEASOME INHIBITION BY FELLUTAMIDE B | ANTI-PARALLEL BETA-SHEET STRUCTURE FLANKED BY ALPHA-HELICES, CYTOPLASM, HYDROLASE, NUCLEUS, PROTEASE, PROTEASOME, THREONINE PROTEASE, UBL CONJUGATION, PHOSPHOPROTEIN, ZYMOGEN
3d29:N (LYS33) to (ASN141) PROTEASOME INHIBITION BY FELLUTAMIDE B | ANTI-PARALLEL BETA-SHEET STRUCTURE FLANKED BY ALPHA-HELICES, CYTOPLASM, HYDROLASE, NUCLEUS, PROTEASE, PROTEASOME, THREONINE PROTEASE, UBL CONJUGATION, PHOSPHOPROTEIN, ZYMOGEN
3d29:S (LYS66) to (ILE18) PROTEASOME INHIBITION BY FELLUTAMIDE B | ANTI-PARALLEL BETA-SHEET STRUCTURE FLANKED BY ALPHA-HELICES, CYTOPLASM, HYDROLASE, NUCLEUS, PROTEASE, PROTEASOME, THREONINE PROTEASE, UBL CONJUGATION, PHOSPHOPROTEIN, ZYMOGEN
3d29:T (ILE67) to (ASN205) PROTEASOME INHIBITION BY FELLUTAMIDE B | ANTI-PARALLEL BETA-SHEET STRUCTURE FLANKED BY ALPHA-HELICES, CYTOPLASM, HYDROLASE, NUCLEUS, PROTEASE, PROTEASOME, THREONINE PROTEASE, UBL CONJUGATION, PHOSPHOPROTEIN, ZYMOGEN
3d29:W (LYS33) to (ASP166) PROTEASOME INHIBITION BY FELLUTAMIDE B | ANTI-PARALLEL BETA-SHEET STRUCTURE FLANKED BY ALPHA-HELICES, CYTOPLASM, HYDROLASE, NUCLEUS, PROTEASE, PROTEASOME, THREONINE PROTEASE, UBL CONJUGATION, PHOSPHOPROTEIN, ZYMOGEN
3d29:Z (LYS33) to (ARG165) PROTEASOME INHIBITION BY FELLUTAMIDE B | ANTI-PARALLEL BETA-SHEET STRUCTURE FLANKED BY ALPHA-HELICES, CYTOPLASM, HYDROLASE, NUCLEUS, PROTEASE, PROTEASOME, THREONINE PROTEASE, UBL CONJUGATION, PHOSPHOPROTEIN, ZYMOGEN
3d29:1 (ARG33) to (ARG165) PROTEASOME INHIBITION BY FELLUTAMIDE B | ANTI-PARALLEL BETA-SHEET STRUCTURE FLANKED BY ALPHA-HELICES, CYTOPLASM, HYDROLASE, NUCLEUS, PROTEASE, PROTEASOME, THREONINE PROTEASE, UBL CONJUGATION, PHOSPHOPROTEIN, ZYMOGEN
3d29:2 (LYS33) to (ASN141) PROTEASOME INHIBITION BY FELLUTAMIDE B | ANTI-PARALLEL BETA-SHEET STRUCTURE FLANKED BY ALPHA-HELICES, CYTOPLASM, HYDROLASE, NUCLEUS, PROTEASE, PROTEASOME, THREONINE PROTEASE, UBL CONJUGATION, PHOSPHOPROTEIN, ZYMOGEN
4cr3:3 (LYS33) to (ASP169) DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME | HYDROLASE, AAA-ATPASE, ATP-ANALOG, CLASSIFICATION
4cr3:6 (LYS33) to (HIS186) DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME | HYDROLASE, AAA-ATPASE, ATP-ANALOG, CLASSIFICATION
4cr3:7 (ARG33) to (ALA181) DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME | HYDROLASE, AAA-ATPASE, ATP-ANALOG, CLASSIFICATION
4cr3:A (TYR71) to (ALA213) DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME | HYDROLASE, AAA-ATPASE, ATP-ANALOG, CLASSIFICATION
4cr3:B (LYS63) to (SER199) DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME | HYDROLASE, AAA-ATPASE, ATP-ANALOG, CLASSIFICATION
4cr3:C (LYS65) to (THR201) DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME | HYDROLASE, AAA-ATPASE, ATP-ANALOG, CLASSIFICATION
4cr3:D (LYS63) to (GLN204) DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME | HYDROLASE, AAA-ATPASE, ATP-ANALOG, CLASSIFICATION
4cr3:F (LYS62) to (ILE182) DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME | HYDROLASE, AAA-ATPASE, ATP-ANALOG, CLASSIFICATION
4cr4:2 (LYS33) to (LEU167) DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME | HYDROLASE, AAA-ATPASE, ATP-ANALOG, CLASSIFICATION
4cr4:3 (LYS33) to (ASP169) DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME | HYDROLASE, AAA-ATPASE, ATP-ANALOG, CLASSIFICATION
4cr4:4 (LYS33) to (LYS169) DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME | HYDROLASE, AAA-ATPASE, ATP-ANALOG, CLASSIFICATION
4cr4:7 (ARG33) to (THR160) DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME | HYDROLASE, AAA-ATPASE, ATP-ANALOG, CLASSIFICATION
4cr4:B (LYS63) to (SER199) DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME | HYDROLASE, AAA-ATPASE, ATP-ANALOG, CLASSIFICATION
4cr4:D (LYS63) to (GLN204) DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME | HYDROLASE, AAA-ATPASE, ATP-ANALOG, CLASSIFICATION
4cr4:E (LYS66) to (TRP187) DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME | HYDROLASE, AAA-ATPASE, ATP-ANALOG, CLASSIFICATION
4cr4:F (LYS62) to (ILE182) DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME | HYDROLASE, AAA-ATPASE, ATP-ANALOG, CLASSIFICATION
3oeu:E (SER59) to (ILE180) STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 24 | 20S PROTEASOME, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
3oeu:I (LYS33) to (ASP166) STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 24 | 20S PROTEASOME, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
3oeu:L (LYS33) to (ARG165) STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 24 | 20S PROTEASOME, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
3oeu:M (ARG33) to (THR146) STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 24 | 20S PROTEASOME, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
3oeu:N (LYS33) to (ASN141) STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 24 | 20S PROTEASOME, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
3oeu:U (TYR66) to (ALA200) STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 24 | 20S PROTEASOME, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
3oeu:W (LYS33) to (ASP166) STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 24 | 20S PROTEASOME, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
3oeu:Z (LYS33) to (ARG165) STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 24 | 20S PROTEASOME, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
3oeu:1 (ARG33) to (ARG165) STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 24 | 20S PROTEASOME, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
3oeu:2 (LYS33) to (ASN141) STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 24 | 20S PROTEASOME, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
3oev:E (LYS66) to (ILE180) STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 25 | 20S PROTEASOME, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
3oev:I (LYS33) to (ASP166) STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 25 | 20S PROTEASOME, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
3oev:L (LYS33) to (ARG165) STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 25 | 20S PROTEASOME, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
3oev:M (ARG33) to (THR146) STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 25 | 20S PROTEASOME, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
3oev:N (LYS33) to (ASN141) STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 25 | 20S PROTEASOME, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
3oev:S (LYS66) to (ILE182) STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 25 | 20S PROTEASOME, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
3oev:T (LYS66) to (LYS206) STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 25 | 20S PROTEASOME, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
3oev:W (LYS33) to (ASP166) STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 25 | 20S PROTEASOME, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
3oev:Z (LYS33) to (ARG165) STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 25 | 20S PROTEASOME, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
3oev:1 (ARG33) to (THR146) STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 25 | 20S PROTEASOME, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
3oev:2 (LYS33) to (LYS164) STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 25 | 20S PROTEASOME, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
3dy3:E (LYS66) to (ILE18) CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE EPIMER FORM OF SPIROLACTACYSTIN | PROTEASOME, INHIBITOR, PROTEIN DEGRADATION, UBIQUITIN- PROTEASOME-PATHWAY, CYTOPLASM, HYDROLASE, NUCLEUS, PROTEASE, THREONINE PROTEASE, UBL CONJUGATION, PHOSPHOPROTEIN, ZYMOGEN
3dy3:J (LYS33) to (HIS141) CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE EPIMER FORM OF SPIROLACTACYSTIN | PROTEASOME, INHIBITOR, PROTEIN DEGRADATION, UBIQUITIN- PROTEASOME-PATHWAY, CYTOPLASM, HYDROLASE, NUCLEUS, PROTEASE, THREONINE PROTEASE, UBL CONJUGATION, PHOSPHOPROTEIN, ZYMOGEN
3dy3:L (LYS33) to (ARG165) CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE EPIMER FORM OF SPIROLACTACYSTIN | PROTEASOME, INHIBITOR, PROTEIN DEGRADATION, UBIQUITIN- PROTEASOME-PATHWAY, CYTOPLASM, HYDROLASE, NUCLEUS, PROTEASE, THREONINE PROTEASE, UBL CONJUGATION, PHOSPHOPROTEIN, ZYMOGEN
3dy3:M (ARG33) to (ARG165) CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE EPIMER FORM OF SPIROLACTACYSTIN | PROTEASOME, INHIBITOR, PROTEIN DEGRADATION, UBIQUITIN- PROTEASOME-PATHWAY, CYTOPLASM, HYDROLASE, NUCLEUS, PROTEASE, THREONINE PROTEASE, UBL CONJUGATION, PHOSPHOPROTEIN, ZYMOGEN
3dy3:N (LYS33) to (ASN141) CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE EPIMER FORM OF SPIROLACTACYSTIN | PROTEASOME, INHIBITOR, PROTEIN DEGRADATION, UBIQUITIN- PROTEASOME-PATHWAY, CYTOPLASM, HYDROLASE, NUCLEUS, PROTEASE, THREONINE PROTEASE, UBL CONJUGATION, PHOSPHOPROTEIN, ZYMOGEN
3dy3:S (LYS66) to (ILE18) CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE EPIMER FORM OF SPIROLACTACYSTIN | PROTEASOME, INHIBITOR, PROTEIN DEGRADATION, UBIQUITIN- PROTEASOME-PATHWAY, CYTOPLASM, HYDROLASE, NUCLEUS, PROTEASE, THREONINE PROTEASE, UBL CONJUGATION, PHOSPHOPROTEIN, ZYMOGEN
3dy3:X (LYS33) to (HIS141) CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE EPIMER FORM OF SPIROLACTACYSTIN | PROTEASOME, INHIBITOR, PROTEIN DEGRADATION, UBIQUITIN- PROTEASOME-PATHWAY, CYTOPLASM, HYDROLASE, NUCLEUS, PROTEASE, THREONINE PROTEASE, UBL CONJUGATION, PHOSPHOPROTEIN, ZYMOGEN
3dy3:Z (LYS33) to (ARG165) CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE EPIMER FORM OF SPIROLACTACYSTIN | PROTEASOME, INHIBITOR, PROTEIN DEGRADATION, UBIQUITIN- PROTEASOME-PATHWAY, CYTOPLASM, HYDROLASE, NUCLEUS, PROTEASE, THREONINE PROTEASE, UBL CONJUGATION, PHOSPHOPROTEIN, ZYMOGEN
3dy3:1 (ARG33) to (ARG165) CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE EPIMER FORM OF SPIROLACTACYSTIN | PROTEASOME, INHIBITOR, PROTEIN DEGRADATION, UBIQUITIN- PROTEASOME-PATHWAY, CYTOPLASM, HYDROLASE, NUCLEUS, PROTEASE, THREONINE PROTEASE, UBL CONJUGATION, PHOSPHOPROTEIN, ZYMOGEN
3dy3:2 (LYS33) to (ASN141) CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE EPIMER FORM OF SPIROLACTACYSTIN | PROTEASOME, INHIBITOR, PROTEIN DEGRADATION, UBIQUITIN- PROTEASOME-PATHWAY, CYTOPLASM, HYDROLASE, NUCLEUS, PROTEASE, THREONINE PROTEASE, UBL CONJUGATION, PHOSPHOPROTEIN, ZYMOGEN
3e47:B (LYS66) to (THR200) CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH HOMOBELACTOSIN C | PROTEASOME, UBIQUITIN, PROTEIN DEGRADATION, INHIBITOR, IMMUNOLOGY, CYTOPLASM, HYDROLASE, NUCLEUS, PHOSPHOPROTEIN, PROTEASE, THREONINE PROTEASE, UBL CONJUGATION, ZYMOGEN
3e47:E (LYS66) to (ILE18) CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH HOMOBELACTOSIN C | PROTEASOME, UBIQUITIN, PROTEIN DEGRADATION, INHIBITOR, IMMUNOLOGY, CYTOPLASM, HYDROLASE, NUCLEUS, PHOSPHOPROTEIN, PROTEASE, THREONINE PROTEASE, UBL CONJUGATION, ZYMOGEN
3e47:I (LYS33) to (ASP166) CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH HOMOBELACTOSIN C | PROTEASOME, UBIQUITIN, PROTEIN DEGRADATION, INHIBITOR, IMMUNOLOGY, CYTOPLASM, HYDROLASE, NUCLEUS, PHOSPHOPROTEIN, PROTEASE, THREONINE PROTEASE, UBL CONJUGATION, ZYMOGEN
3e47:J (LYS33) to (HIS141) CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH HOMOBELACTOSIN C | PROTEASOME, UBIQUITIN, PROTEIN DEGRADATION, INHIBITOR, IMMUNOLOGY, CYTOPLASM, HYDROLASE, NUCLEUS, PHOSPHOPROTEIN, PROTEASE, THREONINE PROTEASE, UBL CONJUGATION, ZYMOGEN
3e47:L (LYS33) to (ARG165) CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH HOMOBELACTOSIN C | PROTEASOME, UBIQUITIN, PROTEIN DEGRADATION, INHIBITOR, IMMUNOLOGY, CYTOPLASM, HYDROLASE, NUCLEUS, PHOSPHOPROTEIN, PROTEASE, THREONINE PROTEASE, UBL CONJUGATION, ZYMOGEN
3e47:M (ARG33) to (ARG165) CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH HOMOBELACTOSIN C | PROTEASOME, UBIQUITIN, PROTEIN DEGRADATION, INHIBITOR, IMMUNOLOGY, CYTOPLASM, HYDROLASE, NUCLEUS, PHOSPHOPROTEIN, PROTEASE, THREONINE PROTEASE, UBL CONJUGATION, ZYMOGEN
3e47:N (LYS33) to (ASN141) CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH HOMOBELACTOSIN C | PROTEASOME, UBIQUITIN, PROTEIN DEGRADATION, INHIBITOR, IMMUNOLOGY, CYTOPLASM, HYDROLASE, NUCLEUS, PHOSPHOPROTEIN, PROTEASE, THREONINE PROTEASE, UBL CONJUGATION, ZYMOGEN
3e47:P (LYS66) to (THR200) CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH HOMOBELACTOSIN C | PROTEASOME, UBIQUITIN, PROTEIN DEGRADATION, INHIBITOR, IMMUNOLOGY, CYTOPLASM, HYDROLASE, NUCLEUS, PHOSPHOPROTEIN, PROTEASE, THREONINE PROTEASE, UBL CONJUGATION, ZYMOGEN
3e47:S (LYS66) to (ILE18) CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH HOMOBELACTOSIN C | PROTEASOME, UBIQUITIN, PROTEIN DEGRADATION, INHIBITOR, IMMUNOLOGY, CYTOPLASM, HYDROLASE, NUCLEUS, PHOSPHOPROTEIN, PROTEASE, THREONINE PROTEASE, UBL CONJUGATION, ZYMOGEN
3e47:W (LYS33) to (ASP166) CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH HOMOBELACTOSIN C | PROTEASOME, UBIQUITIN, PROTEIN DEGRADATION, INHIBITOR, IMMUNOLOGY, CYTOPLASM, HYDROLASE, NUCLEUS, PHOSPHOPROTEIN, PROTEASE, THREONINE PROTEASE, UBL CONJUGATION, ZYMOGEN
3e47:X (LYS33) to (HIS141) CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH HOMOBELACTOSIN C | PROTEASOME, UBIQUITIN, PROTEIN DEGRADATION, INHIBITOR, IMMUNOLOGY, CYTOPLASM, HYDROLASE, NUCLEUS, PHOSPHOPROTEIN, PROTEASE, THREONINE PROTEASE, UBL CONJUGATION, ZYMOGEN
3e47:Z (LYS33) to (ARG165) CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH HOMOBELACTOSIN C | PROTEASOME, UBIQUITIN, PROTEIN DEGRADATION, INHIBITOR, IMMUNOLOGY, CYTOPLASM, HYDROLASE, NUCLEUS, PHOSPHOPROTEIN, PROTEASE, THREONINE PROTEASE, UBL CONJUGATION, ZYMOGEN
3e47:1 (ARG33) to (ARG165) CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH HOMOBELACTOSIN C | PROTEASOME, UBIQUITIN, PROTEIN DEGRADATION, INHIBITOR, IMMUNOLOGY, CYTOPLASM, HYDROLASE, NUCLEUS, PHOSPHOPROTEIN, PROTEASE, THREONINE PROTEASE, UBL CONJUGATION, ZYMOGEN
3e47:2 (LYS33) to (ASN141) CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH HOMOBELACTOSIN C | PROTEASOME, UBIQUITIN, PROTEIN DEGRADATION, INHIBITOR, IMMUNOLOGY, CYTOPLASM, HYDROLASE, NUCLEUS, PHOSPHOPROTEIN, PROTEASE, THREONINE PROTEASE, UBL CONJUGATION, ZYMOGEN
4eu2:F (LYS62) to (ILE182) CRYSTAL STRUCTURE OF 20S PROTEASOME WITH NOVEL INHIBITOR K-7174 | PROTEASOME INHIBITOR, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4eu2:H (LYS33) to (ASN141) CRYSTAL STRUCTURE OF 20S PROTEASOME WITH NOVEL INHIBITOR K-7174 | PROTEASOME INHIBITOR, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4eu2:I (LYS33) to (ALA161) CRYSTAL STRUCTURE OF 20S PROTEASOME WITH NOVEL INHIBITOR K-7174 | PROTEASOME INHIBITOR, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4eu2:J (LYS33) to (ASP169) CRYSTAL STRUCTURE OF 20S PROTEASOME WITH NOVEL INHIBITOR K-7174 | PROTEASOME INHIBITOR, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4eu2:K (LYS33) to (HIS146) CRYSTAL STRUCTURE OF 20S PROTEASOME WITH NOVEL INHIBITOR K-7174 | PROTEASOME INHIBITOR, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4eu2:T (LYS62) to (ILE182) CRYSTAL STRUCTURE OF 20S PROTEASOME WITH NOVEL INHIBITOR K-7174 | PROTEASOME INHIBITOR, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4eu2:V (LYS33) to (ASN141) CRYSTAL STRUCTURE OF 20S PROTEASOME WITH NOVEL INHIBITOR K-7174 | PROTEASOME INHIBITOR, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4eu2:X (LYS33) to (ASP169) CRYSTAL STRUCTURE OF 20S PROTEASOME WITH NOVEL INHIBITOR K-7174 | PROTEASOME INHIBITOR, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4eu2:Y (LYS33) to (HIS146) CRYSTAL STRUCTURE OF 20S PROTEASOME WITH NOVEL INHIBITOR K-7174 | PROTEASOME INHIBITOR, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4eu2:1 (LYS33) to (ARG185) CRYSTAL STRUCTURE OF 20S PROTEASOME WITH NOVEL INHIBITOR K-7174 | PROTEASOME INHIBITOR, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
5jhr:E (SER56) to (ILE181) YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 27 | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS
5jhr:I (LYS41) to (ASP177) YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 27 | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS
5jhr:L (LYS42) to (ARG194) YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 27 | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS
5jhr:M (ARG41) to (ARG187) YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 27 | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS
5jhr:N (LYS33) to (ASN141) YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 27 | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS
5jhr:S (SER56) to (ILE181) YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 27 | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS
5jhr:W (LYS41) to (ASP177) YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 27 | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS
5jhr:Z (LYS42) to (ARG194) YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 27 | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS
5jhr:a (ARG41) to (ARG187) YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 27 | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS
5jhr:b (LYS33) to (ASN141) YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 27 | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS
5jhs:E (SER56) to (ILE181) YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 15 | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS
5jhs:L (LYS42) to (ARG194) YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 15 | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS
5jhs:M (ARG41) to (ARG187) YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 15 | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS
5jhs:N (LYS33) to (ASN141) YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 15 | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS
5jhs:S (SER56) to (ILE181) YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 15 | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS
5jhs:Z (LYS42) to (ARG194) YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 15 | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS
5jhs:a (ARG41) to (ARG187) YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 15 | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS
5jhs:b (LYS33) to (ASN141) YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 15 | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS
4fzc:E (SER56) to (ILE181) 20S YEAST PROTEASOME IN COMPLEX WITH CEPAFUNGIN I | UBIQUITIN, PROTEASOME, DRUG DEVELOPMENT, INHIBITOR, NATURAL PRODUCT, N-TERMINAL NUCLEOPHILIC HYDROLASE, PROTEIN DEGRADATION, HYDROLASE- HYDROLASE INHIBITOR COMPLEX
4fzc:I (LYS41) to (ASP177) 20S YEAST PROTEASOME IN COMPLEX WITH CEPAFUNGIN I | UBIQUITIN, PROTEASOME, DRUG DEVELOPMENT, INHIBITOR, NATURAL PRODUCT, N-TERMINAL NUCLEOPHILIC HYDROLASE, PROTEIN DEGRADATION, HYDROLASE- HYDROLASE INHIBITOR COMPLEX
4fzc:J (LYS34) to (HIS147) 20S YEAST PROTEASOME IN COMPLEX WITH CEPAFUNGIN I | UBIQUITIN, PROTEASOME, DRUG DEVELOPMENT, INHIBITOR, NATURAL PRODUCT, N-TERMINAL NUCLEOPHILIC HYDROLASE, PROTEIN DEGRADATION, HYDROLASE- HYDROLASE INHIBITOR COMPLEX
4fzc:L (LYS42) to (ARG194) 20S YEAST PROTEASOME IN COMPLEX WITH CEPAFUNGIN I | UBIQUITIN, PROTEASOME, DRUG DEVELOPMENT, INHIBITOR, NATURAL PRODUCT, N-TERMINAL NUCLEOPHILIC HYDROLASE, PROTEIN DEGRADATION, HYDROLASE- HYDROLASE INHIBITOR COMPLEX
4fzc:N (LYS33) to (ASN141) 20S YEAST PROTEASOME IN COMPLEX WITH CEPAFUNGIN I | UBIQUITIN, PROTEASOME, DRUG DEVELOPMENT, INHIBITOR, NATURAL PRODUCT, N-TERMINAL NUCLEOPHILIC HYDROLASE, PROTEIN DEGRADATION, HYDROLASE- HYDROLASE INHIBITOR COMPLEX
4fzc:S (SER56) to (ILE181) 20S YEAST PROTEASOME IN COMPLEX WITH CEPAFUNGIN I | UBIQUITIN, PROTEASOME, DRUG DEVELOPMENT, INHIBITOR, NATURAL PRODUCT, N-TERMINAL NUCLEOPHILIC HYDROLASE, PROTEIN DEGRADATION, HYDROLASE- HYDROLASE INHIBITOR COMPLEX
4fzc:W (LYS41) to (ASP177) 20S YEAST PROTEASOME IN COMPLEX WITH CEPAFUNGIN I | UBIQUITIN, PROTEASOME, DRUG DEVELOPMENT, INHIBITOR, NATURAL PRODUCT, N-TERMINAL NUCLEOPHILIC HYDROLASE, PROTEIN DEGRADATION, HYDROLASE- HYDROLASE INHIBITOR COMPLEX
4fzc:X (LYS34) to (HIS147) 20S YEAST PROTEASOME IN COMPLEX WITH CEPAFUNGIN I | UBIQUITIN, PROTEASOME, DRUG DEVELOPMENT, INHIBITOR, NATURAL PRODUCT, N-TERMINAL NUCLEOPHILIC HYDROLASE, PROTEIN DEGRADATION, HYDROLASE- HYDROLASE INHIBITOR COMPLEX
4fzc:Z (LYS42) to (ARG194) 20S YEAST PROTEASOME IN COMPLEX WITH CEPAFUNGIN I | UBIQUITIN, PROTEASOME, DRUG DEVELOPMENT, INHIBITOR, NATURAL PRODUCT, N-TERMINAL NUCLEOPHILIC HYDROLASE, PROTEIN DEGRADATION, HYDROLASE- HYDROLASE INHIBITOR COMPLEX
4fzc:b (LYS33) to (ASN141) 20S YEAST PROTEASOME IN COMPLEX WITH CEPAFUNGIN I | UBIQUITIN, PROTEASOME, DRUG DEVELOPMENT, INHIBITOR, NATURAL PRODUCT, N-TERMINAL NUCLEOPHILIC HYDROLASE, PROTEIN DEGRADATION, HYDROLASE- HYDROLASE INHIBITOR COMPLEX
4g4s:B (LYS63) to (LYS177) STRUCTURE OF PROTEASOME-PBA1-PBA2 COMPLEX | ALPHA BETA, NTN-HYDROLASE, PEPTIDE BINDING, HYDROLASE-CHAPERONE COMPLEX
4g4s:E (LYS66) to (TRP187) STRUCTURE OF PROTEASOME-PBA1-PBA2 COMPLEX | ALPHA BETA, NTN-HYDROLASE, PEPTIDE BINDING, HYDROLASE-CHAPERONE COMPLEX
4g4s:F (LYS62) to (ILE182) STRUCTURE OF PROTEASOME-PBA1-PBA2 COMPLEX | ALPHA BETA, NTN-HYDROLASE, PEPTIDE BINDING, HYDROLASE-CHAPERONE COMPLEX
4g4s:G (LYS66) to (LYS208) STRUCTURE OF PROTEASOME-PBA1-PBA2 COMPLEX | ALPHA BETA, NTN-HYDROLASE, PEPTIDE BINDING, HYDROLASE-CHAPERONE COMPLEX
4g4s:H (LYS33) to (ASN141) STRUCTURE OF PROTEASOME-PBA1-PBA2 COMPLEX | ALPHA BETA, NTN-HYDROLASE, PEPTIDE BINDING, HYDROLASE-CHAPERONE COMPLEX
4g4s:J (LYS42) to (ASP178) STRUCTURE OF PROTEASOME-PBA1-PBA2 COMPLEX | ALPHA BETA, NTN-HYDROLASE, PEPTIDE BINDING, HYDROLASE-CHAPERONE COMPLEX
4g4s:M (LYS32) to (ARG184) STRUCTURE OF PROTEASOME-PBA1-PBA2 COMPLEX | ALPHA BETA, NTN-HYDROLASE, PEPTIDE BINDING, HYDROLASE-CHAPERONE COMPLEX
4g4s:N (ARG33) to (ARG179) STRUCTURE OF PROTEASOME-PBA1-PBA2 COMPLEX | ALPHA BETA, NTN-HYDROLASE, PEPTIDE BINDING, HYDROLASE-CHAPERONE COMPLEX
5l52:E (SER56) to (ILE181) YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 14 | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS
5l52:I (LYS41) to (ASP177) YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 14 | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS
5l52:L (LYS42) to (ARG194) YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 14 | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS
5l52:M (ARG41) to (THR168) YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 14 | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS
5l52:N (LYS33) to (ASN141) YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 14 | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS
5l52:S (SER56) to (ILE181) YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 14 | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS
5l52:W (LYS41) to (ASP177) YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 14 | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS
5l52:Z (LYS42) to (ARG194) YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 14 | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS
5l52:a (ARG41) to (ARG187) YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 14 | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS
5l52:b (LYS33) to (ASN141) YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 14 | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS
5l54:E (SER56) to (ILE181) YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 16 | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS
5l54:L (LYS42) to (ARG194) YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 16 | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS
5l54:M (ARG41) to (ARG187) YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 16 | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS
5l54:N (LYS33) to (ASN141) YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 16 | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS
5l54:S (SER56) to (ILE181) YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 16 | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS
5l54:Z (LYS42) to (ARG194) YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 16 | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS
5l54:a (ARG41) to (ARG187) YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 16 | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS
5l54:b (LYS33) to (ASN141) YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 16 | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS
5l55:E (LYS61) to (ILE181) YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 18 | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS
5l55:I (LYS41) to (ASP177) YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 18 | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS
5l55:L (LYS42) to (ARG194) YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 18 | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS
5l55:M (ARG41) to (ARG187) YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 18 | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS
5l55:N (LYS33) to (LYS164) YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 18 | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS
5l55:S (LYS61) to (ILE181) YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 18 | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS
5l55:W (LYS41) to (ASP177) YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 18 | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS
5l55:Z (LYS42) to (ARG194) YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 18 | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS
5l55:a (ARG41) to (ARG187) YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 18 | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS
5l55:b (LYS33) to (LYS164) YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 18 | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS
5l5a:E (SER56) to (ILE181) YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T) | HYDROLASE COMPLEX, PROTEASOME, MUTANT, BINDING ANALYSIS, HYDROLASE- HYDROLASE INHIBITOR COMPLEX
5l5a:I (LYS41) to (ASP177) YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T) | HYDROLASE COMPLEX, PROTEASOME, MUTANT, BINDING ANALYSIS, HYDROLASE- HYDROLASE INHIBITOR COMPLEX
5l5a:L (LYS42) to (ARG194) YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T) | HYDROLASE COMPLEX, PROTEASOME, MUTANT, BINDING ANALYSIS, HYDROLASE- HYDROLASE INHIBITOR COMPLEX
5l5a:M (ARG41) to (ARG187) YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T) | HYDROLASE COMPLEX, PROTEASOME, MUTANT, BINDING ANALYSIS, HYDROLASE- HYDROLASE INHIBITOR COMPLEX
5l5a:N (LYS33) to (ASN141) YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T) | HYDROLASE COMPLEX, PROTEASOME, MUTANT, BINDING ANALYSIS, HYDROLASE- HYDROLASE INHIBITOR COMPLEX
5l5a:S (SER56) to (ILE181) YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T) | HYDROLASE COMPLEX, PROTEASOME, MUTANT, BINDING ANALYSIS, HYDROLASE- HYDROLASE INHIBITOR COMPLEX
5l5a:W (LYS41) to (ASP177) YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T) | HYDROLASE COMPLEX, PROTEASOME, MUTANT, BINDING ANALYSIS, HYDROLASE- HYDROLASE INHIBITOR COMPLEX
5l5a:X (LYS34) to (HIS147) YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T) | HYDROLASE COMPLEX, PROTEASOME, MUTANT, BINDING ANALYSIS, HYDROLASE- HYDROLASE INHIBITOR COMPLEX
5l5a:Z (LYS42) to (ARG194) YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T) | HYDROLASE COMPLEX, PROTEASOME, MUTANT, BINDING ANALYSIS, HYDROLASE- HYDROLASE INHIBITOR COMPLEX
5l5a:a (ARG41) to (ARG187) YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T) | HYDROLASE COMPLEX, PROTEASOME, MUTANT, BINDING ANALYSIS, HYDROLASE- HYDROLASE INHIBITOR COMPLEX
5l5a:b (LYS33) to (ASN141) YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T) | HYDROLASE COMPLEX, PROTEASOME, MUTANT, BINDING ANALYSIS, HYDROLASE- HYDROLASE INHIBITOR COMPLEX
5l5b:E (LYS61) to (ILE181) YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) | HYDROLASE COMPLEX, PROTEASOME, MUTANT, BINDING ANALYSIS, HYDROLASE- HYDROLASE INHIBITOR COMPLEX
5l5b:J (LYS34) to (HIS147) YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) | HYDROLASE COMPLEX, PROTEASOME, MUTANT, BINDING ANALYSIS, HYDROLASE- HYDROLASE INHIBITOR COMPLEX
5l5b:L (LYS42) to (ARG194) YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) | HYDROLASE COMPLEX, PROTEASOME, MUTANT, BINDING ANALYSIS, HYDROLASE- HYDROLASE INHIBITOR COMPLEX
5l5b:M (ARG41) to (ARG187) YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) | HYDROLASE COMPLEX, PROTEASOME, MUTANT, BINDING ANALYSIS, HYDROLASE- HYDROLASE INHIBITOR COMPLEX
5l5b:N (LYS33) to (ASN141) YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) | HYDROLASE COMPLEX, PROTEASOME, MUTANT, BINDING ANALYSIS, HYDROLASE- HYDROLASE INHIBITOR COMPLEX
5l5b:S (LYS61) to (ILE181) YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) | HYDROLASE COMPLEX, PROTEASOME, MUTANT, BINDING ANALYSIS, HYDROLASE- HYDROLASE INHIBITOR COMPLEX
5l5b:X (LYS34) to (HIS147) YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) | HYDROLASE COMPLEX, PROTEASOME, MUTANT, BINDING ANALYSIS, HYDROLASE- HYDROLASE INHIBITOR COMPLEX
5l5b:Z (LYS42) to (ARG194) YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) | HYDROLASE COMPLEX, PROTEASOME, MUTANT, BINDING ANALYSIS, HYDROLASE- HYDROLASE INHIBITOR COMPLEX
5l5b:a (ARG41) to (ARG187) YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) | HYDROLASE COMPLEX, PROTEASOME, MUTANT, BINDING ANALYSIS, HYDROLASE- HYDROLASE INHIBITOR COMPLEX
5l5b:b (LYS33) to (ASN141) YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) | HYDROLASE COMPLEX, PROTEASOME, MUTANT, BINDING ANALYSIS, HYDROLASE- HYDROLASE INHIBITOR COMPLEX
5l5d:E (LYS61) to (ILE181) YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914 | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5l5d:I (LYS41) to (ASP177) YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914 | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5l5d:J (LYS34) to (HIS147) YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914 | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5l5d:L (LYS42) to (ARG194) YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914 | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5l5d:M (ARG41) to (ARG187) YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914 | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5l5d:N (LYS33) to (ASN141) YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914 | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5l5d:S (LYS61) to (ILE181) YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914 | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5l5d:X (LYS34) to (HIS147) YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914 | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5l5d:Z (LYS42) to (ARG194) YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914 | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5l5d:a (ARG41) to (ARG187) YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914 | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5l5d:b (LYS33) to (ASN141) YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914 | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5l5h:E (LYS61) to (ILE181) YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924 | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5l5h:I (LYS41) to (ASP177) YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924 | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5l5h:L (LYS42) to (ARG194) YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924 | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5l5h:M (ARG41) to (ARG187) YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924 | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5l5h:N (LYS33) to (ASN141) YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924 | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5l5h:S (LYS61) to (ILE181) YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924 | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5l5h:W (LYS41) to (ASP177) YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924 | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5l5h:Z (LYS42) to (ARG194) YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924 | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5l5h:a (ARG41) to (ARG187) YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924 | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5l5h:b (LYS33) to (ASN141) YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924 | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5l5i:E (LYS61) to (ILE181) YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 9 | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5l5i:I (LYS41) to (ASP177) YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 9 | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5l5i:J (LYS34) to (HIS147) YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 9 | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5l5i:L (LYS42) to (ARG194) YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 9 | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5l5i:M (ARG41) to (ARG187) YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 9 | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5l5i:N (LYS33) to (ASN141) YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 9 | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5l5i:S (LYS61) to (ILE181) YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 9 | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5l5i:W (LYS41) to (ASP177) YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 9 | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5l5i:X (LYS34) to (HIS147) YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 9 | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5l5i:Z (LYS42) to (ARG194) YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 9 | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5l5i:a (ARG41) to (ARG187) YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 9 | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5l5i:b (LYS33) to (ASN141) YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 9 | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5l5j:E (SER56) to (ILE181) YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14 | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5l5j:I (LYS41) to (ASP177) YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14 | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5l5j:L (LYS42) to (ARG194) YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14 | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5l5j:M (ARG41) to (ARG187) YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14 | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5l5j:N (LYS33) to (ASN141) YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14 | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5l5j:S (SER56) to (ILE181) YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14 | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5l5j:W (LYS41) to (ASP177) YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14 | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5l5j:X (LYS34) to (HIS147) YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14 | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5l5j:Z (LYS42) to (ARG194) YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14 | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5l5j:a (ARG41) to (ARG187) YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14 | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5l5j:b (LYS33) to (ASN141) YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14 | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5l5o:E (SER56) to (ILE181) YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16 | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5l5o:I (LYS41) to (ASP177) YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16 | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5l5o:J (LYS34) to (HIS147) YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16 | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5l5o:L (LYS42) to (ARG194) YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16 | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5l5o:M (ARG41) to (ARG187) YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16 | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5l5o:N (LYS33) to (ASN141) YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16 | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5l5o:S (SER56) to (ILE181) YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16 | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5l5o:W (LYS41) to (ASP177) YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16 | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5l5o:X (LYS34) to (HIS147) YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16 | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5l5o:Z (LYS42) to (ARG194) YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16 | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5l5o:a (ARG41) to (ARG187) YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16 | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5l5o:b (LYS33) to (ASN141) YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16 | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5l5p:E (SER56) to (ILE181) YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17 | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5l5p:I (LYS41) to (ASP177) YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17 | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5l5p:L (LYS42) to (ARG194) YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17 | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5l5p:M (ARG41) to (ARG187) YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17 | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5l5p:N (LYS33) to (ASN141) YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17 | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5l5p:S (SER56) to (ILE181) YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17 | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5l5p:W (LYS41) to (ASP177) YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17 | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5l5p:Z (LYS42) to (ARG194) YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17 | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5l5p:a (ARG41) to (ARG187) YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17 | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5l5p:b (LYS33) to (ASN141) YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17 | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5l5q:E (SER56) to (ILE181) YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE 18 | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5l5q:I (LYS41) to (ASP177) YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE 18 | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5l5q:L (LYS42) to (ARG194) YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE 18 | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5l5q:M (ARG41) to (ARG187) YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE 18 | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5l5q:N (LYS33) to (ASN141) YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE 18 | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5l5q:S (SER56) to (ILE181) YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE 18 | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5l5q:W (LYS41) to (ASP177) YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE 18 | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5l5q:Z (LYS42) to (ARG194) YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE 18 | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5l5q:a (ARG41) to (ARG187) YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE 18 | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5l5q:b (LYS33) to (ASN141) YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE 18 | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5l5s:E (SER56) to (ILE181) YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH PR-924 | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5l5s:I (LYS41) to (ASP177) YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH PR-924 | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5l5s:L (LYS42) to (ARG194) YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH PR-924 | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5l5s:N (LYS33) to (ASN141) YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH PR-924 | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5l5s:S (SER56) to (ILE181) YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH PR-924 | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5l5s:W (LYS41) to (ASP177) YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH PR-924 | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5l5s:Z (LYS42) to (ARG194) YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH PR-924 | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5l5s:b (LYS33) to (ASN141) YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH PR-924 | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5l5u:E (LYS61) to (ILE181) YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17 | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5l5u:I (LYS41) to (ASP177) YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17 | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5l5u:J (LYS34) to (HIS147) YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17 | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5l5u:L (LYS42) to (ARG194) YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17 | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5l5u:M (ARG41) to (ARG187) YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17 | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5l5u:N (LYS33) to (ASN141) YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17 | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5l5u:S (LYS61) to (ILE181) YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17 | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5l5u:W (LYS41) to (ASP177) YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17 | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5l5u:X (LYS34) to (HIS147) YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17 | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5l5u:Z (LYS42) to (ARG194) YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17 | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5l5u:a (ARG41) to (ARG187) YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17 | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5l5u:b (LYS33) to (ASN141) YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17 | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5l5v:E (SER56) to (ILE181) 'YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18 | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5l5v:L (LYS42) to (ARG194) 'YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18 | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5l5v:N (LYS33) to (ASN141) 'YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18 | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5l5v:S (SER56) to (ILE181) 'YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18 | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5l5v:Z (LYS42) to (ARG194) 'YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18 | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5l5v:b (LYS33) to (ASN141) 'YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18 | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5l5w:E (SER56) to (ILE181) YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) | HYDROLASE COMPLEX, PROTEASOME, MUTANT, BINDING ANALYSIS, HYDROLASE- HYDROLASE INHIBITOR COMPLEX
5l5w:I (LYS41) to (ASP177) YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) | HYDROLASE COMPLEX, PROTEASOME, MUTANT, BINDING ANALYSIS, HYDROLASE- HYDROLASE INHIBITOR COMPLEX
5l5w:L (LYS42) to (ARG194) YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) | HYDROLASE COMPLEX, PROTEASOME, MUTANT, BINDING ANALYSIS, HYDROLASE- HYDROLASE INHIBITOR COMPLEX
5l5w:M (ARG41) to (ARG187) YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) | HYDROLASE COMPLEX, PROTEASOME, MUTANT, BINDING ANALYSIS, HYDROLASE- HYDROLASE INHIBITOR COMPLEX
5l5w:N (LYS33) to (ASN141) YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) | HYDROLASE COMPLEX, PROTEASOME, MUTANT, BINDING ANALYSIS, HYDROLASE- HYDROLASE INHIBITOR COMPLEX
5l5w:S (SER56) to (ILE181) YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) | HYDROLASE COMPLEX, PROTEASOME, MUTANT, BINDING ANALYSIS, HYDROLASE- HYDROLASE INHIBITOR COMPLEX
5l5w:W (LYS41) to (ASP177) YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) | HYDROLASE COMPLEX, PROTEASOME, MUTANT, BINDING ANALYSIS, HYDROLASE- HYDROLASE INHIBITOR COMPLEX
5l5w:Z (LYS42) to (ARG194) YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) | HYDROLASE COMPLEX, PROTEASOME, MUTANT, BINDING ANALYSIS, HYDROLASE- HYDROLASE INHIBITOR COMPLEX
5l5w:a (ARG41) to (ARG187) YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) | HYDROLASE COMPLEX, PROTEASOME, MUTANT, BINDING ANALYSIS, HYDROLASE- HYDROLASE INHIBITOR COMPLEX
5l5w:b (LYS33) to (ASN141) YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) | HYDROLASE COMPLEX, PROTEASOME, MUTANT, BINDING ANALYSIS, HYDROLASE- HYDROLASE INHIBITOR COMPLEX
5l5x:E (SER56) to (ILE181) 'YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914 | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5l5x:K (LYS33) to (ASP167) 'YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914 | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5l5x:L (LYS42) to (ARG194) 'YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914 | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5l5x:M (ARG41) to (ARG187) 'YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914 | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5l5x:N (LYS33) to (ASN141) 'YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914 | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5l5x:S (SER56) to (ILE181) 'YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914 | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5l5x:Y (LYS33) to (ASP167) 'YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914 | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5l5x:Z (LYS42) to (ARG194) 'YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914 | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5l5x:a (ARG41) to (ARG187) 'YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914 | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5l5x:b (LYS33) to (ASN141) 'YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914 | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5l5y:E (SER56) to (ILE181) YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5l5y:L (LYS42) to (ARG194) YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5l5y:M (ARG41) to (ARG187) YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5l5y:N (LYS33) to (ASN141) YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5l5y:S (SER56) to (ILE181) YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5l5y:Z (LYS42) to (ARG194) YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5l5y:b (LYS33) to (ASN141) YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5l5z:E (SER56) to (ILE181) YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5l5z:I (LYS41) to (ASP177) YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5l5z:L (LYS42) to (ARG194) YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5l5z:M (ARG41) to (ARG187) YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5l5z:N (LYS33) to (ASN141) YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5l5z:S (SER56) to (ILE181) YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5l5z:W (LYS41) to (ASP177) YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5l5z:Z (LYS42) to (ARG194) YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5l5z:a (ARG41) to (ARG187) YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5l5z:b (LYS33) to (ASN141) YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5l60:E (SER56) to (ILE181) YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924 | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5l60:I (LYS41) to (ASP177) YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924 | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5l60:L (LYS42) to (ARG194) YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924 | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5l60:M (ARG41) to (ARG187) YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924 | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5l60:N (LYS33) to (ASN141) YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924 | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5l60:S (SER56) to (ILE181) YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924 | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5l60:W (LYS41) to (ASP177) YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924 | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5l60:Z (LYS42) to (ARG194) YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924 | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5l60:b (LYS33) to (ASN141) YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924 | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5l61:E (LYS61) to (ILE181) YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (99- 132) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14 | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5l61:K (LYS33) to (ASP167) YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (99- 132) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14 | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5l61:L (LYS42) to (ARG194) YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (99- 132) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14 | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5l61:M (ARG41) to (ARG187) YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (99- 132) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14 | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5l61:N (LYS33) to (ASN141) YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (99- 132) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14 | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5l61:S (LYS61) to (ILE181) YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (99- 132) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14 | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5l61:Y (LYS33) to (ASP167) YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (99- 132) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14 | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5l61:Z (LYS42) to (ARG194) YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (99- 132) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14 | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5l61:a (ARG41) to (ARG187) YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (99- 132) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14 | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5l61:b (LYS33) to (ASN141) YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (99- 132) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14 | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5l62:E (LYS61) to (ILE181) YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16 | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5l62:L (LYS42) to (ARG194) YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16 | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5l62:M (ARG41) to (ARG187) YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16 | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5l62:N (LYS33) to (ASN141) YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16 | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5l62:S (LYS61) to (ILE181) YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16 | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5l62:Z (LYS42) to (ARG194) YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16 | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5l62:a (ARG41) to (ARG187) YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16 | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5l62:b (LYS33) to (ASN141) YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16 | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5l64:E (SER56) to (ILE181) YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18 | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5l64:L (LYS42) to (ARG194) YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18 | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5l64:M (ARG41) to (ARG187) YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18 | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5l64:N (LYS33) to (ASN141) YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18 | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5l64:S (SER56) to (ILE181) YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18 | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5l64:Z (LYS42) to (ARG194) YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18 | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5l64:a (ARG41) to (ARG187) YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18 | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5l64:b (LYS33) to (ASN141) YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18 | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5l65:E (LYS61) to (ILE181) YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5l65:I (LYS41) to (ASP177) YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5l65:K (LYS33) to (ARG166) YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5l65:L (LYS42) to (ARG194) YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5l65:M (ARG41) to (ARG187) YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5l65:N (LYS33) to (ASN141) YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5l65:S (SER56) to (ILE181) YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5l65:W (LYS41) to (ASP177) YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5l65:Y (LYS33) to (ASP167) YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5l65:Z (LYS42) to (ARG194) YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5l65:a (ARG41) to (ARG187) YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5l65:b (LYS33) to (ASN141) YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5l66:E (SER56) to (ILE181) YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5l66:I (LYS41) to (ASP177) YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5l66:K (LYS33) to (ASP167) YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5l66:L (LYS42) to (ARG194) YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5l66:M (ARG41) to (ARG187) YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5l66:N (LYS33) to (ASN141) YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5l66:S (SER56) to (ILE181) YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5l66:W (LYS41) to (ASP177) YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5l66:Y (LYS33) to (ASP167) YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5l66:Z (LYS42) to (ARG194) YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5l66:a (ARG41) to (ARG187) YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5l66:b (LYS33) to (ASN141) YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5l67:E (SER56) to (ILE181) YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924 | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5l67:I (LYS41) to (ASP177) YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924 | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5l67:K (LYS33) to (ARG166) YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924 | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5l67:L (LYS42) to (ARG194) YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924 | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5l67:M (ARG41) to (ARG187) YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924 | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5l67:N (LYS33) to (ASN141) YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924 | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5l67:S (SER56) to (ILE181) YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924 | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5l67:W (LYS41) to (ASP177) YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924 | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5l67:Y (LYS33) to (ARG166) YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924 | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5l67:Z (LYS42) to (ARG194) YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924 | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5l67:a (ARG41) to (ARG187) YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924 | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5l67:b (LYS33) to (ASN141) YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924 | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5l68:E (SER56) to (ILE181) YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14 | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5l68:K (LYS33) to (ARG166) YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14 | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5l68:L (LYS42) to (ARG194) YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14 | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5l68:M (ARG41) to (ARG187) YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14 | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5l68:N (LYS33) to (ASN141) YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14 | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5l68:S (SER56) to (ILE181) YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14 | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5l68:Y (LYS33) to (ARG166) YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14 | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5l68:Z (LYS42) to (ARG194) YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14 | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5l68:a (ARG41) to (ARG187) YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14 | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5l68:b (LYS33) to (ASN141) YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14 | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5l69:E (LYS61) to (ILE181) YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16 | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5l69:K (LYS33) to (ARG166) YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16 | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5l69:L (LYS42) to (ARG194) YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16 | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5l69:M (ARG41) to (ARG187) YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16 | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5l69:N (LYS33) to (ASN141) YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16 | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5l69:S (LYS61) to (ILE181) YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16 | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5l69:Y (LYS33) to (ARG166) YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16 | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5l69:Z (LYS42) to (ARG194) YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16 | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5l69:a (ARG41) to (ARG187) YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16 | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5l69:b (LYS33) to (ASN141) YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16 | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5l6a:E (SER56) to (ILE181) YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17 | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5l6a:I (LYS41) to (ASP177) YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17 | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5l6a:J (LYS34) to (HIS147) YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17 | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5l6a:K (LYS33) to (ARG166) YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17 | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5l6a:L (LYS42) to (ARG194) YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17 | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5l6a:M (ARG41) to (ARG187) YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17 | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5l6a:N (LYS33) to (ASN141) YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17 | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5l6a:S (SER56) to (ILE181) YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17 | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5l6a:W (LYS41) to (ASP177) YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17 | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5l6a:X (LYS34) to (HIS147) YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17 | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5l6a:Y (LYS33) to (ARG166) YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17 | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5l6a:Z (LYS42) to (ARG194) YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17 | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5l6a:a (ARG41) to (ARG187) YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17 | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5l6a:b (LYS33) to (ASN141) YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17 | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5l6b:E (SER56) to (ILE181) YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914 | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5l6b:I (LYS41) to (ASP177) YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914 | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5l6b:K (LYS33) to (ARG166) YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914 | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5l6b:L (LYS42) to (ARG194) YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914 | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5l6b:M (ARG41) to (ARG187) YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914 | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5l6b:N (LYS33) to (ASN141) YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914 | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5l6b:S (SER56) to (ILE181) YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914 | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5l6b:W (LYS41) to (ASP177) YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914 | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5l6b:X (LYS34) to (HIS147) YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914 | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5l6b:Y (LYS33) to (ARG166) YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914 | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5l6b:Z (LYS42) to (ARG194) YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914 | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5l6b:a (ARG41) to (ARG187) YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914 | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5l6b:b (LYS33) to (ASN141) YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914 | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5l6c:E (LYS61) to (ILE181) YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18 | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5l6c:I (LYS41) to (ASP177) YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18 | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5l6c:K (LYS33) to (ARG166) YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18 | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5l6c:L (LYS42) to (ARG194) YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18 | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5l6c:M (ARG41) to (ARG187) YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18 | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5l6c:N (LYS33) to (ASN141) YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18 | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5l6c:S (LYS61) to (ILE181) YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18 | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5l6c:W (LYS41) to (ASP177) YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18 | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5l6c:Y (LYS33) to (ARG166) YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18 | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5l6c:Z (LYS42) to (ARG194) YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18 | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5l6c:a (ARG41) to (ARG187) YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18 | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5l6c:b (LYS33) to (ASN141) YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18 | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5le5:E (LYS62) to (CYS182) NATIVE HUMAN 20S PROTEASOME AT 1.8 ANGSTROM | PROTEASOME, MULTICATALYTIC PROTEINASE, NTN-HYDROLASE, HYDROLASE
5le5:F (ARG65) to (ILE199) NATIVE HUMAN 20S PROTEASOME AT 1.8 ANGSTROM | PROTEASOME, MULTICATALYTIC PROTEINASE, NTN-HYDROLASE, HYDROLASE
5le5:I (LYS40) to (ASP177) NATIVE HUMAN 20S PROTEASOME AT 1.8 ANGSTROM | PROTEASOME, MULTICATALYTIC PROTEINASE, NTN-HYDROLASE, HYDROLASE
5le5:J (LYS34) to (LYS169) NATIVE HUMAN 20S PROTEASOME AT 1.8 ANGSTROM | PROTEASOME, MULTICATALYTIC PROTEINASE, NTN-HYDROLASE, HYDROLASE
5le5:L (LYS42) to (ARG185) NATIVE HUMAN 20S PROTEASOME AT 1.8 ANGSTROM | PROTEASOME, MULTICATALYTIC PROTEINASE, NTN-HYDROLASE, HYDROLASE
5le5:N (LYS33) to (THR142) NATIVE HUMAN 20S PROTEASOME AT 1.8 ANGSTROM | PROTEASOME, MULTICATALYTIC PROTEINASE, NTN-HYDROLASE, HYDROLASE
5le5:O (LYS63) to (GLU196) NATIVE HUMAN 20S PROTEASOME AT 1.8 ANGSTROM | PROTEASOME, MULTICATALYTIC PROTEINASE, NTN-HYDROLASE, HYDROLASE
5le5:S (LYS62) to (CYS182) NATIVE HUMAN 20S PROTEASOME AT 1.8 ANGSTROM | PROTEASOME, MULTICATALYTIC PROTEINASE, NTN-HYDROLASE, HYDROLASE
5le5:T (ARG65) to (ILE199) NATIVE HUMAN 20S PROTEASOME AT 1.8 ANGSTROM | PROTEASOME, MULTICATALYTIC PROTEINASE, NTN-HYDROLASE, HYDROLASE
5le5:W (LYS40) to (ASP177) NATIVE HUMAN 20S PROTEASOME AT 1.8 ANGSTROM | PROTEASOME, MULTICATALYTIC PROTEINASE, NTN-HYDROLASE, HYDROLASE
5le5:X (LYS34) to (LYS169) NATIVE HUMAN 20S PROTEASOME AT 1.8 ANGSTROM | PROTEASOME, MULTICATALYTIC PROTEINASE, NTN-HYDROLASE, HYDROLASE
5le5:Z (LYS42) to (ARG185) NATIVE HUMAN 20S PROTEASOME AT 1.8 ANGSTROM | PROTEASOME, MULTICATALYTIC PROTEINASE, NTN-HYDROLASE, HYDROLASE
5le5:b (LYS33) to (THR142) NATIVE HUMAN 20S PROTEASOME AT 1.8 ANGSTROM | PROTEASOME, MULTICATALYTIC PROTEINASE, NTN-HYDROLASE, HYDROLASE
5lex:A (LYS63) to (GLU196) NATIVE HUMAN 20S PROTEASOME IN MG-ACETATE AT 2.2 ANGSTROM | PROTEASOME, MULTICATALYTIC PROTEINASE, NTN-HYDROLASE, HYDROLASE
5lex:B (LYS64) to (LYS199) NATIVE HUMAN 20S PROTEASOME IN MG-ACETATE AT 2.2 ANGSTROM | PROTEASOME, MULTICATALYTIC PROTEINASE, NTN-HYDROLASE, HYDROLASE
5lex:E (LYS62) to (CYS182) NATIVE HUMAN 20S PROTEASOME IN MG-ACETATE AT 2.2 ANGSTROM | PROTEASOME, MULTICATALYTIC PROTEINASE, NTN-HYDROLASE, HYDROLASE
5lex:F (ARG65) to (ILE199) NATIVE HUMAN 20S PROTEASOME IN MG-ACETATE AT 2.2 ANGSTROM | PROTEASOME, MULTICATALYTIC PROTEINASE, NTN-HYDROLASE, HYDROLASE
5lex:I (LYS40) to (ASP177) NATIVE HUMAN 20S PROTEASOME IN MG-ACETATE AT 2.2 ANGSTROM | PROTEASOME, MULTICATALYTIC PROTEINASE, NTN-HYDROLASE, HYDROLASE
5lex:J (LYS34) to (LYS169) NATIVE HUMAN 20S PROTEASOME IN MG-ACETATE AT 2.2 ANGSTROM | PROTEASOME, MULTICATALYTIC PROTEINASE, NTN-HYDROLASE, HYDROLASE
5lex:L (LYS42) to (ARG185) NATIVE HUMAN 20S PROTEASOME IN MG-ACETATE AT 2.2 ANGSTROM | PROTEASOME, MULTICATALYTIC PROTEINASE, NTN-HYDROLASE, HYDROLASE
5lex:M (ARG41) to (ARG179) NATIVE HUMAN 20S PROTEASOME IN MG-ACETATE AT 2.2 ANGSTROM | PROTEASOME, MULTICATALYTIC PROTEINASE, NTN-HYDROLASE, HYDROLASE
5lex:O (LYS63) to (GLU196) NATIVE HUMAN 20S PROTEASOME IN MG-ACETATE AT 2.2 ANGSTROM | PROTEASOME, MULTICATALYTIC PROTEINASE, NTN-HYDROLASE, HYDROLASE
5lex:T (ARG65) to (ILE199) NATIVE HUMAN 20S PROTEASOME IN MG-ACETATE AT 2.2 ANGSTROM | PROTEASOME, MULTICATALYTIC PROTEINASE, NTN-HYDROLASE, HYDROLASE
5lex:W (LYS40) to (ASP177) NATIVE HUMAN 20S PROTEASOME IN MG-ACETATE AT 2.2 ANGSTROM | PROTEASOME, MULTICATALYTIC PROTEINASE, NTN-HYDROLASE, HYDROLASE
5lex:X (LYS34) to (LYS169) NATIVE HUMAN 20S PROTEASOME IN MG-ACETATE AT 2.2 ANGSTROM | PROTEASOME, MULTICATALYTIC PROTEINASE, NTN-HYDROLASE, HYDROLASE
5lex:Z (LYS42) to (ARG185) NATIVE HUMAN 20S PROTEASOME IN MG-ACETATE AT 2.2 ANGSTROM | PROTEASOME, MULTICATALYTIC PROTEINASE, NTN-HYDROLASE, HYDROLASE
5lex:a (ARG41) to (ARG179) NATIVE HUMAN 20S PROTEASOME IN MG-ACETATE AT 2.2 ANGSTROM | PROTEASOME, MULTICATALYTIC PROTEINASE, NTN-HYDROLASE, HYDROLASE
5ley:B (LYS64) to (LYS199) HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB AT 1.9 ANGSTROM | PROTEASOME, MULTICATALYTIC PROTEINASE, NTN-HYDROLASE, HYDROLASE
5ley:E (LYS62) to (CYS182) HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB AT 1.9 ANGSTROM | PROTEASOME, MULTICATALYTIC PROTEINASE, NTN-HYDROLASE, HYDROLASE
5ley:F (ARG65) to (ILE199) HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB AT 1.9 ANGSTROM | PROTEASOME, MULTICATALYTIC PROTEINASE, NTN-HYDROLASE, HYDROLASE
5ley:I (LYS40) to (ASP177) HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB AT 1.9 ANGSTROM | PROTEASOME, MULTICATALYTIC PROTEINASE, NTN-HYDROLASE, HYDROLASE
5ley:J (LYS34) to (LYS169) HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB AT 1.9 ANGSTROM | PROTEASOME, MULTICATALYTIC PROTEINASE, NTN-HYDROLASE, HYDROLASE
5ley:L (LYS42) to (ARG185) HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB AT 1.9 ANGSTROM | PROTEASOME, MULTICATALYTIC PROTEINASE, NTN-HYDROLASE, HYDROLASE
5ley:M (ARG41) to (ARG179) HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB AT 1.9 ANGSTROM | PROTEASOME, MULTICATALYTIC PROTEINASE, NTN-HYDROLASE, HYDROLASE
5ley:O (LYS63) to (GLU196) HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB AT 1.9 ANGSTROM | PROTEASOME, MULTICATALYTIC PROTEINASE, NTN-HYDROLASE, HYDROLASE
5ley:T (ARG65) to (ILE199) HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB AT 1.9 ANGSTROM | PROTEASOME, MULTICATALYTIC PROTEINASE, NTN-HYDROLASE, HYDROLASE
5ley:W (LYS40) to (ASP177) HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB AT 1.9 ANGSTROM | PROTEASOME, MULTICATALYTIC PROTEINASE, NTN-HYDROLASE, HYDROLASE
5ley:X (LYS34) to (LYS169) HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB AT 1.9 ANGSTROM | PROTEASOME, MULTICATALYTIC PROTEINASE, NTN-HYDROLASE, HYDROLASE
5ley:Z (LYS42) to (ARG185) HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB AT 1.9 ANGSTROM | PROTEASOME, MULTICATALYTIC PROTEINASE, NTN-HYDROLASE, HYDROLASE
5lez:A (LYS63) to (GLU196) HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB IN MG-ACETATE AT 2.2 ANGSTROM | PROTEASOME, MULTICATALYTIC PROTEINASE, NTN-HYDROLASE, HYDROLASE
5lez:B (LYS64) to (LYS199) HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB IN MG-ACETATE AT 2.2 ANGSTROM | PROTEASOME, MULTICATALYTIC PROTEINASE, NTN-HYDROLASE, HYDROLASE
5lez:E (LYS62) to (CYS182) HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB IN MG-ACETATE AT 2.2 ANGSTROM | PROTEASOME, MULTICATALYTIC PROTEINASE, NTN-HYDROLASE, HYDROLASE
5lez:F (ARG65) to (ILE199) HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB IN MG-ACETATE AT 2.2 ANGSTROM | PROTEASOME, MULTICATALYTIC PROTEINASE, NTN-HYDROLASE, HYDROLASE
5lez:H (LYS33) to (ASP166) HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB IN MG-ACETATE AT 2.2 ANGSTROM | PROTEASOME, MULTICATALYTIC PROTEINASE, NTN-HYDROLASE, HYDROLASE
5lez:I (LYS40) to (ASP177) HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB IN MG-ACETATE AT 2.2 ANGSTROM | PROTEASOME, MULTICATALYTIC PROTEINASE, NTN-HYDROLASE, HYDROLASE
5lez:J (LYS34) to (LYS169) HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB IN MG-ACETATE AT 2.2 ANGSTROM | PROTEASOME, MULTICATALYTIC PROTEINASE, NTN-HYDROLASE, HYDROLASE
5lez:L (LYS42) to (ARG185) HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB IN MG-ACETATE AT 2.2 ANGSTROM | PROTEASOME, MULTICATALYTIC PROTEINASE, NTN-HYDROLASE, HYDROLASE
5lez:M (ARG41) to (ARG179) HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB IN MG-ACETATE AT 2.2 ANGSTROM | PROTEASOME, MULTICATALYTIC PROTEINASE, NTN-HYDROLASE, HYDROLASE
5lez:O (LYS63) to (GLU196) HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB IN MG-ACETATE AT 2.2 ANGSTROM | PROTEASOME, MULTICATALYTIC PROTEINASE, NTN-HYDROLASE, HYDROLASE
5lez:T (ARG65) to (ILE199) HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB IN MG-ACETATE AT 2.2 ANGSTROM | PROTEASOME, MULTICATALYTIC PROTEINASE, NTN-HYDROLASE, HYDROLASE
5lez:X (LYS34) to (LYS169) HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB IN MG-ACETATE AT 2.2 ANGSTROM | PROTEASOME, MULTICATALYTIC PROTEINASE, NTN-HYDROLASE, HYDROLASE
5lez:Z (LYS42) to (ARG185) HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB IN MG-ACETATE AT 2.2 ANGSTROM | PROTEASOME, MULTICATALYTIC PROTEINASE, NTN-HYDROLASE, HYDROLASE
5lf0:A (LYS63) to (GLU196) HUMAN 20S PROTEASOME COMPLEX WITH EPOXOMICIN AT 2.4 ANGSTROM | PROTEASOME, MULTICATALYTIC PROTEINASE, NTN-HYDROLASE, HYDROLASE
5lf0:B (LYS64) to (LYS199) HUMAN 20S PROTEASOME COMPLEX WITH EPOXOMICIN AT 2.4 ANGSTROM | PROTEASOME, MULTICATALYTIC PROTEINASE, NTN-HYDROLASE, HYDROLASE
5lf0:E (LYS62) to (CYS182) HUMAN 20S PROTEASOME COMPLEX WITH EPOXOMICIN AT 2.4 ANGSTROM | PROTEASOME, MULTICATALYTIC PROTEINASE, NTN-HYDROLASE, HYDROLASE
5lf0:F (ARG65) to (ILE199) HUMAN 20S PROTEASOME COMPLEX WITH EPOXOMICIN AT 2.4 ANGSTROM | PROTEASOME, MULTICATALYTIC PROTEINASE, NTN-HYDROLASE, HYDROLASE
5lf0:I (LYS40) to (ASP177) HUMAN 20S PROTEASOME COMPLEX WITH EPOXOMICIN AT 2.4 ANGSTROM | PROTEASOME, MULTICATALYTIC PROTEINASE, NTN-HYDROLASE, HYDROLASE
5lf0:J (LYS34) to (LYS169) HUMAN 20S PROTEASOME COMPLEX WITH EPOXOMICIN AT 2.4 ANGSTROM | PROTEASOME, MULTICATALYTIC PROTEINASE, NTN-HYDROLASE, HYDROLASE
5lf0:L (LYS42) to (ARG185) HUMAN 20S PROTEASOME COMPLEX WITH EPOXOMICIN AT 2.4 ANGSTROM | PROTEASOME, MULTICATALYTIC PROTEINASE, NTN-HYDROLASE, HYDROLASE
5lf0:N (LYS33) to (THR142) HUMAN 20S PROTEASOME COMPLEX WITH EPOXOMICIN AT 2.4 ANGSTROM | PROTEASOME, MULTICATALYTIC PROTEINASE, NTN-HYDROLASE, HYDROLASE
5lf0:S (LYS62) to (CYS182) HUMAN 20S PROTEASOME COMPLEX WITH EPOXOMICIN AT 2.4 ANGSTROM | PROTEASOME, MULTICATALYTIC PROTEINASE, NTN-HYDROLASE, HYDROLASE
5lf0:T (ARG65) to (ILE199) HUMAN 20S PROTEASOME COMPLEX WITH EPOXOMICIN AT 2.4 ANGSTROM | PROTEASOME, MULTICATALYTIC PROTEINASE, NTN-HYDROLASE, HYDROLASE
5lf0:W (LYS40) to (ASP177) HUMAN 20S PROTEASOME COMPLEX WITH EPOXOMICIN AT 2.4 ANGSTROM | PROTEASOME, MULTICATALYTIC PROTEINASE, NTN-HYDROLASE, HYDROLASE
5lf0:X (LYS34) to (LYS169) HUMAN 20S PROTEASOME COMPLEX WITH EPOXOMICIN AT 2.4 ANGSTROM | PROTEASOME, MULTICATALYTIC PROTEINASE, NTN-HYDROLASE, HYDROLASE
5lf0:Z (LYS42) to (ARG185) HUMAN 20S PROTEASOME COMPLEX WITH EPOXOMICIN AT 2.4 ANGSTROM | PROTEASOME, MULTICATALYTIC PROTEINASE, NTN-HYDROLASE, HYDROLASE
5lf0:b (LYS33) to (THR142) HUMAN 20S PROTEASOME COMPLEX WITH EPOXOMICIN AT 2.4 ANGSTROM | PROTEASOME, MULTICATALYTIC PROTEINASE, NTN-HYDROLASE, HYDROLASE
5lf1:A (LYS63) to (GLU196) HUMAN 20S PROTEASOME COMPLEX WITH DIHYDROEPONEMYCIN AT 2.0 ANGSTROM | PROTEASOME, MULTICATALYTIC PROTEINASE, NTN-HYDROLASE, HYDROLASE
5lf1:B (LYS64) to (LYS199) HUMAN 20S PROTEASOME COMPLEX WITH DIHYDROEPONEMYCIN AT 2.0 ANGSTROM | PROTEASOME, MULTICATALYTIC PROTEINASE, NTN-HYDROLASE, HYDROLASE
5lf1:E (LYS62) to (CYS182) HUMAN 20S PROTEASOME COMPLEX WITH DIHYDROEPONEMYCIN AT 2.0 ANGSTROM | PROTEASOME, MULTICATALYTIC PROTEINASE, NTN-HYDROLASE, HYDROLASE
5lf1:F (ARG65) to (ILE199) HUMAN 20S PROTEASOME COMPLEX WITH DIHYDROEPONEMYCIN AT 2.0 ANGSTROM | PROTEASOME, MULTICATALYTIC PROTEINASE, NTN-HYDROLASE, HYDROLASE
5lf1:I (LYS40) to (ASP177) HUMAN 20S PROTEASOME COMPLEX WITH DIHYDROEPONEMYCIN AT 2.0 ANGSTROM | PROTEASOME, MULTICATALYTIC PROTEINASE, NTN-HYDROLASE, HYDROLASE
5lf1:J (LYS34) to (LYS169) HUMAN 20S PROTEASOME COMPLEX WITH DIHYDROEPONEMYCIN AT 2.0 ANGSTROM | PROTEASOME, MULTICATALYTIC PROTEINASE, NTN-HYDROLASE, HYDROLASE
5lf1:L (LYS42) to (ARG185) HUMAN 20S PROTEASOME COMPLEX WITH DIHYDROEPONEMYCIN AT 2.0 ANGSTROM | PROTEASOME, MULTICATALYTIC PROTEINASE, NTN-HYDROLASE, HYDROLASE
5lf1:O (LYS63) to (GLU196) HUMAN 20S PROTEASOME COMPLEX WITH DIHYDROEPONEMYCIN AT 2.0 ANGSTROM | PROTEASOME, MULTICATALYTIC PROTEINASE, NTN-HYDROLASE, HYDROLASE
5lf1:S (LYS62) to (CYS182) HUMAN 20S PROTEASOME COMPLEX WITH DIHYDROEPONEMYCIN AT 2.0 ANGSTROM | PROTEASOME, MULTICATALYTIC PROTEINASE, NTN-HYDROLASE, HYDROLASE
5lf1:T (ARG65) to (ILE199) HUMAN 20S PROTEASOME COMPLEX WITH DIHYDROEPONEMYCIN AT 2.0 ANGSTROM | PROTEASOME, MULTICATALYTIC PROTEINASE, NTN-HYDROLASE, HYDROLASE
5lf1:W (LYS40) to (ASP177) HUMAN 20S PROTEASOME COMPLEX WITH DIHYDROEPONEMYCIN AT 2.0 ANGSTROM | PROTEASOME, MULTICATALYTIC PROTEINASE, NTN-HYDROLASE, HYDROLASE
5lf1:X (LYS34) to (LYS169) HUMAN 20S PROTEASOME COMPLEX WITH DIHYDROEPONEMYCIN AT 2.0 ANGSTROM | PROTEASOME, MULTICATALYTIC PROTEINASE, NTN-HYDROLASE, HYDROLASE
5lf1:Z (LYS42) to (ARG185) HUMAN 20S PROTEASOME COMPLEX WITH DIHYDROEPONEMYCIN AT 2.0 ANGSTROM | PROTEASOME, MULTICATALYTIC PROTEINASE, NTN-HYDROLASE, HYDROLASE
5lf3:A (LYS63) to (GLU196) HUMAN 20S PROTEASOME COMPLEX WITH BORTEZOMIB AT 2.1 ANGSTROM | PROTEASOME, MULTICATALYTIC PROTEINASE, NTN-HYDROLASE, HYDROLASE
5lf3:B (LYS64) to (LYS199) HUMAN 20S PROTEASOME COMPLEX WITH BORTEZOMIB AT 2.1 ANGSTROM | PROTEASOME, MULTICATALYTIC PROTEINASE, NTN-HYDROLASE, HYDROLASE
5lf3:E (LYS62) to (CYS182) HUMAN 20S PROTEASOME COMPLEX WITH BORTEZOMIB AT 2.1 ANGSTROM | PROTEASOME, MULTICATALYTIC PROTEINASE, NTN-HYDROLASE, HYDROLASE
5lf3:F (ARG65) to (HIS201) HUMAN 20S PROTEASOME COMPLEX WITH BORTEZOMIB AT 2.1 ANGSTROM | PROTEASOME, MULTICATALYTIC PROTEINASE, NTN-HYDROLASE, HYDROLASE
5lf3:I (LYS40) to (ASP177) HUMAN 20S PROTEASOME COMPLEX WITH BORTEZOMIB AT 2.1 ANGSTROM | PROTEASOME, MULTICATALYTIC PROTEINASE, NTN-HYDROLASE, HYDROLASE
5lf3:J (LYS34) to (LYS169) HUMAN 20S PROTEASOME COMPLEX WITH BORTEZOMIB AT 2.1 ANGSTROM | PROTEASOME, MULTICATALYTIC PROTEINASE, NTN-HYDROLASE, HYDROLASE
5lf3:L (LYS42) to (ARG185) HUMAN 20S PROTEASOME COMPLEX WITH BORTEZOMIB AT 2.1 ANGSTROM | PROTEASOME, MULTICATALYTIC PROTEINASE, NTN-HYDROLASE, HYDROLASE
5lf3:O (LYS63) to (GLU196) HUMAN 20S PROTEASOME COMPLEX WITH BORTEZOMIB AT 2.1 ANGSTROM | PROTEASOME, MULTICATALYTIC PROTEINASE, NTN-HYDROLASE, HYDROLASE
5lf3:S (LYS62) to (CYS182) HUMAN 20S PROTEASOME COMPLEX WITH BORTEZOMIB AT 2.1 ANGSTROM | PROTEASOME, MULTICATALYTIC PROTEINASE, NTN-HYDROLASE, HYDROLASE
5lf3:T (ARG65) to (ILE199) HUMAN 20S PROTEASOME COMPLEX WITH BORTEZOMIB AT 2.1 ANGSTROM | PROTEASOME, MULTICATALYTIC PROTEINASE, NTN-HYDROLASE, HYDROLASE
5lf3:W (LYS40) to (ASP177) HUMAN 20S PROTEASOME COMPLEX WITH BORTEZOMIB AT 2.1 ANGSTROM | PROTEASOME, MULTICATALYTIC PROTEINASE, NTN-HYDROLASE, HYDROLASE
5lf3:X (LYS34) to (LYS169) HUMAN 20S PROTEASOME COMPLEX WITH BORTEZOMIB AT 2.1 ANGSTROM | PROTEASOME, MULTICATALYTIC PROTEINASE, NTN-HYDROLASE, HYDROLASE
5lf3:Z (LYS42) to (ARG185) HUMAN 20S PROTEASOME COMPLEX WITH BORTEZOMIB AT 2.1 ANGSTROM | PROTEASOME, MULTICATALYTIC PROTEINASE, NTN-HYDROLASE, HYDROLASE
5lf4:A (LYS63) to (GLU196) HUMAN 20S PROTEASOME COMPLEX WITH DELANZOMIB AT 2.0 ANGSTROM | PROTEASOME, MULTICATALYTIC PROTEINASE, NTN-HYDROLASE, HYDROLASE
5lf4:B (LYS64) to (LYS199) HUMAN 20S PROTEASOME COMPLEX WITH DELANZOMIB AT 2.0 ANGSTROM | PROTEASOME, MULTICATALYTIC PROTEINASE, NTN-HYDROLASE, HYDROLASE
5lf4:E (LYS62) to (CYS182) HUMAN 20S PROTEASOME COMPLEX WITH DELANZOMIB AT 2.0 ANGSTROM | PROTEASOME, MULTICATALYTIC PROTEINASE, NTN-HYDROLASE, HYDROLASE
5lf4:F (ARG65) to (ILE199) HUMAN 20S PROTEASOME COMPLEX WITH DELANZOMIB AT 2.0 ANGSTROM | PROTEASOME, MULTICATALYTIC PROTEINASE, NTN-HYDROLASE, HYDROLASE
5lf4:I (LYS40) to (ASP177) HUMAN 20S PROTEASOME COMPLEX WITH DELANZOMIB AT 2.0 ANGSTROM | PROTEASOME, MULTICATALYTIC PROTEINASE, NTN-HYDROLASE, HYDROLASE
5lf4:J (LYS34) to (LYS169) HUMAN 20S PROTEASOME COMPLEX WITH DELANZOMIB AT 2.0 ANGSTROM | PROTEASOME, MULTICATALYTIC PROTEINASE, NTN-HYDROLASE, HYDROLASE
5lf4:L (LYS42) to (ARG185) HUMAN 20S PROTEASOME COMPLEX WITH DELANZOMIB AT 2.0 ANGSTROM | PROTEASOME, MULTICATALYTIC PROTEINASE, NTN-HYDROLASE, HYDROLASE
5lf4:O (LYS63) to (GLU196) HUMAN 20S PROTEASOME COMPLEX WITH DELANZOMIB AT 2.0 ANGSTROM | PROTEASOME, MULTICATALYTIC PROTEINASE, NTN-HYDROLASE, HYDROLASE
5lf4:S (LYS62) to (CYS182) HUMAN 20S PROTEASOME COMPLEX WITH DELANZOMIB AT 2.0 ANGSTROM | PROTEASOME, MULTICATALYTIC PROTEINASE, NTN-HYDROLASE, HYDROLASE
5lf4:T (ARG65) to (ILE199) HUMAN 20S PROTEASOME COMPLEX WITH DELANZOMIB AT 2.0 ANGSTROM | PROTEASOME, MULTICATALYTIC PROTEINASE, NTN-HYDROLASE, HYDROLASE
5lf4:W (LYS40) to (ASP177) HUMAN 20S PROTEASOME COMPLEX WITH DELANZOMIB AT 2.0 ANGSTROM | PROTEASOME, MULTICATALYTIC PROTEINASE, NTN-HYDROLASE, HYDROLASE
5lf4:X (LYS34) to (LYS169) HUMAN 20S PROTEASOME COMPLEX WITH DELANZOMIB AT 2.0 ANGSTROM | PROTEASOME, MULTICATALYTIC PROTEINASE, NTN-HYDROLASE, HYDROLASE
5lf4:Z (LYS42) to (ARG185) HUMAN 20S PROTEASOME COMPLEX WITH DELANZOMIB AT 2.0 ANGSTROM | PROTEASOME, MULTICATALYTIC PROTEINASE, NTN-HYDROLASE, HYDROLASE
5lf7:A (LYS63) to (GLU196) HUMAN 20S PROTEASOME COMPLEX WITH IXAZOMIB AT 2.0 ANSTROM | PROTEASOME, MULTICATALYTIC PROTEINASE, NTN-HYDROLASE, HYDROLASE
5lf7:B (LYS64) to (LYS199) HUMAN 20S PROTEASOME COMPLEX WITH IXAZOMIB AT 2.0 ANSTROM | PROTEASOME, MULTICATALYTIC PROTEINASE, NTN-HYDROLASE, HYDROLASE
5lf7:E (LYS62) to (CYS182) HUMAN 20S PROTEASOME COMPLEX WITH IXAZOMIB AT 2.0 ANSTROM | PROTEASOME, MULTICATALYTIC PROTEINASE, NTN-HYDROLASE, HYDROLASE
5lf7:F (ARG65) to (ILE199) HUMAN 20S PROTEASOME COMPLEX WITH IXAZOMIB AT 2.0 ANSTROM | PROTEASOME, MULTICATALYTIC PROTEINASE, NTN-HYDROLASE, HYDROLASE
5lf7:I (LYS40) to (ASP177) HUMAN 20S PROTEASOME COMPLEX WITH IXAZOMIB AT 2.0 ANSTROM | PROTEASOME, MULTICATALYTIC PROTEINASE, NTN-HYDROLASE, HYDROLASE
5lf7:J (LYS34) to (LYS169) HUMAN 20S PROTEASOME COMPLEX WITH IXAZOMIB AT 2.0 ANSTROM | PROTEASOME, MULTICATALYTIC PROTEINASE, NTN-HYDROLASE, HYDROLASE
5lf7:L (LYS42) to (ARG185) HUMAN 20S PROTEASOME COMPLEX WITH IXAZOMIB AT 2.0 ANSTROM | PROTEASOME, MULTICATALYTIC PROTEINASE, NTN-HYDROLASE, HYDROLASE
5lf7:O (LYS63) to (GLU196) HUMAN 20S PROTEASOME COMPLEX WITH IXAZOMIB AT 2.0 ANSTROM | PROTEASOME, MULTICATALYTIC PROTEINASE, NTN-HYDROLASE, HYDROLASE
5lf7:T (ARG65) to (ILE199) HUMAN 20S PROTEASOME COMPLEX WITH IXAZOMIB AT 2.0 ANSTROM | PROTEASOME, MULTICATALYTIC PROTEINASE, NTN-HYDROLASE, HYDROLASE
5lf7:W (LYS40) to (ASP177) HUMAN 20S PROTEASOME COMPLEX WITH IXAZOMIB AT 2.0 ANSTROM | PROTEASOME, MULTICATALYTIC PROTEINASE, NTN-HYDROLASE, HYDROLASE
5lf7:X (LYS34) to (LYS169) HUMAN 20S PROTEASOME COMPLEX WITH IXAZOMIB AT 2.0 ANSTROM | PROTEASOME, MULTICATALYTIC PROTEINASE, NTN-HYDROLASE, HYDROLASE
5lf7:Z (LYS42) to (ARG185) HUMAN 20S PROTEASOME COMPLEX WITH IXAZOMIB AT 2.0 ANSTROM | PROTEASOME, MULTICATALYTIC PROTEINASE, NTN-HYDROLASE, HYDROLASE
5ltt:E (LYS61) to (ILE181) YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)IN COMPLEX WITH PR-924 | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5ltt:I (LYS41) to (ASP177) YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)IN COMPLEX WITH PR-924 | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5ltt:L (LYS42) to (ARG194) YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)IN COMPLEX WITH PR-924 | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5ltt:M (ARG41) to (ARG187) YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)IN COMPLEX WITH PR-924 | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5ltt:N (LYS33) to (ASN141) YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)IN COMPLEX WITH PR-924 | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5ltt:S (LYS61) to (ILE181) YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)IN COMPLEX WITH PR-924 | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5ltt:W (LYS41) to (ASP177) YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)IN COMPLEX WITH PR-924 | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5ltt:Z (LYS42) to (ARG194) YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)IN COMPLEX WITH PR-924 | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5ltt:a (ARG41) to (ARG187) YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)IN COMPLEX WITH PR-924 | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5ltt:b (LYS33) to (ASN141) YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)IN COMPLEX WITH PR-924 | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5t0h:G (HIS68) to (THR204) STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME | UBIQUITIN-PROTEASOME SYSTEM, AAA-ATPASE, HYDROLASE
5t0h:J (LYS61) to (THR183) STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME | UBIQUITIN-PROTEASOME SYSTEM, AAA-ATPASE, HYDROLASE
5t0h:K (LYS66) to (MET206) STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME | UBIQUITIN-PROTEASOME SYSTEM, AAA-ATPASE, HYDROLASE
5t0h:L (HIS43) to (MET180) STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME | UBIQUITIN-PROTEASOME SYSTEM, AAA-ATPASE, HYDROLASE
5t0h:M (ARG65) to (VAL200) STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME | UBIQUITIN-PROTEASOME SYSTEM, AAA-ATPASE, HYDROLASE
5t0h:O (LYS33) to (PHE142) STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME | UBIQUITIN-PROTEASOME SYSTEM, AAA-ATPASE, HYDROLASE
5t0h:P (LYS41) to (ALA179) STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME | UBIQUITIN-PROTEASOME SYSTEM, AAA-ATPASE, HYDROLASE
5t0h:S (LYS42) to (PHE155) STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME | UBIQUITIN-PROTEASOME SYSTEM, AAA-ATPASE, HYDROLASE
5t0i:G (HIS68) to (THR204) STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME | UBIQUITIN-PROTEASOME SYSTEM, AAA-ATPASE, HYDROLASE
5t0i:L (HIS43) to (MET180) STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME | UBIQUITIN-PROTEASOME SYSTEM, AAA-ATPASE, HYDROLASE
5t0i:O (LYS33) to (ASP166) STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME | UBIQUITIN-PROTEASOME SYSTEM, AAA-ATPASE, HYDROLASE
5t0i:P (LYS41) to (ASP178) STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME | UBIQUITIN-PROTEASOME SYSTEM, AAA-ATPASE, HYDROLASE
5t0i:S (LYS42) to (PHE155) STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME | UBIQUITIN-PROTEASOME SYSTEM, AAA-ATPASE, HYDROLASE
5t0i:T (ARG41) to (ARG179) STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME | UBIQUITIN-PROTEASOME SYSTEM, AAA-ATPASE, HYDROLASE
5t0j:H (LYS64) to (GLU197) STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME | UBIQUITIN-PROTEASOME SYSTEM, AAA-ATPASE, HYDROLASE
5t0j:J (LYS61) to (ASP184) STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME | UBIQUITIN-PROTEASOME SYSTEM, AAA-ATPASE, HYDROLASE
5t0j:O (LYS33) to (PHE142) STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME | UBIQUITIN-PROTEASOME SYSTEM, AAA-ATPASE, HYDROLASE
5t0j:P (LYS41) to (ALA179) STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME | UBIQUITIN-PROTEASOME SYSTEM, AAA-ATPASE, HYDROLASE
5t0j:S (LYS42) to (GLN152) STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME | UBIQUITIN-PROTEASOME SYSTEM, AAA-ATPASE, HYDROLASE
5t0j:T (ARG41) to (ARG179) STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME | UBIQUITIN-PROTEASOME SYSTEM, AAA-ATPASE, HYDROLASE
2pk0:D (GLN17) to (HIS156) STRUCTURE OF THE S. AGALACTIAE SERINE/THREONINE PHOSPHATASE AT 2.65 RESOLUTION | STREPTOCOCCUS AGALACTIAE, SERINE, THREONINE, PHOSPHATASE, SIGNALING MOTIF, SIGNALING PROTEIN
1ofh:H (LYS33) to (ILE159) ASYMMETRIC COMPLEX BETWEEN HSLV AND I-DOMAIN DELETED HSLU (H. INFLUENZAE) | CHAPERONE, HYDROLASE, ATP-BINDING
1ofh:I (LYS33) to (ILE159) ASYMMETRIC COMPLEX BETWEEN HSLV AND I-DOMAIN DELETED HSLU (H. INFLUENZAE) | CHAPERONE, HYDROLASE, ATP-BINDING
1ofh:N (LYS33) to (ILE159) ASYMMETRIC COMPLEX BETWEEN HSLV AND I-DOMAIN DELETED HSLU (H. INFLUENZAE) | CHAPERONE, HYDROLASE, ATP-BINDING
3gpt:E (LYS66) to (ILE18) CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: SLOW SUBSTRATE LIGAND | PROTEASOME, UBIQUITIN, CANCER THERAPY, INHIBITOR, IMMUNOLOGY, TIME DEPENDENT LEAVING GROUP ELIMINATION, CYTOPLASM, HYDROLASE, NUCLEUS, PHOSPHOPROTEIN, PROTEASE, THREONINE PROTEASE, ISOPEPTIDE BOND, UBL CONJUGATION, ZYMOGEN
3gpt:K (LYS33) to (ASP166) CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: SLOW SUBSTRATE LIGAND | PROTEASOME, UBIQUITIN, CANCER THERAPY, INHIBITOR, IMMUNOLOGY, TIME DEPENDENT LEAVING GROUP ELIMINATION, CYTOPLASM, HYDROLASE, NUCLEUS, PHOSPHOPROTEIN, PROTEASE, THREONINE PROTEASE, ISOPEPTIDE BOND, UBL CONJUGATION, ZYMOGEN
3gpt:L (LYS33) to (ARG165) CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: SLOW SUBSTRATE LIGAND | PROTEASOME, UBIQUITIN, CANCER THERAPY, INHIBITOR, IMMUNOLOGY, TIME DEPENDENT LEAVING GROUP ELIMINATION, CYTOPLASM, HYDROLASE, NUCLEUS, PHOSPHOPROTEIN, PROTEASE, THREONINE PROTEASE, ISOPEPTIDE BOND, UBL CONJUGATION, ZYMOGEN
3gpt:M (ARG33) to (ARG165) CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: SLOW SUBSTRATE LIGAND | PROTEASOME, UBIQUITIN, CANCER THERAPY, INHIBITOR, IMMUNOLOGY, TIME DEPENDENT LEAVING GROUP ELIMINATION, CYTOPLASM, HYDROLASE, NUCLEUS, PHOSPHOPROTEIN, PROTEASE, THREONINE PROTEASE, ISOPEPTIDE BOND, UBL CONJUGATION, ZYMOGEN
3gpt:N (LYS33) to (ASN141) CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: SLOW SUBSTRATE LIGAND | PROTEASOME, UBIQUITIN, CANCER THERAPY, INHIBITOR, IMMUNOLOGY, TIME DEPENDENT LEAVING GROUP ELIMINATION, CYTOPLASM, HYDROLASE, NUCLEUS, PHOSPHOPROTEIN, PROTEASE, THREONINE PROTEASE, ISOPEPTIDE BOND, UBL CONJUGATION, ZYMOGEN
3gpt:S (LYS66) to (ILE18) CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: SLOW SUBSTRATE LIGAND | PROTEASOME, UBIQUITIN, CANCER THERAPY, INHIBITOR, IMMUNOLOGY, TIME DEPENDENT LEAVING GROUP ELIMINATION, CYTOPLASM, HYDROLASE, NUCLEUS, PHOSPHOPROTEIN, PROTEASE, THREONINE PROTEASE, ISOPEPTIDE BOND, UBL CONJUGATION, ZYMOGEN
3gpt:Y (LYS33) to (ASP166) CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: SLOW SUBSTRATE LIGAND | PROTEASOME, UBIQUITIN, CANCER THERAPY, INHIBITOR, IMMUNOLOGY, TIME DEPENDENT LEAVING GROUP ELIMINATION, CYTOPLASM, HYDROLASE, NUCLEUS, PHOSPHOPROTEIN, PROTEASE, THREONINE PROTEASE, ISOPEPTIDE BOND, UBL CONJUGATION, ZYMOGEN
3gpt:Z (LYS33) to (ARG165) CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: SLOW SUBSTRATE LIGAND | PROTEASOME, UBIQUITIN, CANCER THERAPY, INHIBITOR, IMMUNOLOGY, TIME DEPENDENT LEAVING GROUP ELIMINATION, CYTOPLASM, HYDROLASE, NUCLEUS, PHOSPHOPROTEIN, PROTEASE, THREONINE PROTEASE, ISOPEPTIDE BOND, UBL CONJUGATION, ZYMOGEN
3gpt:1 (ARG33) to (ARG165) CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: SLOW SUBSTRATE LIGAND | PROTEASOME, UBIQUITIN, CANCER THERAPY, INHIBITOR, IMMUNOLOGY, TIME DEPENDENT LEAVING GROUP ELIMINATION, CYTOPLASM, HYDROLASE, NUCLEUS, PHOSPHOPROTEIN, PROTEASE, THREONINE PROTEASE, ISOPEPTIDE BOND, UBL CONJUGATION, ZYMOGEN
3gpt:2 (LYS33) to (ASN141) CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: SLOW SUBSTRATE LIGAND | PROTEASOME, UBIQUITIN, CANCER THERAPY, INHIBITOR, IMMUNOLOGY, TIME DEPENDENT LEAVING GROUP ELIMINATION, CYTOPLASM, HYDROLASE, NUCLEUS, PHOSPHOPROTEIN, PROTEASE, THREONINE PROTEASE, ISOPEPTIDE BOND, UBL CONJUGATION, ZYMOGEN
3tdd:E (LYS66) to (ILE18) CRYSTAL STRUCTURE OF YEAST CP IN COMPLEX WITH BELACTOSIN C | UBIQUITIN, INHIBITOR, PROTEASOME, DRUG DEVELOPMENT, PRIMED SUBSTRATE BINDING CHANNEL, BETA-SANDWICH FLANKED BY ALPHA-HELICES, HYDROLASE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
3tdd:I (LYS33) to (ASP166) CRYSTAL STRUCTURE OF YEAST CP IN COMPLEX WITH BELACTOSIN C | UBIQUITIN, INHIBITOR, PROTEASOME, DRUG DEVELOPMENT, PRIMED SUBSTRATE BINDING CHANNEL, BETA-SANDWICH FLANKED BY ALPHA-HELICES, HYDROLASE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
3tdd:L (LYS33) to (ARG165) CRYSTAL STRUCTURE OF YEAST CP IN COMPLEX WITH BELACTOSIN C | UBIQUITIN, INHIBITOR, PROTEASOME, DRUG DEVELOPMENT, PRIMED SUBSTRATE BINDING CHANNEL, BETA-SANDWICH FLANKED BY ALPHA-HELICES, HYDROLASE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
3tdd:M (ARG33) to (ARG165) CRYSTAL STRUCTURE OF YEAST CP IN COMPLEX WITH BELACTOSIN C | UBIQUITIN, INHIBITOR, PROTEASOME, DRUG DEVELOPMENT, PRIMED SUBSTRATE BINDING CHANNEL, BETA-SANDWICH FLANKED BY ALPHA-HELICES, HYDROLASE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
3tdd:N (LYS33) to (ASN141) CRYSTAL STRUCTURE OF YEAST CP IN COMPLEX WITH BELACTOSIN C | UBIQUITIN, INHIBITOR, PROTEASOME, DRUG DEVELOPMENT, PRIMED SUBSTRATE BINDING CHANNEL, BETA-SANDWICH FLANKED BY ALPHA-HELICES, HYDROLASE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
3tdd:S (LYS66) to (ILE18) CRYSTAL STRUCTURE OF YEAST CP IN COMPLEX WITH BELACTOSIN C | UBIQUITIN, INHIBITOR, PROTEASOME, DRUG DEVELOPMENT, PRIMED SUBSTRATE BINDING CHANNEL, BETA-SANDWICH FLANKED BY ALPHA-HELICES, HYDROLASE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
3tdd:W (LYS33) to (ASP166) CRYSTAL STRUCTURE OF YEAST CP IN COMPLEX WITH BELACTOSIN C | UBIQUITIN, INHIBITOR, PROTEASOME, DRUG DEVELOPMENT, PRIMED SUBSTRATE BINDING CHANNEL, BETA-SANDWICH FLANKED BY ALPHA-HELICES, HYDROLASE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
3tdd:Z (LYS33) to (ARG165) CRYSTAL STRUCTURE OF YEAST CP IN COMPLEX WITH BELACTOSIN C | UBIQUITIN, INHIBITOR, PROTEASOME, DRUG DEVELOPMENT, PRIMED SUBSTRATE BINDING CHANNEL, BETA-SANDWICH FLANKED BY ALPHA-HELICES, HYDROLASE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
3tdd:1 (ARG33) to (THR146) CRYSTAL STRUCTURE OF YEAST CP IN COMPLEX WITH BELACTOSIN C | UBIQUITIN, INHIBITOR, PROTEASOME, DRUG DEVELOPMENT, PRIMED SUBSTRATE BINDING CHANNEL, BETA-SANDWICH FLANKED BY ALPHA-HELICES, HYDROLASE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
3tdd:2 (LYS33) to (ASN141) CRYSTAL STRUCTURE OF YEAST CP IN COMPLEX WITH BELACTOSIN C | UBIQUITIN, INHIBITOR, PROTEASOME, DRUG DEVELOPMENT, PRIMED SUBSTRATE BINDING CHANNEL, BETA-SANDWICH FLANKED BY ALPHA-HELICES, HYDROLASE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4y75:E (SER56) to (ILE181) YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAF-EP | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS
4y75:I (LYS41) to (ASP177) YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAF-EP | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS
4y75:L (LYS42) to (ARG194) YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAF-EP | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS
4y75:M (ARG41) to (ARG187) YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAF-EP | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS
4y75:N (LYS33) to (ASN141) YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAF-EP | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS
4y75:S (SER56) to (ILE181) YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAF-EP | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS
4y75:W (LYS41) to (ASP177) YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAF-EP | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS
4y75:Z (LYS42) to (ARG194) YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAF-EP | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS
4y75:a (ARG41) to (ARG187) YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAF-EP | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS
4y75:b (LYS33) to (ASN141) YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAF-EP | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS
4y8i:E (SER56) to (ILE181) YEAST 20S PROTEASOME IN COMPLEX WITH AC-PLL-EP | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS
4y8i:I (LYS41) to (ASP177) YEAST 20S PROTEASOME IN COMPLEX WITH AC-PLL-EP | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS
4y8i:L (LYS42) to (ARG194) YEAST 20S PROTEASOME IN COMPLEX WITH AC-PLL-EP | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS
4y8i:M (ARG41) to (ARG187) YEAST 20S PROTEASOME IN COMPLEX WITH AC-PLL-EP | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS
4y8i:N (LYS33) to (ASN141) YEAST 20S PROTEASOME IN COMPLEX WITH AC-PLL-EP | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS
4y8i:S (SER56) to (ILE181) YEAST 20S PROTEASOME IN COMPLEX WITH AC-PLL-EP | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS
4y8i:W (LYS41) to (ASP177) YEAST 20S PROTEASOME IN COMPLEX WITH AC-PLL-EP | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS
4y8i:Z (LYS42) to (ARG194) YEAST 20S PROTEASOME IN COMPLEX WITH AC-PLL-EP | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS
4y8i:a (ARG41) to (ARG187) YEAST 20S PROTEASOME IN COMPLEX WITH AC-PLL-EP | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS
4y8i:b (LYS33) to (ASN141) YEAST 20S PROTEASOME IN COMPLEX WITH AC-PLL-EP | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS
4y8k:E (SER56) to (ILE181) YEAST 20S PROTEASOME IN COMPLEX WITH H-APLL-EP | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS
4y8k:L (LYS42) to (ARG194) YEAST 20S PROTEASOME IN COMPLEX WITH H-APLL-EP | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS
4y8k:M (ARG41) to (ARG187) YEAST 20S PROTEASOME IN COMPLEX WITH H-APLL-EP | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS
4y8k:N (LYS33) to (ASN141) YEAST 20S PROTEASOME IN COMPLEX WITH H-APLL-EP | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS
4y8k:S (SER56) to (ILE181) YEAST 20S PROTEASOME IN COMPLEX WITH H-APLL-EP | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS
4y8k:Z (LYS42) to (ARG194) YEAST 20S PROTEASOME IN COMPLEX WITH H-APLL-EP | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS
4y8k:a (ARG41) to (ARG187) YEAST 20S PROTEASOME IN COMPLEX WITH H-APLL-EP | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS
4y8k:b (LYS33) to (ASN141) YEAST 20S PROTEASOME IN COMPLEX WITH H-APLL-EP | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS
4y8p:E (SER56) to (ILE181) YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAL- EP | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
4y8p:I (LYS41) to (ASP177) YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAL- EP | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
4y8p:L (LYS42) to (ARG194) YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAL- EP | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
4y8p:M (ARG41) to (ARG187) YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAL- EP | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
4y8p:N (LYS33) to (ASN141) YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAL- EP | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
4y8p:S (SER56) to (ILE181) YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAL- EP | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
4y8p:W (LYS41) to (ASP177) YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAL- EP | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
4y8p:Z (LYS42) to (ARG194) YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAL- EP | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
4y8p:a (ARG41) to (ARG187) YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAL- EP | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
4y8p:b (LYS33) to (ASN141) YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAL- EP | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
4y8r:E (SER56) to (ILE181) YEAST 20S PROTEASOME BETA2-H116D MUTANT | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, BINDING ANALYSIS
4y8r:I (LYS41) to (ASP177) YEAST 20S PROTEASOME BETA2-H116D MUTANT | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, BINDING ANALYSIS
4y8r:L (LYS42) to (ARG194) YEAST 20S PROTEASOME BETA2-H116D MUTANT | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, BINDING ANALYSIS
4y8r:M (ARG41) to (ARG187) YEAST 20S PROTEASOME BETA2-H116D MUTANT | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, BINDING ANALYSIS
4y8r:N (LYS33) to (ASN141) YEAST 20S PROTEASOME BETA2-H116D MUTANT | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, BINDING ANALYSIS
4y8r:S (SER56) to (ILE181) YEAST 20S PROTEASOME BETA2-H116D MUTANT | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, BINDING ANALYSIS
4y8r:W (LYS41) to (ASP177) YEAST 20S PROTEASOME BETA2-H116D MUTANT | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, BINDING ANALYSIS
4y8r:Z (LYS42) to (ARG194) YEAST 20S PROTEASOME BETA2-H116D MUTANT | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, BINDING ANALYSIS
4y8r:a (ARG41) to (ARG187) YEAST 20S PROTEASOME BETA2-H116D MUTANT | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, BINDING ANALYSIS
4y8r:b (LYS33) to (ASN141) YEAST 20S PROTEASOME BETA2-H116D MUTANT | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, BINDING ANALYSIS
4ya5:E (LYS61) to (ILE181) YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAE-EP | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
4ya5:I (LYS41) to (ASP177) YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAE-EP | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
4ya5:L (LYS42) to (ARG194) YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAE-EP | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
4ya5:M (ARG41) to (ARG187) YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAE-EP | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
4ya5:N (LYS33) to (ASN141) YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAE-EP | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
4ya5:S (SER56) to (ILE181) YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAE-EP | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
4ya5:W (LYS41) to (ASP177) YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAE-EP | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
4ya5:Z (LYS42) to (ARG194) YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAE-EP | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
4ya5:a (ARG41) to (ARG187) YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAE-EP | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
4ya5:b (LYS33) to (ASN141) YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAE-EP | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
3unb:C (LYS60) to (LEU195) MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957 | 20S PROTEASOME COMPRISES 28 SUBUNITS; EACH SUBUNIT ADOPTS THE FOLD OF AN ANTIPARALLEL BETA-SHEET FLANKED BY HELICES, PROTEASE, REGULATORY COMPLEXES, COVALENT BINDING OF PR-957 TO ALL ACTIVE SITES, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
3unb:F (ARG65) to (ILE199) MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957 | 20S PROTEASOME COMPRISES 28 SUBUNITS; EACH SUBUNIT ADOPTS THE FOLD OF AN ANTIPARALLEL BETA-SHEET FLANKED BY HELICES, PROTEASE, REGULATORY COMPLEXES, COVALENT BINDING OF PR-957 TO ALL ACTIVE SITES, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
3unb:I (LYS40) to (ASP177) MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957 | 20S PROTEASOME COMPRISES 28 SUBUNITS; EACH SUBUNIT ADOPTS THE FOLD OF AN ANTIPARALLEL BETA-SHEET FLANKED BY HELICES, PROTEASE, REGULATORY COMPLEXES, COVALENT BINDING OF PR-957 TO ALL ACTIVE SITES, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
3unb:J (LYS34) to (LYS169) MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957 | 20S PROTEASOME COMPRISES 28 SUBUNITS; EACH SUBUNIT ADOPTS THE FOLD OF AN ANTIPARALLEL BETA-SHEET FLANKED BY HELICES, PROTEASE, REGULATORY COMPLEXES, COVALENT BINDING OF PR-957 TO ALL ACTIVE SITES, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
3unb:L (LYS42) to (ARG185) MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957 | 20S PROTEASOME COMPRISES 28 SUBUNITS; EACH SUBUNIT ADOPTS THE FOLD OF AN ANTIPARALLEL BETA-SHEET FLANKED BY HELICES, PROTEASE, REGULATORY COMPLEXES, COVALENT BINDING OF PR-957 TO ALL ACTIVE SITES, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
3unb:N (LYS33) to (THR142) MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957 | 20S PROTEASOME COMPRISES 28 SUBUNITS; EACH SUBUNIT ADOPTS THE FOLD OF AN ANTIPARALLEL BETA-SHEET FLANKED BY HELICES, PROTEASE, REGULATORY COMPLEXES, COVALENT BINDING OF PR-957 TO ALL ACTIVE SITES, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
3unb:T (ARG65) to (HIS201) MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957 | 20S PROTEASOME COMPRISES 28 SUBUNITS; EACH SUBUNIT ADOPTS THE FOLD OF AN ANTIPARALLEL BETA-SHEET FLANKED BY HELICES, PROTEASE, REGULATORY COMPLEXES, COVALENT BINDING OF PR-957 TO ALL ACTIVE SITES, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
3unb:W (LYS40) to (ASP177) MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957 | 20S PROTEASOME COMPRISES 28 SUBUNITS; EACH SUBUNIT ADOPTS THE FOLD OF AN ANTIPARALLEL BETA-SHEET FLANKED BY HELICES, PROTEASE, REGULATORY COMPLEXES, COVALENT BINDING OF PR-957 TO ALL ACTIVE SITES, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
3unb:X (LYS34) to (LYS169) MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957 | 20S PROTEASOME COMPRISES 28 SUBUNITS; EACH SUBUNIT ADOPTS THE FOLD OF AN ANTIPARALLEL BETA-SHEET FLANKED BY HELICES, PROTEASE, REGULATORY COMPLEXES, COVALENT BINDING OF PR-957 TO ALL ACTIVE SITES, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
3unb:Z (LYS42) to (ARG185) MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957 | 20S PROTEASOME COMPRISES 28 SUBUNITS; EACH SUBUNIT ADOPTS THE FOLD OF AN ANTIPARALLEL BETA-SHEET FLANKED BY HELICES, PROTEASE, REGULATORY COMPLEXES, COVALENT BINDING OF PR-957 TO ALL ACTIVE SITES, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
3unb:b (LYS33) to (THR142) MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957 | 20S PROTEASOME COMPRISES 28 SUBUNITS; EACH SUBUNIT ADOPTS THE FOLD OF AN ANTIPARALLEL BETA-SHEET FLANKED BY HELICES, PROTEASE, REGULATORY COMPLEXES, COVALENT BINDING OF PR-957 TO ALL ACTIVE SITES, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
3unb:c (LYS63) to (GLU196) MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957 | 20S PROTEASOME COMPRISES 28 SUBUNITS; EACH SUBUNIT ADOPTS THE FOLD OF AN ANTIPARALLEL BETA-SHEET FLANKED BY HELICES, PROTEASE, REGULATORY COMPLEXES, COVALENT BINDING OF PR-957 TO ALL ACTIVE SITES, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
3unb:e (LYS60) to (LEU195) MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957 | 20S PROTEASOME COMPRISES 28 SUBUNITS; EACH SUBUNIT ADOPTS THE FOLD OF AN ANTIPARALLEL BETA-SHEET FLANKED BY HELICES, PROTEASE, REGULATORY COMPLEXES, COVALENT BINDING OF PR-957 TO ALL ACTIVE SITES, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
3unb:h (ARG65) to (HIS201) MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957 | 20S PROTEASOME COMPRISES 28 SUBUNITS; EACH SUBUNIT ADOPTS THE FOLD OF AN ANTIPARALLEL BETA-SHEET FLANKED BY HELICES, PROTEASE, REGULATORY COMPLEXES, COVALENT BINDING OF PR-957 TO ALL ACTIVE SITES, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
3unb:k (LYS40) to (ASP177) MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957 | 20S PROTEASOME COMPRISES 28 SUBUNITS; EACH SUBUNIT ADOPTS THE FOLD OF AN ANTIPARALLEL BETA-SHEET FLANKED BY HELICES, PROTEASE, REGULATORY COMPLEXES, COVALENT BINDING OF PR-957 TO ALL ACTIVE SITES, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
3unb:l (LYS34) to (LYS169) MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957 | 20S PROTEASOME COMPRISES 28 SUBUNITS; EACH SUBUNIT ADOPTS THE FOLD OF AN ANTIPARALLEL BETA-SHEET FLANKED BY HELICES, PROTEASE, REGULATORY COMPLEXES, COVALENT BINDING OF PR-957 TO ALL ACTIVE SITES, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
3unb:n (LYS42) to (ARG185) MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957 | 20S PROTEASOME COMPRISES 28 SUBUNITS; EACH SUBUNIT ADOPTS THE FOLD OF AN ANTIPARALLEL BETA-SHEET FLANKED BY HELICES, PROTEASE, REGULATORY COMPLEXES, COVALENT BINDING OF PR-957 TO ALL ACTIVE SITES, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
3unb:p (LYS33) to (THR142) MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957 | 20S PROTEASOME COMPRISES 28 SUBUNITS; EACH SUBUNIT ADOPTS THE FOLD OF AN ANTIPARALLEL BETA-SHEET FLANKED BY HELICES, PROTEASE, REGULATORY COMPLEXES, COVALENT BINDING OF PR-957 TO ALL ACTIVE SITES, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
3unb:v (ARG65) to (HIS201) MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957 | 20S PROTEASOME COMPRISES 28 SUBUNITS; EACH SUBUNIT ADOPTS THE FOLD OF AN ANTIPARALLEL BETA-SHEET FLANKED BY HELICES, PROTEASE, REGULATORY COMPLEXES, COVALENT BINDING OF PR-957 TO ALL ACTIVE SITES, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
3unb:2 (LYS42) to (ARG185) MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957 | 20S PROTEASOME COMPRISES 28 SUBUNITS; EACH SUBUNIT ADOPTS THE FOLD OF AN ANTIPARALLEL BETA-SHEET FLANKED BY HELICES, PROTEASE, REGULATORY COMPLEXES, COVALENT BINDING OF PR-957 TO ALL ACTIVE SITES, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
3unb:4 (LYS33) to (THR142) MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957 | 20S PROTEASOME COMPRISES 28 SUBUNITS; EACH SUBUNIT ADOPTS THE FOLD OF AN ANTIPARALLEL BETA-SHEET FLANKED BY HELICES, PROTEASE, REGULATORY COMPLEXES, COVALENT BINDING OF PR-957 TO ALL ACTIVE SITES, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
1g4a:B (LYS33) to (THR140) CRYSTAL STRUCTURES OF THE HSLVU PEPTIDASE-ATPASE COMPLEX REVEAL AN ATP-DEPENDENT PROTEOLYSIS MECHANISM | HSLVU, PEPTIDASE-ATPASE COMPLEX, CHAPERONE/HYDROLASE COMPLEX
1g4a:D (LYS33) to (ILE158) CRYSTAL STRUCTURES OF THE HSLVU PEPTIDASE-ATPASE COMPLEX REVEAL AN ATP-DEPENDENT PROTEOLYSIS MECHANISM | HSLVU, PEPTIDASE-ATPASE COMPLEX, CHAPERONE/HYDROLASE COMPLEX
2fhh:D (LYS52) to (SER192) CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH A PEPTIDYL BORONATE INHIBITOR MLN-273 | MULTI-SUBUNIT PROTEIN ASSEMBLY, INHIBITOR-COMPLEX, HYDROLASE
5a0q:A (LEU69) to (SER207) CRYO-EM REVEALS THE CONFORMATION OF A SUBSTRATE ANALOGUE IN THE HUMAN 20S PROTEASOME CORE | HYDROLASE, PROTEASOME, 20S, ADAAHX3L3VS, LIGAND, INHIBITOR, DRUG DESIGN
5a0q:B (LYS63) to (LYS175) CRYO-EM REVEALS THE CONFORMATION OF A SUBSTRATE ANALOGUE IN THE HUMAN 20S PROTEASOME CORE | HYDROLASE, PROTEASOME, 20S, ADAAHX3L3VS, LIGAND, INHIBITOR, DRUG DESIGN
5a0q:F (LYS62) to (HIS175) CRYO-EM REVEALS THE CONFORMATION OF A SUBSTRATE ANALOGUE IN THE HUMAN 20S PROTEASOME CORE | HYDROLASE, PROTEASOME, 20S, ADAAHX3L3VS, LIGAND, INHIBITOR, DRUG DESIGN
5a0q:O (LEU69) to (SER207) CRYO-EM REVEALS THE CONFORMATION OF A SUBSTRATE ANALOGUE IN THE HUMAN 20S PROTEASOME CORE | HYDROLASE, PROTEASOME, 20S, ADAAHX3L3VS, LIGAND, INHIBITOR, DRUG DESIGN
5a0q:P (LYS63) to (LYS175) CRYO-EM REVEALS THE CONFORMATION OF A SUBSTRATE ANALOGUE IN THE HUMAN 20S PROTEASOME CORE | HYDROLASE, PROTEASOME, 20S, ADAAHX3L3VS, LIGAND, INHIBITOR, DRUG DESIGN
5a0q:T (LYS62) to (HIS175) CRYO-EM REVEALS THE CONFORMATION OF A SUBSTRATE ANALOGUE IN THE HUMAN 20S PROTEASOME CORE | HYDROLASE, PROTEASOME, 20S, ADAAHX3L3VS, LIGAND, INHIBITOR, DRUG DESIGN
5a5b:3 (LYS33) to (ASP169) STRUCTURE OF THE 26S PROTEASOME-UBP6 COMPLEX | HYDROLASE, CONFORMATIONAL SWITCHING, PROTEIN DEGRADATION, PROTEOSTASIS, QUALITY CONTROL, UBP6, USP14
5a5b:6 (LYS33) to (HIS186) STRUCTURE OF THE 26S PROTEASOME-UBP6 COMPLEX | HYDROLASE, CONFORMATIONAL SWITCHING, PROTEIN DEGRADATION, PROTEOSTASIS, QUALITY CONTROL, UBP6, USP14
5a5b:7 (ARG33) to (ALA181) STRUCTURE OF THE 26S PROTEASOME-UBP6 COMPLEX | HYDROLASE, CONFORMATIONAL SWITCHING, PROTEIN DEGRADATION, PROTEOSTASIS, QUALITY CONTROL, UBP6, USP14
5a5b:A (TYR71) to (ALA213) STRUCTURE OF THE 26S PROTEASOME-UBP6 COMPLEX | HYDROLASE, CONFORMATIONAL SWITCHING, PROTEIN DEGRADATION, PROTEOSTASIS, QUALITY CONTROL, UBP6, USP14
5a5b:B (LYS63) to (SER199) STRUCTURE OF THE 26S PROTEASOME-UBP6 COMPLEX | HYDROLASE, CONFORMATIONAL SWITCHING, PROTEIN DEGRADATION, PROTEOSTASIS, QUALITY CONTROL, UBP6, USP14
5a5b:C (LYS65) to (THR201) STRUCTURE OF THE 26S PROTEASOME-UBP6 COMPLEX | HYDROLASE, CONFORMATIONAL SWITCHING, PROTEIN DEGRADATION, PROTEOSTASIS, QUALITY CONTROL, UBP6, USP14
5a5b:D (LYS63) to (GLN204) STRUCTURE OF THE 26S PROTEASOME-UBP6 COMPLEX | HYDROLASE, CONFORMATIONAL SWITCHING, PROTEIN DEGRADATION, PROTEOSTASIS, QUALITY CONTROL, UBP6, USP14
5a5b:F (LYS62) to (ILE182) STRUCTURE OF THE 26S PROTEASOME-UBP6 COMPLEX | HYDROLASE, CONFORMATIONAL SWITCHING, PROTEIN DEGRADATION, PROTEOSTASIS, QUALITY CONTROL, UBP6, USP14
2x1c:C (THR142) to (LEU289) THE CRYSTAL STRUCTURE OF PRECURSOR ACYL COENZYME A:ISOPENICILLIN N ACYLTRANSFERASE FROM PENICILLIUM CHRYSOGENUM | ZYMOGEN, TRANSFERASE, NTN-HYDROLASE, PENICILLIN BIOSYNTHESIS, ACYLTRANSFERASE, ANTIBIOTIC BIOSYNTHESIS
2x1c:D (THR142) to (LEU289) THE CRYSTAL STRUCTURE OF PRECURSOR ACYL COENZYME A:ISOPENICILLIN N ACYLTRANSFERASE FROM PENICILLIUM CHRYSOGENUM | ZYMOGEN, TRANSFERASE, NTN-HYDROLASE, PENICILLIN BIOSYNTHESIS, ACYLTRANSFERASE, ANTIBIOTIC BIOSYNTHESIS
5bou:E (SER56) to (ILE181) YEAST 20S PROTEASOME IN COMPLEX WITH A BETA1 / BETA2 SPECIFIC NON- PEPTIDIC SULFONAMIDE LIGAND | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, NON-COVALENT LIGAND, BINDING ANALYSIS
5bou:L (LYS42) to (ARG194) YEAST 20S PROTEASOME IN COMPLEX WITH A BETA1 / BETA2 SPECIFIC NON- PEPTIDIC SULFONAMIDE LIGAND | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, NON-COVALENT LIGAND, BINDING ANALYSIS
5bou:M (ARG41) to (ARG187) YEAST 20S PROTEASOME IN COMPLEX WITH A BETA1 / BETA2 SPECIFIC NON- PEPTIDIC SULFONAMIDE LIGAND | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, NON-COVALENT LIGAND, BINDING ANALYSIS
5bou:N (LYS33) to (ASN141) YEAST 20S PROTEASOME IN COMPLEX WITH A BETA1 / BETA2 SPECIFIC NON- PEPTIDIC SULFONAMIDE LIGAND | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, NON-COVALENT LIGAND, BINDING ANALYSIS
5bou:S (SER56) to (ILE181) YEAST 20S PROTEASOME IN COMPLEX WITH A BETA1 / BETA2 SPECIFIC NON- PEPTIDIC SULFONAMIDE LIGAND | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, NON-COVALENT LIGAND, BINDING ANALYSIS
5bou:Z (LYS42) to (ARG194) YEAST 20S PROTEASOME IN COMPLEX WITH A BETA1 / BETA2 SPECIFIC NON- PEPTIDIC SULFONAMIDE LIGAND | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, NON-COVALENT LIGAND, BINDING ANALYSIS
5bou:a (ARG41) to (ARG187) YEAST 20S PROTEASOME IN COMPLEX WITH A BETA1 / BETA2 SPECIFIC NON- PEPTIDIC SULFONAMIDE LIGAND | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, NON-COVALENT LIGAND, BINDING ANALYSIS
5bou:b (LYS33) to (ASN141) YEAST 20S PROTEASOME IN COMPLEX WITH A BETA1 / BETA2 SPECIFIC NON- PEPTIDIC SULFONAMIDE LIGAND | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, NON-COVALENT LIGAND, BINDING ANALYSIS
5bxl:E (LYS61) to (ILE181) YEAST 20S PROTEASOME BETA2-G170A MUTANT | HYDROLASE, IMMUNODEFICIENCY, PROTEASOME, MUTANT, ASSEMBLY DEFECT
5bxl:I (LYS41) to (ASP177) YEAST 20S PROTEASOME BETA2-G170A MUTANT | HYDROLASE, IMMUNODEFICIENCY, PROTEASOME, MUTANT, ASSEMBLY DEFECT
5bxl:L (LYS42) to (ARG194) YEAST 20S PROTEASOME BETA2-G170A MUTANT | HYDROLASE, IMMUNODEFICIENCY, PROTEASOME, MUTANT, ASSEMBLY DEFECT
5bxl:M (ARG41) to (ARG187) YEAST 20S PROTEASOME BETA2-G170A MUTANT | HYDROLASE, IMMUNODEFICIENCY, PROTEASOME, MUTANT, ASSEMBLY DEFECT
5bxl:N (LYS33) to (ASN141) YEAST 20S PROTEASOME BETA2-G170A MUTANT | HYDROLASE, IMMUNODEFICIENCY, PROTEASOME, MUTANT, ASSEMBLY DEFECT
5bxl:S (LYS61) to (ILE181) YEAST 20S PROTEASOME BETA2-G170A MUTANT | HYDROLASE, IMMUNODEFICIENCY, PROTEASOME, MUTANT, ASSEMBLY DEFECT
5bxl:W (LYS41) to (ASP177) YEAST 20S PROTEASOME BETA2-G170A MUTANT | HYDROLASE, IMMUNODEFICIENCY, PROTEASOME, MUTANT, ASSEMBLY DEFECT
5bxl:Z (LYS42) to (ARG194) YEAST 20S PROTEASOME BETA2-G170A MUTANT | HYDROLASE, IMMUNODEFICIENCY, PROTEASOME, MUTANT, ASSEMBLY DEFECT
5bxl:a (ARG41) to (ARG187) YEAST 20S PROTEASOME BETA2-G170A MUTANT | HYDROLASE, IMMUNODEFICIENCY, PROTEASOME, MUTANT, ASSEMBLY DEFECT
5bxl:b (LYS33) to (ASN141) YEAST 20S PROTEASOME BETA2-G170A MUTANT | HYDROLASE, IMMUNODEFICIENCY, PROTEASOME, MUTANT, ASSEMBLY DEFECT
5bxn:E (LYS61) to (ILE181) YEAST 20S PROTEASOME BETA2-G170A MUTANT IN COMPLEX WITH BORTEZOMIB | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, IMMUNODEFICIENCY, PROTEASOME, MUTANT, ASSEMBLY DEFECT
5bxn:I (LYS41) to (ASP177) YEAST 20S PROTEASOME BETA2-G170A MUTANT IN COMPLEX WITH BORTEZOMIB | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, IMMUNODEFICIENCY, PROTEASOME, MUTANT, ASSEMBLY DEFECT
5bxn:L (LYS42) to (ARG194) YEAST 20S PROTEASOME BETA2-G170A MUTANT IN COMPLEX WITH BORTEZOMIB | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, IMMUNODEFICIENCY, PROTEASOME, MUTANT, ASSEMBLY DEFECT
5bxn:M (ARG41) to (ARG187) YEAST 20S PROTEASOME BETA2-G170A MUTANT IN COMPLEX WITH BORTEZOMIB | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, IMMUNODEFICIENCY, PROTEASOME, MUTANT, ASSEMBLY DEFECT
5bxn:N (LYS33) to (ASN141) YEAST 20S PROTEASOME BETA2-G170A MUTANT IN COMPLEX WITH BORTEZOMIB | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, IMMUNODEFICIENCY, PROTEASOME, MUTANT, ASSEMBLY DEFECT
5bxn:S (LYS61) to (ILE181) YEAST 20S PROTEASOME BETA2-G170A MUTANT IN COMPLEX WITH BORTEZOMIB | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, IMMUNODEFICIENCY, PROTEASOME, MUTANT, ASSEMBLY DEFECT
5bxn:W (LYS41) to (ASP177) YEAST 20S PROTEASOME BETA2-G170A MUTANT IN COMPLEX WITH BORTEZOMIB | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, IMMUNODEFICIENCY, PROTEASOME, MUTANT, ASSEMBLY DEFECT
5bxn:Z (LYS42) to (ARG194) YEAST 20S PROTEASOME BETA2-G170A MUTANT IN COMPLEX WITH BORTEZOMIB | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, IMMUNODEFICIENCY, PROTEASOME, MUTANT, ASSEMBLY DEFECT
5bxn:a (ARG41) to (ARG187) YEAST 20S PROTEASOME BETA2-G170A MUTANT IN COMPLEX WITH BORTEZOMIB | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, IMMUNODEFICIENCY, PROTEASOME, MUTANT, ASSEMBLY DEFECT
5bxn:b (LYS33) to (ASN141) YEAST 20S PROTEASOME BETA2-G170A MUTANT IN COMPLEX WITH BORTEZOMIB | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, IMMUNODEFICIENCY, PROTEASOME, MUTANT, ASSEMBLY DEFECT
4no9:C (LYS61) to (LEU198) YCP IN COMPLEX WITH Z-LEU-LEU-LEU-EPOXYKETONE | PROTEASOME, PEPTIDE ELECTROPHILE, BINDING ANALYSIS, IRREVERSIBLE INHIBITOR, EPOXYKETONE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4no9:E (SER56) to (ILE181) YCP IN COMPLEX WITH Z-LEU-LEU-LEU-EPOXYKETONE | PROTEASOME, PEPTIDE ELECTROPHILE, BINDING ANALYSIS, IRREVERSIBLE INHIBITOR, EPOXYKETONE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4no9:I (LYS41) to (ASP177) YCP IN COMPLEX WITH Z-LEU-LEU-LEU-EPOXYKETONE | PROTEASOME, PEPTIDE ELECTROPHILE, BINDING ANALYSIS, IRREVERSIBLE INHIBITOR, EPOXYKETONE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4no9:L (LYS42) to (ARG194) YCP IN COMPLEX WITH Z-LEU-LEU-LEU-EPOXYKETONE | PROTEASOME, PEPTIDE ELECTROPHILE, BINDING ANALYSIS, IRREVERSIBLE INHIBITOR, EPOXYKETONE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4no9:M (ARG41) to (ARG187) YCP IN COMPLEX WITH Z-LEU-LEU-LEU-EPOXYKETONE | PROTEASOME, PEPTIDE ELECTROPHILE, BINDING ANALYSIS, IRREVERSIBLE INHIBITOR, EPOXYKETONE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4no9:N (LYS33) to (ASN141) YCP IN COMPLEX WITH Z-LEU-LEU-LEU-EPOXYKETONE | PROTEASOME, PEPTIDE ELECTROPHILE, BINDING ANALYSIS, IRREVERSIBLE INHIBITOR, EPOXYKETONE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4no9:Q (LYS61) to (LEU198) YCP IN COMPLEX WITH Z-LEU-LEU-LEU-EPOXYKETONE | PROTEASOME, PEPTIDE ELECTROPHILE, BINDING ANALYSIS, IRREVERSIBLE INHIBITOR, EPOXYKETONE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4no9:S (SER56) to (ILE181) YCP IN COMPLEX WITH Z-LEU-LEU-LEU-EPOXYKETONE | PROTEASOME, PEPTIDE ELECTROPHILE, BINDING ANALYSIS, IRREVERSIBLE INHIBITOR, EPOXYKETONE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4no9:W (LYS41) to (ASP177) YCP IN COMPLEX WITH Z-LEU-LEU-LEU-EPOXYKETONE | PROTEASOME, PEPTIDE ELECTROPHILE, BINDING ANALYSIS, IRREVERSIBLE INHIBITOR, EPOXYKETONE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4no9:Z (LYS42) to (ARG194) YCP IN COMPLEX WITH Z-LEU-LEU-LEU-EPOXYKETONE | PROTEASOME, PEPTIDE ELECTROPHILE, BINDING ANALYSIS, IRREVERSIBLE INHIBITOR, EPOXYKETONE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4no9:a (ARG41) to (ARG187) YCP IN COMPLEX WITH Z-LEU-LEU-LEU-EPOXYKETONE | PROTEASOME, PEPTIDE ELECTROPHILE, BINDING ANALYSIS, IRREVERSIBLE INHIBITOR, EPOXYKETONE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4no9:b (LYS33) to (ASN141) YCP IN COMPLEX WITH Z-LEU-LEU-LEU-EPOXYKETONE | PROTEASOME, PEPTIDE ELECTROPHILE, BINDING ANALYSIS, IRREVERSIBLE INHIBITOR, EPOXYKETONE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
3jrm:A (LYS66) to (LEU201) CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR | 20S PROTEASOME, PA26, CYTOPLASM, HYDROLASE, PROTEASE, PROTEASOME, THREONINE PROTEASE, HYDROLASE/HYDROLASE ACTIVATOR COMPLEX
3jrm:B (LYS66) to (LEU201) CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR | 20S PROTEASOME, PA26, CYTOPLASM, HYDROLASE, PROTEASE, PROTEASOME, THREONINE PROTEASE, HYDROLASE/HYDROLASE ACTIVATOR COMPLEX
3jrm:G (LYS66) to (LEU201) CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR | 20S PROTEASOME, PA26, CYTOPLASM, HYDROLASE, PROTEASE, PROTEASOME, THREONINE PROTEASE, HYDROLASE/HYDROLASE ACTIVATOR COMPLEX
3jrm:H (LYS33) to (ARG165) CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR | 20S PROTEASOME, PA26, CYTOPLASM, HYDROLASE, PROTEASE, PROTEASOME, THREONINE PROTEASE, HYDROLASE/HYDROLASE ACTIVATOR COMPLEX
3jrm:I (LYS33) to (ARG165) CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR | 20S PROTEASOME, PA26, CYTOPLASM, HYDROLASE, PROTEASE, PROTEASOME, THREONINE PROTEASE, HYDROLASE/HYDROLASE ACTIVATOR COMPLEX
3jrm:J (LYS33) to (ARG165) CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR | 20S PROTEASOME, PA26, CYTOPLASM, HYDROLASE, PROTEASE, PROTEASOME, THREONINE PROTEASE, HYDROLASE/HYDROLASE ACTIVATOR COMPLEX
3jrm:K (LYS33) to (ARG165) CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR | 20S PROTEASOME, PA26, CYTOPLASM, HYDROLASE, PROTEASE, PROTEASOME, THREONINE PROTEASE, HYDROLASE/HYDROLASE ACTIVATOR COMPLEX
3jrm:L (LYS33) to (ARG165) CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR | 20S PROTEASOME, PA26, CYTOPLASM, HYDROLASE, PROTEASE, PROTEASOME, THREONINE PROTEASE, HYDROLASE/HYDROLASE ACTIVATOR COMPLEX
3jrm:M (LYS33) to (ARG165) CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR | 20S PROTEASOME, PA26, CYTOPLASM, HYDROLASE, PROTEASE, PROTEASOME, THREONINE PROTEASE, HYDROLASE/HYDROLASE ACTIVATOR COMPLEX
3jrm:N (LYS33) to (ARG165) CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR | 20S PROTEASOME, PA26, CYTOPLASM, HYDROLASE, PROTEASE, PROTEASOME, THREONINE PROTEASE, HYDROLASE/HYDROLASE ACTIVATOR COMPLEX
5cgf:E (SER56) to (ILE181) YEAST 20S PROTEASOME BETA5-G48C MUTANT | HYDROLASE, PROTEASOME, MUTANT, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
5cgf:L (LYS42) to (ARG194) YEAST 20S PROTEASOME BETA5-G48C MUTANT | HYDROLASE, PROTEASOME, MUTANT, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
5cgf:M (ARG41) to (ARG187) YEAST 20S PROTEASOME BETA5-G48C MUTANT | HYDROLASE, PROTEASOME, MUTANT, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
5cgf:N (LYS33) to (ASN141) YEAST 20S PROTEASOME BETA5-G48C MUTANT | HYDROLASE, PROTEASOME, MUTANT, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
5cgf:S (SER56) to (ILE181) YEAST 20S PROTEASOME BETA5-G48C MUTANT | HYDROLASE, PROTEASOME, MUTANT, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
5cgf:Z (LYS42) to (ARG194) YEAST 20S PROTEASOME BETA5-G48C MUTANT | HYDROLASE, PROTEASOME, MUTANT, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
5cgf:a (ARG41) to (ARG187) YEAST 20S PROTEASOME BETA5-G48C MUTANT | HYDROLASE, PROTEASOME, MUTANT, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
5cgf:b (LYS33) to (ASN141) YEAST 20S PROTEASOME BETA5-G48C MUTANT | HYDROLASE, PROTEASOME, MUTANT, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
5cz4:E (SER56) to (ILE181) YEAST 20S PROTEASOME AT 2.3 A RESOLUTION | HYDROLASE-HYDROLASE COMPLEX, UBIQUITIN-DEGRADATION SYSTEM, PROTEASOME, NTN-HYDROLASE, THR-PROTEASE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
5cz4:I (LYS41) to (ASP177) YEAST 20S PROTEASOME AT 2.3 A RESOLUTION | HYDROLASE-HYDROLASE COMPLEX, UBIQUITIN-DEGRADATION SYSTEM, PROTEASOME, NTN-HYDROLASE, THR-PROTEASE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
5cz4:L (LYS42) to (ARG194) YEAST 20S PROTEASOME AT 2.3 A RESOLUTION | HYDROLASE-HYDROLASE COMPLEX, UBIQUITIN-DEGRADATION SYSTEM, PROTEASOME, NTN-HYDROLASE, THR-PROTEASE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
5cz4:M (ARG41) to (ARG187) YEAST 20S PROTEASOME AT 2.3 A RESOLUTION | HYDROLASE-HYDROLASE COMPLEX, UBIQUITIN-DEGRADATION SYSTEM, PROTEASOME, NTN-HYDROLASE, THR-PROTEASE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
5cz4:N (LYS33) to (ASN141) YEAST 20S PROTEASOME AT 2.3 A RESOLUTION | HYDROLASE-HYDROLASE COMPLEX, UBIQUITIN-DEGRADATION SYSTEM, PROTEASOME, NTN-HYDROLASE, THR-PROTEASE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
5cz4:S (SER56) to (ILE181) YEAST 20S PROTEASOME AT 2.3 A RESOLUTION | HYDROLASE-HYDROLASE COMPLEX, UBIQUITIN-DEGRADATION SYSTEM, PROTEASOME, NTN-HYDROLASE, THR-PROTEASE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
5cz4:W (LYS41) to (ASP177) YEAST 20S PROTEASOME AT 2.3 A RESOLUTION | HYDROLASE-HYDROLASE COMPLEX, UBIQUITIN-DEGRADATION SYSTEM, PROTEASOME, NTN-HYDROLASE, THR-PROTEASE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
5cz4:Z (LYS42) to (ARG194) YEAST 20S PROTEASOME AT 2.3 A RESOLUTION | HYDROLASE-HYDROLASE COMPLEX, UBIQUITIN-DEGRADATION SYSTEM, PROTEASOME, NTN-HYDROLASE, THR-PROTEASE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
5cz4:a (ARG41) to (ARG187) YEAST 20S PROTEASOME AT 2.3 A RESOLUTION | HYDROLASE-HYDROLASE COMPLEX, UBIQUITIN-DEGRADATION SYSTEM, PROTEASOME, NTN-HYDROLASE, THR-PROTEASE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
5cz4:b (LYS33) to (ASN141) YEAST 20S PROTEASOME AT 2.3 A RESOLUTION | HYDROLASE-HYDROLASE COMPLEX, UBIQUITIN-DEGRADATION SYSTEM, PROTEASOME, NTN-HYDROLASE, THR-PROTEASE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
5cz7:E (SER56) to (ILE181) YEAST 20S PROTEASOME BETA5-T1A BETA5-K81R DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB, PROPEPTIDE EXPRESSED IN CIS | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5cz7:I (LYS41) to (ASP177) YEAST 20S PROTEASOME BETA5-T1A BETA5-K81R DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB, PROPEPTIDE EXPRESSED IN CIS | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5cz7:L (LYS42) to (ARG194) YEAST 20S PROTEASOME BETA5-T1A BETA5-K81R DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB, PROPEPTIDE EXPRESSED IN CIS | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5cz7:M (ARG41) to (ARG187) YEAST 20S PROTEASOME BETA5-T1A BETA5-K81R DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB, PROPEPTIDE EXPRESSED IN CIS | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5cz7:N (LYS33) to (ASN141) YEAST 20S PROTEASOME BETA5-T1A BETA5-K81R DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB, PROPEPTIDE EXPRESSED IN CIS | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5cz7:S (SER56) to (ILE181) YEAST 20S PROTEASOME BETA5-T1A BETA5-K81R DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB, PROPEPTIDE EXPRESSED IN CIS | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5cz7:W (LYS41) to (ASP177) YEAST 20S PROTEASOME BETA5-T1A BETA5-K81R DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB, PROPEPTIDE EXPRESSED IN CIS | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5cz7:Z (LYS42) to (ARG194) YEAST 20S PROTEASOME BETA5-T1A BETA5-K81R DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB, PROPEPTIDE EXPRESSED IN CIS | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5cz7:a (ARG41) to (ARG187) YEAST 20S PROTEASOME BETA5-T1A BETA5-K81R DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB, PROPEPTIDE EXPRESSED IN CIS | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5cz7:b (LYS33) to (ASN141) YEAST 20S PROTEASOME BETA5-T1A BETA5-K81R DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB, PROPEPTIDE EXPRESSED IN CIS | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5cz8:E (SER56) to (ILE181) YEAST 20S PROTEASOME BETA5-L(-49)S-K33A MUTANT IN COMPLEX WITH CARFILZOMIB | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5cz8:I (LYS41) to (ASP177) YEAST 20S PROTEASOME BETA5-L(-49)S-K33A MUTANT IN COMPLEX WITH CARFILZOMIB | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5cz8:K (ALA33) to (HIS166) YEAST 20S PROTEASOME BETA5-L(-49)S-K33A MUTANT IN COMPLEX WITH CARFILZOMIB | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5cz8:L (LYS42) to (ARG194) YEAST 20S PROTEASOME BETA5-L(-49)S-K33A MUTANT IN COMPLEX WITH CARFILZOMIB | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5cz8:M (ARG41) to (ARG187) YEAST 20S PROTEASOME BETA5-L(-49)S-K33A MUTANT IN COMPLEX WITH CARFILZOMIB | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5cz8:N (LYS33) to (ASN141) YEAST 20S PROTEASOME BETA5-L(-49)S-K33A MUTANT IN COMPLEX WITH CARFILZOMIB | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5cz8:S (SER56) to (ILE181) YEAST 20S PROTEASOME BETA5-L(-49)S-K33A MUTANT IN COMPLEX WITH CARFILZOMIB | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5cz8:W (LYS41) to (ASP177) YEAST 20S PROTEASOME BETA5-L(-49)S-K33A MUTANT IN COMPLEX WITH CARFILZOMIB | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5cz8:Y (ALA33) to (HIS166) YEAST 20S PROTEASOME BETA5-L(-49)S-K33A MUTANT IN COMPLEX WITH CARFILZOMIB | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5cz8:Z (LYS42) to (ARG194) YEAST 20S PROTEASOME BETA5-L(-49)S-K33A MUTANT IN COMPLEX WITH CARFILZOMIB | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5cz8:a (ARG41) to (ARG187) YEAST 20S PROTEASOME BETA5-L(-49)S-K33A MUTANT IN COMPLEX WITH CARFILZOMIB | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5cz8:b (LYS33) to (ASN141) YEAST 20S PROTEASOME BETA5-L(-49)S-K33A MUTANT IN COMPLEX WITH CARFILZOMIB | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5cz9:E (SER56) to (ILE181) YEAST 20S PROTEASOME BETA5-D17N MUTANT IN COMPLEX WITH CARFILZOMIB; PROPEPTIDE EXPRESSED IN TRANS | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5cz9:L (LYS42) to (ARG194) YEAST 20S PROTEASOME BETA5-D17N MUTANT IN COMPLEX WITH CARFILZOMIB; PROPEPTIDE EXPRESSED IN TRANS | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5cz9:M (ARG41) to (ARG187) YEAST 20S PROTEASOME BETA5-D17N MUTANT IN COMPLEX WITH CARFILZOMIB; PROPEPTIDE EXPRESSED IN TRANS | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5cz9:N (LYS33) to (ASN141) YEAST 20S PROTEASOME BETA5-D17N MUTANT IN COMPLEX WITH CARFILZOMIB; PROPEPTIDE EXPRESSED IN TRANS | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5cz9:S (SER56) to (ILE181) YEAST 20S PROTEASOME BETA5-D17N MUTANT IN COMPLEX WITH CARFILZOMIB; PROPEPTIDE EXPRESSED IN TRANS | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5cz9:Z (LYS42) to (ARG194) YEAST 20S PROTEASOME BETA5-D17N MUTANT IN COMPLEX WITH CARFILZOMIB; PROPEPTIDE EXPRESSED IN TRANS | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5cz9:a (ARG41) to (ARG187) YEAST 20S PROTEASOME BETA5-D17N MUTANT IN COMPLEX WITH CARFILZOMIB; PROPEPTIDE EXPRESSED IN TRANS | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5cz9:b (LYS33) to (ASN141) YEAST 20S PROTEASOME BETA5-D17N MUTANT IN COMPLEX WITH CARFILZOMIB; PROPEPTIDE EXPRESSED IN TRANS | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
1yar:H (LYS33) to (ARG165) STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME MUTANT D9S- PA26 COMPLEX | PROTEASOME 20S, PA26 PROTEASOME ACTIVATOR 11S, HYDROLASE-HYDROLASE ACTIVATOR COMPLEX
1yar:I (LYS33) to (ARG165) STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME MUTANT D9S- PA26 COMPLEX | PROTEASOME 20S, PA26 PROTEASOME ACTIVATOR 11S, HYDROLASE-HYDROLASE ACTIVATOR COMPLEX
1yar:J (LYS33) to (ARG165) STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME MUTANT D9S- PA26 COMPLEX | PROTEASOME 20S, PA26 PROTEASOME ACTIVATOR 11S, HYDROLASE-HYDROLASE ACTIVATOR COMPLEX
1yar:K (LYS33) to (ARG165) STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME MUTANT D9S- PA26 COMPLEX | PROTEASOME 20S, PA26 PROTEASOME ACTIVATOR 11S, HYDROLASE-HYDROLASE ACTIVATOR COMPLEX
1yar:L (LYS33) to (ARG165) STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME MUTANT D9S- PA26 COMPLEX | PROTEASOME 20S, PA26 PROTEASOME ACTIVATOR 11S, HYDROLASE-HYDROLASE ACTIVATOR COMPLEX
1yar:M (LYS33) to (ARG165) STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME MUTANT D9S- PA26 COMPLEX | PROTEASOME 20S, PA26 PROTEASOME ACTIVATOR 11S, HYDROLASE-HYDROLASE ACTIVATOR COMPLEX
1yar:N (LYS33) to (ARG165) STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME MUTANT D9S- PA26 COMPLEX | PROTEASOME 20S, PA26 PROTEASOME ACTIVATOR 11S, HYDROLASE-HYDROLASE ACTIVATOR COMPLEX
4qlv:C (LYS61) to (LEU198) YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 17 | PROTEASOME, EPOXYKETONE, IMMUNOPROTEASOME INHIBITOR, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4qlv:E (LYS61) to (ILE181) YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 17 | PROTEASOME, EPOXYKETONE, IMMUNOPROTEASOME INHIBITOR, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4qlv:L (LYS42) to (ARG194) YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 17 | PROTEASOME, EPOXYKETONE, IMMUNOPROTEASOME INHIBITOR, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4qlv:N (LYS33) to (ASN141) YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 17 | PROTEASOME, EPOXYKETONE, IMMUNOPROTEASOME INHIBITOR, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4qlv:Q (LYS61) to (LEU198) YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 17 | PROTEASOME, EPOXYKETONE, IMMUNOPROTEASOME INHIBITOR, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4qlv:S (LYS61) to (ILE181) YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 17 | PROTEASOME, EPOXYKETONE, IMMUNOPROTEASOME INHIBITOR, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4qlv:Z (LYS42) to (ARG194) YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 17 | PROTEASOME, EPOXYKETONE, IMMUNOPROTEASOME INHIBITOR, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4qlv:b (LYS33) to (ASN141) YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 17 | PROTEASOME, EPOXYKETONE, IMMUNOPROTEASOME INHIBITOR, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
3bdm:A (LYS66) to (VAL202) YEAST 20S PROTEASOME:GLIDOBACTIN A-COMPLEX | PROTEASOME, UBIQUITIN, PROTEOLYSIS, PATHOGEN, VIRULENCE FACTOR, CYTOPLASM, HYDROLASE, NUCLEUS, PROTEASE, THREONINE PROTEASE, UBL CONJUGATION, PHOSPHOPROTEIN, ZYMOGEN
3bdm:D (LYS66) to (TRP180) YEAST 20S PROTEASOME:GLIDOBACTIN A-COMPLEX | PROTEASOME, UBIQUITIN, PROTEOLYSIS, PATHOGEN, VIRULENCE FACTOR, CYTOPLASM, HYDROLASE, NUCLEUS, PROTEASE, THREONINE PROTEASE, UBL CONJUGATION, PHOSPHOPROTEIN, ZYMOGEN
3bdm:E (LYS66) to (ILE18) YEAST 20S PROTEASOME:GLIDOBACTIN A-COMPLEX | PROTEASOME, UBIQUITIN, PROTEOLYSIS, PATHOGEN, VIRULENCE FACTOR, CYTOPLASM, HYDROLASE, NUCLEUS, PROTEASE, THREONINE PROTEASE, UBL CONJUGATION, PHOSPHOPROTEIN, ZYMOGEN
3bdm:G (TYR66) to (GLY202) YEAST 20S PROTEASOME:GLIDOBACTIN A-COMPLEX | PROTEASOME, UBIQUITIN, PROTEOLYSIS, PATHOGEN, VIRULENCE FACTOR, CYTOPLASM, HYDROLASE, NUCLEUS, PROTEASE, THREONINE PROTEASE, UBL CONJUGATION, PHOSPHOPROTEIN, ZYMOGEN
3bdm:I (LYS33) to (ASP166) YEAST 20S PROTEASOME:GLIDOBACTIN A-COMPLEX | PROTEASOME, UBIQUITIN, PROTEOLYSIS, PATHOGEN, VIRULENCE FACTOR, CYTOPLASM, HYDROLASE, NUCLEUS, PROTEASE, THREONINE PROTEASE, UBL CONJUGATION, PHOSPHOPROTEIN, ZYMOGEN
3bdm:J (LYS33) to (ARG165) YEAST 20S PROTEASOME:GLIDOBACTIN A-COMPLEX | PROTEASOME, UBIQUITIN, PROTEOLYSIS, PATHOGEN, VIRULENCE FACTOR, CYTOPLASM, HYDROLASE, NUCLEUS, PROTEASE, THREONINE PROTEASE, UBL CONJUGATION, PHOSPHOPROTEIN, ZYMOGEN
3bdm:L (LYS33) to (ARG165) YEAST 20S PROTEASOME:GLIDOBACTIN A-COMPLEX | PROTEASOME, UBIQUITIN, PROTEOLYSIS, PATHOGEN, VIRULENCE FACTOR, CYTOPLASM, HYDROLASE, NUCLEUS, PROTEASE, THREONINE PROTEASE, UBL CONJUGATION, PHOSPHOPROTEIN, ZYMOGEN
3bdm:M (ARG33) to (ARG165) YEAST 20S PROTEASOME:GLIDOBACTIN A-COMPLEX | PROTEASOME, UBIQUITIN, PROTEOLYSIS, PATHOGEN, VIRULENCE FACTOR, CYTOPLASM, HYDROLASE, NUCLEUS, PROTEASE, THREONINE PROTEASE, UBL CONJUGATION, PHOSPHOPROTEIN, ZYMOGEN
3bdm:N (LYS33) to (ASN141) YEAST 20S PROTEASOME:GLIDOBACTIN A-COMPLEX | PROTEASOME, UBIQUITIN, PROTEOLYSIS, PATHOGEN, VIRULENCE FACTOR, CYTOPLASM, HYDROLASE, NUCLEUS, PROTEASE, THREONINE PROTEASE, UBL CONJUGATION, PHOSPHOPROTEIN, ZYMOGEN
3bdm:O (LYS66) to (VAL202) YEAST 20S PROTEASOME:GLIDOBACTIN A-COMPLEX | PROTEASOME, UBIQUITIN, PROTEOLYSIS, PATHOGEN, VIRULENCE FACTOR, CYTOPLASM, HYDROLASE, NUCLEUS, PROTEASE, THREONINE PROTEASE, UBL CONJUGATION, PHOSPHOPROTEIN, ZYMOGEN
3bdm:R (LYS66) to (TRP180) YEAST 20S PROTEASOME:GLIDOBACTIN A-COMPLEX | PROTEASOME, UBIQUITIN, PROTEOLYSIS, PATHOGEN, VIRULENCE FACTOR, CYTOPLASM, HYDROLASE, NUCLEUS, PROTEASE, THREONINE PROTEASE, UBL CONJUGATION, PHOSPHOPROTEIN, ZYMOGEN
3bdm:S (LYS66) to (ILE18) YEAST 20S PROTEASOME:GLIDOBACTIN A-COMPLEX | PROTEASOME, UBIQUITIN, PROTEOLYSIS, PATHOGEN, VIRULENCE FACTOR, CYTOPLASM, HYDROLASE, NUCLEUS, PROTEASE, THREONINE PROTEASE, UBL CONJUGATION, PHOSPHOPROTEIN, ZYMOGEN
3bdm:U (TYR66) to (GLY202) YEAST 20S PROTEASOME:GLIDOBACTIN A-COMPLEX | PROTEASOME, UBIQUITIN, PROTEOLYSIS, PATHOGEN, VIRULENCE FACTOR, CYTOPLASM, HYDROLASE, NUCLEUS, PROTEASE, THREONINE PROTEASE, UBL CONJUGATION, PHOSPHOPROTEIN, ZYMOGEN
3bdm:W (LYS33) to (ASP166) YEAST 20S PROTEASOME:GLIDOBACTIN A-COMPLEX | PROTEASOME, UBIQUITIN, PROTEOLYSIS, PATHOGEN, VIRULENCE FACTOR, CYTOPLASM, HYDROLASE, NUCLEUS, PROTEASE, THREONINE PROTEASE, UBL CONJUGATION, PHOSPHOPROTEIN, ZYMOGEN
3bdm:X (LYS33) to (LYS164) YEAST 20S PROTEASOME:GLIDOBACTIN A-COMPLEX | PROTEASOME, UBIQUITIN, PROTEOLYSIS, PATHOGEN, VIRULENCE FACTOR, CYTOPLASM, HYDROLASE, NUCLEUS, PROTEASE, THREONINE PROTEASE, UBL CONJUGATION, PHOSPHOPROTEIN, ZYMOGEN
3bdm:Z (LYS33) to (ARG165) YEAST 20S PROTEASOME:GLIDOBACTIN A-COMPLEX | PROTEASOME, UBIQUITIN, PROTEOLYSIS, PATHOGEN, VIRULENCE FACTOR, CYTOPLASM, HYDROLASE, NUCLEUS, PROTEASE, THREONINE PROTEASE, UBL CONJUGATION, PHOSPHOPROTEIN, ZYMOGEN
3bdm:0 (ARG33) to (ARG165) YEAST 20S PROTEASOME:GLIDOBACTIN A-COMPLEX | PROTEASOME, UBIQUITIN, PROTEOLYSIS, PATHOGEN, VIRULENCE FACTOR, CYTOPLASM, HYDROLASE, NUCLEUS, PROTEASE, THREONINE PROTEASE, UBL CONJUGATION, PHOSPHOPROTEIN, ZYMOGEN
3bdm:1 (LYS33) to (ASN141) YEAST 20S PROTEASOME:GLIDOBACTIN A-COMPLEX | PROTEASOME, UBIQUITIN, PROTEOLYSIS, PATHOGEN, VIRULENCE FACTOR, CYTOPLASM, HYDROLASE, NUCLEUS, PROTEASE, THREONINE PROTEASE, UBL CONJUGATION, PHOSPHOPROTEIN, ZYMOGEN
4qw3:E (LYS61) to (ILE181) YCP BETA5-C63F MUTANT IN COMPLEX WITH BORTEZOMIB | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4qw3:I (LYS41) to (ASP177) YCP BETA5-C63F MUTANT IN COMPLEX WITH BORTEZOMIB | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4qw3:L (LYS42) to (ARG194) YCP BETA5-C63F MUTANT IN COMPLEX WITH BORTEZOMIB | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4qw3:M (ARG41) to (ARG187) YCP BETA5-C63F MUTANT IN COMPLEX WITH BORTEZOMIB | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4qw3:N (LYS33) to (ASN141) YCP BETA5-C63F MUTANT IN COMPLEX WITH BORTEZOMIB | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4qw3:S (LYS61) to (ILE181) YCP BETA5-C63F MUTANT IN COMPLEX WITH BORTEZOMIB | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4qw3:W (LYS41) to (ASP177) YCP BETA5-C63F MUTANT IN COMPLEX WITH BORTEZOMIB | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4qw3:Z (LYS42) to (ARG194) YCP BETA5-C63F MUTANT IN COMPLEX WITH BORTEZOMIB | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4qw3:a (ARG41) to (ARG187) YCP BETA5-C63F MUTANT IN COMPLEX WITH BORTEZOMIB | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4qw3:b (LYS33) to (ASN141) YCP BETA5-C63F MUTANT IN COMPLEX WITH BORTEZOMIB | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4qw7:E (SER56) to (ILE181) YCP BETA5-M45T MUTANT IN COMPLEX WITH CARFILZOMIB | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4qw7:I (LYS41) to (ASP177) YCP BETA5-M45T MUTANT IN COMPLEX WITH CARFILZOMIB | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4qw7:L (LYS42) to (ARG194) YCP BETA5-M45T MUTANT IN COMPLEX WITH CARFILZOMIB | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4qw7:M (ARG41) to (ARG187) YCP BETA5-M45T MUTANT IN COMPLEX WITH CARFILZOMIB | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4qw7:N (LYS33) to (ASN141) YCP BETA5-M45T MUTANT IN COMPLEX WITH CARFILZOMIB | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4qw7:S (SER56) to (ILE181) YCP BETA5-M45T MUTANT IN COMPLEX WITH CARFILZOMIB | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4qw7:W (LYS41) to (ASP177) YCP BETA5-M45T MUTANT IN COMPLEX WITH CARFILZOMIB | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4qw7:Z (LYS42) to (ARG194) YCP BETA5-M45T MUTANT IN COMPLEX WITH CARFILZOMIB | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4qw7:a (ARG41) to (ARG187) YCP BETA5-M45T MUTANT IN COMPLEX WITH CARFILZOMIB | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4qw7:b (LYS33) to (ASN141) YCP BETA5-M45T MUTANT IN COMPLEX WITH CARFILZOMIB | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4qwi:E (SER56) to (ILE181) YCP BETA5-A49S-MUTANT IN COMPLEX WITH CARFILZOMIB | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4qwi:I (LYS41) to (ASP177) YCP BETA5-A49S-MUTANT IN COMPLEX WITH CARFILZOMIB | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4qwi:L (LYS42) to (ARG194) YCP BETA5-A49S-MUTANT IN COMPLEX WITH CARFILZOMIB | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4qwi:M (ARG41) to (ARG187) YCP BETA5-A49S-MUTANT IN COMPLEX WITH CARFILZOMIB | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4qwi:N (LYS33) to (ASN141) YCP BETA5-A49S-MUTANT IN COMPLEX WITH CARFILZOMIB | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4qwi:S (SER56) to (ILE181) YCP BETA5-A49S-MUTANT IN COMPLEX WITH CARFILZOMIB | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4qwi:W (LYS41) to (ASP177) YCP BETA5-A49S-MUTANT IN COMPLEX WITH CARFILZOMIB | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4qwi:Z (LYS42) to (ARG194) YCP BETA5-A49S-MUTANT IN COMPLEX WITH CARFILZOMIB | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4qwi:a (ARG41) to (ARG187) YCP BETA5-A49S-MUTANT IN COMPLEX WITH CARFILZOMIB | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4qwi:b (LYS33) to (ASN141) YCP BETA5-A49S-MUTANT IN COMPLEX WITH CARFILZOMIB | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4qz1:E (SER56) to (ILE181) YCP BETA5-M45T MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914 | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4qz1:I (LYS41) to (ASP177) YCP BETA5-M45T MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914 | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4qz1:L (LYS42) to (ARG194) YCP BETA5-M45T MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914 | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4qz1:M (ARG41) to (ARG187) YCP BETA5-M45T MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914 | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4qz1:S (SER56) to (ILE181) YCP BETA5-M45T MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914 | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4qz1:W (LYS41) to (ASP177) YCP BETA5-M45T MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914 | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4qz1:Z (LYS42) to (ARG194) YCP BETA5-M45T MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914 | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4qz1:a (ARG41) to (ARG187) YCP BETA5-M45T MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914 | CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
5fga:E (SER56) to (ILE181) YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) | HYDROLASE COMPLEX, PROTEASOME, MUTANT, BINDING ANALYSIS, HYDROLASE- HYDROLASE INHIBITOR COMPLEX
5fga:I (LYS41) to (ASP177) YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) | HYDROLASE COMPLEX, PROTEASOME, MUTANT, BINDING ANALYSIS, HYDROLASE- HYDROLASE INHIBITOR COMPLEX
5fga:J (LYS34) to (HIS147) YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) | HYDROLASE COMPLEX, PROTEASOME, MUTANT, BINDING ANALYSIS, HYDROLASE- HYDROLASE INHIBITOR COMPLEX
5fga:L (LYS42) to (ARG194) YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) | HYDROLASE COMPLEX, PROTEASOME, MUTANT, BINDING ANALYSIS, HYDROLASE- HYDROLASE INHIBITOR COMPLEX
5fga:M (ARG41) to (ARG187) YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) | HYDROLASE COMPLEX, PROTEASOME, MUTANT, BINDING ANALYSIS, HYDROLASE- HYDROLASE INHIBITOR COMPLEX
5fga:N (LYS33) to (ASN141) YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) | HYDROLASE COMPLEX, PROTEASOME, MUTANT, BINDING ANALYSIS, HYDROLASE- HYDROLASE INHIBITOR COMPLEX
5fga:S (SER56) to (ILE181) YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) | HYDROLASE COMPLEX, PROTEASOME, MUTANT, BINDING ANALYSIS, HYDROLASE- HYDROLASE INHIBITOR COMPLEX
5fga:W (LYS41) to (ASP177) YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) | HYDROLASE COMPLEX, PROTEASOME, MUTANT, BINDING ANALYSIS, HYDROLASE- HYDROLASE INHIBITOR COMPLEX
5fga:X (LYS34) to (HIS147) YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) | HYDROLASE COMPLEX, PROTEASOME, MUTANT, BINDING ANALYSIS, HYDROLASE- HYDROLASE INHIBITOR COMPLEX
5fga:Z (LYS42) to (ARG194) YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) | HYDROLASE COMPLEX, PROTEASOME, MUTANT, BINDING ANALYSIS, HYDROLASE- HYDROLASE INHIBITOR COMPLEX
5fga:a (ARG41) to (ARG187) YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) | HYDROLASE COMPLEX, PROTEASOME, MUTANT, BINDING ANALYSIS, HYDROLASE- HYDROLASE INHIBITOR COMPLEX
5fga:b (LYS33) to (ASN141) YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) | HYDROLASE COMPLEX, PROTEASOME, MUTANT, BINDING ANALYSIS, HYDROLASE- HYDROLASE INHIBITOR COMPLEX
5fgg:E (SER56) to (ILE181) YEAST 20S PROTEASOME BETA5-L(-49S)_D17N DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5fgg:I (LYS41) to (ASP177) YEAST 20S PROTEASOME BETA5-L(-49S)_D17N DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5fgg:L (LYS42) to (ARG194) YEAST 20S PROTEASOME BETA5-L(-49S)_D17N DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5fgg:M (ARG41) to (ARG187) YEAST 20S PROTEASOME BETA5-L(-49S)_D17N DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5fgg:N (LYS33) to (ASN141) YEAST 20S PROTEASOME BETA5-L(-49S)_D17N DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5fgg:S (SER56) to (ILE181) YEAST 20S PROTEASOME BETA5-L(-49S)_D17N DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5fgg:W (LYS41) to (ASP177) YEAST 20S PROTEASOME BETA5-L(-49S)_D17N DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5fgg:Z (LYS42) to (ARG194) YEAST 20S PROTEASOME BETA5-L(-49S)_D17N DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5fgg:a (ARG41) to (ARG187) YEAST 20S PROTEASOME BETA5-L(-49S)_D17N DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5fgg:b (LYS33) to (ASN141) YEAST 20S PROTEASOME BETA5-L(-49S)_D17N DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5fgh:E (LYS61) to (ILE181) YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH MG132 | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5fgh:I (LYS41) to (ASP177) YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH MG132 | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5fgh:L (LYS42) to (ARG194) YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH MG132 | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5fgh:M (ARG41) to (ARG187) YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH MG132 | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5fgh:N (LYS33) to (ASN141) YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH MG132 | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5fgh:S (LYS61) to (ILE181) YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH MG132 | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5fgh:W (LYS41) to (ASP177) YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH MG132 | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5fgh:Z (LYS42) to (ARG194) YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH MG132 | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5fgh:a (ARG41) to (ARG187) YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH MG132 | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5fgh:b (LYS33) to (ASN141) YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH MG132 | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5fgi:E (SER56) to (ILE181) YEAST 20S PROTEASOME BETA1-T1A BETA2-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5fgi:I (LYS41) to (ASP177) YEAST 20S PROTEASOME BETA1-T1A BETA2-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5fgi:L (LYS42) to (ARG194) YEAST 20S PROTEASOME BETA1-T1A BETA2-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5fgi:M (ARG41) to (ARG187) YEAST 20S PROTEASOME BETA1-T1A BETA2-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5fgi:N (LYS33) to (ASN141) YEAST 20S PROTEASOME BETA1-T1A BETA2-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5fgi:S (SER56) to (ILE181) YEAST 20S PROTEASOME BETA1-T1A BETA2-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5fgi:W (LYS41) to (ASP177) YEAST 20S PROTEASOME BETA1-T1A BETA2-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5fgi:Z (LYS42) to (ARG194) YEAST 20S PROTEASOME BETA1-T1A BETA2-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5fgi:a (ARG41) to (ARG187) YEAST 20S PROTEASOME BETA1-T1A BETA2-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
5fgi:b (LYS33) to (ASN141) YEAST 20S PROTEASOME BETA1-T1A BETA2-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB | HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS
4r67:D (LYS61) to (GLU197) HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB | HYDROLASE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4r67:G (ARG65) to (ILE199) HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB | HYDROLASE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4r67:H (LYS33) to (THR142) HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB | HYDROLASE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4r67:J (LYS41) to (ASP178) HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB | HYDROLASE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4r67:K (LYS34) to (LYS169) HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB | HYDROLASE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4r67:M (LYS42) to (ARG185) HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB | HYDROLASE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4r67:R (LYS61) to (GLU197) HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB | HYDROLASE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4r67:U (ARG65) to (ILE199) HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB | HYDROLASE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4r67:V (LYS33) to (THR142) HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB | HYDROLASE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4r67:X (LYS41) to (ASP178) HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB | HYDROLASE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4r67:Y (LYS34) to (LYS169) HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB | HYDROLASE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4r67:1 (LYS42) to (ARG185) HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB | HYDROLASE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4r67:f (LYS61) to (GLU197) HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB | HYDROLASE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4r67:i (ARG65) to (ILE199) HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB | HYDROLASE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4r67:j (LYS33) to (THR142) HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB | HYDROLASE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4r67:l (LYS41) to (ASP178) HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB | HYDROLASE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4r67:m (LYS34) to (LYS169) HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB | HYDROLASE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4r67:o (LYS42) to (ARG185) HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB | HYDROLASE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4r67:t (LYS61) to (GLU197) HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB | HYDROLASE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4r67:w (ARG65) to (ILE199) HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB | HYDROLASE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4r67:x (LYS33) to (THR142) HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB | HYDROLASE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4r67:z (LYS41) to (ASP178) HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB | HYDROLASE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4r67:0 (LYS34) to (LYS169) HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB | HYDROLASE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4r67:a (LYS42) to (ARG185) HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB | HYDROLASE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
3c91:A (LYS66) to (SER200) THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE | PROTEIN PEPTIDE COMPLEX, PEPTIDE NOT MODELED., HYDROLASE, PROTEASE, PROTEASOME, THREONINE PROTEASE
3c91:B (LYS66) to (SER200) THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE | PROTEIN PEPTIDE COMPLEX, PEPTIDE NOT MODELED., HYDROLASE, PROTEASE, PROTEASOME, THREONINE PROTEASE
3c91:C (LYS66) to (SER200) THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE | PROTEIN PEPTIDE COMPLEX, PEPTIDE NOT MODELED., HYDROLASE, PROTEASE, PROTEASOME, THREONINE PROTEASE
3c91:D (LYS66) to (SER200) THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE | PROTEIN PEPTIDE COMPLEX, PEPTIDE NOT MODELED., HYDROLASE, PROTEASE, PROTEASOME, THREONINE PROTEASE
3c91:E (LYS66) to (SER200) THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE | PROTEIN PEPTIDE COMPLEX, PEPTIDE NOT MODELED., HYDROLASE, PROTEASE, PROTEASOME, THREONINE PROTEASE
3c91:F (LYS66) to (SER200) THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE | PROTEIN PEPTIDE COMPLEX, PEPTIDE NOT MODELED., HYDROLASE, PROTEASE, PROTEASOME, THREONINE PROTEASE
3c91:G (LYS66) to (SER200) THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE | PROTEIN PEPTIDE COMPLEX, PEPTIDE NOT MODELED., HYDROLASE, PROTEASE, PROTEASOME, THREONINE PROTEASE
3c91:J (LYS33) to (ARG165) THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE | PROTEIN PEPTIDE COMPLEX, PEPTIDE NOT MODELED., HYDROLASE, PROTEASE, PROTEASOME, THREONINE PROTEASE
3c91:K (LYS33) to (ARG165) THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE | PROTEIN PEPTIDE COMPLEX, PEPTIDE NOT MODELED., HYDROLASE, PROTEASE, PROTEASOME, THREONINE PROTEASE
3c91:L (LYS33) to (ARG165) THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE | PROTEIN PEPTIDE COMPLEX, PEPTIDE NOT MODELED., HYDROLASE, PROTEASE, PROTEASOME, THREONINE PROTEASE
3c91:M (LYS33) to (ARG165) THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE | PROTEIN PEPTIDE COMPLEX, PEPTIDE NOT MODELED., HYDROLASE, PROTEASE, PROTEASOME, THREONINE PROTEASE
3c91:N (LYS33) to (ARG165) THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE | PROTEIN PEPTIDE COMPLEX, PEPTIDE NOT MODELED., HYDROLASE, PROTEASE, PROTEASOME, THREONINE PROTEASE
3c91:O (LYS66) to (SER200) THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE | PROTEIN PEPTIDE COMPLEX, PEPTIDE NOT MODELED., HYDROLASE, PROTEASE, PROTEASOME, THREONINE PROTEASE
3c91:P (LYS66) to (SER200) THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE | PROTEIN PEPTIDE COMPLEX, PEPTIDE NOT MODELED., HYDROLASE, PROTEASE, PROTEASOME, THREONINE PROTEASE
3c91:Q (LYS66) to (SER200) THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE | PROTEIN PEPTIDE COMPLEX, PEPTIDE NOT MODELED., HYDROLASE, PROTEASE, PROTEASOME, THREONINE PROTEASE
3c91:R (LYS66) to (SER200) THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE | PROTEIN PEPTIDE COMPLEX, PEPTIDE NOT MODELED., HYDROLASE, PROTEASE, PROTEASOME, THREONINE PROTEASE
3c91:S (LYS66) to (SER200) THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE | PROTEIN PEPTIDE COMPLEX, PEPTIDE NOT MODELED., HYDROLASE, PROTEASE, PROTEASOME, THREONINE PROTEASE
3c91:T (LYS66) to (SER200) THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE | PROTEIN PEPTIDE COMPLEX, PEPTIDE NOT MODELED., HYDROLASE, PROTEASE, PROTEASOME, THREONINE PROTEASE
3c91:U (LYS66) to (SER200) THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE | PROTEIN PEPTIDE COMPLEX, PEPTIDE NOT MODELED., HYDROLASE, PROTEASE, PROTEASOME, THREONINE PROTEASE
3c91:X (LYS33) to (ARG165) THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE | PROTEIN PEPTIDE COMPLEX, PEPTIDE NOT MODELED., HYDROLASE, PROTEASE, PROTEASOME, THREONINE PROTEASE
3c91:Y (LYS33) to (ARG165) THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE | PROTEIN PEPTIDE COMPLEX, PEPTIDE NOT MODELED., HYDROLASE, PROTEASE, PROTEASOME, THREONINE PROTEASE
3c91:Z (LYS33) to (ARG165) THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE | PROTEIN PEPTIDE COMPLEX, PEPTIDE NOT MODELED., HYDROLASE, PROTEASE, PROTEASOME, THREONINE PROTEASE
3c91:1 (LYS33) to (ARG165) THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE | PROTEIN PEPTIDE COMPLEX, PEPTIDE NOT MODELED., HYDROLASE, PROTEASE, PROTEASOME, THREONINE PROTEASE
3c91:2 (LYS33) to (ARG165) THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE | PROTEIN PEPTIDE COMPLEX, PEPTIDE NOT MODELED., HYDROLASE, PROTEASE, PROTEASOME, THREONINE PROTEASE
3c92:A (LYS66) to (SER200) THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE | PROTEIN COMPLEX, HYDROLASE, PROTEASE, PROTEASOME, THREONINE PROTEASE
3c92:B (LYS66) to (SER200) THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE | PROTEIN COMPLEX, HYDROLASE, PROTEASE, PROTEASOME, THREONINE PROTEASE
3c92:C (LYS66) to (SER200) THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE | PROTEIN COMPLEX, HYDROLASE, PROTEASE, PROTEASOME, THREONINE PROTEASE
3c92:D (LYS66) to (SER200) THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE | PROTEIN COMPLEX, HYDROLASE, PROTEASE, PROTEASOME, THREONINE PROTEASE
3c92:E (LYS66) to (SER200) THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE | PROTEIN COMPLEX, HYDROLASE, PROTEASE, PROTEASOME, THREONINE PROTEASE
3c92:F (LYS66) to (SER200) THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE | PROTEIN COMPLEX, HYDROLASE, PROTEASE, PROTEASOME, THREONINE PROTEASE
3c92:G (LYS66) to (SER200) THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE | PROTEIN COMPLEX, HYDROLASE, PROTEASE, PROTEASOME, THREONINE PROTEASE
3c92:J (LYS33) to (ARG165) THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE | PROTEIN COMPLEX, HYDROLASE, PROTEASE, PROTEASOME, THREONINE PROTEASE
3c92:K (LYS33) to (ARG165) THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE | PROTEIN COMPLEX, HYDROLASE, PROTEASE, PROTEASOME, THREONINE PROTEASE
3c92:L (LYS33) to (ARG165) THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE | PROTEIN COMPLEX, HYDROLASE, PROTEASE, PROTEASOME, THREONINE PROTEASE
3c92:M (LYS33) to (ARG165) THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE | PROTEIN COMPLEX, HYDROLASE, PROTEASE, PROTEASOME, THREONINE PROTEASE
3c92:N (LYS33) to (ARG165) THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE | PROTEIN COMPLEX, HYDROLASE, PROTEASE, PROTEASOME, THREONINE PROTEASE
3c92:O (LYS66) to (SER200) THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE | PROTEIN COMPLEX, HYDROLASE, PROTEASE, PROTEASOME, THREONINE PROTEASE
3c92:P (LYS66) to (SER200) THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE | PROTEIN COMPLEX, HYDROLASE, PROTEASE, PROTEASOME, THREONINE PROTEASE
3c92:Q (LYS66) to (SER200) THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE | PROTEIN COMPLEX, HYDROLASE, PROTEASE, PROTEASOME, THREONINE PROTEASE
3c92:R (LYS66) to (SER200) THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE | PROTEIN COMPLEX, HYDROLASE, PROTEASE, PROTEASOME, THREONINE PROTEASE
3c92:S (LYS66) to (SER200) THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE | PROTEIN COMPLEX, HYDROLASE, PROTEASE, PROTEASOME, THREONINE PROTEASE
3c92:T (LYS66) to (SER200) THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE | PROTEIN COMPLEX, HYDROLASE, PROTEASE, PROTEASOME, THREONINE PROTEASE
3c92:U (LYS66) to (SER200) THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE | PROTEIN COMPLEX, HYDROLASE, PROTEASE, PROTEASOME, THREONINE PROTEASE
3c92:X (LYS33) to (ARG165) THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE | PROTEIN COMPLEX, HYDROLASE, PROTEASE, PROTEASOME, THREONINE PROTEASE
3c92:Y (LYS33) to (ARG165) THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE | PROTEIN COMPLEX, HYDROLASE, PROTEASE, PROTEASOME, THREONINE PROTEASE
3c92:Z (LYS33) to (ARG165) THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE | PROTEIN COMPLEX, HYDROLASE, PROTEASE, PROTEASOME, THREONINE PROTEASE
3c92:1 (LYS33) to (ARG165) THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE | PROTEIN COMPLEX, HYDROLASE, PROTEASE, PROTEASOME, THREONINE PROTEASE
3c92:2 (LYS33) to (ARG165) THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE | PROTEIN COMPLEX, HYDROLASE, PROTEASE, PROTEASOME, THREONINE PROTEASE
5fmg:C (LYS64) to (ASP201) STRUCTURE AND FUNCTION BASED DESIGN OF PLASMODIUM-SELECTIVE PROTEASOME INHIBITORS | HYDROLASE, PROTEASOME, 20S, PLASMODIUM, MALARIA, INHIBITOR, DRUG DESIGN, CRYO-EM
5fmg:D (LEU62) to (ILE193) STRUCTURE AND FUNCTION BASED DESIGN OF PLASMODIUM-SELECTIVE PROTEASOME INHIBITORS | HYDROLASE, PROTEASOME, 20S, PLASMODIUM, MALARIA, INHIBITOR, DRUG DESIGN, CRYO-EM
5fmg:F (LYS62) to (GLU180) STRUCTURE AND FUNCTION BASED DESIGN OF PLASMODIUM-SELECTIVE PROTEASOME INHIBITORS | HYDROLASE, PROTEASOME, 20S, PLASMODIUM, MALARIA, INHIBITOR, DRUG DESIGN, CRYO-EM
5fmg:G (ARG68) to (ILE187) STRUCTURE AND FUNCTION BASED DESIGN OF PLASMODIUM-SELECTIVE PROTEASOME INHIBITORS | HYDROLASE, PROTEASOME, 20S, PLASMODIUM, MALARIA, INHIBITOR, DRUG DESIGN, CRYO-EM
5fmg:H (LYS33) to (GLN190) STRUCTURE AND FUNCTION BASED DESIGN OF PLASMODIUM-SELECTIVE PROTEASOME INHIBITORS | HYDROLASE, PROTEASOME, 20S, PLASMODIUM, MALARIA, INHIBITOR, DRUG DESIGN, CRYO-EM
5fmg:I (LYS33) to (ASP166) STRUCTURE AND FUNCTION BASED DESIGN OF PLASMODIUM-SELECTIVE PROTEASOME INHIBITORS | HYDROLASE, PROTEASOME, 20S, PLASMODIUM, MALARIA, INHIBITOR, DRUG DESIGN, CRYO-EM
5fmg:J (LYS43) to (ASP191) STRUCTURE AND FUNCTION BASED DESIGN OF PLASMODIUM-SELECTIVE PROTEASOME INHIBITORS | HYDROLASE, PROTEASOME, 20S, PLASMODIUM, MALARIA, INHIBITOR, DRUG DESIGN, CRYO-EM
5fmg:K (LYS35) to (TYR146) STRUCTURE AND FUNCTION BASED DESIGN OF PLASMODIUM-SELECTIVE PROTEASOME INHIBITORS | HYDROLASE, PROTEASOME, 20S, PLASMODIUM, MALARIA, INHIBITOR, DRUG DESIGN, CRYO-EM
5fmg:L (ILE34) to (ARG166) STRUCTURE AND FUNCTION BASED DESIGN OF PLASMODIUM-SELECTIVE PROTEASOME INHIBITORS | HYDROLASE, PROTEASOME, 20S, PLASMODIUM, MALARIA, INHIBITOR, DRUG DESIGN, CRYO-EM
5fmg:M (LYS70) to (ARG212) STRUCTURE AND FUNCTION BASED DESIGN OF PLASMODIUM-SELECTIVE PROTEASOME INHIBITORS | HYDROLASE, PROTEASOME, 20S, PLASMODIUM, MALARIA, INHIBITOR, DRUG DESIGN, CRYO-EM
5fmg:N (ARG42) to (ASP217) STRUCTURE AND FUNCTION BASED DESIGN OF PLASMODIUM-SELECTIVE PROTEASOME INHIBITORS | HYDROLASE, PROTEASOME, 20S, PLASMODIUM, MALARIA, INHIBITOR, DRUG DESIGN, CRYO-EM
5fmg:Q (LYS64) to (ASP201) STRUCTURE AND FUNCTION BASED DESIGN OF PLASMODIUM-SELECTIVE PROTEASOME INHIBITORS | HYDROLASE, PROTEASOME, 20S, PLASMODIUM, MALARIA, INHIBITOR, DRUG DESIGN, CRYO-EM
5fmg:R (LEU62) to (ILE193) STRUCTURE AND FUNCTION BASED DESIGN OF PLASMODIUM-SELECTIVE PROTEASOME INHIBITORS | HYDROLASE, PROTEASOME, 20S, PLASMODIUM, MALARIA, INHIBITOR, DRUG DESIGN, CRYO-EM
5fmg:T (LYS62) to (GLU180) STRUCTURE AND FUNCTION BASED DESIGN OF PLASMODIUM-SELECTIVE PROTEASOME INHIBITORS | HYDROLASE, PROTEASOME, 20S, PLASMODIUM, MALARIA, INHIBITOR, DRUG DESIGN, CRYO-EM
5fmg:U (ARG68) to (ILE187) STRUCTURE AND FUNCTION BASED DESIGN OF PLASMODIUM-SELECTIVE PROTEASOME INHIBITORS | HYDROLASE, PROTEASOME, 20S, PLASMODIUM, MALARIA, INHIBITOR, DRUG DESIGN, CRYO-EM
5fmg:V (LYS33) to (GLN190) STRUCTURE AND FUNCTION BASED DESIGN OF PLASMODIUM-SELECTIVE PROTEASOME INHIBITORS | HYDROLASE, PROTEASOME, 20S, PLASMODIUM, MALARIA, INHIBITOR, DRUG DESIGN, CRYO-EM
5fmg:W (LYS33) to (ASP166) STRUCTURE AND FUNCTION BASED DESIGN OF PLASMODIUM-SELECTIVE PROTEASOME INHIBITORS | HYDROLASE, PROTEASOME, 20S, PLASMODIUM, MALARIA, INHIBITOR, DRUG DESIGN, CRYO-EM
5fmg:X (LYS43) to (ASP191) STRUCTURE AND FUNCTION BASED DESIGN OF PLASMODIUM-SELECTIVE PROTEASOME INHIBITORS | HYDROLASE, PROTEASOME, 20S, PLASMODIUM, MALARIA, INHIBITOR, DRUG DESIGN, CRYO-EM
5fmg:Y (LYS35) to (TYR146) STRUCTURE AND FUNCTION BASED DESIGN OF PL